,cluster 1 qvalues,cluster 10 qvalues,cluster 11 qvalues,cluster 2 qvalues,cluster 3 qvalues,cluster 4ER+ qvalues,cluster 4ER- qvalues,cluster 5 qvalues,cluster 6 qvalues,cluster 7 qvalues,cluster 8 qvalues,cluster 9 qvalues
Golgi-to-ER retrograde transport,43.64978077834563,58.4451607851984,0.3012475178972396,27.538757263190867,49.10991282299334,43.826969399271626,27.31842413498581,51.903068241941455,31.352520596887423,46.196298963178435,55.90155622887166,45.13355468926681
tRNA processing,43.641320877472815,58.4451607851984,0.3012475178972396,26.300606049758215,47.17785408334602,40.6339679730673,25.075932910580903,49.15973705836588,31.195263988946287,42.19780442071162,52.6551744844177,44.77688070637028
Recycling pathway of L1,43.641320877472815,50.48167961429896,0.3012475178972396,27.538757263190867,51.74553186004216,40.04181471817009,22.304435088742437,50.440642870701815,31.195263988946287,49.06283447751466,59.14424137730968,44.77688070637028
COPI-dependent Golgi-to-ER retrograde traffic,43.641320877472815,58.4451607851984,0.3012475178972396,27.538757263190867,48.12227048392487,43.00226913205254,27.046630114725016,51.56441011409142,31.195263988946287,44.92749767458973,54.41927262666863,44.81696591204401
Intra-Golgi and retrograde Golgi-to-ER traffic,43.55937595264529,58.00164936755326,0.3012475178972396,27.501347188559862,40.26512631520261,29.957042076841482,23.14271018983331,51.4336674759819,31.352520596887423,47.15197123010915,54.602552439806395,45.13355468926681
Factors involved in megakaryocyte development and platelet production,43.55937595264529,58.27595848649183,0.3012475178972396,27.501347188559862,46.97169286675006,41.37281805266995,27.071281067093985,51.00949017916947,31.195263988946287,45.236212641030384,54.086273551477674,44.73937739705695
Regulation of TP53 Activity through Phosphorylation,43.55937595264529,58.4451607851984,0.3012475178972396,27.538757263190867,42.79191837204379,35.84932138809647,25.67576052746898,50.84855893462843,31.195263988946287,44.497133901891615,52.185832596923454,44.95056672610443
Mitotic Prometaphase,43.55937595264529,58.4451607851984,0.3012475178972396,27.501347188559862,47.17785408334602,41.27449293404236,27.31842413498581,51.4066358977357,31.195263988946287,45.18559814105872,52.51418035985093,44.73937739705695
Regulation of PLK1 Activity at G2/M Transition,43.55937595264529,58.4451607851984,0.3012475178972396,27.484102493691008,45.47857185308757,38.057338662382065,27.31842413498581,51.903068241941455,31.195263988946287,46.65566542296242,51.659964779094736,44.39374256817362
Cyclin A/B1/B2 associated events during G2/M transition,43.55937595264529,58.4451607851984,0.3012475178972396,27.501347188559862,39.1183285368245,32.4001138698007,25.095811458947665,51.00949017916947,31.192939650029526,44.94543130366752,49.203894559280954,44.78512539490024
Signaling by Nuclear Receptors,43.55937595264529,44.88717155895607,0.3012475178972396,27.314191156812576,52.14678922392161,38.495447281282104,19.69667620903062,47.38142588938117,31.2767945362768,48.4828676726359,59.62688751512823,44.147209756661
Polo-like kinase mediated events,43.54185073684872,58.21920392462648,0.3012475178972396,27.501347188559862,41.449379184457655,30.91725163003885,24.72791737461186,51.00949017916947,31.135334455143617,44.70716637193424,52.80599889021722,44.73937739705695
RHO GTPases Activate Formins,43.54185073684872,58.27633196798173,0.3012475178972396,27.314191156812576,44.86082065321072,38.39548945951044,27.071281067093985,51.00949017916947,31.195263988946287,43.7869794980191,51.7060699984798,44.40903463019143
tRNA processing in the nucleus,43.54185073684872,57.91047439345853,0.3012475178972396,26.055140077759752,45.209164970988105,38.54203045789617,22.44348457730035,46.96771408597971,31.195263988946287,41.46112826845741,51.111044818198174,44.10318294715061
AURKA Activation by TPX2,43.54185073684872,58.4451607851984,0.3012475178972396,27.501347188559862,43.339399434532034,36.02024024406627,26.749201742970143,51.711468662387944,31.176525644849743,45.939171178158894,50.22756112147237,44.31168321751836
Mitotic Spindle Checkpoint,43.54185073684872,58.18397976398919,0.3012475178972396,27.314191156812576,44.838092353109424,37.01858980224547,26.79460571005446,50.79115370668333,31.176525644849743,43.49136755446423,51.63757588612928,44.35219227546219
Signal Transduction,43.54185073684872,53.04140374010684,0.3012475178972396,27.501347188559862,51.260042077503016,43.599697670618,24.851199524933136,49.08912127669065,31.195263988946287,47.87164263692895,58.13308679053478,44.56243162040837
Resolution of Sister Chromatid Cohesion,43.54185073684872,58.21920392462648,0.3012475178972396,27.336360081294234,45.62499136964471,39.22834366607232,27.01619665879858,50.9274253049722,31.195263988946287,43.818518850764455,51.79685308551926,44.43073924663528
EML4 and NUDC in mitotic spindle formation,43.54185073684872,58.27595848649183,0.3012475178972396,27.319721145963758,44.76754108571134,37.76726473030469,27.046630114725016,50.9885366207759,31.195263988946287,43.74385632598602,51.57007748146913,44.39374256817362
Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase,43.54185073684872,55.88081891552129,0.3012475178972396,26.836227417357843,39.479071683756196,33.663584948771785,24.998376577402887,49.639459774613364,30.13206084466091,42.46129215856349,50.11077525003227,44.31168321751836
"Cell Cycle, Mitotic",43.54185073684872,58.27595848649183,0.3012475178972396,27.314191156812576,46.59744536477268,40.98227496846776,26.931773871744625,50.717188192847395,31.02492034013245,43.526336048487,51.678678305787294,44.13754201837411
Cell Cycle,43.54185073684872,58.27595848649183,0.3012475178972396,27.314191156812576,46.19876549984101,40.18593151522966,26.65863869235919,50.61016970308661,31.01973768609438,43.473084607678324,51.63757588612928,44.18481557924172
Amplification of signal from the kinetochores,43.54185073684872,58.20152090503758,0.3012475178972396,27.314191156812576,43.95873760179419,35.686540962249886,26.749285741782113,50.79115370668333,31.176525644849743,43.522894399432644,51.45410443781117,44.35219227546219
Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,43.54185073684872,58.20152090503758,0.3012475178972396,27.314191156812576,43.95873760179419,35.686540962249886,26.749285741782113,50.79115370668333,31.176525644849743,43.522894399432644,51.45410443781117,44.35219227546219
Kinesins,43.54185073684872,58.4451607851984,0.3012475178972396,27.501347188559862,43.06635805950639,39.09945343649398,26.749201742970143,51.00949017916947,31.195263988946287,44.427824406361545,50.937841000625546,44.53774153432614
RHO GTPase Effectors,43.54185073684872,57.65852732663101,0.3012475178972396,26.80962551107829,47.510900716813836,42.47280474490717,26.85674321328383,49.7530744185287,30.989045248824418,42.92732504423164,52.21460499536552,43.80247585509208
Metabolism of vitamins and cofactors,43.54127533686685,54.12623349653356,0.3012475178972396,27.501347188559862,50.158047695476384,37.223357835081025,22.376964708706655,49.68447653990534,31.195263988946287,48.46841931464395,59.26172294002655,45.13355468926681
Signaling by Rho GTPases,43.54010702010222,57.194988921938744,0.3012475178972396,27.06804159738956,48.36235785601394,43.4544840132996,26.612364613537213,49.44426011836836,31.04014173704591,43.86659764401841,53.08275019159476,43.89762259536724
Signaling by Activin,43.529909171140865,54.40911283936904,0.3012475178972396,27.538757263190867,48.71490262296621,46.82473060950219,27.114671920671995,47.779746017885124,30.079212109232543,46.6885712704371,53.69443462772704,44.43073924663528
Synthesis of active ubiquitin: roles of E1 and E2 enzymes,43.454047503665805,56.9792756068103,0.3012475178972396,27.411711030034756,43.16292272910211,32.554991575873764,23.37583057318132,49.56744578931662,31.195263988946287,44.99212409911142,52.11611693952636,44.43193555531165
Activated NTRK2 signals through CDK5,43.454047503665805,52.316025153340654,0.3012475178972396,27.501347188559862,52.736993646499734,43.70798080998215,27.31842413498581,50.9523837624689,31.352520596887423,46.91506997805573,58.70462962623125,44.21035165110194
M Phase,43.454047503665805,58.02265847396109,0.3012475178972396,27.236935924334084,48.04696471801849,42.555729108274654,27.046630114725016,50.28882632823447,30.904250251857594,43.254136922396235,51.873854281640256,43.79540858155979
Abacavir transport and metabolism,43.42959050447645,57.32740213252904,0.3012475178972396,27.314191156812576,49.83311467700381,37.91321291349088,26.7362614719098,51.03726667011305,31.195263988946287,45.530439003035696,58.673031042969015,44.81696591204401
Signaling by FGFR,43.42959050447645,52.0475344880324,0.3012475178972396,27.501347188559862,52.109782828640185,44.72027676896178,25.14972344649806,49.57719285541442,31.195263988946287,48.49539969365023,58.51705567847015,44.56243162040837
Signaling by TGF-beta family members,43.399880237888475,49.076085151866664,0.3012475178972396,27.501347188559862,47.155102461948324,36.591840563543194,19.81627672651296,46.13908145699054,30.170994665683224,48.34062299717409,57.7818867949606,44.31168321751836
Aspartate and asparagine metabolism,43.38405786488995,57.4842562210241,0.3012475178972396,26.472542874972575,45.86683545005972,36.523066988636664,26.10876474715467,51.129081232339644,31.195263988946287,45.141546249113865,52.97075964741876,43.772563496731145
Cell Cycle Checkpoints,43.38405786488995,58.05866263626104,0.3012475178972396,27.134786544699125,45.853718807685134,39.60568591383123,26.42071686546494,50.131015912126784,30.77003410684492,42.52397483527752,50.87303626190103,43.744336490068704
APC-Cdc20 mediated degradation of Nek2A,43.38405786488995,57.03817427197838,0.3012475178972396,27.314191156812576,45.66922669485812,38.45366030718177,24.23196951857169,49.39686453111199,30.86810693560594,42.6963356584117,51.75580882487328,44.056943742928674
Mitotic Metaphase and Anaphase,43.38405786488995,57.866050111953065,0.3012475178972396,27.142211181023065,47.11943048386545,42.37450168213371,27.01735212157316,50.130701907434414,30.62821848613195,42.43783998526511,50.03347493542827,43.716615436352676
E2F mediated regulation of DNA replication,43.38405786488995,57.9322454648542,0.3012475178972396,27.314191156812576,44.09499813848138,33.21666261795582,24.531766143954194,49.41000410130506,31.195263988946287,44.02398409422379,51.74212306131149,43.7881517863368
Mitotic Anaphase,43.38405786488995,57.866050111953065,0.3012475178972396,27.121349689972273,47.09357646717742,42.304091712549415,27.003516524008475,50.10053685940584,30.604620824098696,42.26957645663063,49.96107399912718,43.704302250723735
Mitotic G2-G2/M phases,43.369177599501725,58.14887327280463,0.3012475178972396,27.314191156812576,48.56341753926762,43.625406250576305,27.114671920671995,50.93614767988483,30.916098018554717,43.98754901006394,52.2166638570878,43.96008340687479
Separation of Sister Chromatids,43.35891448335546,57.931451660465044,0.3012475178972396,27.08335769173269,46.97169286675006,42.19880566547027,26.868489668497613,50.09186448300645,30.583279594265427,42.055709402427134,49.96107399912718,43.67568281670305
G2/M Transition,43.35891448335546,58.068338783473784,0.3012475178972396,27.314191156812576,48.53377565769386,43.57392880980516,27.071281067093985,50.82810918002626,30.860014907014854,43.777056664088,52.02911625169457,43.83381727610411
Signaling by FGFR1 in disease,43.35891448335546,53.584718700395086,0.3012475178972396,27.47494961662432,52.31906028161975,47.748126562001175,27.046539436563794,50.044882167446595,31.195263988946287,46.75652593333684,55.613949123521905,43.073377373766135
Regulation of TP53 Activity,43.35891448335546,58.048332583889355,0.3012475178972396,27.538757263190867,47.70711591556156,37.39859481645933,26.093993662374636,51.00949017916947,31.195263988946287,47.91752958200481,59.26172294002655,45.13355468926681
G1/S-Specific Transcription,43.35891448335546,58.27595848649183,0.3012475178972396,27.090990680402474,41.14045531889142,33.71266508996108,25.25055352542998,49.75081082912992,30.57232773992963,41.34551169298238,47.81567786495872,43.469723951847364
FGFR1 mutant receptor activation,43.35117608249435,52.53300935848284,0.3012475178972396,27.314191156812576,51.53137889860477,47.44073485158147,26.760785930006744,50.07568525227914,31.195263988946287,46.65139314105471,55.2312566848853,43.06208285628536
Cardiac conduction,43.326877410206315,49.64524801432315,0.3012475178972396,27.444098305109293,50.988037096680344,39.26956407561751,23.321654418881966,49.30569201714626,31.195263988946287,48.20325624830343,58.524407261181146,44.43073924663528
Recruitment of NuMA to mitotic centrosomes,43.326877410206315,58.27595848649183,0.3012475178972396,27.501347188559862,43.48396652348364,37.504713206432534,27.14102247143043,51.903068241941455,31.195263988946287,46.620968141332234,50.494797603517185,44.39529868611338
Mitotic Telophase/Cytokinesis,43.326877410206315,58.27987764217971,0.3012475178972396,26.5494416910982,39.73483179457638,37.97966389844306,25.558663296729552,50.72904607245357,30.364491472367934,42.44303206911796,49.377826121082656,44.69232647029131
Signaling by FGFR in disease,43.326877410206315,56.431103260637556,0.3012475178972396,27.29919730783921,51.13183208527296,46.68552017607941,27.114671920671995,49.94902173879411,31.177740266769224,45.41542874913177,53.84736432005633,43.716615436352676
L1CAM interactions,43.32671591414852,53.721808157321384,0.3012475178972396,27.538757263190867,50.28358729849905,41.33710015581021,23.6369072691586,49.41297436429939,30.860014907014854,48.505242947983376,57.869476437724835,44.73937739705695
Hyaluronan metabolism,43.31796818435653,54.159749686384856,0.3012475178972396,27.484102493691008,52.47375935312441,41.78612621548929,24.44465410599428,49.00046363162571,31.195263988946287,48.32123768548545,58.58838838854168,44.35219227546219
G2/M DNA replication checkpoint,43.29221557011218,57.60296554522329,0.3012475178972396,27.413944424901597,46.11673764622496,39.491279893244645,26.65863869235919,50.83848221768168,31.135334455143617,44.9964917533162,52.08018180129146,44.39374256817362
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),43.2831849837108,56.01072146918443,0.3012475178972396,27.413944424901597,45.6871929183281,32.4001138698007,20.41146298224855,49.49537502301674,30.04961958077522,46.0695930624922,57.93147090060114,44.28691168403021
Post-translational protein phosphorylation,43.28244506242894,56.39566211872815,0.3012475178972396,27.316522885074587,44.25136124308995,34.68248724525584,23.765654029993293,49.802930725064506,29.420950738373865,45.311041503247225,56.54708299317558,44.17558101795356
Signaling by cytosolic FGFR1 fusion mutants,43.205775140972726,52.73117916907094,0.3012475178972396,27.130389766725536,51.62759927321714,46.24856588420577,25.699666013706928,49.96809627949068,31.195263988946287,46.18270315156769,54.96951101937335,42.389271048673926
HDR through Single Strand Annealing (SSA),43.1795325592776,58.11696102791886,0.3012475178972396,27.354512174221394,41.328886017399924,27.184514843397185,21.994211620758296,50.11545719775221,30.518496407143317,45.05189492802429,55.2285475347642,43.90408382033254
ESR-mediated signaling,43.16159033213055,45.38180963416849,0.3012475178972396,25.507443070686634,49.66629384439569,40.77331639953511,20.683835001651065,44.471147758051686,30.51409534741555,44.44679585470593,55.1631838085257,41.68326299293331
SUMO E3 ligases SUMOylate target proteins,43.15194531279327,58.27595848649183,0.3012475178972396,25.29571518330604,41.038522768369674,33.08534650038958,26.044001616534675,48.41510088300518,30.812777745315795,36.723104250922304,46.7650394929164,43.58664099779998
Presynaptic phase of homologous DNA pairing and strand exchange,43.15059657728468,58.0357185299387,0.3012475178972396,27.314191156812576,42.1200358726938,29.81470305892065,23.307022827413387,50.260078075215965,30.387015325626408,43.9844039544884,54.09459135840375,43.52506767174017
SUMOylation,43.11550460709113,58.21920392462648,0.3012475178972396,25.176591096494857,41.60704751929081,33.763723104074025,26.12350455211512,48.251694337752696,30.857792196050678,36.95691144261155,46.673808125468646,43.58557932306302
EGFR downregulation,43.11393828955272,47.28182151729904,0.3012475178972396,27.314191156812576,51.17721693328881,41.121512412606805,22.116723678484107,47.23170936341562,31.195263988946287,48.21862437648689,58.606747012924956,44.35219227546219
Hyaluronan uptake and degradation,43.11226673812823,55.02205027699162,0.3012475178972396,27.501347188559862,51.13183208527296,37.73544360121367,21.452346199543037,48.792607909391066,31.195263988946287,48.21862437648689,58.673031042969015,44.00635902399835
Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1,43.09368736268101,58.23173556997003,0.3012475178972396,27.162017744810168,43.34313708996943,31.057084711463432,23.713927955171982,48.69930950270933,30.126311863958108,37.52183275520889,48.3613099646957,44.083369732194456
Chromosome Maintenance,43.08341563352171,53.871702020542166,0.3012475178972396,25.5641535875508,45.79917965734103,37.77061913249528,22.56554835097935,45.818293923988875,30.063450380401292,41.4429292197034,50.937841000625546,41.76878533634084
Glucose metabolism,43.05625424665387,58.4451607851984,0.3012475178972396,25.571659333308514,47.66386129766227,39.77973442674692,27.550777157941614,50.651592621081996,30.518496407143317,34.81397790385683,47.788492751439755,42.90831535061102
Signaling by NTRK2 (TRKB),43.037406285799086,46.31616803887429,0.3012475178972396,27.413944424901597,52.71716218530657,45.57355652666642,26.696973041436213,48.77457860102373,31.195263988946287,47.6085874557061,57.310285727686136,43.426371924391724
Homology Directed Repair,43.03526080473285,56.152197128108895,0.3012475178972396,26.081246301806324,41.36399074301073,29.571429214267813,21.617425552988987,46.86947173279169,30.29696759874789,41.69904137245313,50.21385607224739,42.55231971189947
APC/C:Cdc20 mediated degradation of Cyclin B,43.03302749106918,56.31643148019089,0.3012475178972396,27.156999689924803,46.80906917140765,40.9731334106732,25.42825084487775,48.62273691970542,30.387015325626408,43.28561819444028,50.65026056825861,43.45781222003879
Transport of small molecules,43.02231681796564,55.76541201174596,0.3012475178972396,27.314191156812576,52.067245822389594,47.32851043617805,27.49251834909931,50.27450829622023,31.121425290220635,46.716963466770345,55.90155622887166,44.012041142747655
Phosphorylation of Emi1,43.019915983206076,58.048332583889355,0.3012475178972396,27.314191156812576,41.18464325739025,34.973201455283814,26.12879934017187,50.40228993465675,30.718338269714184,43.85671471851716,48.1969876573417,43.90408382033254
CRMPs in Sema3A signaling,43.00065609529781,47.58671091048483,0.3012475178972396,27.162017744810168,47.78071188362514,32.21007427988405,14.903878515247134,48.09978573554368,31.069086810984686,47.18872610726071,57.4330301376993,44.147209756661
Visual phototransduction,42.998097672392255,53.80073953608492,0.3012475178972396,26.403411448704794,48.57799649512682,39.80485001868445,26.683728630421115,49.992353234106325,30.819055966774414,45.15933885268975,55.499432052712756,44.21035165110194
Phosphorylation of the APC/C,42.96482017961018,56.3204425220848,0.3012475178972396,27.130389766725536,44.444785048506034,37.702561252968295,23.701281318770786,48.66605608019611,30.155446904677,42.12872641547903,48.87714477933242,43.26942674285414
Homologous DNA Pairing and Strand Exchange,42.96482017961018,58.048332583889355,0.3012475178972396,27.285563426271636,42.083847034679565,29.77704137144975,23.101668855403474,49.582348152098696,30.396740731520918,43.86659764401841,53.70797864699998,43.42421952062182
Metabolism of folate and pterines,42.96482017961018,58.068338783473784,0.3012475178972396,26.969321856025847,46.19876549984101,41.70452259807134,29.493320703788193,51.798569394560026,30.75727757395281,43.65257701040299,50.95530511720386,44.77688070637028
Post-chaperonin tubulin folding pathway,42.961970357409115,55.75450748127553,0.3012475178972396,26.82298851388573,51.70845606487262,41.371075185969715,23.796084077604412,47.746871364629385,30.77003410684492,40.88684316316933,57.028583373632046,43.46786515305174
"Activation of NIMA Kinases NEK9, NEK6, NEK7",42.95067105539811,58.00164936755326,0.3012475178972396,27.314191156812576,43.706763156517674,37.926200789433814,26.9184878909868,50.85832284226455,30.72489513905219,44.55139441724742,50.09707158318085,44.011293105670966
HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA),42.93930712142005,55.71518822817385,0.3012475178972396,25.896435213783235,42.02038464629055,30.185539198715567,21.510115650126455,46.34059314500202,30.284114073033994,41.31443895633096,49.96386096917519,42.134327468574085
Negative regulation of FGFR3 signaling,42.93314446089438,46.30500233264637,0.3012475178972396,27.501347188559862,51.85715251770182,46.5353723099789,24.760129855289122,46.43673067826585,31.195263988946287,48.77647646524141,57.25127500572889,43.716615436352676
Oncogene Induced Senescence,42.93314446089438,58.4451607851984,0.3012475178972396,26.90159438593991,37.42543681790695,34.444065635123465,26.259083690968854,50.37410113425387,30.04170405871521,44.277635194418295,46.089763903484155,44.56112916742174
G2/M DNA damage checkpoint,42.91321811323547,54.8931804705542,0.3012475178972396,25.302226056896043,44.27290920991052,33.20397540300957,20.891711097526482,45.888941752067396,30.04961958077522,40.153192393625005,50.004980182051256,41.75453852712933
Gluconeogenesis,42.901318260160956,57.47252573060157,0.3012475178972396,25.402316729276485,47.319487875396355,41.354097666026355,26.50457836923121,50.967078968000436,30.35696401030192,38.67446620704702,48.893715747321146,43.539653623061604
Opioid Signalling,42.901318260160956,50.61475791447948,0.3012475178972396,27.314191156812576,50.013784398899624,38.4648172876987,20.934884138117805,47.84494955628672,31.195263988946287,47.389634678651895,57.374414945544764,43.58173491147232
Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA),42.901318260160956,57.693832327263195,0.3012475178972396,26.836227417357843,42.54613527846222,30.56865795249788,23.496041500336833,49.77581048618114,30.184351820416357,44.79954924714612,54.56856519844149,43.45275441947429
SUMOylation of DNA replication proteins,42.901318260160956,58.4451607851984,0.3012475178972396,25.337749482580904,39.07443929011824,25.14149079948499,23.931871485902395,49.46842645633835,30.54829568724801,37.682616345673814,47.96386503229166,43.98745761102764
Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models,42.901318260160956,54.63154542407185,0.3012475178972396,27.312707856553804,46.89213616627823,42.18844357385111,26.083158184226576,46.37722538327598,31.195263988946287,44.853445066151636,52.133338334281376,42.94506494051709
Neurodegenerative Diseases,42.901318260160956,54.63154542407185,0.3012475178972396,27.312707856553804,46.89213616627823,42.18844357385111,26.083158184226576,46.38259525090412,31.195263988946287,44.853445066151636,52.133338334281376,42.94506494051709
Negative regulation of FGFR1 signaling,42.889377568137185,49.920053840221726,0.3012475178972396,27.314191156812576,52.50139817052592,47.54423425401117,26.330828453109085,47.84494955628672,30.600923462798182,48.34062299717409,57.560591289277795,43.716615436352676
Semaphorin interactions,42.87738766006137,49.08746665315065,0.3012475178972396,27.339165066090818,47.90699415616314,38.09626873912247,21.140346633678135,46.91777812087817,30.936165373854664,46.79328359831679,56.011408193429595,44.166232732775924
Anchoring of the basal body to the plasma membrane,42.8757720365045,58.152345523544646,0.3012475178972396,27.333418598495477,42.59094537686058,35.22758857080922,26.612364613537213,51.51996634919535,30.951807748302993,46.5836376830603,50.571781243138076,43.89762259536724
Deactivation of the beta-catenin transactivating complex,42.8757720365045,44.85472057150595,0.3012475178972396,27.501347188559862,50.75483366878046,39.761833677172035,21.869362346874944,47.34968933574196,31.195263988946287,47.439121691857274,58.89479758367584,43.79540858155979
Signaling by FGFR1,42.8757720365045,47.51154519785273,0.3012475178972396,27.501347188559862,52.18393795571501,45.939710237639865,25.005030749675058,47.77247687292382,30.64498722108325,48.61570094032086,58.19722756628766,43.80593582629398
Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template,42.8757720365045,57.03817427197838,0.3012475178972396,27.162017744810168,45.6657638276371,38.56412852492551,24.95084709447006,48.71035707369825,30.537058375370798,41.63144963858581,50.87303626190103,42.964514969960305
DNA Double-Strand Break Repair,42.8757720365045,56.419383572332116,0.3012475178972396,25.8409756992574,40.67237045727308,29.425780380305092,21.650187232194764,46.30249994661061,30.170994665683224,40.16386501549033,48.24267295960711,42.361014974668294
HDR through Homologous Recombination (HRR),42.8757720365045,57.692111155686476,0.3012475178972396,27.314191156812576,43.14041536930636,31.412132425557466,23.210233530092687,48.7635631231706,30.41617727380712,44.39533118433673,53.25082776412853,43.333491585722946
Fanconi Anemia Pathway,42.8757720365045,54.084375362748595,0.3012475178972396,26.90159438593991,45.81091498292702,34.480891103118246,21.846109187388066,47.288222001793535,30.266584832373855,46.090267049128954,54.41621953620084,43.46786515305174
TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest,42.8342879678641,57.54676182147967,0.3012475178972396,26.588231399838158,40.56703970020932,33.115198239606855,24.112429213978647,48.06764053793688,30.36957411419239,40.80797338028307,47.995898692079095,43.14728451112988
Cellular Senescence,42.8342879678641,50.6677480389038,0.3012475178972396,24.7183875051826,47.71280322327483,41.556392594317344,23.796084077604412,45.10324465360831,29.677545999817497,41.840802507623145,52.08018180129146,41.25083835848558
Pyrimidine salvage,42.82608686639054,58.23173556997003,0.3012475178972396,26.215073873333257,46.07747022475455,39.390378123557035,26.139274965455428,50.896653352561,29.10464173458978,41.89551186619731,53.14389090761767,43.86165830239804
Protein repair,42.82608686639054,42.64769978626028,0.3012475178972396,26.089941290277828,36.06615616147617,17.264045708820998,9.051780726195757,47.0742525262556,31.195263988946287,44.75465852353656,45.23171903926115,42.90479692018061
Bile acid and bile salt metabolism,42.821925716697514,43.935201682265955,0.3012475178972396,27.314191156812576,50.20377059417594,39.81761282638343,19.052680375450635,46.26297490250083,30.374603537107056,46.74497483726762,58.3001630789758,42.71675145454595
Extra-nuclear estrogen signaling,42.79266069871364,37.696258365270495,0.3012475178972396,27.501347188559862,47.64323570111634,28.305468122513936,12.82134483710304,44.74005431356127,31.04014173704591,48.34062299717409,58.89479758367584,43.25872298766311
Metabolism of nucleotides,42.78842404031378,58.18250500236767,0.3012475178972396,25.302226056896043,43.466114417197666,37.61324249591883,27.01686782643667,49.77167307871312,30.387015325626408,32.3120450460212,45.40931798214371,43.42198746947348
Processing of DNA double-strand break ends,42.77579792735241,54.12623349653356,0.3012475178972396,24.790647734428898,43.776215638219675,31.94695397773101,20.485714501191744,44.62176603418719,29.866767326789272,39.93554367104636,49.605947471264514,41.09496439257092
Signaling by FGFR2 in disease,42.749991203840985,56.94591469143616,0.3012475178972396,25.877466923595847,45.95518732590451,42.577299822139565,26.462876021786833,48.92961186963615,30.518496407143317,40.67484343368304,47.597438213009006,43.552585270671244
Integration of energy metabolism,42.749991203840985,54.12623349653356,0.3012475178972396,27.346708752274086,47.92460555270976,37.223357835081025,23.342048388028424,50.02222272075983,31.352520596887423,47.87164263692895,58.373243870894036,44.685938747251015
Interleukin-7 signaling,42.749991203840985,51.95132932248386,0.3012475178972396,24.952811164323556,47.47246367187957,40.099047347996866,24.741733844029756,47.70953938713257,29.753318408441384,43.39994159589396,53.27795090338446,41.10142172250728
Nef Mediated CD4 Down-regulation,42.749991203840985,53.14130220141251,0.3012475178972396,27.314191156812576,51.12686863439413,45.75012179398464,25.6392114140559,50.31736487536054,31.195263988946287,47.17604297341034,57.20566407768315,44.55931301116983
Interleukin-12 signaling,42.74553948659726,55.448104994700266,0.3012475178972396,26.610431682767974,48.029361984182614,44.36311844671585,26.96371724788371,49.01483369521682,29.97624580100196,41.71078765308689,50.48108933422789,42.89319173240442
E2F-enabled inhibition of pre-replication complex formation,42.74408835468871,57.56959927737715,0.3012475178972396,26.80962551107829,38.86933713996217,27.62820980278932,22.842545463796252,49.582348152098696,30.52995116344993,41.00954713827614,47.58385641054926,42.65064599539354
Vasopressin regulates renal water homeostasis via Aquaporins,42.74408835468871,53.33526528111205,0.3012475178972396,27.339165066090818,51.260042077503016,44.09634313126025,25.310344413379525,48.886324795566814,31.195263988946287,46.75422302211605,56.3806384166079,43.71666061635027
Loss of Nlp from mitotic centrosomes,42.74408835468871,58.18250500236767,0.3012475178972396,27.264891035953834,40.297713401068876,32.81967014679166,26.297351995284277,51.529710880474966,30.72489513905219,45.646061235062795,47.951973716899225,43.6259942949986
Loss of proteins required for interphase microtubule organization from the centrosome,42.74408835468871,58.18250500236767,0.3012475178972396,27.264891035953834,40.297713401068876,32.81967014679166,26.297351995284277,51.529710880474966,30.72489513905219,45.646061235062795,47.951973716899225,43.6259942949986
Gap junction trafficking and regulation,42.734824506016444,56.727542944299216,0.3012475178972396,27.176959403085494,48.78948968282697,45.57355652666642,27.31842413498581,49.60862488888609,30.284114073033994,44.063472211877084,52.56324245657321,43.58173491147232
Synthesis of bile acids and bile salts,42.734824506016444,42.946922372053656,0.3012475178972396,27.314191156812576,49.49280883987006,38.35051082847459,17.5124583948326,45.38914121934657,30.126311863958108,46.36353055618282,57.85970973688714,42.16444787285825
Signaling by BMP,42.733781023272996,48.60115619417667,0.3012475178972396,27.314191156812576,49.082712149844106,42.342350802002315,23.15006205555537,47.18067405196895,29.709958214963066,47.17604297341034,57.25161742483606,43.655173455617245
Signaling by Receptor Tyrosine Kinases,42.733781023272996,47.338072295885105,0.3012475178972396,27.413293975911728,49.41657780723956,37.064893084107545,18.667174979631625,47.10514363815322,30.927791595935723,48.259498605322605,58.4826652400002,43.98745761102764
Platelet homeostasis,42.72070212834963,51.74594180535475,0.3012475178972396,27.314191156812576,48.65532834089405,35.28604160272206,21.50710726224216,47.993487160367565,31.195263988946287,47.38875518112204,57.64480027727936,43.73273774659032
Spry regulation of FGF signaling,42.71948157176381,45.20448650773236,0.3012475178972396,27.413293975911728,51.740680632483794,44.6244982289873,23.17498480333216,46.3718510965131,31.195263988946287,48.94480764043737,58.034514322252214,42.91407870792415
Synthesis of Prostaglandins (PG) and Thromboxanes (TX),42.71948157176381,50.131590551785465,0.3012475178972396,27.157976116907843,51.22199581472619,35.90456187358234,20.437294176801146,47.34968933574196,30.763670368618953,46.679026634103806,58.01579498562851,43.15837411714566
Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex,42.714658655701726,57.600789145825566,0.3012475178972396,26.140434364993173,39.661238859807575,29.710298161962452,22.6149617823557,49.95782685043578,30.26124221678135,38.62021357778776,46.19864962221092,43.6259942949986
Aquaporin-mediated transport,42.71177038438606,53.589646704947164,0.3012475178972396,27.387966497202214,51.260042077503016,44.94195129293707,26.012301269348015,48.832515467299736,31.176525644849743,46.51966008560504,56.20877344898689,43.58173491147232
Signaling by FGFR2 IIIa TM,42.71177038438606,56.99249552681582,0.3012475178972396,25.73971531308097,43.35709388566939,39.653598232441475,24.86473521659076,48.45596073181108,30.495124206293077,40.91137345247459,48.26596562544822,43.32298703856546
Erythrocytes take up oxygen and release carbon dioxide,42.71177038438606,55.66711113923536,0.3012475178972396,27.278701636321454,52.50139817052592,44.6430878951505,27.42268073960029,49.27105843579937,30.96281369688899,48.21862437648689,58.954664761429335,44.02225189292947
FOXO-mediated transcription,42.71177038438606,54.38672622844638,0.3012475178972396,27.314191156812576,50.94163661719126,43.4544840132996,25.846857758875245,49.79395117613365,31.176525644849743,46.65139314105471,57.039964504536606,44.21035165110194
Erythrocytes take up carbon dioxide and release oxygen,42.710166701027106,55.225233684802504,0.3012475178972396,27.314191156812576,52.65285011748939,44.4793355607012,27.31842413498581,49.25465771675541,31.04014173704591,48.21862437648689,59.14424137730968,44.00113485282704
O2/CO2 exchange in erythrocytes,42.710166701027106,55.225233684802504,0.3012475178972396,27.314191156812576,52.65285011748939,44.4793355607012,27.31842413498581,49.25465771675541,31.04014173704591,48.21862437648689,59.14424137730968,44.00113485282704
Metabolism of water-soluble vitamins and cofactors,42.70515838627891,47.32310218667957,0.3012475178972396,27.389280923816187,48.70264918889671,28.813273486874653,14.76773992350962,46.99176290789272,31.195263988946287,48.49539969365023,59.60282161099179,44.89615869949604
FGFR1b ligand binding and activation,42.69506863915525,51.22427322493975,0.3012475178972396,25.000655829249784,48.28744665621491,41.72114131755204,26.700603655243714,51.00949017916947,6.988787362273668,46.12109312175624,49.9572136408991,42.89319173240442
DNA Damage Bypass,42.69506863915525,56.50206677456663,0.3012475178972396,26.780138881672638,45.920718557383736,38.34243095704871,24.851199524933136,48.41078794828691,30.495124206293077,40.67484343368304,50.39540704483924,42.51200252296589
Signaling by FGFR2,42.6880890457974,48.531420975492615,0.3012475178972396,27.348913950475886,50.57905307473405,42.18844357385111,23.054696948302706,48.27007142504447,31.195263988946287,48.381564831192456,58.28090750765959,44.011293105670966
Tight junction interactions,42.6880890457974,51.056627737015184,0.3012475178972396,27.314191156812576,51.719449158600696,37.7532997859961,18.1792482589907,46.67955897451907,30.715161905763736,47.08609385615766,58.354382119767436,43.35201741287351
Basigin interactions,42.6880890457974,55.865688809925615,0.3012475178972396,27.162017744810168,48.961615682636236,46.425555958844754,29.171876088245877,50.07667130890907,30.921964469886486,45.5955463467019,53.5226062995752,43.72879004147445
Golgi Cisternae Pericentriolar Stack Reorganization,42.68293848607889,57.56728987380925,0.3012475178972396,27.314191156812576,43.763066318736584,37.05429941829944,25.97649151865421,50.53263927518141,30.56531030190743,41.392484738502,47.145727174998214,43.736645264865274
G alpha (z) signalling events,42.67776559473522,53.18322551588729,0.3012475178972396,27.285563426271636,50.30288664180699,43.39732885142255,24.35537328933589,48.583514822136145,31.10347263271218,45.68089845214121,55.400712679120026,43.59207744143965
Muscle contraction,42.67257070591499,45.86386637699833,0.3012475178972396,27.501347188559862,50.22530860696075,39.01197882465432,22.590249536861307,46.118838940535625,31.117551987812153,47.92940150279237,57.82850873953021,43.612792092928636
TP53 Regulates Transcription of Genes Involved in Cytochrome C Release,42.66735414658068,53.26779014849155,0.3012475178972396,24.187845255702662,47.049841836070144,41.5730976922934,26.79699821672259,47.98189435000344,30.600207025439754,42.00095611601382,48.08149891843199,41.969599477582946
Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation,42.66518546844092,54.92290303665635,0.3012475178972396,26.60677801342825,48.07717321934603,44.013063778728274,26.760785930006744,48.792607909391066,29.942471973341554,42.25131258466906,50.62662726524392,42.84574515154576
G0 and Early G1,42.66518546844092,57.83803237287709,0.3012475178972396,25.820306416462913,38.34286222613002,27.39131840538524,22.49279437841256,47.62997710450135,30.092918709171343,36.77616738580636,44.32195492596645,43.58664099779998
FGFR2 mutant receptor activation,42.65990498259146,56.52009476138404,0.3012475178972396,26.215073873333257,45.217504290259996,42.2561533699234,25.598960883337732,48.36011835697285,30.57232773992963,41.93199006315266,49.44435826241735,43.26942674285414
Mitotic G1 phase and G1/S transition,42.64627750309496,57.6606123208001,0.3012475178972396,26.610431682767974,45.44047515910677,41.021613241758004,26.546874862176708,49.14209147514041,29.958425763343726,40.91667883192362,47.742068394785974,42.56638390685283
GAB1 signalosome,42.63263231075116,44.523498918118804,0.3012475178972396,26.729516783899474,52.71716218530657,47.748126562001175,27.071281067093985,47.352726484787645,30.705196493696516,48.178833537407655,55.57493705108663,42.92325521497935
G2/M Checkpoints,42.57736515470933,56.70400828785677,0.3012475178972396,26.331039884090913,45.393585089234364,40.02936035875091,25.64535778102411,48.42640064950865,29.814978498571726,40.223289892531255,47.95508149405422,42.205282130200246
Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes,42.572011149638755,58.00900152918004,0.3012475178972396,26.626664189457955,40.42849390422905,32.631362468220935,25.25055352542998,49.91162485793095,30.011880526357505,39.64295580320365,45.60131891259595,43.53481531846944
Activated NTRK2 signals through PI3K,42.55000492559798,41.91438082904327,0.3012475178972396,24.453011098273013,42.78814857767685,30.272870835547582,22.369604055755534,46.945365519077896,28.311006824232912,41.7848917180668,47.64446845850216,41.205800078131745
S Phase,42.51136129547424,57.80859216603243,0.3012475178972396,26.48928043860323,44.39828214539013,40.12143164068526,26.006646070043132,48.86136726995277,29.779244421558055,39.782342644670386,47.11389705108381,42.51200252296589
DNA Replication,42.48933507100191,57.767015817828906,0.3012475178972396,26.514474861995403,43.78936481541037,39.71451108556372,25.699666013706928,48.98971576086439,29.624995736709813,40.363340705214036,46.782510060244505,42.300827479446646
MASTL Facilitates Mitotic Progression,42.47560398863636,54.94702333868527,0.3012475178972396,27.312707856553804,48.23729660040919,36.307445092698075,22.95797745436715,48.492472464522734,30.715161905763736,45.512891571667765,53.934078118420814,43.171969532655794
Resolution of D-Loop Structures,42.42033738076661,56.3811471228965,0.3012475178972396,26.571880485670103,43.638292399889686,32.43337378034163,23.765654029993293,48.50369834059447,30.00392181418125,44.969860357025944,54.12264128307767,43.234307616244976
Cell-cell junction organization,42.414883705407206,50.323770821129784,0.3012475178972396,26.729516783899474,50.29993992925196,36.600161675688746,17.800448345629004,46.52953652336292,30.401515319470388,46.32960245212595,57.2402662889635,43.223352679367274
DNA Repair,42.40941228508066,54.78177762414179,0.3012475178972396,25.346627030514952,45.79572717195608,38.27927647635266,22.064034681201033,45.76110525332044,30.401515319470388,38.60242311237918,47.57507597308593,41.36457336952347
Resolution of D-loop Structures through Holliday Junction Intermediates,42.40392335995511,56.42330636800092,0.3012475178972396,26.565868289712565,43.49710957428522,32.041917255204815,23.701281318770786,48.50369834059447,30.03764183679257,44.98099763340373,54.30600604766732,43.24254626897391
"FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes",42.37629978320121,49.41777600362945,0.3012475178972396,27.348913950475886,51.1973636564886,41.41340348773071,23.686887584686087,47.29631498291166,31.04014173704591,47.282519614767075,57.560591289277795,42.857430271635536
Cell junction organization,42.37629978320121,47.75686293467832,0.3012475178972396,27.314191156812576,51.22199581472619,43.43903968345802,24.663767713916176,45.724343925264925,30.600207025439754,46.719448975528294,56.60599787041018,43.234307616244976
"Plasma lipoprotein assembly, remodeling, and clearance",42.36792919524742,48.28434560038871,0.3012475178972396,27.157976116907843,50.196248154455155,42.18844357385111,24.199849929265703,46.76373716960688,30.671742718305453,47.01116022971439,56.785701714437046,42.447600352334234
Termination of translesion DNA synthesis,42.36792919524742,57.149297062331605,0.3012475178972396,26.508230507538578,42.06411438297206,32.90446400549555,22.794292306218964,47.62238166819928,30.08708160042528,40.16386501549033,48.83134782334995,42.383129922890916
Loss of Function of SMAD2/3 in Cancer,42.36792919524742,47.32682174947197,0.3012475178972396,27.090990680402474,50.42284673119248,42.32030839166924,24.934988981156845,50.40228993465675,30.611432372625046,47.08609385615766,57.71314652229504,44.22053500213054
tRNA modification in the mitochondrion,42.36234084134437,57.04736690765522,0.3012475178972396,25.71056287068641,44.22980832470102,33.186784242147574,23.06205827526477,47.110239942410665,28.885293108933265,40.65035927656275,48.76904829494382,41.55328972646621
Deposition of new CENPA-containing nucleosomes at the centromere,42.359409130317296,49.51523719786203,0.3012475178972396,23.80927873618109,46.44613430379966,38.117359310207355,21.25783416919527,43.49928689995214,29.120023276607856,40.09576380101127,50.62400748081584,39.95290183762466
Nucleosome assembly,42.359409130317296,49.51523719786203,0.3012475178972396,23.80927873618109,46.44613430379966,38.117359310207355,21.25783416919527,43.49928689995214,29.120023276607856,40.09576380101127,50.62400748081584,39.95290183762466
PKMTs methylate histone lysines,42.35377274244087,48.737994935999374,0.3012475178972396,22.2346165730771,45.75838388534882,37.69433222864832,22.95797745436715,43.85318954166935,29.43306847454681,38.78045438890832,49.661747043998425,39.676162841488605
Sema3A PAK dependent Axon repulsion,42.29010086999699,43.25125932310404,0.3012475178972396,25.498589317852204,26.787873593259015,13.684280722975684,6.217467620956024,44.714376802052065,27.879170397739205,37.73547878877688,41.671490950237214,43.11751747607179
Senescence-Associated Secretory Phenotype (SASP),42.28704803628659,46.98436652946978,0.3012475178972396,22.502691817705443,46.499806216217806,38.31003444234368,20.605830182372227,42.671866008613435,28.691355514339232,40.521643594057885,51.08238146271707,39.59122094724892
DNA strand elongation,42.28704803628659,58.068338783473784,0.3012475178972396,26.801666843340676,32.21699535844925,24.711198226983107,21.50710726224216,48.086157451173996,29.580780393237024,39.084644957839224,45.46413746829453,42.86325722911711
FOXO-mediated transcription of cell cycle genes,42.281356294092014,52.91045271350641,0.3012475178972396,27.314191156812576,52.621925909375726,44.520765886561854,25.648277531991464,48.82157792034843,30.825302961104608,47.8095254351477,58.58838838854168,43.51522770207273
Glucagon signaling in metabolic regulation,42.27564997207739,52.40994780176041,0.3012475178972396,27.106205291601498,50.563050138185126,43.74919076707361,24.46766942075259,47.62238166819928,31.04014173704591,45.757186040801585,55.62686371249343,43.067736441487845
Estrogen-dependent gene expression,42.27247644082311,44.088340169605885,0.3012475178972396,23.36015097579167,47.72058434798801,39.29505884325344,19.259504463762195,42.56998691110278,29.204759805805256,41.25762369203606,51.769492435242945,39.170078801238155
Growth hormone receptor signaling,42.27247644082311,50.10435900342323,0.3012475178972396,27.501347188559862,52.604581720921956,44.42478657302872,25.64535778102411,50.09982157670309,30.84156135900621,48.21862437648689,58.62452063030413,43.247954374472364
Activation of gene expression by SREBF (SREBP),42.26924430439585,54.32250669312243,0.3012475178972396,26.386557523137032,45.19247816164254,34.133280478959755,22.064034681201033,51.4066358977357,29.608557891312532,41.8160850987981,53.390026640619105,43.90408382033254
Negative regulation of FGFR2 signaling,42.26924430439585,47.38538432882859,0.3012475178972396,27.314191156812576,51.719449158600696,47.29148277737807,25.94263677006992,46.64832267630792,31.04014173704591,48.34062299717409,56.567601304805905,43.08462067625421
Regulation of FOXO transcriptional activity by acetylation,42.23862701156707,53.188218329680105,0.3012475178972396,27.125910039224173,49.04838800967616,45.17077831482207,25.453096371327973,47.269388102111584,31.050657995496596,44.34077227924775,51.980221079303455,42.184875518348015
Netrin-1 signaling,42.22703505930019,52.16274773816855,0.3012475178972396,27.412613689312625,50.41180836163069,46.00660623402901,26.172713276517552,47.63267805922881,31.04014173704591,46.36353055618282,55.3824800054926,43.52506767174017
Early Phase of HIV Life Cycle,42.22703505930019,55.98922240363372,0.3012475178972396,26.357469625503626,42.18318636807875,36.105267339962154,23.990558579097332,48.886324795566814,28.23691432743294,41.6067707905306,45.80781265591364,43.58173491147232
RHO GTPases activate CIT,42.19884134455246,56.2779647345671,0.3012475178972396,25.656339442433012,41.41965326334946,30.119046408708073,21.91819914671577,47.46050696140092,30.480562422428942,42.77972881852292,51.2668734545299,43.58758669388806
Negative regulation of FGFR4 signaling,42.19884134455246,47.01953703741284,0.3012475178972396,27.29919730783921,51.386066577172556,46.818399043865824,26.029080920907546,46.794866459312146,30.968245875496322,48.12606691659302,56.282625111956825,43.079005502930855
Platelet degranulation ,42.18955423965613,48.473056601410086,0.3012475178972396,27.257943256612197,49.694737998232085,31.691428499438704,16.526316262594634,45.6659310798483,30.349424904369332,47.71239304233518,59.26172294002655,43.27727101078303
TCF dependent signaling in response to WNT,42.18955423965613,50.91826055318125,0.3012475178972396,25.193222228663895,49.42344711603145,43.841913251140305,25.25055352542998,45.7433833227558,29.677545999817497,42.19780442071162,51.27058866217844,40.52978067210659
Synthesis of DNA,42.18955423965613,57.2981184240576,0.3012475178972396,26.35277497998676,43.88350212497116,39.80485001868445,25.325956142932142,48.36011835697285,29.46908563745065,39.28683935482081,46.126802112951225,41.95871837907721
Signaling by WNT,42.1860551275775,50.6677480389038,0.3012475178972396,25.441502352578883,49.37435339366502,44.080274663029,25.237605891144806,46.13107309433977,29.703523560114625,42.54224194202819,51.387958298993155,40.57929703946083
Mitotic Prophase,42.1860551275775,51.28364254622164,0.3012475178972396,23.802219725254123,46.33057862587791,38.044356387732805,22.763466189576448,43.782261488490725,29.11300084980525,38.90612871134828,49.602072461752385,40.05090290302761
Activation of kainate receptors upon glutamate binding,42.1328969976479,49.3528776997968,0.3012475178972396,26.743248842881147,39.262874623386246,25.41432445005725,17.426874973388212,46.19617832348021,31.195263988946287,44.26612497675321,56.16821656040978,43.26408307904667
Regulation of FZD by ubiquitination,42.1328969976479,44.44457690505276,0.3012475178972396,25.656339442433012,51.35942217171654,41.77468814040761,25.592757054496683,46.73100909266771,30.600207025439754,45.61699021392413,53.21349637738783,40.5649709089464
Signaling by FGFR4,42.11044514472059,43.58758336984732,0.3012475178972396,27.413944424901597,51.26707403950041,44.080274663029,24.44465410599428,47.0622460862004,31.176525644849743,48.496981916791405,57.00379273475529,43.152836278563726
p75NTR regulates axonogenesis,42.104511066492876,52.61808304371046,0.3012475178972396,24.77284733467806,46.92789563243994,42.898480270386436,28.34410609311812,49.96809627949068,31.195263988946287,41.20954097863913,54.08308655230464,42.44147701105028
CDC6 association with the ORC:origin complex,42.09260820658396,58.4451607851984,0.3012475178972396,25.167694119663544,29.992030639733436,24.870663347680416,23.92474340160878,50.79115370668333,29.197857162281874,38.021168176510656,39.21530231373929,41.7830292806137
Unwinding of DNA,42.09260820658396,58.13454397839785,0.3012475178972396,26.089941290277828,32.435059830498304,28.558148930948366,23.910469473880017,49.01118742175938,29.649622043215537,39.04266693933854,42.26345978295139,43.58173491147232
Neuronal System,42.072401242195475,40.09554889960269,0.3012475178972396,27.501347188559862,52.315410304180475,41.38129895098347,17.97684273927663,45.75563811545418,31.142625273733167,48.34062299717409,58.88054801684729,42.59645573532659
Depolymerisation of the Nuclear Lamina,42.072401242195475,53.02626430203099,0.3012475178972396,26.80962551107829,42.17014216297456,26.69949361721228,17.246241461182905,48.00967134435175,29.68243351100332,42.903925773825485,49.83134405178574,42.25839871384405
Interleukin-12 family signaling,42.06265462579713,57.113124446542,0.3012475178972396,25.640032341944583,46.35664195565829,44.7914766018965,28.335679051492168,49.25465771675541,28.56391331983577,38.28219371237877,43.76056864779298,41.92861660062035
Ion homeostasis,42.06265462579713,48.690889371313986,0.3012475178972396,27.121349689972273,50.94140897328746,40.656249053464975,24.524817781743412,47.875139686347026,30.705196493696516,47.69245568097571,58.06511651988856,42.76056086519778
G1/S Transition,42.06265462579713,56.969312494639176,0.3012475178972396,26.268201025344297,44.68982669266963,39.693765718119344,26.012301269348015,48.08828028495975,29.513358335356187,38.36551038056785,45.37794963693503,41.632558840864256
Activation of the pre-replicative complex,42.05663122945498,58.05866263626104,0.3012475178972396,26.187626494196305,36.44539376498452,27.26401060258673,23.0224483002968,48.633871893535854,29.020921199584652,40.14785332635499,46.126802112951225,42.222121977528666
PI3K events in ERBB2 signaling,42.050597219517414,26.03704837038561,0.3012475178972396,26.977072491340945,51.394141425644314,38.88722639668819,19.373790655658315,43.279878657741754,29.884622690739057,47.18872610726071,56.20877344898689,40.405654538878984
Telomere Maintenance,42.038497822085056,47.078681049697344,0.3012475178972396,22.695951382515307,44.91107820369591,35.61119213538938,18.78693257334529,41.07610764438367,28.337467044632326,38.9837506899992,49.35537745234586,38.80753006134857
PERK regulates gene expression,42.038497822085056,55.0422691502456,0.3012475178972396,27.016246532646754,46.9604961927767,32.1532086512645,20.042341575140664,46.8692026476434,31.195263988946287,47.18045750046254,57.624125420014316,44.56243162040837
DARPP-32 events,42.03677564283655,50.576202654800866,0.3012475178972396,26.435089787228076,47.64323570111634,35.54523138626787,21.610079130406447,46.1907845997633,30.73081013816988,46.85072637979954,55.4943698114976,42.453716376124895
Recruitment of mitotic centrosome proteins and complexes,42.03677564283655,57.676011960475336,0.3012475178972396,26.520681832943296,36.12796536430443,29.964896141453792,25.697079539241418,51.03726667011305,30.537058375370798,44.94543130366752,45.49624957521223,42.91983078617086
Centrosome maturation,42.03677564283655,57.676011960475336,0.3012475178972396,26.520681832943296,36.12796536430443,29.964896141453792,25.697079539241418,51.03726667011305,30.537058375370798,44.94543130366752,45.49624957521223,42.91983078617086
Response to elevated platelet cytosolic Ca2+,42.0059268476226,47.461256558631035,0.3012475178972396,27.162017744810168,49.45731962858875,30.443576925737823,15.349944090518765,45.44008744437415,30.364491472367934,47.68604231297351,59.26172294002655,43.193626858510854
Transmission across Chemical Synapses,41.99982250887265,46.073390262799464,0.3012475178972396,27.106205291601498,51.20713996374404,44.6244982289873,23.465339793171683,45.76110525332044,30.698488179645253,46.36353055618282,56.275633751130016,41.99174899301076
Activation of HOX genes during differentiation,41.971092381499254,46.40623067178335,0.3012475178972396,22.519348111660264,46.652785452779135,39.01197882465432,21.23043335883237,41.78765846299662,28.77815015341433,39.9725451416947,50.69635090791822,38.68191486753158
Activation of anterior HOX genes in hindbrain development during early embryogenesis,41.971092381499254,46.40623067178335,0.3012475178972396,22.519348111660264,46.652785452779135,39.01197882465432,21.23043335883237,41.78765846299662,28.77815015341433,39.9725451416947,50.69635090791822,38.68191486753158
Ligand-receptor interactions,41.964960772767256,32.88081738077658,0.3012475178972396,27.314191156812576,48.01175145055305,32.132587641577715,15.433728825862046,44.683133950521864,29.54785484102175,47.69245568097571,57.81323894012818,38.148867115305144
Interaction between L1 and Ankyrins,41.94233384070679,56.594530270643446,0.3012475178972396,27.314191156812576,46.678773080207606,35.641845604933486,23.765654029993293,50.94447561189248,30.284114073033994,46.15190529559037,56.21430483540226,44.73937739705695
Resolution of Abasic Sites (AP sites),41.936185093489875,56.99554595439754,0.3012475178972396,25.812907219707213,33.075504705417465,20.585789154164,17.362804666393,45.78838782952251,28.81552456807039,38.97214833285929,45.890384059753224,41.4562404938338
Extension of Telomeres,41.93002711574413,56.94591469143616,0.3012475178972396,26.508230507538578,34.670677347203345,22.737246868658552,16.35648493012319,44.32166205865201,29.16460523709735,39.511916887424235,47.67162777800794,42.21593025026823
Activation of ATR in response to replication stress,41.9238600033008,58.20152090503758,0.3012475178972396,26.435089787228076,34.43735511712106,25.73604867300175,23.273263558199055,49.0184535460327,28.674451880584133,39.36568224768065,44.78504733438104,42.76439059178234
Oxidative Stress Induced Senescence,41.91149875084374,47.083924110325235,0.3012475178972396,23.093639477674675,47.127430717030286,40.47501054840958,22.49279437841256,42.3058190804623,28.76970798015179,39.75173385068885,50.68878856526056,38.9067254950148
Cell-Cell communication,41.91149875084374,46.48212182868983,0.3012475178972396,27.201721403226824,51.07045646079513,44.080274663029,24.112429213978647,45.42353845173427,30.495124206293077,46.580686967827546,56.64995707862519,42.851592874860835
HDMs demethylate histones,41.89706790600384,45.37660943016612,0.3012475178972396,18.625833213662744,43.08229278619831,35.28604160272206,21.746340351662507,41.64234188698801,28.40179675773084,37.34008968781095,47.71886291343016,38.70288213915138
Transcription of E2F targets under negative control by DREAM complex,41.896911954474945,57.24219322396884,0.3012475178972396,25.474521197164215,38.30822053053463,26.985362847233652,17.698965671043176,44.85624074868464,29.84891087317474,33.7660652155163,42.41139180398694,42.61051140140416
IL-6-type cytokine receptor ligand interactions,41.896911954474945,42.795738047244605,0.3012475178972396,27.034458199961282,50.40073055665167,38.3745460902217,15.589951496964103,48.235868619723654,31.195263988946287,46.360302494384634,56.846172147929735,44.011293105670966
HDR through MMEJ (alt-NHEJ),41.896911954474945,56.50206677456663,0.3012475178972396,26.5329805570709,40.28178241822208,25.464812342497094,18.006880633224572,47.828631708321396,29.181236841324633,43.86659764401841,53.210108369030685,44.43073924663528
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),41.896911954474945,47.844263873189405,0.3012475178972396,26.541215388515717,50.474708065179264,41.676295473190024,24.67071106200452,49.49255992841674,29.69706462025829,47.657749480330665,57.0268602997354,43.25334668277376
N-Glycan antennae elongation,41.890673440115464,54.53324578916498,0.3012475178972396,26.830895495102887,47.49315562981449,32.52010893371906,22.376964708706655,50.70512033521922,28.92857640157954,44.51522571495425,54.13091820098317,43.74051178961364
FOXO-mediated transcription of cell death genes,41.85972804310397,53.871702020542166,0.3012475178972396,26.565868289712565,51.29674466582828,45.81421945908797,26.70415442903185,46.8692026476434,30.36957411419239,42.70149719973974,53.20671392577073,41.13003346499098
Protein folding,41.85347537407413,55.965323708102375,0.3012475178972396,27.25451310474643,45.30025688057052,37.4421270786137,23.520284002506063,49.064378326668226,30.860014907014854,46.08678104158678,55.936761475672064,44.370774232353725
Nuclear signaling by ERBB4,41.83898492036741,42.41978938768623,0.3012475178972396,27.501347188559862,51.39692214870221,36.253045139454095,14.248250041703713,43.693508971138066,30.51409534741555,46.69807617934392,60.073660942998906,42.097963552114216
IGF1R signaling cascade,41.8162616099021,47.47776184563099,0.3012475178972396,26.52685065914217,50.90960353703453,42.18844357385111,24.748627672477824,49.512338354154004,29.653023640376347,47.68604231297351,56.91710007969337,43.08774811928454
IRS-related events triggered by IGF1R,41.803704685371486,47.494265070637766,0.3012475178972396,26.48928043860323,50.9202558779368,42.27244079552762,24.75326732142551,49.515069459453265,29.661202164500978,47.68604231297351,56.94987915886095,43.08462067625421
KSRP (KHSRP) binds and destabilizes mRNA,41.803704685371486,53.66856273206824,0.3012475178972396,26.185746513266558,44.20239800569504,34.85036336927448,20.388587049457897,45.09770014328586,31.04014173704591,46.65139314105471,55.921814078471535,44.53774153432614
RMTs methylate histone arginines,41.77467086310313,44.82097138975739,0.3012475178972396,19.62829016901626,43.11322349674881,34.08847101734159,18.508097612960213,39.4434536484166,28.11103409726949,37.3790213211055,48.3652452737363,37.98761897890987
HCMV Infection,41.77467086310313,47.18957921559972,0.3012475178972396,22.26063363259421,45.470257800938754,38.14813491789887,19.867267984775044,39.61732692711781,28.369112786825106,38.021168176510656,47.98711515162209,38.07781230963901
Keratan sulfate biosynthesis,41.71083856979342,53.963515638866625,0.3012475178972396,24.133700605938078,37.6404803717572,30.427775163108738,23.917609376527107,48.2954299682941,27.915053424266905,39.746377617432536,51.68234312083426,44.56243162040837
Effects of PIP2 hydrolysis,41.69631820980949,43.475540048995484,0.3012475178972396,26.1474858182719,50.24172168402715,35.9942023439376,22.558179635423443,49.79203123217776,28.682904419275523,46.06933577572318,58.88791225598623,42.205282130200246
HCMV Early Events,41.6817927265639,47.46650103534956,0.3012475178972396,21.650986891113305,45.58422261668848,38.71804929265158,21.50710726224216,40.707693257493275,28.21048611511162,38.228192514559936,48.92197189327789,38.31062484791958
ARMS-mediated activation,41.675473232649416,44.387077238850544,0.3012475178972396,26.684457085069802,51.24034124333244,44.930923951752185,23.558091034350223,46.70514863139963,30.055558310443622,42.881946351009866,51.40667124496522,40.86317492944599
Gap junction assembly,41.65272668053912,57.19784514834315,0.3012475178972396,26.28530188431278,44.88834263162999,42.57684238202963,25.735990294656357,49.23736733586868,29.16460523709735,38.168880282404885,45.78971685812531,42.459825012410846
Processive synthesis on the lagging strand,41.64639406913748,55.750144196840736,0.3012475178972396,26.78814666360102,28.97109378852991,18.16501865216026,15.500821889748613,43.47480151756611,28.063233799054718,38.38944986144146,46.30518947351828,39.9781307659727
Base Excision Repair,41.64005419666816,44.87094630094995,0.3012475178972396,21.917460056322014,45.33488318333794,36.43542340385227,18.999532455510096,40.6329749543448,28.083572202113622,38.8517448437593,49.346599089050635,38.01602865679593
Regulation of insulin secretion,41.63286203887434,48.496564600449396,0.3012475178972396,26.12309682218941,40.28178241822208,25.92760701199714,16.399742090774062,48.13221443133408,30.934959815971478,44.59681228381017,55.82747658382541,43.45781222003879
Abortive elongation of HIV-1 transcript in the absence of Tat,41.63286203887434,57.230061686940665,0.3012475178972396,25.507443070686634,27.698869599455104,25.25760078500473,19.666038862640416,46.941904169474846,28.44735886864955,40.87091105979052,44.71011015426369,44.011293105670966
Removal of the Flap Intermediate,41.63286203887434,56.03459313144293,0.3012475178972396,27.04986738932701,36.63427207593553,25.005051101337198,18.3510710499113,44.90973215781377,28.80108079440989,39.66627518010116,49.37394590998579,40.68866207079928
Inactivation of APC/C via direct inhibition of the APC/C complex,41.63286203887434,55.828742397925836,0.3012475178972396,25.83647332063265,39.28007179925958,31.679729678178745,20.282505775076835,48.23396070162176,30.092918709171343,38.080392481970286,41.89621830541282,42.51200252296589
Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components,41.63286203887434,55.828742397925836,0.3012475178972396,25.83647332063265,39.28007179925958,31.679729678178745,20.282505775076835,48.23396070162176,30.092918709171343,38.080392481970286,41.89621830541282,42.51200252296589
DNA Replication Pre-Initiation,41.62647759754452,56.44157386477727,0.3012475178972396,25.909537750869017,44.67543131422909,41.21830045451051,25.153598039886145,47.83331850099387,28.92857640157954,38.732371014746164,44.72268581773167,41.01926541519858
PI3K Cascade,41.61727762312916,48.14807471266057,0.3012475178972396,26.008524141882706,51.66613702128473,44.963364877092616,27.046630114725016,49.77167307871312,29.120023276607856,47.373887635739635,55.92929761719747,42.90479692018061
APC/C-mediated degradation of cell cycle proteins,41.61727762312916,55.84395771595503,0.3012475178972396,26.008524141882706,44.67543131422909,40.44033138843034,24.794288247117766,47.504981997626516,28.81552456807039,36.666195932449284,42.68609879947445,40.85932648279402
Regulation of mitotic cell cycle,41.61727762312916,55.84395771595503,0.3012475178972396,26.008524141882706,44.67543131422909,40.44033138843034,24.794288247117766,47.504981997626516,28.81552456807039,36.666195932449284,42.68609879947445,40.85932648279402
Gene Silencing by RNA,41.61727762312916,46.65050672662421,0.3012475178972396,21.885010365164334,45.19601454943627,37.590568980687,19.88912411921132,39.911575996553864,28.34592709869963,37.991160151489666,48.57609936705405,37.929971649400954
Transcriptional regulation by small RNAs,41.59623097172845,46.49329938795235,0.3012475178972396,20.891629179403818,44.28381506452859,36.01192298115219,19.576541010856037,39.52372141371459,28.05475173056942,37.293525888558484,47.819642703082124,37.72303488224289
Reproduction,41.59623097172845,44.732736299117434,0.3012475178972396,21.908828859162078,45.57243035617034,38.169197707565914,19.71200276142002,40.673902244106934,28.11950356951321,38.49939494797164,49.16779646614402,38.0093517252878
Signaling by FGFR3,41.58979945599013,37.823616113364054,0.3012475178972396,27.348913950475886,50.052231110432984,40.07167208422321,20.192895905972133,43.99571383619325,31.195263988946287,48.61570094032086,56.60599787041018,42.97586905915455
Meiosis,41.566964533439084,44.710683357886104,0.3012475178972396,21.56435068188596,45.312107651298845,37.51776214633793,19.63045616612333,40.47111194359808,28.029301275659883,38.31145879595519,49.08287273814996,37.95836725841764
Telomere C-strand (Lagging Strand) Synthesis,41.56226961994473,56.965957907295355,0.3012475178972396,26.187626494196305,31.348107808860366,19.116363788058358,17.13192712517537,45.20071184415212,28.14490690815854,37.908173526103205,45.5644774647206,40.479000447890236
Class B/2 (Secretin family receptors),41.56226961994473,44.9040528517489,0.3012475178972396,26.514474861995403,41.215111408768585,30.044063196064744,14.248250041703713,42.30971008023127,30.968245875496322,46.43106893458272,55.95991271406484,42.964514969960305
ABC transporters in lipid homeostasis,41.54761809021343,49.26522557874921,0.3012475178972396,27.339165066090818,51.22199581472619,44.67117726427801,25.332312134638457,47.352726484787645,31.177740266769224,48.32123768548545,58.15279336434118,43.79180337145229
Transcriptional regulation by RUNX1,41.542883738344116,51.89533009268811,0.3012475178972396,24.4451497766005,47.32246594766183,42.34817104020527,25.332312134638457,44.874079011596564,29.09759823670243,36.891591274274816,46.810286134850834,38.86194359646793
Interleukin-9 signaling,41.542883738344116,55.04682383510547,0.3012475178972396,27.156999689924803,48.23729660040919,46.5575624324729,27.9863023636735,49.95782685043578,29.779244421558055,43.5795343988034,50.84937496611293,42.184875518348015
Metabolism of Angiotensinogen to Angiotensins,41.53812283798596,57.03505278102414,0.3012475178972396,27.501347188559862,48.96877695436488,34.37611149250091,23.858628484957677,47.67218256884306,28.960924492409532,45.62476179436489,60.02751606185972,44.00635902399835
Protein-protein interactions at synapses,41.53812283798596,31.57783169845199,0.3012475178972396,27.501347188559862,51.458374108227005,41.75812087256281,16.22154222969574,47.62997710450135,30.927791595935723,48.34062299717409,57.671012604256994,41.245856735671055
"Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)",41.49887103752272,40.76239932622999,0.3012475178972396,26.185746513266558,41.37236959154945,24.50323466641294,17.00183800845587,43.44371504313355,29.918493553011427,44.108350281576826,51.244452171012526,41.144337035544005
Phase I - Functionalization of compounds,41.494074750900054,44.44457690505276,0.3012475178972396,27.312707856553804,52.14678922392161,36.340708725634926,19.197398374269394,43.96299932952523,30.379578487779014,48.61570094032086,60.10545140329593,42.74270697040564
"Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA",41.494074750900054,52.399762887719454,0.3012475178972396,25.691588209667575,47.22262426184286,40.98429310457379,22.778212904357947,44.45327383697037,30.08708160042528,43.85671471851716,52.57027419262442,43.58557932306302
Nuclear Envelope Breakdown,41.48925296990661,58.00925963891157,0.3012475178972396,23.96952759596281,37.766042473899255,25.993910097586117,23.189679713062013,47.625142726351,29.120023276607856,31.19109687470093,41.30439497832316,41.922327598394034
p75 NTR receptor-mediated signalling,41.48925296990661,53.2095605762136,0.3012475178972396,25.95318941910709,48.269941765915554,41.533071359358814,24.778352295595337,47.87978213330606,29.69706462025829,42.220016053686244,50.84063164386625,41.733953380356446
FGFR2b ligand binding and activation,41.48273893982856,27.390164906282607,0.3012475178972396,26.893747368742225,52.067245822389594,44.635990357666145,22.00038532396672,47.12222491008787,30.600923462798182,48.21862437648689,55.10572094643774,39.121422502384114
IRS-mediated signalling,41.476219293003396,45.779424760870434,0.3012475178972396,26.07254774378353,51.40724912626793,43.38159635019145,26.058894343725196,49.57979381475124,28.953785961614383,47.58723412802256,56.37895390579622,42.77030382504952
Pre-NOTCH Expression and Processing,41.453324505048734,44.15538617807924,0.3012475178972396,21.83392018566022,46.33873801353843,37.34495828184579,18.660755466435813,40.357603073373035,28.187228168115443,38.78580905894557,50.298332035690756,37.908257068520165
UCH proteinases,41.44026079816814,52.74769790488112,0.3012475178972396,25.063075975182613,47.595814359765946,43.449396959814614,24.771532647710767,44.29710279204155,29.197857162281874,36.434915466008185,44.75386279042662,38.1213108663307
Insulin receptor signalling cascade,41.44026079816814,44.85472057150595,0.3012475178972396,26.154515273570198,51.45097773287054,43.66149634026139,26.014132866917056,49.19149079490328,29.079549939117687,47.908843109842216,56.60599787041018,42.7206941235063
Sulfur amino acid metabolism,41.4091797536087,55.640759148431364,0.3012475178972396,24.08557612053505,38.804694687810574,35.47463659396858,25.136585822052503,49.33004186623787,30.209707831805993,41.25232232884509,49.65296602985168,43.772563496731145
Interaction between PHLDA1 and AURKA,41.40426641254906,46.62142970220234,0.3012475178972396,26.48928043860323,36.91797521804855,18.102819988196423,14.508328175261486,48.85750952360963,21.293331274520618,36.32358654932788,46.05026369204311,39.227362470395335
Nuclear Receptor transcription pathway,41.40426641254906,42.66931961947825,0.3012475178972396,26.830895495102887,52.7757029103179,47.118455406898626,25.53988817779415,47.22667258373073,28.11950356951321,46.32631759232418,56.78690425372607,39.68279273934944
Pre-NOTCH Transcription and Translation,41.397712024491966,44.16635806035665,0.3012475178972396,21.350806542623133,46.120098445198785,37.6503629051714,18.899883660142514,40.144883254480675,27.84523892406228,38.91772545349407,50.171630541911924,37.89574422637977
HCMV Late Events,41.38458757647447,44.671140900917266,0.3012475178972396,19.831290569650363,43.74991686855658,35.90456187358234,18.42457974364537,37.73986588833373,27.642577276719233,36.909063581319565,47.571095443035624,37.431592507804886
O-linked glycosylation,41.38458757647447,45.78845594720795,0.3012475178972396,27.042170712487795,50.57905307473405,35.60755096244514,16.11844081112455,45.5420222571844,29.046061395804248,47.94280054265446,58.70462962623125,42.47392047317014
RHO GTPases activate PKNs,41.34034559121423,44.36509028360146,0.3012475178972396,21.412662671021508,45.92753246088028,36.77949080879744,19.475411535904897,40.83010282217344,27.986870321095278,39.32893180529492,49.99127425174114,38.01602865679593
Formation of the beta-catenin:TCF transactivating complex,41.34034559121423,43.74771006569307,0.3012475178972396,21.315314787995778,45.62151818309619,36.33711961103642,18.38780959933681,40.430239220329646,27.76506154738386,38.86333612584753,50.35810127981397,37.58723420364984
STAT5 Activation,41.34034559121423,50.51176654407794,0.3012475178972396,24.509335692701672,52.182339260435896,44.7914766018965,22.915651554266752,49.76240078205112,30.201983474216316,46.065751805407075,55.98828630742713,40.58582351142184
Formation of Fibrin Clot (Clotting Cascade),41.325593013025184,47.23682463486141,0.3012475178972396,26.735211339811904,46.50304130915576,25.58900082310887,14.514677681166399,45.34983747875925,29.293378161233406,45.61699021392413,58.70462962623125,42.76056086519778
Amyloid fiber formation,41.32058249692177,44.24567531535091,0.3012475178972396,21.030523559036162,46.228155215391766,36.703453933412156,18.696374759617157,40.67879172534723,27.94148583231867,39.32357250593804,50.69635090791822,38.01602865679593
Signaling by Leptin,41.32058249692177,50.6677480389038,0.3012475178972396,27.314191156812576,51.345506311188416,44.57946961222957,26.65863869235919,50.11545719775221,29.661202164500978,45.411385624024845,55.4943698114976,41.71178133672944
Meiotic recombination,41.29105014693659,43.935201682265955,0.3012475178972396,20.306630575371074,44.2429622987854,35.82225065911083,18.431660139851306,39.16269252201944,27.47236568660976,37.217242587232,48.38279847251672,37.13857392577975
Metalloprotease DUBs,41.29105014693659,45.414364399490616,0.3012475178972396,19.79757125090357,45.143398815417065,35.813939177090916,16.879059472558144,38.30825799003267,27.597401386260934,37.12959117807749,50.32687411517475,37.75221167616843
DAG and IP3 signaling,41.26811698782341,54.99335727321165,0.3012475178972396,25.450381497684607,48.54610307547828,41.55491264412593,27.003516524008475,48.66605608019611,29.496853924590386,41.510445024016015,51.30427348150584,41.50554566829826
Ethanol oxidation,41.24518551917872,52.247631489356166,0.3012475178972396,26.185746513266558,46.15597936662938,35.24983561801498,23.629699802128975,46.048074987916024,30.230602873596816,45.04327039891962,57.222838598087904,42.792264417582686
Constitutive Signaling by AKT1 E17K in Cancer,41.23857365766787,47.27657584867578,0.3012475178972396,26.472542874972575,47.70711591556156,38.42299674548378,24.73483037324822,46.8692026476434,29.84267139578839,47.67194664752648,55.82989406666407,42.22830716142306
Downstream signaling of activated FGFR1,41.23195710375578,49.19339365128904,0.3012475178972396,26.713362303527784,52.14678922392161,47.748126562001175,27.046630114725016,47.14799915927242,29.149330431797576,45.1898149502439,54.201996924364614,41.22512595067182
Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding,41.21055315498015,53.85396447987195,0.3012475178972396,26.315852597971748,43.03918016000797,36.60373818740207,22.81774225832756,47.192647306413924,30.304535935777484,42.65978682199652,51.02132769793689,42.792264417582686
Condensation of Prophase Chromosomes,41.21055315498015,45.442405124651444,0.3012475178972396,20.4820961863636,44.09133724062619,35.028583395847356,18.53078156252073,39.788850037331926,27.507146639765214,37.40115293616619,48.76514155370422,37.509791982621906
Removal of the Flap Intermediate from the C-strand,41.20392356359638,56.2779647345671,0.3012475178972396,26.90159438593991,36.55913763476945,25.507485192928797,17.713540036373626,45.51748014443667,28.47381313549794,38.30611156503366,48.567314854593626,40.51545042011805
"Gamma-carboxylation, transport, and amino-terminal cleavage of proteins",41.19728943311493,50.29467711742917,0.3012475178972396,27.314191156812576,51.37840007575132,37.494377095825364,23.525895100753985,47.288222001793535,29.84267139578839,47.04772346632265,58.62421936900554,43.42421952062182
Lagging Strand Synthesis,41.19065080086033,57.213968693820725,0.3012475178972396,26.426700855514333,28.729543557909366,17.751654187713903,16.448023953302968,44.823827881390734,28.00285199609456,36.717775789110384,45.20436958025362,40.27833150833171
PCNA-Dependent Long Patch Base Excision Repair,41.151401028695524,57.018629221873844,0.3012475178972396,25.934243082992207,33.163913324532366,21.451734126062195,17.15252070209861,44.40415228017218,27.923536938310143,36.41825133650477,43.73364942486771,40.13027599040064
Ovarian tumor domain proteases,41.131455004864854,58.00064291510507,0.3012475178972396,19.702672771867356,27.454949948555168,27.049575125342663,25.91814158715936,48.42640064950865,20.71029644643084,38.168880282404885,37.089520798213606,43.426371924391724
DNA Damage Recognition in GG-NER,41.131455004864854,50.46402243785597,0.3012475178972396,27.06804159738956,49.83461257889256,47.118455406898626,26.434818511460186,46.58815913141323,31.04014173704591,41.20954097863913,48.38279847251672,38.81329392617418
RNA Polymerase III Transcription Termination,41.131455004864854,56.75588799295718,0.3012475178972396,23.835829339463086,32.75546936414089,25.73267271052423,18.253116272116774,45.51748014443667,30.95733397801963,39.419451484571965,46.0415685319485,44.443731218896914
Removal of aminoterminal propeptides from gamma-carboxylated proteins,41.116651222632406,50.306123180071104,0.3012475178972396,27.314191156812576,51.458374108227005,37.96668096403718,23.622487523013326,47.02444096649138,29.890809907005135,47.17443783469634,58.70462962623125,43.333491585722946
Interleukin-6 family signaling,41.10999038079114,42.713147955823146,0.3012475178972396,26.721444815352967,50.20257274663464,38.45366030718177,17.844303917200993,46.8502180814423,30.72489513905219,45.89777928516974,56.26861512079213,43.520159051710266
RUNX1 regulates transcription of genes involved in differentiation of HSCs,41.10332528783482,48.946641655349,0.3012475178972396,22.659509943087883,45.457117440394256,39.934502526305366,22.362241394030193,42.47385802598151,27.99535781625756,35.743591374967636,44.6835889095324,37.10293936729206
Gap junction trafficking,41.09812567319899,56.14148961893127,0.3012475178972396,25.748523476107575,45.045057279973236,41.2657358982213,23.653000723270836,47.77722751853385,28.077148053484677,35.57677208431799,44.12191464773493,41.041414426166945
ATF4 activates genes in response to endoplasmic reticulum  stress,41.09812567319899,52.940991230252635,0.3012475178972396,26.77211970564606,49.66629384439569,37.7532997859961,20.583808256735082,44.93981116128372,31.064966215246265,47.91424758901207,58.954664761429335,43.90517883888165
cGMP effects,41.091447223905604,52.095654156628896,0.3012475178972396,26.60677801342825,47.060980646973775,30.933897906527395,21.30509805132852,46.41383146516825,30.453345494038313,45.47775562345678,55.470970402513316,42.62059499371249
Neurotransmitter receptors and postsynaptic signal transmission,41.0847646588431,50.77793667661519,0.3012475178972396,25.474521197164215,51.11155138531123,45.4838106697718,25.26985472702157,45.96236065975109,29.746995765700845,40.49291807225699,50.98769790409434,40.66652880086423
RNA Polymerase I Transcription,41.07952807739427,45.24354331398353,0.3012475178972396,21.377765276964976,44.79983645596667,35.47828543260345,18.39419400873972,38.72071696513621,27.78953760795032,38.70298365266222,48.3652452737363,37.274575693947725
Passive transport by Aquaporins,41.07952807739427,52.22987427271376,0.3012475178972396,27.314191156812576,51.52962621719981,46.15225651404716,27.31842413498581,48.68824329308394,30.374603537107056,45.93554927757905,57.17845042895164,42.61051140140416
Assembly of active LPL and LIPC lipase complexes,41.07283255390469,51.272203170822756,0.3012475178972396,26.140434364993173,44.58458266021001,36.240008856831004,24.410512177916633,45.807411472006365,29.649622043215537,43.544609384145296,55.016672148320836,41.86068661948118
Ca-dependent events,41.06756873017703,44.788524697923904,0.3012475178972396,26.185746513266558,49.29110394121466,37.50127178686921,18.765517095560764,44.20590232531859,29.709958214963066,45.16359718415757,54.94592070912548,40.82152207020855
FRS-mediated FGFR1 signaling,41.06756873017703,49.39409239775493,0.3012475178972396,26.394987658166748,52.04821998435557,47.61501283346593,26.929998162729575,46.92984344981624,29.013815944217246,44.65515956338879,53.86088517194803,40.933416069830976
Signal attenuation,41.0608605363742,36.450460326959295,0.3012475178972396,27.314191156812576,51.719449158600696,45.98954868274946,26.172713276517552,46.689296850873944,29.649622043215537,47.56516452270181,55.124069355490725,41.212245932691054
Prefoldin mediated transfer of substrate  to CCT/TriC,41.046010917470866,53.03636095453937,0.3012475178972396,25.85850184625231,41.88168286755769,33.535529714582374,21.696541121208465,46.95052705194058,30.063450380401292,42.74975164775002,51.24817365046783,42.792264417582686
ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression,41.03929577887192,43.20717861220549,0.3012475178972396,18.82726038533856,44.19034343677102,34.67419800054404,17.008678047322018,38.91894903990986,27.130909235181246,37.81749377148469,49.064337169794356,37.1957722145729
CaM pathway,41.03257680985734,45.78324695791074,0.3012475178972396,26.24251241389401,49.27709951030627,37.7532997859961,19.289851120842748,44.40415228017218,29.734272369994095,45.014344033881756,54.78937553223661,40.92828770651758
Calmodulin induced events,41.02585404059312,45.779424760870434,0.3012475178972396,26.24251241389401,49.27709951030627,37.7532997859961,19.28263443317493,44.40415228017218,29.734272369994095,45.014344033881756,54.78937553223661,40.92828770651758
Switching of origins to a post-replicative state,41.0191275009519,56.065029473071554,0.3012475178972396,25.450381497684607,43.97343165945445,39.7645038123871,24.723171880123353,46.91258621662264,28.26442016528457,35.27049233350752,41.27821782704103,40.501119565991964
Signaling by NOTCH,41.01519012070099,50.64385987029523,0.3012475178972396,23.951820949554055,47.26422601072339,40.4772983520032,22.770840759447115,44.113742750007894,28.76126422936989,35.656816335234886,46.73329600026789,38.52217680856292
Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta),41.01519012070099,56.3917087517998,0.3012475178972396,27.229880391021915,32.515533427823364,24.60957828378499,17.066513354319962,42.833911909469855,28.369112786825106,37.27673337530582,45.083842129018876,39.2626731450562
Sphingolipid de novo biosynthesis,41.01519012070099,26.662210617825465,0.3012475178972396,27.501347188559862,53.2540395661748,29.496440295725296,8.862589263689827,42.115948264375774,30.312093057683402,49.10000773021311,60.365426811795516,42.71277160236378
Regulation of commissural axon pathfinding by SLIT and ROBO,41.00031529769982,49.99237045595059,0.3012475178972396,26.932843017203812,48.41968800883413,38.20156373476035,22.6149617823557,44.89190952522765,30.21742283521706,44.95196858245693,54.987909374813945,41.66899987923723
Transcriptional regulation of granulopoiesis,40.96918116778469,43.475540048995484,0.3012475178972396,19.651992044478767,44.4531750051122,35.20999319556578,17.662231018568335,39.05978798765111,27.139359112480214,37.406490972253614,48.74273224217833,36.9420620339361
DNA Damage/Telomere Stress Induced Senescence,40.96243423268087,42.35340175315517,0.3012475178972396,19.702672771867356,43.698333883905626,34.05827069488847,15.447354079865782,38.67915115747041,27.06917953114933,37.187514112260004,48.45274045567911,37.06655013401612
Mismatch Repair,40.947557503011836,56.99249552681582,0.3012475178972396,27.142211181023065,29.185448364441037,21.717410443698427,16.82214656673499,43.23566027432456,27.99535781625756,36.80207251263227,43.59391992832354,39.78755106644296
Negative epigenetic regulation of rRNA expression,40.935411075803984,45.38632898255858,0.3012475178972396,20.866823497692852,44.28381506452859,34.900267195645554,17.83732077250254,37.906958563661505,27.436681693279727,37.345433124505455,47.345836274643275,37.06065528203245
Nuclear Envelope Reassembly,40.935411075803984,54.838381584555265,0.3012475178972396,25.056365694772758,42.87707580035747,37.410363423585814,25.53988817779415,47.7983665055494,30.225128373395265,40.279453826538735,41.163481789309614,41.527733746974604
Initiation of Nuclear Envelope Reformation,40.935411075803984,54.838381584555265,0.3012475178972396,25.056365694772758,42.87707580035747,37.410363423585814,25.53988817779415,47.7983665055494,30.225128373395265,40.279453826538735,41.163481789309614,41.527733746974604
Positive epigenetic regulation of rRNA expression,40.92864656881054,45.779424760870434,0.3012475178972396,20.53983647519581,44.25136124308995,35.706798394988546,18.899883660142514,38.33236140836511,27.411292720835917,37.694094655000654,47.07171940214013,37.11703734454001
Rho GTPase cycle,40.91779641931502,43.85037161107804,0.3012475178972396,26.35277497998676,47.05295756784915,31.691428499438704,11.996127589253692,43.455957017160586,30.139864656081272,44.68913559084506,54.31732241748283,41.54690747708461
RNA Polymerase I Promoter Clearance,40.91779641931502,44.815779841413644,0.3012475178972396,20.866823497692852,44.32913615851117,35.130356153116296,17.941824779028575,38.213768049287786,27.562579516444007,38.16353381373511,47.63569382167123,36.98945499392325
DNA replication initiation,40.91779641931502,53.11393052895808,0.3012475178972396,23.70045144435458,32.36432824708864,19.41871570355616,16.42782893940034,41.493269353394126,25.44617214959869,36.60111103445643,43.32099410258882,38.14306767967895
Telomere C-strand synthesis initiation,40.91779641931502,53.11393052895808,0.3012475178972396,23.70045144435458,32.36432824708864,19.41871570355616,16.42782893940034,41.493269353394126,25.44617214959869,36.60111103445643,43.32099410258882,38.14306767967895
"Gamma carboxylation, hypusine formation and arylsulfatase activation",40.89477305582688,39.92894220224418,0.3012475178972396,27.314191156812576,50.842468243511505,34.513096146599246,17.492328851709978,43.285523073506695,29.726172700732413,48.21862437648689,59.26172294002655,42.71675145454595
Activation of GABAB receptors,40.88931849150162,51.84723756088545,0.3012475178972396,25.83647332063265,51.37840007575132,47.455393152336136,27.14102247143043,47.20967340398101,29.918493553011427,41.37014767230184,49.17657250489878,40.598867482233686
GABA B receptor activation,40.88931849150162,51.84723756088545,0.3012475178972396,25.83647332063265,51.37840007575132,47.455393152336136,27.14102247143043,47.20967340398101,29.918493553011427,41.37014767230184,49.17657250489878,40.598867482233686
Diseases of glycosylation,40.87440909365491,34.87680358736119,0.3012475178972396,27.314191156812576,51.62618996989852,36.92934142611434,14.547969391516242,44.09026522655067,29.574097586355332,48.206323025953665,59.41388950637822,40.542849648582845
ABC-family proteins mediated transport,40.87024671082583,54.58975567022767,0.3012475178972396,25.176591096494857,47.87174917763438,44.54489549625569,25.699666013706928,46.13107309433977,28.14490690815854,37.78302817318044,45.24504195670927,40.46181974239442
Gamma-carboxylation of protein precursors,40.87024671082583,49.27048323170642,0.3012475178972396,27.312707856553804,51.13183208527296,37.37591921376523,23.17498480333216,46.97974099048734,29.505107941791383,46.46162550676302,58.373243870894036,42.79972419362078
HDACs deacetylate histones,40.87024671082583,42.474864290806764,0.3012475178972396,16.79394426230711,42.72171287478962,34.96490232917832,17.356532005136007,37.495980414113205,26.734156300887015,36.36223367074155,46.9659673656288,36.46789261054113
GABA receptor activation,40.85532615807571,51.41385888455241,0.3012475178972396,25.979342418740845,51.62759927321714,47.61501283346593,27.108296667241977,47.24364430329118,29.950452096476695,41.74196089689255,49.84012328507125,40.4552601555776
RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function,40.84040489600434,42.50781000427892,0.3012475178972396,18.95352268519502,43.96976168022316,35.09519992523897,17.462726338966874,38.171803565485455,26.98976676980662,36.42356841882779,48.17547143327741,36.72804208917981
Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA,40.81867040946885,50.3900981557197,0.3012475178972396,24.170116776222503,39.36029515373339,33.16757216635368,16.604795887883277,40.85185246571403,29.11300084980525,41.15921973422588,49.51092860113898,43.58173491147232
Meiotic synapsis,40.81867040946885,40.44848784349807,0.3012475178972396,19.415413308860497,44.63594238713872,35.59923428539329,15.893114522212088,37.7098075802606,26.933206568355512,37.55087983705251,48.66388862311625,36.56754051443794
PRC2 methylates histones and DNA,40.81314543200988,42.82937693498912,0.3012475178972396,19.163879354151245,43.8713919443671,34.444065635123465,17.20247521779561,38.373151873338784,26.924761887953675,37.03445101243738,48.44396277948898,36.85169330928312
Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus,40.81314543200988,49.11022911038891,0.3012475178972396,27.314191156812576,51.31601059543871,37.879065941683464,23.40809113864296,46.78960409133869,29.529848105000998,46.652933312301656,58.524407261181146,42.71277160236378
Transcriptional regulation of white adipocyte differentiation,40.807605965744386,54.99335727321165,0.3012475178972396,24.399756814670226,43.844042817567654,35.976483937354224,25.14316177888887,47.0742525262556,29.703523560114625,42.93756061913668,52.58234700689823,43.42198746947348
HATs acetylate histones,40.807605965744386,43.29595264858672,0.3012475178972396,19.68613399425436,42.85084443453597,35.14329640626567,14.614158367118593,37.10646071861542,27.249192833802443,33.755086235453675,44.12518974288648,34.12909773825062
Recognition of DNA damage by PCNA-containing replication complex,40.800776728681676,56.47842344256129,0.3012475178972396,25.900798234130914,39.06173678653471,25.839950982695097,18.37366047107219,45.459119079198025,29.141000727479405,37.23478254849203,46.032873069591375,40.39908392255592
Response of EIF2AK1 (HRI) to heme deficiency,40.79521626948824,56.769584202998615,0.3012475178972396,21.83392018566022,20.158929529177296,19.66934961136017,21.876729169757418,51.00949017916947,29.761376263972124,29.331510924319705,25.879956347923137,42.34687981501718
NoRC negatively regulates rRNA expression,40.79521626948824,45.04703493057334,0.3012475178972396,20.607830403956005,43.90138881149907,34.64379595164977,17.281918933719677,37.589692082223706,27.302579233024563,37.070208101898544,46.903978374691796,36.7613702374759
NR1H2 and NR1H3-mediated signaling,40.78153573266932,42.77351346539499,0.3012475178972396,26.418305200489673,52.736993646499734,47.748126562001175,26.546874862176708,46.13508612066223,28.14490690815854,44.70716637193424,54.67569926816985,38.835207230197454
SIRT1 negatively regulates rRNA expression,40.78153573266932,42.386873067087876,0.3012475178972396,18.545341494300434,43.90507277368991,34.59958906474116,17.088303912976148,37.81169308135554,26.8269368571479,37.09380643132899,48.69210128870334,36.80948889615515
Processive synthesis on the C-strand of the telomere,40.75038033080037,55.61224170138124,0.3012475178972396,26.307340250434173,24.824020095238218,15.23833253687568,13.808369381377757,42.898543425473044,27.0167982010003,35.61576373024762,42.711437904231296,38.984948884266046
PI-3K cascade:FGFR1,40.743535340151084,47.873678212728485,0.3012475178972396,26.13176752378142,51.065251914432615,47.29148277737807,26.660882507630923,45.76391263956377,28.77815015341433,45.04327039891962,53.53104365994388,41.01417957837009
Adenylate cyclase inhibitory pathway,40.72048757916675,48.27301858651855,0.3012475178972396,26.055140077759752,48.41968800883413,39.696489834283675,20.621421700912524,45.256571655266804,30.03764183679257,43.06987184632624,52.782227645226946,41.00907709559019
Synthesis of bile acids and bile salts via 24-hydroxycholesterol,40.714884767712796,37.01270158786329,0.3012475178972396,25.927007705369235,47.37475174851539,35.6984874751682,14.674627587946956,39.727894024689036,27.870688362510652,43.9844039544884,56.145284142461534,38.31641668897502
Triglyceride catabolism,40.714884767712796,48.37135554601626,0.3012475178972396,25.54650017221171,44.92423052061747,35.78219170491104,24.474636848126394,45.38914121934657,29.677545999817497,44.55139441724742,55.36944087800942,41.62619525215039
DNA methylation,40.709268501281706,42.23663694689344,0.3012475178972396,17.9494762905321,43.00350639771433,33.32807743939183,16.158490860569458,37.36139105250526,26.58684980550845,36.50057077641834,48.12320538904411,36.65848487170161
Inhibition of replication initiation of damaged DNA by RB1/E2F1,40.709268501281706,51.812907555996716,0.3012475178972396,24.316897555258016,36.960045062280464,27.387861657493907,20.426137049378664,43.68787909832271,29.608557891312532,42.426110705026154,47.765278342898114,41.8749367241653
B-WICH complex positively regulates rRNA expression,40.7036389419497,45.01322715427251,0.3012475178972396,20.177681045963126,43.65516341533474,34.900267195645554,18.337615375348882,37.37853019368338,26.907039768803553,36.78149721712684,46.700782659851505,36.78209681732503
DNA Double Strand Break Response,40.7036389419497,42.55156298642138,0.3012475178972396,19.62829016901626,46.411954497202395,38.74066171907681,18.97656919568817,40.10406632878403,27.676486111372956,38.2166620426763,48.51486179829807,36.877597700706154
Triglyceride metabolism,40.696771158016524,45.23902092378263,0.3012475178972396,25.820306416462913,46.46239122762495,37.494377095825364,24.376387097346306,45.23321951862142,29.734272369994095,45.1898149502439,56.21248758328472,40.81501388682984
RNA Polymerase I Promoter Escape,40.689900716156714,44.0606210499181,0.3012475178972396,20.35866781333297,43.58839857121496,34.075653432840355,17.246241461182905,37.18931760865044,27.165582631420644,37.52183275520889,47.66285343266043,36.741374768259995
Plasma lipoprotein remodeling,40.677366747010055,47.746373917608175,0.3012475178972396,26.276753980534906,47.106506154664395,36.32880393482707,22.16573582340543,44.79256597664854,29.68243351100332,45.28250243538522,56.09324819769436,41.63891768071953
Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha),40.677366747010055,56.33761741275989,0.3012475178972396,27.25451310474643,30.23990083270606,22.04092727552112,16.57596509935811,42.79643013770925,28.077148053484677,37.36833840536786,44.84952197542407,39.56255341118411
"Synthesis of IP2, IP, and Ins in the cytosol",40.677366747010055,40.70285998267479,0.3012475178972396,26.409902899950733,49.308159550957875,36.83061507546956,20.2963118983126,48.086157451173996,30.495124206293077,44.427824406361545,53.18803261156988,41.90973320089785
Mitochondrial protein import,40.67048505909649,52.47717756838516,0.3012475178972396,22.38587084797532,33.587830483193635,24.34880361597331,13.415378147295032,40.4654815815962,29.134023421668633,28.732590489709075,36.383338681845345,39.248350357387245
Phospholipid metabolism,40.66360080911613,22.15141001401666,0.3012475178972396,26.5494416910982,50.29993992925196,32.050003308890034,11.53006816744534,44.471147758051686,31.195263988946287,48.225430952587615,58.954664761429335,40.07297247999424
Vitamin B2 (riboflavin) metabolism,40.656714015763036,53.97481361762142,0.3012475178972396,23.802219725254123,38.85666487127204,33.353480646027435,24.930711884324456,49.25465771675541,29.884622690739057,42.634961883988424,49.7842731388757,45.37610171790056
Resolution of AP sites via the multiple-nucleotide patch replacement pathway,40.6498246975761,57.07693448158233,0.3012475178972396,25.28682339270076,27.454949948555168,15.389946527332402,14.815185281467146,43.971192326309634,27.165582631420644,34.76815244577035,41.02221462104316,39.77322304663145
Nonhomologous End-Joining (NHEJ),40.60369035097569,42.529970843361625,0.3012475178972396,20.11809243331116,47.20670605739636,39.68111803571154,19.40497211876958,40.05414568536352,27.74056642527737,38.67446620704702,49.01751567941271,37.01019927010547
PLC beta mediated events,40.60369035097569,43.58758336984732,0.3012475178972396,25.648856106110415,47.79621656625386,33.388777323149505,14.801843616776909,43.04016797146071,29.633208608178105,44.40681352768449,54.437786570143935,40.241895765057116
RNA Polymerase I Promoter Opening,40.596796798684316,41.647906378569914,0.3012475178972396,17.57216262826751,42.771266202168,33.16757216635368,15.837318201492053,36.68472510836941,26.363319377210047,36.193343618543,47.8862121758727,36.4419484083378
Gap-filling DNA repair synthesis and ligation in GG-NER,40.59108577305144,56.57098904693786,0.3012475178972396,25.75595279796876,31.202143928013882,19.44764859144187,15.01168169113222,43.699137084371365,27.480830665401488,38.559782447871775,44.64709941113361,40.02109662119144
G-protein mediated events,40.59108577305144,42.34829596846782,0.3012475178972396,25.648856106110415,47.78071188362514,32.97463602106741,14.027694002515203,42.759862751572555,29.574097586355332,44.519898053471195,54.55006684942006,39.946302190197386
Assembly of the pre-replicative complex,40.58418410971384,55.588160723563696,0.3012475178972396,25.114291175742718,44.177187532715976,41.43188388069922,24.748627672477824,46.52419047214253,27.782020684700978,35.86634543040515,41.48519945463863,39.74675007262905
"Base-Excision Repair, AP Site Formation",40.577280047109,40.043025997232505,0.3012475178972396,18.00635466044854,43.374930246238826,34.49285727298311,15.219290169131806,36.42484151985221,26.595274406425474,36.75266030896045,48.054283429128624,36.12108841096848
tRNA Aminoacylation,40.57388071033603,58.186165223396834,0.3012475178972396,23.98629728581013,41.40209361155017,34.640112511447626,27.39566005180486,51.06826413234681,28.734757791425732,40.97858127074632,52.365083271909825,44.10151813894992
Recognition and association of DNA glycosylase with site containing an affected pyrimidine,40.57388071033603,40.059040296279555,0.3012475178972396,17.942522542284937,43.350606726572295,34.46522977839375,15.173855544123981,36.36847088353107,26.53708906295652,36.78682632132008,48.02311256253923,36.12773280905892
Depyrimidination,40.57388071033603,40.059040296279555,0.3012475178972396,17.942522542284937,43.350606726572295,34.46522977839375,15.173855544123981,36.36847088353107,26.53708906295652,36.78682632132008,48.02311256253923,36.12773280905892
Cleavage of the damaged pyrimidine ,40.57388071033603,40.059040296279555,0.3012475178972396,17.942522542284937,43.350606726572295,34.46522977839375,15.173855544123981,36.36847088353107,26.53708906295652,36.78682632132008,48.02311256253923,36.12773280905892
Glycolysis,40.56696248597216,58.35645924544185,0.3012475178972396,23.58293398362612,42.06789226465,33.556468449817366,23.449202268060844,47.77722751853385,27.27632882086759,27.663942128674975,39.047649971708644,38.63056652654915
Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins,40.55196258498557,54.362598213295534,0.3012475178972396,25.277930404319367,44.50809276557314,39.60845982424902,23.597507066165807,45.60334785924293,27.694383118049,33.71118174089518,40.578640302160935,39.19008069692722
Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3,40.54504059042567,41.4551750348075,0.3012475178972396,17.70239538172625,42.69083766770217,33.068175766846025,15.719988845885187,36.66715285583978,26.276968004546283,36.27683263583411,47.89499514148906,36.385167251353394
Prolactin receptor signaling,40.53003937517401,46.73631077939084,0.3012475178972396,27.184084952045644,52.91333822475106,45.367158008580745,23.210233530092687,47.69086402980632,30.487850782262043,45.88046878764523,56.86315215287502,40.71079825461114
Unfolded Protein Response (UPR),40.52311367603384,56.85288624396047,0.3012475178972396,22.510642300896677,46.36966829981257,40.33555797632945,23.983472256999956,46.667370384824565,28.78302605120014,28.67546825687761,40.94456916836565,39.766607816770744
Cytosolic tRNA aminoacylation,40.48389245720565,58.27595848649183,0.3012475178972396,24.509335692701672,41.180854580436936,38.49856783300485,29.171876088245877,51.903068241941455,28.360661537514435,38.650445487405115,48.62784836060456,44.35219227546219
Glycosaminoglycan metabolism,40.460825358367885,39.805063128891085,0.3012475178972396,24.726238449804644,38.571237989290005,21.341857373353612,11.301485775486588,41.23112008771555,26.371730048442824,44.028865700496574,54.23597664705542,41.49914267672779
Leading Strand Synthesis,40.4319698622275,57.676011960475336,0.3012475178972396,26.180431419658323,26.20038171748278,15.600599628086483,16.153542738972675,44.55148324718011,28.07171514134803,35.43672810415497,42.95254147904997,40.46181974239442
Polymerase switching on the C-strand of the telomere,40.4319698622275,57.676011960475336,0.3012475178972396,26.180431419658323,26.20038171748278,15.600599628086483,16.153542738972675,44.55148324718011,28.07171514134803,35.43672810415497,42.95254147904997,40.46181974239442
Polymerase switching,40.4319698622275,57.676011960475336,0.3012475178972396,26.180431419658323,26.20038171748278,15.600599628086483,16.153542738972675,44.55148324718011,28.07171514134803,35.43672810415497,42.95254147904997,40.46181974239442
NRAGE signals death through JNK,40.42503666338281,45.756500112336674,0.3012475178972396,25.465653650581732,46.80906917140765,37.791789847844974,19.91989136049524,46.1717492746594,29.275369376782425,42.59704477205231,49.401292029883436,40.23532184290126
NGF processing,40.41922790209353,44.74895597130757,0.3012475178972396,26.34801034135122,38.20123998863164,28.71416698973564,13.07507631563106,39.048618053856096,28.187228168115443,41.59620701388572,51.82922825016906,38.835207230197454
Expression and Processing of Neurotrophins,40.41922790209353,44.74895597130757,0.3012475178972396,26.34801034135122,38.20123998863164,28.71416698973564,13.07507631563106,39.048618053856096,28.187228168115443,41.59620701388572,51.82922825016906,38.835207230197454
Processing of Intronless Pre-mRNAs,40.37197947348428,58.27595848649183,0.3012475178972396,24.335634393595033,38.23835464284946,30.197706395595556,24.18572147012519,48.16215291761617,28.708253308368572,40.882630043650025,48.63662373698658,44.27844041130175
Recognition and association of DNA glycosylase with site containing an affected purine,40.3592155470021,38.55992039220464,0.3012475178972396,16.928410137557837,42.01828628499234,32.81967014679166,13.628664838720997,34.838056217183826,25.816606328534508,35.334436856498705,46.9453005460384,35.35207344215156
Cleavage of the damaged purine,40.3592155470021,38.55992039220464,0.3012475178972396,16.928410137557837,42.01828628499234,32.81967014679166,13.628664838720997,34.838056217183826,25.816606328534508,35.334436856498705,46.9453005460384,35.35207344215156
Depurination,40.3592155470021,38.55992039220464,0.3012475178972396,16.928410137557837,42.01828628499234,32.81967014679166,13.628664838720997,34.838056217183826,25.816606328534508,35.334436856498705,46.9453005460384,35.35207344215156
Autointegration results in viral DNA circles,40.33726671157786,55.88508713213399,0.3012475178972396,23.10240972170221,41.79810923804197,38.74066171907681,25.075932910580903,49.23736733586868,24.8096123299469,40.1435142691255,45.37000685871939,43.612792092928636
Integration of viral DNA into host genomic DNA,40.33726671157786,55.88508713213399,0.3012475178972396,23.10240972170221,41.79810923804197,38.74066171907681,25.075932910580903,49.23736733586868,24.8096123299469,40.1435142691255,45.37000685871939,43.612792092928636
Platelet Aggregation (Plug Formation),40.33142171652458,46.32139284540754,0.3012475178972396,25.764751932044145,47.689404399520534,38.42299674548378,18.871264142554054,46.099789928497756,30.857792196050678,44.743404632422894,54.17830736927983,42.077495365616016
Common Pathway of Fibrin Clot Formation,40.33142171652458,44.32050136420749,0.3012475178972396,25.450381497684607,40.297713401068876,20.9677347351126,13.150775991933186,46.794866459312146,27.6680095286804,43.30389482358741,55.8974410049054,41.58184199815742
Metabolism of non-coding RNA,40.3255663384052,56.769584202998615,0.3012475178972396,23.906635780935595,33.55182562765837,20.79070429047974,15.199277038873625,42.09169090602017,26.900257499852415,27.16288502758671,40.506394318023176,39.10139061567029
snRNP Assembly,40.3255663384052,56.769584202998615,0.3012475178972396,23.906635780935595,33.55182562765837,20.79070429047974,15.199277038873625,42.09169090602017,26.900257499852415,27.16288502758671,40.506394318023176,39.10139061567029
Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks,40.31860812466171,40.12260350924837,0.3012475178972396,18.734739221177612,46.77158793193938,39.34804793365227,18.878418318324385,39.895395076114134,27.411292720835917,38.54200371320787,48.86350167578348,36.58158220871159
Mitotic Metaphase/Anaphase Transition,40.31164796302858,57.95977418916855,0.3012475178972396,23.977445963493,15.856872226928198,17.38833612296593,20.035039663430037,46.95052705194058,27.09624598473334,27.42673162049618,26.368352944200435,38.80753006134857
Hemostasis,40.30577296297569,39.418540548025085,0.3012475178972396,26.09706198199384,44.83093637832703,20.177213137987227,6.771730770168297,41.67943673669761,30.243686559120967,46.06933577572318,58.70462962623125,41.733953380356446
Packaging Of Telomere Ends,40.30577296297569,38.523089522241484,0.3012475178972396,16.848467930225695,41.873274402823164,32.46375771798608,13.415378147295032,34.82679764685001,25.6689892491784,35.2876280034966,47.05342585165528,35.30332352355593
EPH-ephrin mediated repulsion of cells,40.298806232596434,42.252501944132625,0.3012475178972396,26.34801034135122,52.13679745813021,25.13424123282648,8.520030435605763,46.831231916791126,28.01133592320788,45.80859027537529,60.31409037997635,42.205282130200246
Chondroitin sulfate/dermatan sulfate metabolism,40.28378811262142,37.60161705359746,0.3012475178972396,25.5641535875508,38.39768264826335,20.66236663683554,10.136341698196343,39.685180980463684,25.616853888078207,43.77208626698376,52.94009792036451,39.121422502384114
Sema4D in semaphorin signaling,40.26877053577131,45.70407589492845,0.3012475178972396,25.14989709073344,45.30377668082835,34.98613021351601,21.994211620758296,43.21026638508235,29.300224316553447,43.423284280130474,52.09742483037699,41.212245932691054
"Regulation of glycolysis by fructose 2,6-bisphosphate metabolism",40.2537535153598,49.217041080323796,0.3012475178972396,26.300606049758215,48.374823929327775,40.958870693322766,24.481595802611693,45.5420222571844,31.004415051185543,44.427824406361545,54.04265112071029,39.87464090014296
Signaling by NOTCH3,40.23980807496432,38.976662318323676,0.3012475178972396,25.309910807146093,49.31510979927371,39.42284595772763,16.73515250557289,43.50958623450182,29.15765745365814,43.777056664088,54.44597799224959,39.740126852492146
Erythropoietin activates STAT5,40.23980807496432,44.09930634449644,0.3012475178972396,27.314191156812576,48.41968800883413,38.54203045789617,19.74267160007646,50.33144958369406,30.139864656081272,44.42866710177066,55.2599463683904,40.86966818610313
APC/C:Cdc20 mediated degradation of mitotic proteins,40.226918471044534,54.048954069848655,0.3012475178972396,25.088697614797717,44.576196114893264,39.42284595772763,23.24833017531252,44.92871896100771,27.411292720835917,33.03110917818137,40.141823013426745,38.73237316475715
A tetrasaccharide linker sequence is required for GAG synthesis,40.226918471044534,44.0606210499181,0.3012475178972396,24.187845255702662,40.162347623864605,29.359433795061797,17.008678047322018,43.10310500909795,25.872935077809043,44.289139429376334,51.77815284234757,39.08706932065544
"Cell death signalling via NRAGE, NRIF and NADE",40.226918471044534,46.337782085109815,0.3012475178972396,25.5389689322431,47.738262933850876,39.297935296961214,20.941266387675075,45.19516960293712,29.293378161233406,42.954355438017686,51.4702031980777,39.98471616975867
Downstream signaling of activated FGFR4,40.195814954566146,44.788524697923904,0.3012475178972396,25.896435213783235,50.09938817697115,45.75012179398464,26.500223463393908,45.76391263956377,28.860048204258806,44.028865700496574,51.618858731957374,39.76108313385573
Glucagon-type ligand receptors,40.18185112702504,51.73449780480593,0.3012475178972396,25.530133598445506,29.096315203511104,19.622158790281993,16.061098827132124,45.622381800656164,30.389359739678305,37.865897076474816,46.56608690947979,43.228837558345916
Chylomicron remodeling,40.18185112702504,50.22315384111689,0.3012475178972396,26.29207565665253,46.12831576797681,40.5347103156218,26.220676063083474,47.61958134301203,28.591530701724047,43.12828441321414,53.74200008469666,42.097963552114216
RHO GTPases Activate ROCKs,40.174866580653315,47.768142387441166,0.3012475178972396,26.249346473628655,45.348026770647884,34.72118557590061,22.083668016471098,44.251491483918194,29.420950738373865,44.24792553249208,52.42774248724858,41.00907709559019
Nuclear Pore Complex (NPC) Disassembly,40.16089228457922,58.048332583889355,0.3012475178972396,22.39456153984392,32.304236373521,18.261969672125005,18.217182345687732,45.42353845173427,27.05228823121209,25.673759886485936,39.317453370176835,39.96380872262733
PTK6 Expression,40.16089228457922,44.87094630094995,0.3012475178972396,24.961725993547752,43.90875444617249,27.896223772843246,13.867587313525869,43.25447471190052,26.06658536621103,45.23203741886749,55.184251582383794,39.91763739034859
Glutamate and glutamine metabolism,40.153902559357384,35.411556714129205,0.3012475178972396,26.63476547513242,44.13554027210057,30.4356760180305,12.647980417179868,42.00904113012923,30.230602873596816,46.37989601366748,56.50858790215095,44.77688070637028
Epigenetic regulation of gene expression,40.1469111321857,44.671140900917266,0.3012475178972396,20.0919313566024,42.69083766770217,33.951416223334384,16.026099929969586,36.70723611260018,26.51103643985283,34.32861417246944,43.22693639327112,34.39323998234691
PIWI-interacting RNA (piRNA) biogenesis,40.0997634098005,54.951639232679234,0.3012475178972396,22.546230883465835,38.37247477672728,38.67771185218222,22.223387239532965,45.585593874090286,28.53743991987698,30.891799874931486,38.33077483281473,39.66953104697268
Metabolism of lipids,40.068692003781585,17.71619489795698,0.3012475178972396,27.125910039224173,52.067245822389594,30.539162496298392,10.332481871294071,43.85318954166935,30.57232773992963,48.61570094032086,60.262462703729966,40.405654538878984
Neurexins and neuroligins,40.053677543261784,42.97431641584426,0.3012475178972396,25.55532784526355,47.87174917763438,33.294493628931264,12.548822216688185,45.38914121934657,29.649622043215537,43.61442314210546,53.00469248799008,39.58457999097037
PKA activation in glucagon signalling,40.046686696134266,49.37655417122102,0.3012475178972396,25.812907219707213,48.199829200165944,41.68278382605551,22.908284781034165,44.97778219344318,29.565862642123133,42.26957645663063,52.03630827239978,40.756381505041425
Translesion synthesis by POLI,40.03167216894626,56.15631422884304,0.3012475178972396,25.105387317800915,43.25107806234795,33.61454037619302,21.082843032941334,44.88635310101968,29.26849976831871,37.69943355739221,45.01523011043043,39.426922394983386
Translesion synthesis by POLK,39.97656843674412,56.180154251642605,0.3012475178972396,25.14099707053208,43.02605915395986,33.76004708049496,21.24414131441905,44.93426639518293,29.09759823670243,37.35077571410152,44.90868922277598,39.49296108808455
PI-3K cascade:FGFR3,39.961563580467164,42.90298839185277,0.3012475178972396,25.522583226524794,48.71490262296621,45.26637962679873,24.723171880123353,42.42345735334765,29.020921199584652,44.34557901141892,50.16779969063992,39.98471616975867
Translesion synthesis by REV1,39.95457269257236,56.20398624485484,0.3012475178972396,25.09648253890916,43.00726945062263,33.49562971828813,21.075499236557725,44.868517939986134,29.26849976831871,37.47521465416496,44.90472401628729,39.50522408103278
Glycerophospholipid biosynthesis,39.93956786170564,20.598273218971567,0.3012475178972396,26.501949509368696,50.09938817697115,33.535529714582374,12.95342813338355,43.090884752193965,31.04014173704591,47.93407419906861,58.177744949813,38.9067254950148
EPHA-mediated growth cone collapse,39.932574599059436,48.065668925129074,0.3012475178972396,25.29571518330604,49.25998656932207,35.5369160569665,19.81627672651296,46.13508612066223,29.181236841324633,44.34557901141892,55.84798105816262,40.85932648279402
Extrinsic Pathway of Fibrin Clot Formation,39.918583361859994,46.16611194988299,0.3012475178972396,26.793696165300023,50.547006085160646,34.05458669452099,20.41146298224855,41.99777340978498,27.489295314487734,45.61307609662285,58.38905832794467,41.49273534287667
Activated NOTCH1 Transmits Signal to the Nucleus,39.918583361859994,41.741897474658465,0.3012475178972396,24.84618942800452,49.22774179328738,39.934502526305366,16.626286299629022,42.690588471364016,29.427761165876753,42.420911884831604,53.78955927658229,39.26933590698854
Adenylate cyclase activating pathway,39.91158540946246,47.45601109595948,0.3012475178972396,25.909537750869017,48.45411557244985,40.71369756058959,21.367124400413754,44.62176603418719,29.633208608178105,42.67150745830556,52.573782137100984,40.10820097378925
Orc1 removal from chromatin,39.89657841522891,55.623232983140326,0.3012475178972396,24.81948318665106,43.21073571775,39.805094704435156,24.371424544809187,45.63464085933807,27.191813619234864,33.58112356660162,39.46388487422884,39.1557598366664
Regulation of APC/C activators between G1/S and early anaphase,39.89158418155666,54.35785544614698,0.3012475178972396,25.056365694772758,43.87981438948091,38.91472808995728,23.19556751414479,44.67086213275731,26.94925507809385,32.040108518983224,38.94529674697422,38.610512173569276
Biological oxidations,39.89158418155666,32.488330489170345,0.3012475178972396,26.60677801342825,50.05081215469567,30.30654217110076,13.867587313525869,41.19172474940077,28.968049955058298,48.34062299717409,59.728540400063956,41.43404965738197
Formation of xylulose-5-phosphate,39.89158418155666,34.64377246535993,0.3012475178972396,24.38200280846498,43.99972250577383,29.726634613003036,10.626706260855348,41.08174009443414,26.241852724603593,45.40732582421681,52.21460499536552,39.114746606834196
Repression of WNT target genes,39.876572745713005,24.906989189355723,0.3012475178972396,27.501347188559862,51.80116557920877,44.72027676896178,21.578459885943353,43.32411357218685,31.195263988946287,48.216139042161444,57.02774432589175,39.49296108808455
Chylomicron assembly,39.82354466667577,48.809532896898155,0.3012475178972396,26.32254613720319,48.34489129049646,46.5575624324729,27.071281067093985,47.61958134301203,26.569210758387054,40.49824458911816,46.77853401425584,39.83164561887364
Sema4D induced cell migration and growth-cone collapse,39.82354466667577,46.49852409886412,0.3012475178972396,24.56467804878785,43.710467848562075,32.94851635711583,22.00038532396672,43.37400815714924,28.935731800007545,42.824257451654994,51.197065861962216,40.592346999679975
Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol,39.82354466667577,38.64986462523488,0.3012475178972396,25.748523476107575,45.45362054005817,34.8143493650046,12.985286755710401,39.16269252201944,27.294127512543067,43.1729252112188,54.116343739669965,38.465124543497
Diseases associated with O-glycosylation of proteins,39.79254545314201,44.12765100509353,0.3012475178972396,26.28530188431278,47.46951312269015,34.18548457903815,13.964804750404843,41.75615548511053,28.354386063807226,45.16359718415757,55.366798066132425,40.411007726089025
O-glycosylation of TSR domain-containing proteins,39.769549871488245,43.40323137482829,0.3012475178972396,26.16315813256444,43.07010912854026,27.353018185331315,10.169255634868044,40.33998766204716,25.43785517390909,44.666493156323604,52.91632230133447,39.595741582202024
Defective B3GALTL causes Peters-plus syndrome (PpS),39.76254282031954,43.46464304927729,0.3012475178972396,26.185746513266558,42.771266202168,26.93336226260852,10.141628410973757,40.357603073373035,25.453110934600005,44.671098912448414,53.07423594105872,39.60237373134134
Striated Muscle Contraction,39.75651580049741,29.42258132238765,0.3012475178972396,27.314191156812576,48.09972485434119,35.33522687015449,14.162594446497797,43.11439633578637,30.929257216236877,44.723035840628356,54.88087617891882,37.90242232070726
SUMOylation of chromatin organization proteins,39.75651580049741,54.8931804705542,0.3012475178972396,22.974825847343777,40.901619024621496,34.136071943919255,20.426137049378664,41.94533845116816,27.0167982010003,30.077528724234604,41.76000220015476,38.330653448464666
Activation of TRKA receptors,39.74950369538374,32.94971633244214,0.3012475178972396,24.735136612611488,44.1939962676874,23.27607910996617,18.88557296579886,46.8692026476434,25.864579015335813,36.79674686244724,49.649093516507655,36.42056375763052
Threonine catabolism,39.72651153465854,35.62077071443539,0.3012475178972396,27.314191156812576,48.959459228188415,41.78733128721394,20.90450856335919,48.50369834059447,28.591530701724047,46.70064741560875,53.991890666574875,38.084483152670494
G alpha (q) signalling events,39.71949826366439,37.25320106577554,0.3012475178972396,25.248903209519494,42.65442015338457,17.95008965038441,8.024388587345985,43.84092841942063,29.072487421411584,45.7194101979814,57.873814580372766,42.435346421385
G alpha (12/13) signalling events,39.71248361692664,45.36553106198706,0.3012475178972396,24.039404538348588,45.240272126170126,37.900222539798726,20.637017950111158,46.048074987916024,28.808308540299677,37.65966137558654,41.31272163524728,37.17422175401683
Antiviral mechanism by IFN-stimulated genes,39.697481908177636,57.693832327263195,0.3012475178972396,20.599400798936177,35.18101043743622,28.113340470188103,23.931871485902395,46.34059314500202,27.22738746825989,28.00966315015129,32.723663625867964,39.911032708441546
Ion transport by P-type ATPases,39.690465346723435,36.382696052865654,0.3012475178972396,26.403411448704794,49.44544414644921,36.151265314028635,17.617295183858843,43.49928689995214,30.230602873596816,47.17905450355152,57.01534713458365,40.19888912789547
NOTCH3 Activation and Transmission of Signal to the Nucleus,39.667481699499696,40.647842158685776,0.3012475178972396,23.537911109514415,48.12490489619328,36.37265064856584,16.153542738972675,42.14583937051789,28.808308540299677,42.110470872306514,54.30909348938308,39.34297164673298
FRS-mediated FGFR4 signaling,39.644503175661896,45.516852483514754,0.3012475178972396,25.212168374822294,50.29993992925196,46.328096349126064,26.27351361692513,45.585593874090286,28.545886277988455,43.08007072133802,51.48891028145319,39.30564578325922
TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest,39.637485833067856,58.001190269347475,0.3012475178972396,22.340951283853908,16.029723884833036,7.6178465176966,15.831827955808748,44.51356220243462,24.49599122458551,27.026992704156324,29.507821936378516,40.90747858227066
RET signaling,39.62248955188813,28.355371901681526,0.3012475178972396,25.479616134681013,50.62116610468924,39.54846607420423,15.112871674953857,45.12225439235165,29.3182284890548,46.19293856279505,55.1711263837078,39.04315519933393
The role of GTSE1 in G2/M progression after G2 checkpoint,39.61547038987698,54.12623349653356,0.3012475178972396,24.170116776222503,44.6862322825387,40.28320292931773,23.189679713062013,44.059087993233334,26.95685399524197,32.23448053769979,39.96454217999558,38.16975120855373
Nucleotide salvage,39.59250034044077,58.4451607851984,0.3012475178972396,21.668195677056012,22.97544425961884,28.219033277020763,26.220676063083474,50.40228993465675,27.65011811306937,24.992852685449336,33.760695794965166,42.61051140140416
SLBP independent Processing of Histone Pre-mRNAs,39.553593948769006,54.03284511460146,0.3012475178972396,24.023590549627894,36.347814016376354,22.969934622342027,17.145655403099983,45.24550196483168,27.242525140464988,34.16883444860257,45.09715117311564,39.38031395933004
APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1,39.51470565721047,54.084375362748595,0.3012475178972396,24.526063538251496,43.443556342828394,39.277386232207874,23.520284002506063,43.96557293146425,26.62134674772319,31.681180781312783,38.14897329115151,38.214163799462916
Activated NTRK2 signals through PLCG1,39.4837977517747,42.70233381315935,0.3012475178972396,20.98680223892593,38.52387049331645,20.888471461135254,21.546855790521764,48.52325383662391,23.16290241657445,34.23178507459973,42.69391064928567,37.253786449716294
VEGFR2 mediated vascular permeability,39.46976635901537,40.27906503748466,0.3012475178972396,26.940619330797944,41.851839804266056,25.001710500424345,13.26030358873656,43.99571383619325,29.134023421668633,47.07039719082601,55.8974410049054,41.527733746974604
FGFR2 alternative splicing,39.46976635901537,55.6911519297548,0.3012475178972396,19.937572703536336,33.93719790184656,22.991261499655426,14.761337880623065,43.9440876260734,27.36536811807626,26.09289530953482,33.598245786443236,36.58158220871159
HDL remodeling,39.43091421854733,30.01398068160551,0.3012475178972396,26.35277497998676,49.566915828273736,35.43368139197412,12.78373603666567,38.823215673042775,28.92140835262217,46.29557383799716,56.02403471612507,39.72579285550778
Intrinsic Pathway of Fibrin Clot Formation,39.423898644485824,44.38189372008442,0.3012475178972396,25.896435213783235,44.834515922352004,25.334225838946463,14.83546883682622,43.65577340499071,28.912995773298853,43.5795343988034,57.21162425897573,40.80850249068857
Scavenging by Class H Receptors,39.393019238363856,47.61605516106834,0.3012475178972396,23.56526690984155,38.37247477672728,26.0557349785448,13.898668428895357,40.351970242969884,26.42219936830316,39.26266383059244,51.14968927186437,40.536316609146596
PKA-mediated phosphorylation of CREB,39.37898683462853,46.084534528974025,0.3012475178972396,25.5389689322431,48.374823929327775,41.43188388069922,20.94764160308053,43.1388330359355,29.06411250947808,42.393550490427835,52.6976202343945,39.51851294116407
Intracellular signaling by second messengers,39.37898683462853,54.02156267243765,0.3012475178972396,23.81722683929381,48.46646239846143,43.42862213775404,26.13405639836582,44.90418044715547,27.897109784256024,32.32280018716698,42.75622527248145,38.528859357293754
Interconversion of 2-oxoglutarate and 2-hydroxyglutarate,39.37196882691798,50.78313883001113,0.3012475178972396,24.83728798212116,35.96851160188772,40.57432097488912,23.23368746675912,47.369561334259984,29.427761165876753,18.94311518361232,29.81572553402674,32.03183362758863
NOTCH2 Activation and Transmission of Signal to the Nucleus,39.36494962681102,42.24173725520108,0.3012475178972396,23.342543319870952,47.58795859155567,35.500595442628104,15.983923978916087,43.058953444174,28.20203170303898,40.352682913920574,53.35270785573,38.93439661440889
Keratan sulfate/keratin metabolism,39.357929242862596,49.90861057709008,0.3012475178972396,21.82529380424014,30.52804803191763,19.441268212379317,16.771522370913683,44.30271351563116,24.991996438371142,36.70033850591857,48.31954417189386,42.792264417582686
Uptake and function of diphtheria toxin,39.34295994216714,48.28434560038871,0.3012475178972396,22.180434065495763,32.06144342048972,22.635632458884597,8.113875771870816,41.40071232006321,26.475795826028,30.945559824878988,32.81741108034408,38.45086438993364
Selective autophagy,39.33593802350602,55.950323794684856,0.3012475178972396,25.673968184592947,43.58839857121496,38.879331482953106,23.307022827413387,45.24550196483168,29.028012861003685,35.68527424522605,40.0594387314241,43.237122568709616
PKA activation,39.28125514612486,49.06470347789059,0.3012475178972396,25.474521197164215,47.86403706806677,41.18098750117803,22.900915374741324,43.99009726738179,28.953785961614383,41.52747915735865,51.71474518393013,39.95836088827451
tRNA processing in the mitochondrion,39.24340108627792,43.54790033147269,0.3012475178972396,21.95199371992026,37.91873586486469,29.34319611913327,13.743097830198295,37.847329587223584,26.302180538939073,31.015458176149643,43.513990301514255,33.68911859799407
SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs,39.24340108627792,53.165456509412365,0.3012475178972396,24.25185465876907,37.28487534997051,25.643609006839238,18.660755466435813,43.34858426709328,26.810890422988827,32.01868674441104,42.95254147904997,39.697125785572254
MECP2 regulates transcription factors,39.22936149037641,46.71391614569831,0.3012475178972396,24.354377001990112,42.37289812629094,31.842555595941782,17.72746845160418,43.1200397725972,29.072487421411584,40.17453021416537,53.096347414234636,38.31062484791958
Nectin/Necl  trans heterodimerization,39.22936149037641,31.14934465542583,0.3012475178972396,23.156704260902554,46.615334378043855,27.923791861462927,7.714778516817262,36.0377872599954,28.77815015341433,41.64199995824098,52.90939331898009,37.372666180179024
APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint,39.21440599872647,53.496459944398154,0.3012475178972396,23.88801645433938,43.714170403920924,38.55617420851857,21.924407004341944,42.666221934342076,26.11836706058675,29.707627676699257,37.57215284955113,37.024284505343644
VLDL assembly,39.19945182033638,48.09514990950348,0.3012475178972396,23.843772180391134,40.20540104072687,40.05924010391391,25.794329192074883,45.41125861020273,22.696693744752903,34.61783439487627,40.45454314179885,37.48229406826446
Smooth Muscle Contraction,39.18449896322744,39.06810106804825,0.3012475178972396,26.1474858182719,42.88928067141027,25.670649035224816,13.710760625787008,37.95432774876927,28.11950356951321,44.72759393717689,53.539474641593166,40.271760368106314
Glucagon-like Peptide-1 (GLP1) regulates insulin secretion,39.17747660394799,53.73313059821713,0.3012475178972396,24.014735255114157,23.812588376957752,19.2455826307371,20.76195727960061,46.80537479172124,29.451076395572606,35.05073832172377,40.87083862326075,43.32298703856546
Signaling by NOTCH2,39.17045315933165,39.392233808945946,0.3012475178972396,23.75706890936889,48.33738976610554,38.813394660223324,16.43397008204253,42.63442916390569,28.376462004753677,42.14047291383141,53.78955927658229,39.06510993858972
Signaling by PTK6,39.12470090627615,31.32232362803722,0.3012475178972396,25.972138593958853,41.59947046548684,24.733869248347006,10.316074392373881,40.199784535845836,28.878105078739676,45.71190885097752,54.74440235539934,39.85369880275459
Signaling by Non-Receptor Tyrosine Kinases,39.12470090627615,31.32232362803722,0.3012475178972396,25.972138593958853,41.59947046548684,24.733869248347006,10.316074392373881,40.199784535845836,28.878105078739676,45.71190885097752,54.74440235539934,39.85369880275459
Nucleobase biosynthesis,39.10975477414521,58.20521596570735,0.3012475178972396,22.668228140334854,39.77389682789667,25.08408793852343,22.68916464284115,46.52953652336292,26.215154227386773,28.670652019918126,47.46799248415278,42.2866890712474
Transport of the SLBP Dependant Mature mRNA,39.03147033146913,57.697102336153264,0.3012475178972396,21.012904670383556,28.153448721240046,16.507380979997272,14.714496874776662,41.02153638256818,24.99894671798969,21.365703078678283,34.79255094809597,37.23966823667511
Signaling by NTRKs,39.00952218306535,39.75065903390872,0.3012475178972396,25.114291175742718,40.69436024071861,28.41919132320558,16.828953712396284,39.41275863982219,28.734757791425732,45.29339183931947,51.718399227218754,41.46265415465466
Purine ribonucleoside monophosphate biosynthesis,39.00952218306535,57.836732431399696,0.3012475178972396,22.778434992447394,40.37031479755244,24.877876836488312,21.554200378790302,45.81285454015832,24.95764116689225,27.782437385129015,47.049454218891555,42.17068302808104
PI-3K cascade:FGFR4,39.00250347131485,43.4485980810957,0.3012475178972396,25.221059954828025,48.319901156494566,45.63441521652893,25.515033224699625,43.630293314118184,28.354386063807226,43.36182113119822,50.19027301050168,38.92771501193012
Platelet calcium homeostasis,38.995483735884136,52.35279006565721,0.3012475178972396,20.71873545525511,41.66526340248,37.29004451082732,27.8925721515543,47.05023442846649,26.206758000189993,40.716358783893824,49.756877410812585,38.60382511073235
Mitochondrial translation elongation,38.988462984269404,48.9877369251891,0.3012475178972396,21.9015838671669,40.30838172469997,27.976754254533077,13.396583719496295,39.7096833430836,26.95685399524197,32.06211166846342,40.349783319319144,37.295366055722745
Tryptophan catabolism,38.91029672919371,55.99341002027828,0.3012475178972396,21.030523559036162,30.456001051148377,39.23127183159694,29.67976205030989,50.651592621081996,25.279482584332158,26.382088529993823,33.5203446323599,39.456610485744946
Mitochondrial translation initiation,38.89538113580021,49.56881623668541,0.3012475178972396,21.892952256911762,40.239424865150674,27.807583135142487,13.590311940275827,40.023221750866306,26.900257499852415,31.614451244244133,39.64061471848222,37.316157494196524
Cdc20:Phospho-APC/C mediated degradation of Cyclin A,38.889247271418185,53.19819161082324,0.3012475178972396,23.546741889856015,43.34313708996943,38.35051082847459,21.846109187388066,41.95013902308774,25.495390552063956,29.023216758347914,36.37548791197975,36.41390177593746
Cholesterol biosynthesis,38.889247271418185,49.034963051959295,0.3012475178972396,25.018493959658002,38.024727176139415,23.134795971556187,15.239853354368174,48.886324795566814,26.71728817804524,33.564388837978726,47.141756632777685,39.881247611113025
Assembly and cell surface presentation of NMDA receptors,38.819948263316924,54.12623349653356,0.3012475178972396,22.904804522091514,39.04013239538706,33.460277224427195,20.97702769320124,46.31471711067841,26.742590514259927,28.63386626015869,37.11434772587475,36.865764920760384
"Platelet activation, signaling and aggregation",38.819948263316924,37.18998611733029,0.3012475178972396,25.063075975182613,42.72171287478962,18.97701871010054,7.029441617093215,41.039208928799034,29.013815944217246,45.244517692537386,58.01579498562851,41.107875313479354
Signaling by Hippo,38.797153512645124,43.36422571950418,0.3012475178972396,24.875050474066636,37.15698857072641,37.08978433522393,21.007397288435467,40.430239220329646,27.597401386260934,41.026567116252174,44.06719236047101,39.95836088827451
APOBEC3G mediated resistance to HIV-1 infection,38.78225144336979,55.22068593959852,0.3012475178972396,22.502691817705443,40.998954955627056,40.60665668441005,26.392373852385962,47.99810102474092,24.075392308855815,35.70249020181431,38.271199042937354,42.26457288382663
Mitochondrial translation,38.77610842068807,48.70224425490489,0.3012475178972396,21.934026335791835,40.26512631520261,27.839223839312,13.383906109109049,39.400888053436084,26.750210773406742,31.878948194343547,40.267761502793675,37.06065528203245
Deubiquitination,38.77610842068807,51.36183383574956,0.3012475178972396,22.367749919095544,46.18571707422884,39.47859612723565,20.783083045894017,40.52690925582367,27.22738746825989,28.571519064858983,39.0731207538563,34.046823279163036
Telomere Extension By Telomerase,38.66750986951106,51.67096628881857,0.3012475178972396,24.509335692701672,35.40216928958153,23.05363871797781,9.50600580296254,36.43633651323787,27.15713141553329,36.333526051263455,44.71011015426369,41.69752349231129
Transport of the SLBP independent Mature mRNA,38.66750986951106,58.02265847396109,0.3012475178972396,20.263027766852673,27.95844200203588,15.354040306196461,15.01168169113222,41.94533845116816,24.991996438371142,20.435029324626317,34.82019814465169,36.970980008067194
"Synthesis And Processing Of GAG, GAGPOL Polyproteins",38.66136506088953,21.631766943211733,0.3012475178972396,26.105744009075845,47.25821635482382,37.057833884021946,14.399860245407003,40.44786056185519,31.04014173704591,47.89754555515897,56.13083136042305,45.13355468926681
Membrane binding and targetting of GAG proteins,38.66136506088953,21.631766943211733,0.3012475178972396,26.105744009075845,47.25821635482382,37.057833884021946,14.399860245407003,40.44786056185519,31.04014173704591,47.89754555515897,56.13083136042305,45.13355468926681
Plasma lipoprotein assembly,38.61499416170028,44.721709532710776,0.3012475178972396,25.522583226524794,47.21959255520484,43.87772234574831,24.930711884324456,45.87671427783511,25.823525486583563,37.46375918987307,43.38310053112254,35.790884197447426
Signaling by NODAL,38.600116979361545,39.5488226085767,0.3012475178972396,26.501949509368696,38.64455428273125,39.33532211281914,20.706798608426386,40.132921052123756,27.200265984401444,42.29958320305146,45.81178623584746,41.61192207896593
G1 Phase,38.5790883332788,58.4451607851984,0.3012475178972396,19.48279018897101,21.548709492796526,29.077292224800548,29.67976205030989,50.40228993465675,27.242525140464988,27.158677287453134,25.879956347923137,42.75669173519246
Lysosphingolipid and LPA receptors,38.5790883332788,42.08610246155438,0.3012475178972396,22.251960502167844,36.51299484409772,14.763439971587212,5.874558600668455,40.16318028775736,27.570125806119012,41.926733385563885,55.06141355710728,39.49857704318615
Cyclin D associated events in G1,38.5790883332788,58.4451607851984,0.3012475178972396,19.48279018897101,21.548709492796526,29.077292224800548,29.67976205030989,50.40228993465675,27.242525140464988,27.158677287453134,25.879956347923137,42.75669173519246
NRIF signals cell death from the nucleus,38.53361463727804,40.574403209798696,0.3012475178972396,25.24001189577404,50.92059043363569,36.91149630532139,14.916223307410489,41.143527191468046,28.501396885658718,43.54962918213596,57.228699690486806,37.36678945060708
Regulation of PTEN stability and activity,38.53361463727804,52.7527734812448,0.3012475178972396,22.868215684251535,45.28229298651941,41.379606956173006,23.47990765987738,41.01590207318524,25.384552895651552,30.586802806623083,37.730732347465405,36.53946264838688
SHC-mediated cascade:FGFR1,38.50472453498934,48.9580164070856,0.3012475178972396,22.60798313495016,46.029930883118695,42.820607949140864,24.905670751956873,43.731253633721394,26.725722186941976,37.79985621338235,46.32336455817837,36.76803443086185
Nitric oxide stimulates guanylate cyclase,38.50472453498934,44.943671515308125,0.3012475178972396,26.16315813256444,42.22869063844718,23.769291640721395,13.590311940275827,39.1794542092473,29.251898992529867,44.16659745724045,52.56324245657321,40.101624536765776
NTF3 activates NTRK2 (TRKB) signaling,38.50472453498934,29.651966090384597,0.3012475178972396,19.937572703536336,28.635948600869217,12.806362593526458,15.857735667292042,49.28131434679139,26.96444794820856,25.772707877019883,35.26987155959316,37.6521842973585
Signaling by ERBB4,38.49939956724249,19.03854545243042,0.3012475178972396,27.156999689924803,49.534923316197876,33.32807743939183,7.700745570259503,35.59601789809574,30.16322514599151,46.91924265201232,58.5385666447073,40.32254325243298
ADP signalling through P2Y purinoceptor 12,38.49939956724249,46.73108147115745,0.3012475178972396,23.835829339463086,28.27730154280571,18.02144209995282,13.427603022124888,41.98565364892496,29.513358335356187,36.542122024702216,46.42927038980057,40.42535060079738
Surfactant metabolism,38.49939956724249,45.93793173596488,0.3012475178972396,25.896435213783235,47.44680468480498,36.869845169766585,20.822662972146702,45.66045180520535,29.15765745365814,44.184800629279586,56.118325156585605,39.241685289794844
Processing of Capped Intronless Pre-mRNA,38.46096599873269,54.28068731309632,0.3012475178972396,23.52908064077984,43.638292399889686,34.71750851224698,21.540613708063887,42.014673235313914,26.742590514259927,30.015209704458645,43.32883901451752,36.970980008067194
Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant,38.43123781905288,32.283765115709706,0.3012475178972396,22.39456153984392,43.02039648269096,33.22033551929051,14.05942960481407,40.67879172534723,26.629773422327844,40.042674561466015,49.125822185791584,36.7887607803652
Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant,38.43123781905288,32.283765115709706,0.3012475178972396,22.39456153984392,43.02039648269096,33.22033551929051,14.05942960481407,40.67879172534723,26.629773422327844,40.042674561466015,49.125822185791584,36.7887607803652
TP53 Regulates Transcription of Cell Cycle Genes,38.4242245747712,49.99237045595059,0.3012475178972396,17.515046137361942,22.189553087012918,12.595485381720248,16.90815842533134,37.775471111437355,24.075392308855815,27.112533909812026,35.86957100106772,40.213224899354245
The canonical retinoid cycle in rods (twilight vision),38.40936291654219,46.248470252513144,0.3012475178972396,21.756316967846985,46.108511498621695,35.188743634486976,22.88481371615122,45.96236065975109,30.176610693722793,41.05754453584078,51.79685308551926,39.76108313385573
Beta-catenin independent WNT signaling,38.38665769499627,51.45667022467666,0.3012475178972396,23.434021780790943,45.08701230312372,40.97105453271665,23.84433647297811,41.493269353394126,25.57309412448793,30.640297542421635,37.87415558281362,35.36393769413616
Activation of SMO,38.36478774441748,6.97262880768765,0.3012475178972396,26.48928043860323,44.098656578443816,27.535282407698737,6.229958854739951,37.03640370415711,29.260200878267504,45.236212641030384,53.61948657410342,31.081754464421106
Ub-specific processing proteases,38.36478774441748,49.639991636702014,0.3012475178972396,21.16320896969283,44.52602037533305,38.501681574481225,19.852698095884907,39.107770483609734,26.04908706345255,27.411599143996092,38.56198669533729,34.081758851032966
Hedgehog 'off' state,38.342092292943065,53.97481361762142,0.3012475178972396,22.741932574878888,45.033155049142245,40.9731334106732,23.694086960103736,43.43807257966171,25.84786807079465,27.802416318734746,35.23382705682188,36.36449157654121
Constitutive Signaling by NOTCH1 HD Domain Mutants,38.33754912041662,34.501568054398014,0.3012475178972396,22.63413249931792,43.65516341533474,32.37497978940291,11.837980011172123,40.12165964293467,27.114009109839213,37.430175422070626,48.881046698984285,36.59419713718558
Signaling by NOTCH1 HD Domain Mutants in Cancer,38.33754912041662,34.501568054398014,0.3012475178972396,22.63413249931792,43.65516341533474,32.37497978940291,11.837980011172123,40.12165964293467,27.114009109839213,37.430175422070626,48.881046698984285,36.59419713718558
Mitochondrial translation termination,38.33754912041662,48.18283204157685,0.3012475178972396,21.56435068188596,39.535272661228156,27.09296075172395,12.758998074251405,38.51178780713424,26.328919466515927,30.061677052244995,38.250814037396744,36.212299135062324
TICAM1-dependent activation of IRF3/IRF7,38.33754912041662,46.5447003723047,0.3012475178972396,25.764751932044145,45.846857227231766,36.164297307304636,24.078389138368955,43.527454352687144,25.358265190203934,41.380743019999194,52.02911625169457,39.50522408103278
Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon,38.33053058422994,46.38911513857417,0.3012475178972396,25.827689545615872,49.491108851893244,41.14367148405461,24.18572147012519,43.592574571380574,25.066397476956183,42.585323104670174,52.11611693952636,39.006891892620615
Molecules associated with elastic fibres,38.32351130936082,44.788524697923904,0.3012475178972396,24.612209379499923,32.79917712958279,18.97994950748367,9.276479419536006,36.04922721781543,23.764363286506896,40.01296489784921,49.050682300106196,37.565594645503765
ISG15 antiviral mechanism,38.30865499007857,57.70533457040012,0.3012475178972396,19.99803225957477,32.668661460905426,23.663678131456074,19.689402146044877,44.084653404617626,25.84023641846009,21.881645347865405,29.072617271451215,37.861509678016944
APC/C:Cdc20 mediated degradation of Securin,38.30163506266223,52.37689469036468,0.3012475178972396,22.98358077708015,42.80035695318656,38.567195705317154,21.650187232194764,40.621699632663905,24.134198806995528,28.06661581678125,35.16030906802523,35.39953117461565
CDK-mediated phosphorylation and removal of Cdc6,38.29542693890783,52.73117916907094,0.3012475178972396,22.58978682257164,41.925383977821326,37.53080953906113,21.000051689360927,40.68930626134888,24.253252385750795,27.290190987100765,34.15153000355946,35.44833068392807
Signaling by NOTCH4,38.29542693890783,51.18153633774752,0.3012475178972396,23.784513003248133,46.05613524060308,39.7645038123871,22.023649759457104,41.24236730751728,26.38778282235882,31.250122430144458,40.75785097248157,36.73470866261224
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition),38.264907233552805,35.559916614279956,0.3012475178972396,25.474521197164215,40.19255462772873,19.359095892987394,4.512334424067748,34.55341168771406,28.465367983098734,45.116986056654675,56.170136360028245,39.121422502384114
Translesion Synthesis by POLH,38.23439893484029,54.751142824200194,0.3012475178972396,24.030553455146652,40.49357884697248,27.656276693823415,16.186369836730563,40.83010282217344,26.552365623737145,27.937995969030467,42.07646224004856,36.81541162139136
Formation of tubulin folding intermediates by CCT/TriC,38.22737949460592,53.80562882100904,0.3012475178972396,24.437281024290993,35.237843261850756,31.48587020191297,18.238331536389637,44.64519505849052,26.810890422988827,27.391263819744875,35.951140532465274,37.87487038264597
PIP3 activates AKT signaling,38.22035936131464,53.059198769628196,0.3012475178972396,23.35134696590652,47.49022215933212,42.321078870765554,24.31623056362538,42.71585575156336,26.595274406425474,30.45632740072545,39.563114049557434,36.755436080561815
Disorders of transmembrane transporters,38.213338540527936,54.32250669312243,0.3012475178972396,20.186036741960613,39.69129325492732,34.93809069593666,19.787143431417043,39.29009414950211,24.02477677303262,23.536786235830995,29.08670066844451,32.84048086353122
Role of ABL in ROBO-SLIT signaling,38.20631703777634,50.14829332092403,0.3012475178972396,25.36559283644993,41.961521586628486,39.934502526305366,23.415382175298532,46.424542754732066,27.75753260221113,39.55223643907919,46.69680400462204,38.041866220992695
MECP2 regulates transcription of neuronal ligands,38.192272008347814,38.90755251348141,0.3012475178972396,21.145536315698287,41.88464309034091,32.132587641577715,15.26747247523799,42.7720517512396,22.507025573416634,40.77815000727512,50.7176034070867,37.80308904121982
Cell-extracellular matrix interactions,38.192272008347814,32.8613336788926,0.3012475178972396,25.15879611240579,42.23710281166571,30.706268172835603,11.225547170187193,33.248497018843075,26.81850196568401,40.63865178823548,51.05496592212706,36.53279813923189
Synthesis of PG,38.18524849257967,17.21226955826627,0.3012475178972396,24.24493923884934,39.458033297344166,27.916186704769437,8.303928703946806,21.379022660011447,27.436681693279727,42.744599631022396,47.788492751439755,33.20908723612972
mRNA Splicing - Minor Pathway,38.16337932225448,58.11696102791886,0.3012475178972396,19.831290569650363,30.247224544714072,22.941683530584022,17.91184042580938,46.41918938719055,27.773541363764764,30.820390516494435,34.27929199583807,40.9218008516824
FGFR1 ligand binding and activation,38.16337932225448,47.16709181216641,0.3012475178972396,22.7959071997307,45.01520367997114,41.48580828567645,25.669725033891357,44.09026522655067,26.04218087057511,39.65461551892836,48.20576896924229,38.04853674938196
Downregulation of ERBB2 signaling,38.15635464953638,1.542856611955695,0.3012475178972396,25.507443070686634,38.23080428966822,14.376434458525855,2.1200087493669373,32.66909480262793,24.74309567636079,44.46963452168805,49.713693354064326,31.78027235959485
Ion channel transport,38.11024869856187,6.175263855080529,0.3012475178972396,26.78814666360102,49.4691724943517,35.738519500205484,11.278282603426371,38.34347948941795,30.396740731520918,48.49539969365023,56.70929040498039,36.54612675251248
ABC transporter disorders,38.1032267798239,51.461831540679434,0.3012475178972396,20.306630575371074,41.96825878409683,38.529172552760485,20.96968200494987,37.942635023593006,23.50587017942946,27.056569001458943,33.571556758789406,32.719556404984104
Regulation of beta-cell development,38.064960711939285,22.002664719093673,0.3012475178972396,25.8409756992574,49.04125687866305,41.415044515129644,15.920198069837445,41.21344736173557,28.151284997543343,43.76710994958807,51.873854281640256,36.68659260430463
PI3K/AKT activation,38.05013270771651,46.248470252513144,0.3012475178972396,25.328870592795347,50.18479896745989,39.934502526305366,26.316562469753414,51.4066358977357,26.67190883941766,44.418289459868184,50.54815298602375,41.23156005286551
MAPK6/MAPK4 signaling,38.03530650248314,51.17635707273919,0.3012475178972396,22.189097255375884,43.72259454862012,38.8243269530049,20.76838022950787,38.63696237345947,24.63866334235922,27.787180617194213,35.36311727295964,33.353101833736524
G1/S DNA Damage Checkpoints,38.02828692505201,53.95864971899448,0.3012475178972396,22.41988854276197,42.28176668845564,38.36331464370769,22.077535871037302,41.2254950299048,23.740691726818184,27.46743563685473,34.9082683895069,35.09029706612606
Transport of Mature mRNAs Derived from Intronless Transcripts,38.021266734833695,57.881705175215124,0.3012475178972396,20.909200840744187,28.56858346459989,16.350523103253934,15.494270564884534,40.953416937712994,24.409068229481843,20.53689898136102,34.73175372413295,37.167555863309786
G-protein activation,38.01502774540895,44.35990649510643,0.3012475178972396,24.30802510014229,28.628815296914766,17.190641761866754,11.867941870449728,40.812452018054486,29.734272369994095,37.611382816037455,48.01432953491502,40.09504569559397
Negative regulation of NOTCH4 signaling,38.01502774540895,51.84209630672364,0.3012475178972396,23.011481137616588,44.97450683358357,39.45814606068797,22.048117328839243,40.203998322237375,25.040930136796515,29.929023940854734,38.418878484772605,35.86913533705871
NOSTRIN mediated eNOS trafficking,38.00800494008499,56.25414314204185,0.3012475178972396,13.96826678621897,13.22965943218935,26.267964969854503,29.67976205030989,44.48901530547215,18.619420179389287,24.593643159875672,12.012341664889517,38.97826820896735
FGFR1c and Klotho ligand binding and activation,37.96978000967911,48.88111961392462,0.3012475178972396,21.780148266418816,46.86934834523047,36.96858200715261,23.3919602625692,45.83731256527768,2.426838489388874,39.62499434416965,52.43985888211818,36.976889119943486
Abacavir metabolism,37.95573791558641,56.516303432384774,0.3012475178972396,21.43706690114561,41.05447630431649,31.610155058819117,25.203458495104435,49.26784413595279,26.241852724603593,33.143472554414515,53.99321504821496,43.26942674285414
Transport of Mature mRNA Derived from an Intronless Transcript,37.95573791558641,58.11940254806578,0.3012475178972396,20.228409550471028,28.490396710420857,15.209799198119294,16.146864101661645,42.347025152820265,24.767791273781533,20.2220292235223,34.966775784988,37.48896875913464
Pausing and recovery of Tat-mediated HIV elongation,37.91051781416231,55.026629391622784,0.3012475178972396,22.153727270339566,14.30660611622103,14.42461442271813,14.31373957639844,41.16199229597807,25.530067765762,33.59786197443343,34.95956072470027,41.96499853230637
Tat-mediated HIV elongation arrest and recovery,37.91051781416231,55.026629391622784,0.3012475178972396,22.153727270339566,14.30660611622103,14.42461442271813,14.31373957639844,41.16199229597807,25.530067765762,33.59786197443343,34.95956072470027,41.96499853230637
Adrenoceptors,37.903497987509446,53.22731621060871,0.3012475178972396,24.290279495606214,38.028497561996055,30.997635773557178,19.082872952304985,44.10813643991492,26.98132721893792,33.09240679088081,43.3961802363339,39.006891892620615
Defective CFTR causes cystic fibrosis,37.89724694189114,50.881868520528116,0.3012475178972396,20.45628106011575,42.07081466294407,38.46794974701422,20.350191827207105,37.36139105250526,23.87503750086568,27.335010271693633,33.767799427534605,32.84048086353122
Interconversion of nucleotide di- and triphosphates,37.89724694189114,47.32310218667957,0.3012475178972396,21.721184065481825,33.957370577896306,26.264563315122906,14.903878515247134,35.26223397756751,24.783611527283185,22.426813914245685,28.636606726896744,32.706194818264784
Transcriptional regulation by RUNX2,37.88243515012969,53.84908308101347,0.3012475178972396,21.64370403711752,43.22855761933717,38.54333466861569,24.144578617495554,42.12158216788867,22.632770067079008,26.141342900111226,34.187498508960346,34.246475192857986
Cholesterol biosynthesis via desmosterol,37.87617837810667,50.76231793602606,0.3012475178972396,25.39465893687888,28.095535742901554,19.72004174292238,14.065190140803658,46.87467952956248,25.24699049857557,34.4034162474677,37.937158776713076,39.59122094724892
Cholesterol biosynthesis via lathosterol,37.87617837810667,50.76231793602606,0.3012475178972396,25.39465893687888,28.095535742901554,19.72004174292238,14.065190140803658,46.87467952956248,25.24699049857557,34.4034162474677,37.937158776713076,39.59122094724892
Signaling by Hedgehog,37.869154439589984,54.42676494858702,0.3012475178972396,21.917460056322014,43.66629740196061,39.802226218479646,23.565315422030373,43.001687597825494,25.092540832948302,26.007589417570504,32.73112654829656,35.603513349441194
Presynaptic function of Kainate receptors,37.8543437124972,47.79753613975621,0.3012475178972396,25.07978815450982,25.512161982580842,18.530806101360024,15.706803730610543,41.03357585245597,30.26124221678135,35.87163560540323,44.77643270269636,41.245856735671055
MET activates PTPN11,37.83953487806916,22.36937020580497,0.3012475178972396,23.36015097579167,41.39371559267101,39.25389510096324,17.174365606636776,33.47671495443347,25.186951637925937,44.00576790068495,48.17853893093467,37.63134308326054
TRAF6 mediated IRF7 activation,37.824727940976246,46.515655456718264,0.3012475178972396,23.942967660053178,41.652265459278,32.61876191331871,20.637017950111158,40.10969808304265,22.696693744752903,39.51634508234671,46.28701694953213,38.84002926321937
AKT phosphorylates targets in the nucleus,37.77880533732326,15.043868493014845,0.3012475178972396,25.507443070686634,31.99462540530317,23.988684230180542,15.118816463431093,35.74875370446791,22.357482298821438,33.715133646209914,35.498272461315196,26.708680801177174
Presynaptic depolarization and calcium channel opening,37.75623290834596,9.20823246343347,0.3012475178972396,24.437281024290993,45.92412777763307,26.729900399956463,6.358193943146687,43.392841440778696,29.37371043415928,44.73214168051633,54.37707158728762,37.55973011123387
Regulation of mRNA stability by proteins that bind AU-rich elements,37.71812217487866,50.580434091187286,0.3012475178972396,20.978312684573048,42.88928067141027,37.53424015092987,19.175794028982914,38.541516136428676,23.967910994323965,26.945298497692107,34.02709736578376,32.82709813723484
Caspase activation via Dependence Receptors in the absence of ligand,37.689303351863444,54.470289818875465,0.3012475178972396,25.063075975182613,51.101319156918244,46.00660623402901,29.67976205030989,51.903068241941455,28.384908127216264,35.43672810415497,48.73882067113357,39.170078801238155
Vpr-mediated nuclear import of PICs,37.689303351863444,58.0357185299387,0.3012475178972396,19.71921684503388,26.449023643189435,14.041670287477032,15.316272309732675,42.328366234162345,23.329485230329478,20.666405092319835,34.384358231410005,37.3302823195425
Platelet sensitization by LDL,37.689303351863444,42.18170503632472,0.3012475178972396,25.122058686404085,45.870255783838935,34.04633601473701,18.779793588504255,41.40634260479074,28.80108079440989,44.58083056428696,54.06127342926405,39.26933590698854
RHO GTPases activate PAKs,37.68228639129001,41.48829310641936,0.3012475178972396,24.453011098273013,38.06301503489538,24.628340959456217,15.790470842671729,36.98460284231462,26.933206568355512,40.509944356622974,48.57609936705405,38.50791200984198
p53-Dependent G1/S DNA damage checkpoint,37.66048574623163,53.407719053157905,0.3012475178972396,22.137848576457134,41.96530965928011,38.35051082847459,21.955037680028273,40.20962609434652,22.762365550258924,26.726192184809427,33.883682839008564,34.20557372185664
p53-Dependent G1 DNA Damage Response,37.66048574623163,53.407719053157905,0.3012475178972396,22.137848576457134,41.96530965928011,38.35051082847459,21.955037680028273,40.20962609434652,22.762365550258924,26.726192184809427,33.883682839008564,34.20557372185664
PCP/CE pathway,37.58362436159799,51.00251358133247,0.3012475178972396,21.771530742095837,42.85084443453597,39.65084328291722,22.801661186988284,39.209392074165805,22.67236783456303,27.10784185795961,33.50477457278499,32.514383643347884
Signaling by Insulin receptor,37.56110320319418,17.89279975931996,0.3012475178972396,26.92505216533195,46.411954497202395,41.119549953590415,17.492328851709978,34.27095464186789,28.960924492409532,47.93407419906861,52.967319567893625,37.86819045487108
Integration of provirus,37.55409353398878,50.458788107219114,0.3012475178972396,21.50033481872972,38.55418450953133,30.261396044242154,17.356532005136007,45.71886792125278,25.546715574218172,32.88341864670044,35.249789598037054,39.931969753033066
Synthesis of bile acids and bile salts via 27-hydroxycholesterol,37.524570529694984,36.35169646557501,0.3012475178972396,23.96067426435524,42.901480183081254,32.55866281771847,12.591986000476004,36.536578217485356,25.823525486583563,40.38139554035963,52.88560823496022,35.546682229384054
NTF4 activates NTRK2 (TRKB) signaling,37.524570529694984,36.882897772012285,0.3012475178972396,19.23953871531881,34.62629019292495,19.457448956783857,19.31225159032194,45.434574168020774,24.571705623871303,31.75246389846021,41.11508014083805,37.53809504509884
Pausing and recovery of HIV elongation,37.511289165672395,54.91363506232721,0.3012475178972396,22.137848576457134,14.324506126781156,14.208782013989106,14.235669132148692,40.83420895708389,24.74309567636079,33.49748676275407,34.85243192877823,41.8749367241653
HIV elongation arrest and recovery,37.511289165672395,54.91363506232721,0.3012475178972396,22.137848576457134,14.324506126781156,14.208782013989106,14.235669132148692,40.83420895708389,24.74309567636079,33.49748676275407,34.85243192877823,41.8749367241653
Nef Mediated CD8 Down-regulation,37.511289165672395,40.95063668120179,0.3012475178972396,24.48065642114429,39.3131432206287,35.764510110083826,18.454296582085323,41.88306784014978,29.746995765700845,42.41050352235014,46.17179793441177,38.48606947454968
CDT1 association with the CDC6:ORC:origin complex,37.505013041319465,52.427711487030095,0.3012475178972396,21.63510013502873,41.549679856767256,38.21451611291814,22.207437622316196,40.3089647506587,22.291848877452782,26.57507013642874,32.95102974882747,32.99128174723416
Aggrephagy,37.505013041319465,52.80236911378462,0.3012475178972396,23.56526690984155,37.19111057346901,34.76544687888487,18.553479313939427,41.23674418205631,24.84386789071973,30.056750292408935,30.18221735845454,37.84731600341292
Prostanoid ligand receptors,37.4902530681596,44.47176555538225,0.3012475178972396,24.69954078597171,38.64076835989372,21.43832794745425,12.23321109654946,44.45887075075819,25.926744410727064,40.67908815849102,56.5592205825533,37.68133881659505
Prostacyclin signalling through prostacyclin receptor,37.41356349739976,48.312254435587136,0.3012475178972396,24.039404538348588,23.928874810846715,15.195541886418509,14.014715838530782,42.228609434342786,28.591530701724047,33.7660652155163,40.92353895211132,41.342399698338305
Degradation of cysteine and homocysteine,37.391084223925574,41.69742587969102,0.3012475178972396,22.315637854530944,39.83027606214897,29.0401018608605,16.640421431750337,48.00967134435175,28.187228168115443,40.626943707084735,53.37647159589005,41.01417957837009
Laminin interactions,37.36861098513417,40.14362545542437,0.3012475178972396,24.763946266326897,40.44589519182388,29.53392282228388,11.372909309304648,36.973031914927894,25.790823537086947,42.88708626734567,50.39921194749387,39.170078801238155
ROBO receptors bind AKAP5,37.362335378584795,33.44087102697152,0.3012475178972396,25.456784547668047,45.81435502345182,31.549433856040135,13.492564305352905,42.42345735334765,28.393353049662256,43.178004419964466,52.601033462602615,38.610512173569276
p75NTR recruits signalling complexes,37.362335378584795,58.14517817662252,0.3012475178972396,19.620032107724864,35.12365387067956,35.38343134728025,25.237605891144806,43.52182422042245,22.12737836295369,25.424938139866658,33.4576190244362,40.97123932632402
RAB geranylgeranylation,37.35533006677342,3.3218470589578666,0.3012475178972396,26.571880485670103,49.60395377527721,27.192027012243013,4.3670324755781245,39.75802457656434,28.92140835262217,48.63795603149775,58.35147689386599,38.03519473379053
Assembly Of The HIV Virion,37.348324347782736,23.368231313810984,0.3012475178972396,24.78174782825947,45.62499136964471,36.18093338244645,15.092394889216951,39.99862964861239,30.708527470897664,46.91718287278239,55.41893368541694,45.13355468926681
Apoptotic cleavage of cell adhesion  proteins,37.34131822566335,11.68654796166009,0.3012475178972396,21.572288938904638,34.29199331825616,33.183109023724214,20.651703654042212,38.208211438868354,25.040930136796515,38.38944986144146,40.024866149839326,35.48989502304519
Ca2+ pathway,37.31885464059892,54.397922239433576,0.3012475178972396,23.879167433105223,23.607157785065155,21.0125174135866,23.241010519525116,46.941904169474846,25.98061050120823,36.12865682254647,38.41565699550214,41.90973320089785
Cyclin A:Cdk2-associated events at S phase entry,37.28939304032369,53.37221267792856,0.3012475178972396,20.16932660277273,39.8949952902431,35.03224464643223,19.53720574997916,38.337920645229985,23.623434443034515,23.69773881301514,30.46737580147886,32.88762324419365
Binding of TCF/LEF:CTNNB1 to target gene promoters,37.28939304032369,2.1050181752693553,0.3012475178972396,25.927007705369235,47.2672183932549,32.61509068200177,13.396583719496295,40.83010282217344,30.03764183679257,45.47775562345678,55.32251098070135,30.92863861820022
SCF(Skp2)-mediated degradation of p27/p21,37.22906097091938,53.262824003939876,0.3012475178972396,20.4820961863636,40.1751909844127,36.38569116883017,20.954988949904976,39.08344594691222,22.3165182753091,24.36894984060602,31.435689248114077,33.26291604871487
Reversible hydration of carbon dioxide,37.22906097091938,18.02211663731499,0.3012475178972396,26.52685065914217,51.74553186004216,39.45814606068797,14.077203817838893,33.17483567483288,30.904250251857594,48.32123768548545,58.70462962623125,37.69469028793539
Phospholipase C-mediated cascade: FGFR1,37.19891252880641,45.15437987483161,0.3012475178972396,23.119951535056344,44.64910619856924,41.26759416515538,24.34835310347877,42.71585575156336,26.39542081472815,38.70833879089386,47.045481351644895,37.00353840259271
Asymmetric localization of PCP proteins,37.1764878032149,50.15354733506436,0.3012475178972396,20.710893368195794,40.94950620853414,38.10923971494275,21.038770304376477,37.448864862105864,21.86572710505787,25.763547409893704,31.714648531704576,30.79771444809334
Loss of Function of TGFBR2 in Cancer,37.162493246052804,41.35029710621239,0.3012475178972396,23.165480678940856,34.54902865794175,25.755231711109623,10.553997472199528,29.16797789931682,26.08408885156142,39.983258981919164,50.064730574884784,36.69253628526794
TGFBR2 Kinase Domain Mutants in Cancer,37.162493246052804,41.35029710621239,0.3012475178972396,23.165480678940856,34.54902865794175,25.755231711109623,10.553997472199528,29.16797789931682,26.08408885156142,39.983258981919164,50.064730574884784,36.69253628526794
Cyclin E associated events during G1/S transition ,37.10925016135826,53.10251428935187,0.3012475178972396,20.058019109681638,39.83408097511996,34.773736988094385,19.067773962491884,38.07622592513736,23.564616442519235,23.66039826724746,30.3474819249484,32.56936796061266
Defective SLC7A7 causes lysinuric protein intolerance (LPI),37.10225681886164,50.94217695202516,0.3012475178972396,22.81338169314415,35.57055776407006,39.261733669198854,25.788505946864934,44.63961939608558,24.94047171743185,30.90786826416996,29.344493829412066,36.80948889615515
InlB-mediated entry of Listeria monocytogenes into host cell,37.09526312028242,15.736246997072016,0.3012475178972396,23.08486968330492,38.65719658400694,25.24642658173978,4.2935863916955785,33.659472802822556,25.460734658242437,35.374019940684576,46.1583734033381,32.397073069124595
PTEN Regulation,37.07286528467586,51.812907555996716,0.3012475178972396,22.8221197840635,45.80747067969086,39.711820407429094,21.406045032870292,40.39283323426717,25.84023641846009,29.008167417507153,37.19785786131033,34.20557372185664
Urea cycle,37.05047355849989,35.49300252460915,0.3012475178972396,24.151425858417472,45.85029019319131,32.30541453082601,18.089448206844647,43.32411357218685,26.560788103403176,48.045023033515655,57.624125420014316,38.235939327731934
Interactions of Vpr with host cellular proteins,37.043482043347986,57.57186475196398,0.3012475178972396,19.58540775716963,26.813116512872607,15.22367166976698,14.674627587946956,41.343609029653464,22.970162577131976,19.768083322534146,31.55085835073438,35.9394764452466
Triglyceride biosynthesis,37.02949799374782,33.791319924349295,0.3012475178972396,24.057106481930372,47.18396945712999,39.195865444884,22.329021753251727,41.20298527112227,27.74904974315098,42.99893332065949,53.93732505276038,35.88306321747861
Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha,37.02949799374782,51.36183383574956,0.3012475178972396,20.6843535404755,41.37236959154945,37.425591887014804,20.591149126376067,38.56505093419092,22.499680174969992,24.55470858067299,31.432253820615948,32.01860872857113
Host Interactions with Influenza Factors,37.022505466729605,57.56493742314288,0.3012475178972396,18.586565563045543,23.323434379000243,10.31417328055836,12.263690878903322,39.90664361330552,22.632770067079008,16.17231799226552,29.972392264833612,34.47778308305538
NS1 Mediated Effects on Host Pathways,37.01551260982268,57.56254278119434,0.3012475178972396,18.586565563045543,23.333278069594805,10.307147113148774,12.269526562355553,39.90664361330552,22.632770067079008,16.175935754148533,29.97953938291165,34.48430886165889
ERBB2 Activates PTK6 Signaling,37.00921933737544,12.437127375564113,0.3012475178972396,25.29571518330604,46.32728748994806,25.839950982695097,9.905594528959654,40.971850400686826,26.126752334976214,45.44659469190506,54.7605955412238,37.929971649400954
RUNX3 regulates WNT signaling,37.00921933737544,0.5278817309057661,0.3012475178972396,27.314191156812576,47.68158663723452,30.511121371308707,9.982326973729949,38.26686937372934,31.195263988946287,46.719448975528294,56.5592205825533,29.712812725560617
Degradation of beta-catenin by the destruction complex,36.99453209638208,51.33785508006226,0.3012475178972396,21.572288938904638,43.07854499101607,38.94223238130252,21.50710726224216,38.49382885782753,22.499680174969992,25.99792048173809,32.266950299263684,31.86841116407445
Cellular response to hypoxia,36.933717945508285,51.51497343456472,0.3012475178972396,20.548256914198657,41.09327988325162,37.28654174200536,20.426137049378664,38.58922733271148,22.491786300555933,24.10278656339082,30.967801375540613,31.827758169479615
Autodegradation of Cdh1 by Cdh1:APC/C,36.92672914444392,50.52844259487288,0.3012475178972396,20.710893368195794,40.853750744278116,36.93643851839263,19.63045616612333,37.6497262799913,21.97186588020087,24.535921833117467,30.900721490363356,31.518215691683338
NOTCH4 Intracellular Domain Regulates Transcription,36.89738558384079,42.02449828916174,0.3012475178972396,24.583478491133413,45.90275813756345,34.98613021351601,17.498610643865927,40.387202149591154,27.05228823121209,37.96732529400913,50.391599378570085,37.49564272790162
FBXL7 down-regulates AURKA during mitotic entry and in early mitosis,36.89738558384079,51.28881515691429,0.3012475178972396,20.473683845830397,40.80438563067394,37.7107869324036,21.421830838650603,38.43252355790009,21.045919138617084,25.124840923249163,30.99431958056574,31.12817632192607
PI-3K cascade:FGFR2,36.86735840283414,39.34954819115058,0.3012475178972396,23.683645441740893,45.496533162747575,42.80990472060367,23.029811989769556,39.917197686582455,27.782020684700978,40.30918862081294,46.331303624610214,36.46263764877741
GLI proteins bind promoters of Hh responsive genes to promote transcription,36.861063428332194,26.800284821812685,0.3012475178972396,22.946946535073057,29.857047424568695,18.75512414949911,10.348902712638385,33.9403642567867,25.323690545211168,39.20715478553125,46.91748774552649,32.03183362758863
SCF-beta-TrCP mediated degradation of Emi1,36.861063428332194,52.00454270017826,0.3012475178972396,20.858964406443206,41.35561145780294,38.38745379450069,22.116723678484107,39.04303235033054,21.19653921692251,25.763547409893704,31.95932970631977,31.672255790061392
NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux,36.854076060438146,33.895697424636964,0.3012475178972396,24.408633361299675,48.56341753926762,44.470571316639166,23.701281318770786,41.56654906214824,23.58998308975687,38.7439527974474,47.349814286993606,33.00469600239363
p53-Independent G1/S DNA damage checkpoint,36.794750105374945,51.69499818425846,0.3012475178972396,20.194393688791852,40.80285680212944,37.7532997859961,21.459707499367994,38.373151873338784,20.982766041214845,24.895445869844437,31.24510193754344,30.90316886243563
Ubiquitin Mediated Degradation of Phosphorylated Cdc25A,36.794750105374945,51.69499818425846,0.3012475178972396,20.194393688791852,40.80285680212944,37.7532997859961,21.459707499367994,38.373151873338784,20.982766041214845,24.895445869844437,31.24510193754344,30.90316886243563
p53-Independent DNA Damage Response,36.794750105374945,51.69499818425846,0.3012475178972396,20.194393688791852,40.80285680212944,37.7532997859961,21.459707499367994,38.373151873338784,20.982766041214845,24.895445869844437,31.24510193754344,30.90316886243563
AUF1 (hnRNP D0) binds and destabilizes mRNA,36.76476046838554,50.099094507570214,0.3012475178972396,20.08359248975492,41.10164324926056,37.40687958554435,19.904505174456155,37.519252248244186,21.100486208551658,24.468888362817903,30.58498097314759,30.440092167045524
Condensation of Prometaphase Chromosomes,36.719456374538595,54.95624730131507,0.3012475178972396,26.331039884090913,39.131039044745734,38.306808800978615,25.14972344649806,43.1087514117864,28.329005915021572,37.28207795400648,40.80101788939341,41.30448050455376
"Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein",36.7048167020509,12.907071395577647,0.3012475178972396,25.00957526082539,52.067245822389594,33.92039021455856,7.873204947576071,41.137893900402766,28.077148053484677,44.80405850123734,57.54470096215367,33.950439119150836
Signaling by TGF-beta Receptor Complex in Cancer,36.69851994449245,24.218653259372918,0.3012475178972396,24.133700605938078,35.00374525225729,18.18438765638575,9.883947784473685,41.06406525765522,23.75627380360571,40.131825228703036,49.25177693229787,39.47094386569112
Regulation of RUNX2 expression and activity,36.69851994449245,52.38832978285975,0.3012475178972396,20.624094554746065,41.4410014939228,38.82131330796933,23.19556751414479,39.90101963810123,20.357837102938902,25.6833679899757,31.67613400337141,31.391269575340104
Inwardly rectifying K+ channels,36.64560048084952,48.5261628926222,0.3012475178972396,20.341314821315923,46.25092649379161,44.4793355607012,24.371424544809187,44.378519288965705,24.965901032828913,34.68707369432395,38.41565699550214,34.04032793400338
Hedgehog 'on' state,36.630972677624165,50.121071939450204,0.3012475178972396,20.27139819116022,41.132091583480246,37.18635864182803,19.93528267175994,37.91249943304091,21.727201972969432,25.031687881625984,31.65755849395822,30.572854311134204
Regulation of RAS by GAPs,36.60869640845859,51.16599168666668,0.3012475178972396,19.36455861066955,40.80285680212944,37.68128257446397,20.515955315625742,37.17829596074193,19.98789629972392,23.93601253500485,29.267158696650252,29.770962675415387
Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding,36.594074559780644,52.85069105220109,0.3012475178972396,25.621056627731164,40.07036650139833,38.36650030634085,23.086954106922246,41.54802113118709,28.691355514339232,37.00479027530098,43.65686825141688,40.31597421530356
VLDL clearance,36.5335874027987,32.527079285461475,0.3012475178972396,23.851709426272453,40.149505410747246,38.68565939256891,22.485425363617406,36.88377006567018,24.734865131727855,40.15852962696555,42.218928430362645,37.28869720046844
SUMOylation of RNA binding proteins,36.52662054178422,54.29836855834571,0.3012475178972396,21.676801557803397,34.89188592625139,28.916748896122456,18.77265509463953,38.22549749193818,24.538252907531792,26.970633024202026,37.61788528299518,35.11853396461905
TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling,36.52032624413939,48.28434560038871,0.3012475178972396,22.8221197840635,43.10478963563466,40.5347103156218,27.046630114725016,42.3058190804623,23.63091659669094,36.542122024702216,39.97275023915406,36.87168349966404
Fructose metabolism,36.52032624413939,22.243950985291786,0.3012475178972396,23.5202504903296,40.93202075863134,18.432683252111012,5.97954144158594,39.467882696857934,27.642577276719233,45.36256723178329,56.11628572664838,39.70375260174458
Regulation of HSF1-mediated heat shock response,36.49808000498248,47.24207156859869,0.3012475178972396,20.91767969189408,29.170583846530974,15.864053340715278,5.213581639025859,32.20453795331219,24.40150921563869,29.664745181728133,36.704049110328455,35.46944328868358
Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB,36.483476098128996,50.59809633758818,0.3012475178972396,17.201306805716495,36.50928316979665,28.677211257418627,26.94301202779389,44.79813312312382,20.27267580954314,26.77666248529688,33.49321589073872,35.71865597191859
Degradation of GLI2 by the proteasome,36.476509683777586,50.62619764481527,0.3012475178972396,19.84568059287951,40.48070633688828,37.47171072926395,20.57646716977903,37.53641316080291,20.748764316933183,24.493008777452868,30.38897741002797,29.85572730530888
Metabolism of polyamines,36.44100974927191,51.50465867833149,0.3012475178972396,19.62829016901626,39.47079053722532,36.837732209754286,20.927530903582475,37.466015644736295,20.13283528969029,22.509751829297567,27.629693520365695,30.091758563025287
Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits,36.44100974927191,47.52280660586064,0.3012475178972396,20.752533169364785,46.15932676577334,44.6244982289873,23.937157222346613,43.96299932952523,25.092540832948302,35.24873847291416,38.55069075214795,33.72387426158086
G protein gated Potassium channels,36.44100974927191,47.52280660586064,0.3012475178972396,20.752533169364785,46.15932676577334,44.6244982289873,23.937157222346613,43.96299932952523,25.092540832948302,35.24873847291416,38.55069075214795,33.72387426158086
Activation of G protein gated Potassium channels,36.44100974927191,47.52280660586064,0.3012475178972396,20.752533169364785,46.15932676577334,44.6244982289873,23.937157222346613,43.96299932952523,25.092540832948302,35.24873847291416,38.55069075214795,33.72387426158086
Degradation of DVL,36.404189627959845,50.09382843832054,0.3012475178972396,19.6354719148274,40.570835826862535,37.722407739241525,20.570024104174994,37.384049020791664,20.412518592659776,24.40194608245011,29.770859688518602,29.5890735921471
Stabilization of p53,36.404189627959845,51.50465867833149,0.3012475178972396,20.16097341435495,41.067409919868986,38.0168463743787,21.428127607897565,37.81169308135554,20.497968954984422,24.715125547714337,31.04695197553099,30.3096730135828
Post-translational modification: synthesis of GPI-anchored proteins,36.39722494080124,23.65496179351635,0.3012475178972396,23.591767950694067,46.095421576902595,34.709218328507994,10.526624925556158,35.81874482600436,27.35691072596872,41.77314339224578,52.948629664503784,33.39355054179919
Viral Messenger RNA Synthesis,36.368046160380686,56.98258111407786,0.3012475178972396,17.312243839268074,17.861859932004656,12.096402137264498,11.790467248592169,39.05978798765111,23.27275101047226,13.328704068552124,23.835249033899117,33.662637790374234
Degradation of GLI1 by the proteasome,36.368046160380686,50.77273246882142,0.3012475178972396,20.144270809660476,40.853750744278116,37.85306643964539,20.83831591459807,37.76993596541384,20.90546660811283,24.43094047285186,30.62281416937251,29.92066362929687
VEGF ligand-receptor interactions,36.354118627871934,40.33936310535076,0.3012475178972396,24.24493923884934,43.2079504605231,28.649287014440688,12.691320527957448,34.84241505281175,25.254605734691495,42.032206344321835,50.925343451766324,35.40612269706133
VEGF binds to VEGFR leading to receptor dimerization,36.354118627871934,40.33936310535076,0.3012475178972396,24.24493923884934,43.2079504605231,28.649287014440688,12.691320527957448,34.84241505281175,25.254605734691495,42.032206344321835,50.925343451766324,35.40612269706133
Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4,36.34781110527111,53.69915199681782,0.3012475178972396,19.83848771849597,35.04528263925471,36.06619070632437,22.298321016494196,41.20861412930624,26.04218087057511,32.86173214617045,32.477369308488406,35.08437033252924
Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4,36.34781110527111,53.69915199681782,0.3012475178972396,19.83848771849597,35.04528263925471,36.06619070632437,22.298321016494196,41.20861412930624,26.04218087057511,32.86173214617045,32.477369308488406,35.08437033252924
Vif-mediated degradation of APOBEC3G,36.33322591267333,50.07000278031403,0.3012475178972396,19.79757125090357,39.92892183299045,37.06841777760353,20.2760222714843,36.9195745181809,20.90546660811283,24.12672195628026,29.311634459796043,30.42822040839374
Ubiquitin-dependent degradation of Cyclin D,36.326261308570345,50.809118372141086,0.3012475178972396,19.264617146561786,40.506452408005885,37.67304756543996,21.352399337915408,37.578047508941815,20.0701026163437,23.987716614637783,29.957675794825768,29.86186485979784
p75NTR signals via NF-kB,36.31929652658136,58.13043291661354,0.3012475178972396,18.718583179117637,31.85915851859647,32.053664834718276,23.83718198826821,41.318688625152056,20.467760017337,22.7036037089886,28.437248682017668,39.79416296844697
XBP1(S) activates chaperone genes,36.304714836022875,52.971535392630734,0.3012475178972396,19.68613399425436,39.13929349113728,35.00638893414256,19.82196977168258,40.508549943141624,23.305410864435302,20.08333704912905,29.233928309373464,31.24311497630477
Regulation of Apoptosis,36.2977505142655,50.17118363639525,0.3012475178972396,19.499251445808103,40.536742311800914,37.45999324376972,20.72976932371727,37.03089933871836,20.288190322279586,24.291477390376084,30.21133660360553,29.436080351167625
GLI3 is processed to GLI3R by the proteasome,36.23750278768526,50.83301470178441,0.3012475178972396,19.11334946406862,40.05823914744248,37.08148963919143,20.853973453653552,37.30824850741709,19.98789629972392,23.674451354131293,28.866775341025715,29.198045374929684
Keratinization,36.231192465614356,2.24988378639991,0.3012475178972396,25.037427193997033,49.36239648675849,36.92934142611434,7.577525093401826,25.13140882159251,29.427761165876753,43.11810834993468,54.17518804300369,30.052270001442658
Autodegradation of the E3 ubiquitin ligase COP1,36.231192465614356,50.33521650335937,0.3012475178972396,19.390241916333466,40.51025003074587,37.42906116780755,20.86133111396203,37.20700164480844,20.02477458976774,23.949712889007763,30.148460269946423,29.327056123978284
Hh mutants that don't undergo autocatalytic processing are degraded by ERAD,36.20141360517932,50.10435900342323,0.3012475178972396,19.339945533523455,40.04089808742015,37.112408326880086,20.706798608426386,36.80839584147606,20.226645694468047,23.873796624243102,29.748650620754194,29.115188106283952
Regulation of activated PAK-2p34 by proteasome mediated degradation,36.14884492101317,50.121071939450204,0.3012475178972396,19.2323950781015,40.127632991454824,37.32228949687156,20.76195727960061,36.872213347006415,19.957568787249834,23.812959601542495,29.55958289751965,29.0511215828958
Interleukin-1 signaling,36.14189173537086,52.54443933268883,0.3012475178972396,18.869300118400787,40.30458470228021,37.05076173574445,20.934884138117805,38.1428042009961,20.567968246325833,22.661933409196536,27.65431731245902,30.785261641537204
IRE1alpha activates chaperones,36.127341035407625,52.99571084265221,0.3012475178972396,19.474561584884206,38.678699873842085,34.64747773396641,19.615153822814325,40.3815703705458,23.13890418712299,19.57809761239231,29.16337845892485,30.99472719120623
Degradation of AXIN,36.120388356239204,50.43589397639374,0.3012475178972396,19.32301882172262,40.28938699053836,37.45999324376972,20.891711097526482,37.17829596074193,19.92632948797083,23.902467957861788,29.481958729128053,29.25010193685074
Regulation of ornithine decarboxylase (ODC),36.10584058976288,50.40058185888752,0.3012475178972396,19.054738869988324,39.661238859807575,36.99596762452176,20.59848977087911,36.81938650579153,19.579727538341327,23.163172018717216,28.67278125307615,28.928294726494702
Cellular response to heat stress,36.09888842838155,45.23902092378263,0.3012475178972396,20.506754033928537,29.047050550717692,15.471388097940503,4.753160395989633,31.375662154395243,24.227539546922237,29.761407429975254,35.793749694248845,34.79543178677549
NGF-independant TRKA activation,36.053981598112,24.774778935295796,0.3012475178972396,22.024636633296304,33.13170298161646,14.262487282173023,19.852698095884907,46.401632399672735,20.483348968180334,27.33030273295061,38.941516837424125,32.6104975230421
Defective EXT2 causes exostoses 2,36.0400846553184,38.0946074512997,0.3012475178972396,21.412662671021508,38.07495028978627,20.94737806597834,11.614442114788261,40.63861150190059,22.12737836295369,39.84359167207934,45.721335233857744,33.86187153964266
"Defective EXT1 causes exostoses 1, TRPS2 and CHDS",36.0400846553184,38.0946074512997,0.3012475178972396,21.412662671021508,38.06678594675299,20.94737806597834,11.614442114788261,40.63861150190059,22.12737836295369,39.83823422837587,45.721335233857744,33.86187153964266
TRAF3-dependent IRF activation pathway,36.01038021648757,45.569168264571175,0.3012475178972396,23.802219725254123,39.70407823155185,30.89626747598381,19.966080647533257,37.230201381503704,20.59922569906636,36.333526051263455,43.54018738515466,36.10711632232663
Transport of connexons to the plasma membrane,36.0034338374719,57.232818550058425,0.3012475178972396,24.4451497766005,26.81634966910029,32.727286110819804,24.898926612162708,49.40699568906191,25.774115348135624,23.63712834524328,24.408895153247276,38.94107691545554
2-LTR circle formation,35.996487331835546,51.94620646332675,0.3012475178972396,20.556085658606953,39.782196757162545,31.06941126810999,17.5055341675706,44.95879601154051,25.09881154324999,30.999363797976816,35.970912092857596,39.525154739492706
Hedgehog ligand biogenesis,35.981959481841194,50.94217695202516,0.3012475178972396,18.7594897857953,38.355461933002516,36.486334282987784,21.05446335189701,37.002244469804204,19.625946033454678,22.61641622874271,27.382561266292,28.554918863629204
G beta:gamma signalling through PLC beta,35.97501353823995,46.68482172230844,0.3012475178972396,24.023590549627894,22.07146458683498,15.62075644454312,14.379885075695025,38.85304089338227,28.986098662781796,32.88341864670044,40.55268975722855,39.60900402261209
Negative regulation of NMDA receptor-mediated neuronal transmission,35.95291068489309,34.92770693936323,0.3012475178972396,20.058019109681638,44.79983645596667,28.036747206382294,10.0210040462189,41.99777340978498,24.596965380916977,29.008167417507153,43.697547900760775,33.05252498895014
Chaperonin-mediated protein folding,35.93838974332787,51.08681868410319,0.3012475178972396,23.3777600614428,32.220513064893666,25.223522824657454,18.006880633224572,43.611432785313674,26.458183097657,40.882630043650025,48.659972935315416,41.559667417614186
Vpu mediated degradation of CD4,35.91629715329072,50.412028973132095,0.3012475178972396,19.10570682800537,39.79948849779029,37.417320036164575,21.367124400413754,37.05405523211139,19.45013997806652,23.651174748035015,28.85315283848252,29.09600904275157
"Glutamate binding, activation of AMPA receptors and synaptic plasticity",35.90998465622775,33.966122202279855,0.3012475178972396,22.0851924064195,46.15932676577334,34.91686709003705,11.754897376557071,36.190938639247165,27.234959101613267,39.62057729423873,51.5226386237026,36.976889119943486
Trafficking of AMPA receptors,35.90998465622775,33.966122202279855,0.3012475178972396,22.0851924064195,46.15932676577334,34.91686709003705,11.754897376557071,36.190938639247165,27.234959101613267,39.62057729423873,51.5226386237026,36.976889119943486
Hh mutants abrogate ligand secretion,35.89546973498866,50.23459694649214,0.3012475178972396,18.936764869537523,38.98359467969298,36.6808896376836,20.79872344884024,36.531646683083494,19.825789441743197,23.1770736474808,28.1086609275487,28.650446523429505
Nicotinamide salvaging,35.88852705375785,25.02732027365344,0.3012475178972396,25.176591096494857,39.48220030144722,14.663685038398361,4.746193259143872,26.229443216251575,25.032663743627754,42.92732504423164,53.45286349820081,40.46466995373521
RUNX1 regulates expression of components of tight junctions,35.8664468514593,43.536996683994,0.3012475178972396,21.867062892328025,32.79917712958279,33.17492833123534,19.950679102649985,33.756340826575496,22.688768975747074,37.44696784863657,38.8403967484287,37.531421022872166
Cross-presentation of soluble exogenous antigens (endosomes),35.859505587309904,49.853956363422554,0.3012475178972396,19.272805903242077,39.53907635405353,37.11592185800378,20.77573181197651,36.327997852540456,19.795120133329267,23.474678142616938,28.716384064318664,28.58594979576509
Downstream signaling events of B Cell Receptor (BCR),35.81474287008644,51.69788324657325,0.3012475178972396,18.266663802931788,38.583870063359605,35.756198852695796,20.2963118983126,35.97249455802318,19.579727538341327,21.33943371666422,25.789921923526656,27.7849952986588
MAPK1/MAPK3 signaling,35.80024441123749,51.14203658266728,0.3012475178972396,20.735632000767836,44.71253926378394,38.060628972026755,21.031422602482312,38.817640768817085,21.93125958763662,24.535921833117467,31.446885117783385,31.094786888867546
Regulation of RUNX3 expression and activity,35.793307713395066,50.51176654407794,0.3012475178972396,19.10570682800537,39.73483179457638,37.26866954984007,21.05446335189701,36.70723611260018,19.663890510406368,23.550801851577383,28.513460494137018,29.179809184277588
Interleukin-6 signaling,35.74920764146674,32.78258019178152,0.3012475178972396,23.62797947982783,42.06789226465,30.4600973199575,13.981565590567184,40.271609736442905,26.65505428554221,40.05971142033393,51.435389448698764,38.01602865679593
Activation of NF-kappaB in B cells,35.74920764146674,51.045190891821704,0.3012475178972396,19.038960266505608,39.595311315107324,36.767608158872534,21.29773669211774,36.72425968229823,19.503581110235864,22.7220900263976,28.022436293729292,28.837380932402514
Trafficking of GluR2-containing AMPA receptors,35.65168182689853,34.0560056847927,0.3012475178972396,22.049876091018753,44.95655822602273,35.5909164024087,14.83546883682622,35.45372970079911,27.562579516444007,40.41855407460687,50.620212616479954,37.55973011123387
DEx/H-box helicases activate type I IFN and inflammatory cytokines production ,35.59197164091028,37.88639224786481,0.3012475178972396,25.088697614797717,46.07409154583199,42.059265346836874,25.111603881800818,40.75161183371945,24.87879692438648,41.46112826845741,45.825175647139986,35.797503638721594
G beta:gamma signalling through BTK,35.55491061147213,44.90924270057156,0.3012475178972396,23.057745945528286,20.89628455597614,13.15964309491217,11.808057612603559,38.25513551351294,28.716699974399297,32.10671696781472,40.60017431816622,39.141441673185135
NIK-->noncanonical NF-kB signaling,35.4802291047098,50.39534088748749,0.3012475178972396,19.054738869988324,39.86038076547187,36.775927864124846,20.426137049378664,36.5141088369803,19.641211454781175,22.685125021959767,28.549961831612958,28.371283094964607
TRAIL  signaling,35.465796179239504,24.975766631692906,0.3012475178972396,26.315852597971748,28.291481125308312,24.474048653103598,2.8409489609976917,24.850283227625884,29.68892733360769,31.34323209763313,38.84417428074169,31.69910697660927
Host Interactions of HIV factors,35.421281226838076,53.257853575179396,0.3012475178972396,18.266663802931788,37.21221890671055,34.20746843075217,19.006705218734105,37.23571304783244,20.742157826743643,19.268112236892424,23.00106832594407,29.72506199289734
FLT3 Signaling,35.407474176374734,51.3972560895051,0.3012475178972396,19.96307210900152,44.385130170419814,37.77061913249528,21.359762305864443,38.55948441002742,21.46954494463827,23.309290172398054,29.912700677023953,30.104588387548496
Phosphate bond hydrolysis by NUDT proteins,35.407474176374734,57.17880373161118,0.3012475178972396,13.40715651280597,22.995381067778506,16.612656964660648,20.2963118983126,48.488238887166354,21.768148332902772,20.209448442402863,19.29026210192734,30.94111175028073
Dectin-1 mediated noncanonical NF-kB signaling,35.40057055715628,50.558538197519326,0.3012475178972396,18.90327148402162,40.09673805956938,36.83417514554439,20.920177184492545,36.813891280518945,19.496202319456277,22.51874729735732,28.3607384221708,28.517889580355376
E3 ubiquitin ligases ubiquitinate target proteins,35.38615102946795,39.85899012911995,0.3012475178972396,15.948677656196333,35.54991406019459,27.353018185331315,11.243111231538059,31.430049038868397,21.11630855919474,18.317300006187484,27.583314487746996,28.560933696673658
Protein ubiquitination,35.35670781677577,44.57462892687616,0.3012475178972396,17.272483145726547,34.71201342835637,26.86182085060483,12.185752992943641,34.449546522997075,21.85847613322576,17.62277070167461,25.93462756403987,29.836813273669406
SUMOylation of ubiquitinylation proteins,35.334786047700746,54.03768119217442,0.3012475178972396,16.690982150502144,26.513784926983853,19.831986036037,16.972657212116108,38.70336020703503,20.19614517407103,18.951349250882476,28.604556019433712,29.025418435805825
ATF6 (ATF6-alpha) activates chaperone genes,35.299075763683916,48.177578107876485,0.3012475178972396,22.76018047934811,48.806718390533945,36.66782298868707,19.45216878382107,40.77001135524437,26.750210773406742,30.93502454199676,51.2057833166037,35.797503638721594
Neddylation,35.299075763683916,50.14303767387499,0.3012475178972396,21.41928599588573,41.88168286755769,32.66630051685717,17.534527813733725,36.542058257818006,23.264732076555198,22.824948383817652,32.04065212296136,30.42822040839374
NOTCH4 Activation and Transmission of Signal to the Nucleus,35.299075763683916,43.26786831872894,0.3012475178972396,21.764935715450914,38.50682641374493,26.17340118718859,14.300629610266984,37.07114023329994,25.625188004127704,32.816599759270815,46.07162536441894,36.65848487170161
Abacavir transmembrane transport,35.23966332552594,43.514589553660855,0.3012475178972396,21.454854857077034,27.44053870065806,13.071270142975088,14.346288727193828,39.17386749683161,24.63108655432147,31.697449358615398,42.07257428360709,35.89699304016039
IRS activation,35.22587944227908,48.317508051021,0.3012475178972396,23.924338141463657,44.054465920319934,35.34353338659826,27.31842413498581,50.06032333135303,20.967498822530388,38.36016190894595,44.33516464663501,36.877597700706154
vRNP Assembly,35.22587944227908,30.136466009961822,0.3012475178972396,22.778434992447394,43.52910095632568,34.496540250739436,18.119581398456464,42.48601827031299,20.60679760349903,40.18620857007462,45.65624449860412,35.35207344215156
Transport of glycerol from adipocytes to the liver by Aquaporins,35.212095407836784,53.31751223392447,0.3012475178972396,18.545341494300434,28.464358567871777,32.00287954275238,25.196950982778244,44.44099444004738,23.489764557528776,28.20285277384915,36.87125836567401,34.80917322135195
Type I hemidesmosome assembly,35.212095407836784,24.507532474734692,0.3012475178972396,22.868215684251535,33.32679680991759,27.976754254533077,16.513414178550505,35.32635373595844,26.663481501627523,37.47521465416496,40.54000905124499,38.65243907027675
Intracellular oxygen transport,35.19831124096374,33.551065478454916,0.3012475178972396,21.9015838671669,33.99827563738579,14.299572332833138,6.8784772376847405,39.73980848631404,26.29377607115246,35.61048485954614,48.27779062874251,37.889065264390275
Interleukin-4 and Interleukin-13 signaling,35.19831124096374,13.425640853208055,0.3012475178972396,23.128723092461126,39.187678112550074,14.324663785694211,2.0284792103599205,33.72210729579045,26.775509597031327,41.87201173889486,56.60599787041018,36.87168349966404
Diseases associated with glycosaminoglycan metabolism,35.16954287492961,41.75823439741057,0.3012475178972396,19.912088453199107,17.8592391565061,10.003732220447112,6.910182503085888,31.050808487328617,18.49988503200568,32.22939893698931,38.08525938989303,34.96304615191375
Diseases of signal transduction,35.16954287492961,51.91307535200847,0.3012475178972396,21.315314787995778,43.95032116526227,36.32520983901472,20.941266387675075,38.823215673042775,22.819060385854304,23.295348026825586,32.26347135674184,31.550757132563056
Intra-Golgi traffic,35.15516228641584,31.752877033862767,0.3012475178972396,21.721184065481825,48.24744461418604,34.99346198755813,11.655054678514084,33.334227515588616,26.51103643985283,37.384361481862165,54.610707232268034,35.289493269797575
Synthesis of substrates in N-glycan biosythesis,35.12640830982058,2.678744857207502,0.3012475178972396,24.023590549627894,52.719593002234674,30.343823094688236,4.9478333419197655,40.621699632663905,28.07171514134803,45.62476179436489,58.71624675319364,33.16230472090698
Potassium Channels,35.12640830982058,45.09909105926034,0.3012475178972396,20.866823497692852,47.84639458215396,43.35020798384845,21.398682311550445,43.756754674931614,23.29738776761845,31.846325613695335,37.90778618410068,31.530799891208794
Neurotransmitter clearance,35.11952010964356,42.952048203036924,0.3012475178972396,19.920395245940963,34.58137548203,25.554130852481038,19.651498787496408,38.73807443412685,24.40150921563869,31.79628170726927,44.58016291683218,37.90242232070726
Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes,35.06773774094036,54.12623349653356,0.3012475178972396,15.87160012276901,3.543733361479755,0.6859373699580225,6.042384195192015,38.29034048647853,18.39463285163209,17.970387819731577,17.66020136326501,36.34312612210771
ERKs are inactivated,35.03842059341587,38.92334064554399,0.3012475178972396,21.988651346809668,27.429843455556494,21.760370930949087,14.117229263604626,20.932835275074478,26.50261372052668,39.13380811986864,36.637892496980754,37.7813989143131
HSP90 chaperone cycle for steroid hormone receptors (SHR),34.8523503428736,30.150345789078493,0.3012475178972396,21.64370403711752,30.62080090108742,15.009448250815334,1.4176984399192079,28.07296404454213,23.305410864435302,34.96407469244137,39.14200767520626,33.56616313292495
Prolonged ERK activation events,34.737882547706846,24.715633180643188,0.3012475178972396,22.03257929423433,42.40455463709133,31.834491185233276,11.091095034324567,34.12193039511338,24.63108655432147,30.25647337959597,42.88944692932177,28.70152391228838
"AXIN mutants destabilize the destruction complex, activating WNT signaling",34.737882547706846,53.11393052895808,0.3012475178972396,19.88053707326807,29.72187102606186,23.734560410273552,23.50331697673873,46.67955897451907,23.967910994323965,35.52194580848425,42.68534121199862,39.41767271033795
Apoptosis,34.737882547706846,53.44962376721636,0.3012475178972396,17.296240614389706,32.73618347734365,30.531253378546474,19.319471066063134,37.3442533321645,20.33476923323111,15.414603965457879,20.581063138642435,27.024458205881196
AMER1 mutants destabilize the destruction complex,34.737882547706846,53.11393052895808,0.3012475178972396,19.88053707326807,29.72187102606186,23.734560410273552,23.50331697673873,46.67955897451907,23.967910994323965,35.52194580848425,42.68534121199862,39.41767271033795
truncated APC mutants destabilize the destruction complex,34.737882547706846,53.11393052895808,0.3012475178972396,19.88053707326807,29.72187102606186,23.734560410273552,23.50331697673873,46.67955897451907,23.967910994323965,35.52453383438834,42.68534121199862,39.41767271033795
Truncations of AMER1 destabilize the destruction complex,34.737882547706846,53.11393052895808,0.3012475178972396,19.88053707326807,29.72187102606186,23.734560410273552,23.50331697673873,46.67955897451907,23.967910994323965,35.52194580848425,42.68534121199862,39.41767271033795
AXIN missense mutants destabilize the destruction complex,34.737882547706846,53.11393052895808,0.3012475178972396,19.88053707326807,29.72187102606186,23.734560410273552,23.50331697673873,46.67955897451907,23.967910994323965,35.52453383438834,42.68534121199862,39.41767271033795
APC truncation mutants have impaired AXIN binding,34.737882547706846,53.11393052895808,0.3012475178972396,19.88053707326807,29.72187102606186,23.734560410273552,23.50331697673873,46.67955897451907,23.967910994323965,35.52194580848425,42.68534121199862,39.41767271033795
Elastic fibre formation,34.67151067337938,36.13842000396349,0.3012475178972396,22.0851924064195,25.075257322533442,11.805025356259994,3.7852145771130696,27.808036925098925,19.350831471745092,35.52194580848425,43.522502845189834,33.53207772159475
Thyroxine biosynthesis,34.657226841649944,31.63109937092314,0.3012475178972396,22.581839589796747,35.85626083773848,37.89689485651823,19.583803771224865,37.384049020791664,21.988011427021277,39.39524328577563,45.19572582382586,34.84321616368653
Metabolism of vitamin K,34.4944441076214,38.773931297102344,0.3012475178972396,23.79336627581415,43.966089335661,36.0781209162163,20.86133111396203,32.61884029388596,26.940812030982134,42.20175661003282,52.43633046207779,30.31585518019166
Transcriptional Regulation by TP53,34.45054234112993,53.74444922990683,0.3012475178972396,19.43237961590536,19.048335411056254,12.117408977179382,16.31387147828857,41.53594355072496,24.067259282506157,29.15157520613106,36.23966413773893,40.77853020826728
Pre-NOTCH Processing in Golgi,34.43630455003758,34.678687938312414,0.3012475178972396,21.988651346809668,37.37501015156395,25.353258750298412,11.732496684558699,34.07686593519531,25.757408932948458,30.60224759994655,42.371304050353345,33.662637790374234
Programmed Cell Death,34.422069199746176,53.459498351494545,0.3012475178972396,16.730962146846068,32.01019052193197,30.368925698725043,19.305032486660807,37.14845166331042,20.055619523373267,14.635611062853327,19.599775615379098,26.62276777295689
Transcriptional regulation by RUNX3,34.3856179770002,50.05854988693787,0.3012475178972396,18.046967721654756,39.53907635405353,35.112776680320906,20.049643582448134,35.801373708376765,19.564943757958954,21.343612472638913,27.47540684224452,28.390220115111102
RAF/MAP kinase cascade,34.36398947816488,50.576202654800866,0.3012475178972396,18.495141278595714,42.28176668845564,36.29912494170202,20.22387233161022,37.05956012253113,19.73385269952876,21.09641146135356,26.66023569209313,27.828878094717872
HDL assembly,34.35716918171609,25.44096735284643,0.3012475178972396,22.456921906011175,37.61986535816816,19.29571262178607,4.052545793929249,30.94736453032178,23.531205397917933,38.06270379266404,49.69999904182449,30.876657634460827
Interleukin-1 family signaling,34.33554880656062,53.03131446686224,0.3012475178972396,16.643432475548725,39.283209250099915,36.17732926270215,21.421830838650603,37.01381896398216,17.964297379902945,19.55297874999764,23.383281153687452,28.070454390310427
Activation of RAC1,34.313934916923294,18.919783351254818,0.3012475178972396,27.314191156812576,44.730473033157196,25.69770337364847,9.203052562455904,36.84854376285424,26.38778282235882,42.903925773825485,51.466508613683395,36.212299135062324
Hyaluronan biosynthesis and export,34.270147928750156,37.66469799850657,0.3012475178972396,21.004410900186596,39.479071683756196,36.58351757952205,23.851485325260438,37.90141735331972,25.230407712152388,37.908173526103205,44.25785906344679,38.1630818408435
HSF1-dependent transactivation,34.255944245880585,21.958831156292327,0.3012475178972396,19.886062227530527,25.398687830570076,11.699347325434577,0.6996145633195007,24.240747960849585,24.991996438371142,37.44696784863657,39.25331554511954,34.3094257627409
Axonal growth stimulation,34.21277157992833,19.20676284285717,0.3012475178972396,19.407197490535722,40.853750744278116,32.89630573432149,16.96643326942072,35.45601051210758,14.486624685675242,28.056579041460623,40.50965070192029,21.44894362298849
p130Cas linkage to MAPK signaling for integrins,34.21277157992833,41.45011153470284,0.3012475178972396,21.9015838671669,33.60377910775174,31.72072468507877,22.07018377990613,45.51197163700646,26.379372996326687,33.71118174089518,39.563114049557434,37.68133881659505
RHO GTPases Activate Rhotekin and Rhophilins,34.15428952576697,8.29316042700824,0.3012475178972396,23.61914269278782,35.918473531834536,15.797275678200256,1.0748099280153647,34.05991200599138,28.501396885658718,43.183078823389394,48.31954417189386,33.03210457808176
Acyl chain remodelling of PI,34.11797983870439,13.940880924677392,0.3012475178972396,19.11334946406862,33.72844025866041,21.828274202201612,8.104142965026247,34.179170554253716,26.28537189148808,38.13965304462996,41.961848649243706,30.032789074576737
Fructose catabolism,34.111180044495654,27.9240702984846,0.3012475178972396,19.2323950781015,36.26750784571348,20.402465986645495,12.050724905133118,38.88910393833064,25.00720967968786,44.03194213273279,54.116343739669965,37.46067489292342
PP2A-mediated dephosphorylation of key metabolic factors,34.09758059893986,43.93003214132425,0.3012475178972396,23.229449374487135,41.19300885406125,33.08534650038958,20.515955315625742,40.199784535845836,28.21048611511162,34.836901307015864,45.77162372718252,34.26011324045959
Other semaphorin interactions,34.09758059893986,46.28789803551253,0.3012475178972396,23.683645441740893,44.54872021484602,44.080274663029,26.755238188244885,40.77001135524437,25.169713378953425,36.88626057584883,37.5052056283645,35.46944328868358
GDP-fucose biosynthesis,34.03919801929412,51.2294501763439,0.3012475178972396,21.243779948937355,46.9604961927767,33.77194379006803,23.472625725583082,48.20853362795639,23.917997415716936,38.6914036919835,48.22905553284338,43.90517883888165
Signaling by EGFR,34.0176749669304,6.782568414641398,0.3012475178972396,22.546230883465835,38.77428614241704,19.995778001723348,4.441466501476084,29.664747283730232,26.328919466515927,43.44818324028933,53.21687789814825,36.865764920760384
Folding of actin by CCT/TriC,34.00579693136093,48.886379706951864,0.3012475178972396,21.386326601388763,28.00300069504229,18.3145096487258,10.158278104806158,38.60036125778273,23.9597903612775,20.782017983767112,30.927211227308813,34.15695376197728
Defective DPM2 causes DPM2-CDG (CDG-1u),34.00579693136093,33.05320231382175,0.3012475178972396,15.392475279091187,37.9707553201788,25.074609029258,10.087657770956852,28.270431035760662,21.566970584160003,26.722969147946287,45.10112102633844,32.255099019403225
Defective DPM1 causes DPM1-CDG (CDG-1e),34.00579693136093,33.05320231382175,0.3012475178972396,15.392475279091187,37.9707553201788,25.074609029258,10.087657770956852,28.270431035760662,21.566970584160003,26.722969147946287,45.10112102633844,32.255099019403225
Synthesis of dolichyl-phosphate mannose,34.00579693136093,33.05320231382175,0.3012475178972396,15.392475279091187,37.9707553201788,25.074609029258,10.087657770956852,28.270431035760662,21.566970584160003,26.722969147946287,45.10112102633844,32.255099019403225
Defective DPM3 causes DPM3-CDG (CDG-1o),34.00579693136093,33.05320231382175,0.3012475178972396,15.392475279091187,37.9707553201788,25.074609029258,10.087657770956852,28.270431035760662,21.566970584160003,26.722969147946287,45.10112102633844,32.255099019403225
Notch-HLH transcription pathway,33.99900253683258,42.64769978626028,0.3012475178972396,22.581839589796747,44.00338633685494,34.50022161177428,16.96643326942072,38.27242662874241,25.6689892491784,32.02375458107533,44.5966948927106,34.64654992398851
Serotonin clearance from the synaptic cleft,33.845159192884125,49.32920557517668,0.3012475178972396,18.710507287241114,30.386489630099,26.502745737972337,21.91819914671577,39.66697874466962,23.71524538988649,25.080957088308477,37.785615872963675,33.87484013557057
Regulation of TP53 Degradation,33.82369553083965,43.39234105948276,0.3012475178972396,21.885010365164334,40.2137279126031,30.261396044242154,19.882643569557306,33.70524144934563,27.853722616016086,43.907992061642894,53.42399613777932,36.68659260430463
Metabolism of serotonin,33.81691909146446,48.560196451528704,0.3012475178972396,18.751406219412786,32.763079657125395,27.05707073357471,21.337670830492094,39.377149799356495,23.917997415716936,27.777694076747814,42.20600811640383,35.546682229384054
Noncanonical activation of NOTCH3,33.803366431762925,20.033730345388353,0.3012475178972396,22.651568577256032,52.067245822389594,28.95805899351022,9.062106721447881,32.55109887133015,26.75782652870452,41.636726185267584,61.29635885117566,34.674611868092775
HSF1 activation,33.803366431762925,24.668709077950638,0.3012475178972396,19.339945533523455,22.658646675101718,9.695210089640051,0.6006321011214071,23.28563427655308,23.7487804424857,33.94939149615091,34.92825521408157,33.36658252478151
Estrogen-dependent nuclear events downstream of ESR-membrane signaling,33.77457763947113,8.057586048868512,0.3012475178972396,25.68277929980158,45.98284656742276,18.72873901767696,0.4655232460136767,14.795498599192545,26.543943324591012,44.49244470180049,55.46318994616254,18.13983738947242
PTK6 promotes HIF1A stabilization,33.723805393278695,14.832986396714476,0.3012475178972396,23.386565124280484,41.11457971528124,19.03016787543121,5.812363717903282,34.98711476258348,26.007198799627563,44.59218217091337,55.03505474899498,36.16232849797626
Terminal pathway of complement,33.70237848736068,47.32310218667957,0.3012475178972396,18.17703727463622,22.68180782028537,16.79532016988625,12.418460706989777,37.6497262799913,21.422219058300332,29.288906922097524,35.951140532465274,36.4419484083378
Axonal growth inhibition (RHOA activation),33.69561138514929,49.005230536166,0.3012475178972396,16.179744230503076,26.650432206862167,28.86289170164857,24.760129855289122,41.895185142565,28.438912797136215,26.31811801391352,38.36890626324373,36.92798291190241
Synthesis of GDP-mannose,33.67419271235925,31.767130426874566,0.3012475178972396,16.179744230503076,37.63672429699667,32.602490925687334,22.49279437841256,44.37291292485579,22.08608745518331,40.03098680923297,48.17547143327741,35.21054293249261
Regulation of TP53 Expression and Degradation,33.63813699247351,42.979442574251664,0.3012475178972396,21.764935715450914,40.06655899131485,30.014811481684514,19.63045616612333,33.42007074277085,27.75753260221113,43.75548529273369,53.25082776412853,36.36449157654121
Acetylcholine binding and downstream events,33.63248999313854,39.88596710791718,0.3012475178972396,22.324321314796105,45.164902872731275,39.93972002244527,21.517465924093504,38.71514581837838,24.564130575899654,35.48691372263868,41.78123073172857,30.572854311134204
Chromatin modifying enzymes,33.63248999313854,33.791319924349295,0.3012475178972396,12.340924503074802,28.095535742901554,22.89856596915659,9.436704791672557,26.715398076752276,20.742157826743643,14.178045653075502,21.0085366683579,22.92812349894171
Chromatin organization,33.63248999313854,33.791319924349295,0.3012475178972396,12.340924503074802,28.095535742901554,22.89856596915659,9.436704791672557,26.715398076752276,20.742157826743643,14.178045653075502,21.0085366683579,22.92812349894171
Postsynaptic nicotinic acetylcholine receptors,33.625726647851906,39.8964506839962,0.3012475178972396,22.332267565546314,45.1613608758169,40.01689459377875,21.50710726224216,38.72628765976336,24.564130575899654,35.44000821684506,41.738169374323725,30.59199147797322
Defective ST3GAL3 causes MCT12 and EIEE15,33.59756633762742,49.09884797493935,0.3012475178972396,17.760302814193654,13.17692659407406,11.89991126717301,13.755948032974105,32.193709818959576,17.985967268378165,24.34489111731926,30.952840372777835,35.13233209089215
Mitochondrial tRNA aminoacylation,33.59756633762742,52.167854602489356,0.3012475178972396,19.038960266505608,35.62517192224081,22.18670802057133,19.175794028982914,37.01381896398216,24.059127001819032,37.17073564434148,48.75636904515403,37.7163596504849
CLEC7A (Dectin-1) signaling,33.59080489551918,51.16599168666668,0.3012475178972396,16.461957571601467,37.7054209670114,35.61119213538938,21.517465924093504,36.372858815504415,18.409399760818143,18.76939926339353,23.832245294056396,26.074843423895157
Arachidonate production from DAG,33.576729424342545,43.93975863462173,0.3012475178972396,21.685408426267607,38.234579792906956,26.154066169019266,13.1126670425651,25.628144907579188,21.485505322076538,37.141023406926735,47.46401141445968,31.604366872082533
ATF6 (ATF6-alpha) activates chaperones,33.56996899113175,46.33255849523832,0.3012475178972396,22.024636633296304,47.027066315854114,33.223169524458996,17.941824779028575,38.05835515444894,25.63352258987661,29.155907494508348,49.770575450095876,34.562430610548816
Metabolism of fat-soluble vitamins,33.51935050860216,46.3660575295752,0.3012475178972396,11.423036099125516,11.038295384114923,12.228099307592444,24.835277955366006,41.48763804709055,20.56040271043069,11.468786713002197,13.745836985479652,36.46263764877741
RUNX1 regulates transcription of genes involved in WNT signaling,33.505839848967895,17.31524761431048,0.3012475178972396,22.554178150798396,40.627656791162025,18.24255826980412,2.868685737835847,21.265501326182708,26.64662719665819,47.225866230209895,56.04188169747631,33.57968316619306
MAPK family signaling cascades,33.505839848967895,47.45076465218907,0.3012475178972396,19.30609948987245,42.24551428711263,34.133280478959755,17.440700927814085,34.29963131212986,21.12345075313242,21.495090868740725,29.64149442074962,26.955565013790267
Amine Oxidase reactions,33.49908468190352,53.193207037663996,0.3012475178972396,13.78107516565941,32.157043105087915,32.31796886055075,29.346548161749226,45.58009827737812,20.33476923323111,26.156120580688633,30.233719993532365,34.892307138968796
Metabolism of carbohydrates,33.49287832378693,16.198210393961517,0.3012475178972396,22.216548927545592,34.25923493481431,21.22463044710761,11.243111231538059,34.74500111867271,24.49599122458551,42.09347682732626,50.28462466235513,36.755436080561815
Signalling to p38 via RIT and RIN,33.49287832378693,46.97912615344253,0.3012475178972396,22.60798313495016,42.54613527846222,24.7040069527625,15.3635310015908,42.20996872250169,25.84786807079465,30.950552128817545,50.03347493542827,32.65165337250497
Developmental Biology,33.44231777894438,47.746373917608175,0.3012475178972396,18.014280464028644,37.48147135055673,29.10120638765023,15.500821889748613,32.92432673975356,21.36568463574555,20.4614952004978,27.142893256664394,26.801014371563323
Regulation of localization of FOXO transcription factors,33.38450372519509,48.78596267783906,0.3012475178972396,17.120238177168815,27.82169094464166,20.734602089682518,10.299288494765541,33.574289427929585,28.354386063807226,21.17860280847789,25.397865459977144,29.352403265451553
activated TAK1 mediates p38 MAPK activation,33.37046807634938,51.91820869835972,0.3012475178972396,18.161608332806008,34.98326545156464,32.41190257476873,18.734849885000582,31.408195698403773,19.358183065225287,22.326929429268546,27.26220430270663,34.88574990108039
Nicotinate metabolism,33.283588128255026,20.883065061758483,0.3012475178972396,24.7183875051826,36.934681179238446,12.241167259502353,2.588776450402454,22.75810190181252,24.49599122458551,41.877274335438614,52.683998746124665,37.63134308326054
CREB3 factors activate genes,33.21864019939326,17.025657940030975,0.3012475178972396,20.607830403956005,45.35153377274201,22.2699538447005,6.178810658028209,41.16199229597807,25.204195300510126,39.506554241285464,55.63454391590198,33.73562147235253
WNT5A-dependent internalization of FZD4,33.2046396023583,31.568500109505166,0.3012475178972396,23.646528529339264,35.18466491916715,22.215491620904622,9.103473072769235,34.048776128286825,30.019832496686927,42.88708626734567,51.14968927186437,37.267906266168474
"Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation",33.15430081632136,42.76327497151081,0.3012475178972396,20.926159664731625,32.10519911429526,24.477359521901967,14.04692758523947,41.449796652598096,23.63091659669094,28.806313697416222,36.634210177376474,31.055167369141014
Sphingolipid metabolism,33.08222305701501,3.1500457319439534,0.3012475178972396,24.893939768656242,53.26432940328558,29.284714751840024,3.0520660642042454,35.36139980326119,28.047270779858454,47.68604231297351,60.526052698778436,30.712130064564462
Downstream signal transduction,33.02526874457025,7.643762538035327,0.3012475178972396,21.617238831398392,36.10774451748528,21.6124140803067,9.883947784473685,38.523551472115244,25.608520245412382,42.41570948228782,48.59087251253303,33.93685379290199
"Adrenaline,noradrenaline inhibits insulin secretion",33.02526874457025,36.84207706346211,0.3012475178972396,22.324321314796105,27.389906915645167,16.66542533428305,8.5152144713639,39.377149799356495,28.047270779858454,32.350569897921446,45.62407987212604,36.19831404257568
Attachment of GPI anchor to uPAR,33.01130831469986,17.86434845065972,0.3012475178972396,21.270032983059043,39.595311315107324,29.881562885586597,7.427833879521759,32.890525540720425,25.47805993841075,35.656816335234886,42.79585198161655,36.52613322880821
Presynaptic nicotinic acetylcholine receptors,33.004599224716266,39.81553702263005,0.3012475178972396,22.119814256015147,44.276547128141296,39.004101424724915,21.337670830492094,38.36759231068621,23.78054461323342,34.300637826028904,40.678680710505745,29.634867525934023
TFAP2 (AP-2) family regulates transcription of growth factors and their receptors,32.97668791045972,1.0766312600634904,0.3012475178972396,23.843772180391134,47.80891188318118,31.94329351444068,1.787755954873331,20.310553351694892,27.94148583231867,43.561269860043886,54.531561761782825,25.687031839765282
Extracellular matrix organization,32.97668791045972,34.000687359167465,0.3012475178972396,20.640960389704865,20.230717873995978,6.603891934611463,1.8064652784213953,26.375890971487532,17.620456630633733,33.71118174089518,41.961848649243706,33.23657819288123
Scavenging by Class F Receptors,32.948249002408666,54.61389114251173,0.3012475178972396,17.917835301250324,38.700208614538035,36.38569116883017,26.434818511460186,47.19771265273296,24.158625637782375,34.345530178366914,38.4570532862196,38.47938586970187
Reelin signalling pathway,32.92706224747976,7.956347110095259,0.3012475178972396,21.101070242354893,36.26750784571348,11.751159392682224,0.792986548284206,27.921744097827492,26.802454062546968,43.06987184632624,53.87952837015515,33.66851249828152
NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose,32.891407906102856,28.79876590560354,0.3012475178972396,21.764935715450914,43.190127394081955,40.40294952602885,21.673362593995975,37.554169078369526,19.965031699472064,35.17829474010539,42.63213880823702,28.428112856331442
Transport of Ribonucleoproteins into the Host Nucleus,32.87747344892046,57.04433181372811,0.3012475178972396,16.627748365404305,18.588850445666505,7.532694532117476,9.510733900799455,35.37867066530246,20.37338376201105,13.105991908855383,27.238537394342835,31.550757132563056
Role of second messengers in netrin-1 signaling,32.870775016974754,32.77307125452729,0.3012475178972396,22.07653903305078,33.60377910775174,28.317271710846395,17.231854832163982,35.86000360645462,22.7697412010055,34.065158008983566,36.65416821604132,31.29019212042645
Highly calcium permeable nicotinic acetylcholine receptors,32.799011883639295,40.61506409222036,0.3012475178972396,20.858964406443206,37.387462461720695,34.48457698199875,18.37366047107219,38.66115920668195,24.134198806995528,28.44447850077492,34.5252561799177,25.788990685764556
MET receptor recycling,32.79232100557177,13.347691083973908,0.3012475178972396,16.12457469969483,12.610598292413137,17.557174285884265,10.811373128753974,17.47839018668489,17.958933182381212,30.093384263614595,20.451005178928032,29.25010193685074
Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane,32.76396135333832,56.42721299950792,0.3012475178972396,21.738412691341594,15.616235199647834,25.997296115759926,24.764702504576654,48.91882409146161,23.053887079105763,17.314890446899323,14.705705204493965,35.32374529231746
G beta:gamma signalling through CDC42,32.73561395144953,42.90298839185277,0.3012475178972396,22.91275335351772,18.869133633232753,11.06421829233938,10.376037094712288,35.63119467900417,26.007198799627563,27.81240793022373,38.617478259223276,36.46263764877741
Electron transport from NADPH to Ferredoxin,32.67842400705304,32.00568934752006,0.3012475178972396,21.917460056322014,23.637690390154226,16.66542533428305,9.234697112002419,26.994338417306018,25.262218353161618,33.54187945532005,37.33177608814276,32.96388967145506
Pre-NOTCH Processing in the Endoplasmic Reticulum,32.66453334723054,37.549252635476925,0.3012475178972396,21.226073976249236,36.724204274618415,26.59389279495753,13.16985200205241,31.931082689663796,24.588755650418353,31.35885005983886,42.111901276050624,33.34665428119411
Response of Mtb to phagocytosis,32.621816279820294,41.14436055670066,0.3012475178972396,13.88164594810799,30.47902683610633,22.312966673321945,16.519568755430125,37.3442533321645,17.395035349012726,24.646502246574222,32.42701137940719,26.123970455131364
ERK/MAPK targets,32.61514164855096,24.58320723415124,0.3012475178972396,21.83981178417325,28.956283639569655,12.407202272619333,6.2424637492987225,20.125251923943324,21.204209920402842,37.17607772294078,41.511441164232444,33.62085093193176
Defective LFNG causes SCDO3,32.58685874760163,36.52785347093099,0.3012475178972396,21.243779948937355,36.59179753049682,26.086968596389962,12.858554189873074,32.377583062480774,24.63866334235922,31.741797958726707,42.47413529323095,33.40703786351849
FGFR2 ligand binding and activation,32.56578688277921,27.878679193107377,0.3012475178972396,20.952228932659448,39.3303476062592,38.151391787406126,18.681419901767793,36.06066853001992,26.371730048442824,34.842152411661175,41.76837148685188,30.42822040839374
Cam-PDE 1 activation,32.54472163285328,45.138124534522284,0.3012475178972396,20.56450768287639,34.667600232748185,16.452550652471803,11.50662189212485,35.22234855116399,22.656526013956906,37.36833840536786,48.58209596320083,33.984716923314195
Bicarbonate transporters,32.43738898585527,38.04677200211007,0.3012475178972396,21.412662671021508,23.825990207036995,28.96579284940835,19.71200276142002,46.69986992910433,30.934959815971478,22.806836894582304,25.518915400190007,30.725089296259778
Translocation of SLC2A4 (GLUT4) to the plasma membrane,32.43073210386905,47.17833539548915,0.3012475178972396,20.522409529356153,31.721001020905927,29.388366698412216,15.700212582936082,39.19129472823734,23.371945304835137,18.275421136154293,21.336639723709677,30.473126173460525
Formation of the cornified envelope,32.40252987239255,10.679696040552011,0.3012475178972396,23.24785949426585,42.03257038281314,28.41152538781196,2.455963839480036,13.819268066419557,27.302579233024563,38.833918100450006,49.98742275085495,26.300951693312047
MET Receptor Activation,32.33846297559552,25.51487269905783,0.3012475178972396,20.960714260919456,31.686016509153053,18.448436813885777,6.8251552526037615,36.701746889030154,25.323690545211168,38.79116246042874,45.46016663213237,31.303268436007635
Attenuation phase,32.23147862221724,21.38820259759609,0.3012475178972396,18.718583179117637,21.805393156861104,9.265470362062532,0.5415619236559719,22.067469525644885,22.696693744752903,33.83444458799757,34.93956580845754,32.315115001985326
Intracellular metabolism of fatty acids regulates insulin secretion,32.21820671211966,21.719154562062794,0.3012475178972396,21.10958060899932,38.1930625784995,28.54629770971787,14.541612809506194,36.60732064469765,26.14427200405868,40.95403723902534,49.30845955495628,33.23657819288123
Disassembly of the destruction complex and recruitment of AXIN to the membrane,32.21820671211966,50.18168495851865,0.3012475178972396,17.62890075190359,27.313825433917298,21.154127919289248,21.821717502508776,43.487044272691335,21.694579430434814,33.23422112014887,39.903694914198326,37.30203424164015
Organic anion transporters,32.21157101817997,37.448985421059405,0.3012475178972396,16.935176050370018,32.387032370782734,20.689642983928767,19.644229188007863,20.619736307172523,19.903499420657273,28.15053123357931,23.871902540736745,26.473195440874335
NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis ,32.16200174171851,26.31273520918801,0.3012475178972396,21.394888978561244,42.47720368817936,39.696489834283675,20.570024104174994,36.372858815504415,19.53402184813117,34.530433449636874,41.899487902909904,27.3575787035718
Retinoid metabolism and transport,32.112471355418236,44.563616188232984,0.3012475178972396,9.80079814041824,8.473101692447576,9.9430293793417,23.94950750852105,40.16318028775736,19.373342753822925,8.868760917700161,10.131326038928172,34.98402408330526
NTF3 activates NTRK3 signaling,32.06297986037906,23.43860727599136,0.3012475178972396,19.6354719148274,24.956131918872615,13.785847428233403,12.269526562355553,42.910743179321415,11.679807732858764,23.2192270766455,33.21111585073779,33.91617666680986
Activated NTRK3 signals through PLCG1,32.00639139051848,24.715633180643188,0.3012475178972396,16.39917386280678,20.784646344679132,10.953818052332316,11.996127589253692,40.673902244106934,9.9621010213928,21.079002913318927,24.631601544553654,30.85691266073548
TP53 Regulates Metabolic Genes,31.97889621345399,24.532127549732397,0.3012475178972396,17.957390217220492,31.65904379213883,20.41904747535491,5.202264881208719,19.56367899807957,20.748764316933183,22.31797107149824,30.20416267048375,22.79623914130662
Activated NTRK2 signals through FYN,31.97889621345399,18.09095061901319,0.3012475178972396,23.860556281038367,47.250273375830545,29.579236425342078,21.23043335883237,44.70210581680676,21.93125958763662,33.34873783763058,49.275224033974546,33.99120798601012
Regulation of cholesterol biosynthesis by SREBP (SREBF),31.9722835592454,41.278043063730884,0.3012475178972396,18.987571791151357,38.739455400174464,25.353258750298412,14.620529534535807,36.83093632638016,23.858224630480326,22.11789511701498,36.23966413773893,29.140931086923228
Signaling by NOTCH1,31.91629441712173,39.295968762720214,0.3012475178972396,19.78044858279813,42.02879123237639,31.51582258463238,14.053178046396253,35.526242905291134,21.445876017943895,25.012266501900047,35.793749694248845,28.549378639784354
Acyl chain remodelling of PG,31.91629441712173,8.647203854696176,0.3012475178972396,23.75706890936889,44.280182417989955,20.41250862789979,2.627868951316935,30.957519380632217,26.14427200405868,41.510445024016015,51.83647399752251,28.549378639784354
Cellular hexose transport,31.824255152087854,55.23430332707745,0.3012475178972396,15.658435516138805,28.51644690800188,30.98532121552913,25.598960883337732,44.51356220243462,17.767302832732447,25.57956907593381,27.514842471254976,31.48515117860002
RUNX1 regulates estrogen receptor mediated transcription,31.817657769320164,0.375819995174919,0.3012475178972396,24.36325270796521,45.03670800397894,27.244280561041183,0.6274429400344234,6.7843448748775135,29.336234285285105,47.56516452270181,56.64334087070566,30.850681333184877
Metabolism of cofactors,31.76129015717534,52.404856935366915,0.3012475178972396,16.762438148448588,25.899704263918082,26.616806980494573,21.05446335189701,42.398266421471206,19.88021658010276,11.152823802067195,16.394830945473156,27.493741053209252
Highly calcium permeable postsynaptic nicotinic acetylcholine receptors,31.754698805824244,40.127597111884604,0.3012475178972396,20.25465858139997,35.68350688612888,33.30183627513391,17.96216703799342,37.88973031309507,23.305410864435302,27.026992704156324,32.93162028682691,24.532110949000284
Export of Viral Ribonucleoproteins from Nucleus,31.73389801304022,55.5248508221646,0.3012475178972396,15.849293027589875,13.320779031176366,5.280900170562528,5.97954144158594,31.66861964162876,18.846505957115788,11.90538824144784,22.272373851515834,28.560933696673658
Ubiquinol biosynthesis,31.698902296128118,57.44993833776117,0.3012475178972396,17.014868315786142,19.316688902111068,27.18106701118101,25.663666651384812,45.405733714308134,18.566359074999177,3.8406752518077982,6.251353823643067,27.487838463643534
MAPK3 (ERK1) activation,31.692316373670046,20.3498221395047,0.3012475178972396,20.51458237390167,37.990226378076464,22.28778661077076,7.705306099242583,32.03665799503532,22.7697412010055,40.352682913920574,50.340582231003765,33.55969947830407
Downstream signaling of activated FGFR2,31.565174941523427,40.35490324633429,0.3012475178972396,16.730962146846068,38.96645725959273,36.745028716734154,19.882643569557306,35.436960855006326,21.317435209281985,23.945290729560927,34.019492369189486,25.522686158896654
Mitophagy,31.544437038932557,50.707273698991365,0.3012475178972396,22.615928240447385,34.94596978862851,33.29816561356051,20.282505775076835,34.68141488298221,24.08291136568579,30.98882055504171,35.07554178348453,37.36678945060708
Defective B4GALT1 causes B4GALT1-CDG (CDG-2d),31.537867041558428,47.704925911226454,0.3012475178972396,16.070383608522857,10.193913777462495,9.667710668602888,12.056508673926023,29.413797267664798,16.7048664624599,21.67177767158578,27.697121870169774,33.46277821117464
PI3K/AKT Signaling in Cancer,31.49590419928916,6.320189078059981,0.3012475178972396,21.084052776186425,39.898799593643176,10.648118229774116,0.31318216618399464,26.769826233069992,26.97288760956376,43.60942803368269,57.342374412956936,33.96402659500907
Apoptosis induced DNA fragmentation,31.489338643096094,33.270692265819704,0.3012475178972396,13.315971476742085,20.826119659592226,9.626047094214016,10.57059875557918,29.535314266707914,17.36593673315501,20.000710178481658,23.317433264419137,25.38898317628651
POLB-Dependent Long Patch Base Excision Repair,31.454479820858428,43.45949443139032,0.3012475178972396,15.994318279054514,7.395123082495861,1.9991169694346274,4.544311953749383,28.428881118989956,16.633883671521993,20.196489029528728,21.123931451138965,29.523503267104413
DCC mediated attractive signaling,31.440847359220186,53.44962376721636,0.3012475178972396,13.874703302397224,28.043840681108783,31.02735331608201,26.392373852385962,42.14020687676774,19.011759552477145,12.753493421154731,13.378087307536227,33.24243509231528
TGFBR2 MSI Frameshift Mutants in Cancer,31.37826581757524,36.66419743965279,0.3012475178972396,18.201905387109534,29.399562668633614,17.391141975447916,9.489931049349618,30.952441947050957,24.141722140969623,34.122805469579546,42.98640637962734,36.58753361381486
Assembly of the ORC complex at the origin of replication,31.37826581757524,55.406434796775756,0.3012475178972396,20.883154584591196,18.492878130076765,9.040554607881523,13.665649414013915,38.58922733271148,25.44617214959869,24.38811736504371,28.61893408374076,30.00665539147753
Defective CHST6 causes MCDC1,31.364649309857256,47.27132924149893,0.3012475178972396,15.98685251447193,9.91813857681263,9.358174589741493,11.697015515915936,29.07851465790027,16.558691464081523,21.45876487675957,27.385781102511473,33.16873900218021
PTK6 Activates STAT3,31.35103543492628,30.564247454307306,0.3012475178972396,23.066512815531045,37.006467507850985,23.62638755823644,11.946982888643314,41.08174009443414,22.834947876887345,40.789862053835286,50.280802232982296,35.53281551114814
Apoptotic factor-mediated response,31.337424194154774,35.4162671002587,0.3012475178972396,12.428920201988465,18.56188822324319,15.121638381831076,15.983923978916087,36.41936740468127,19.764011796044166,23.973570570199875,21.092683652841064,26.930824787801292
Processing and activation of SUMO,31.27444030504893,47.79753613975621,0.3012475178972396,12.45588620204831,20.19937432016471,11.15507463917497,6.225899427332923,26.815680249901217,20.483348968180334,19.65179867374014,21.80459819918788,25.88056838739732
FRS-mediated FGFR2 signaling,31.20447801283872,40.01048796307884,0.3012475178972396,16.53245666990447,38.48094841734969,36.21753976318699,19.79442641746369,34.8590493105383,20.920211039694127,23.422683128213198,33.59470099040272,24.927289358196592
SUMOylation of SUMOylation proteins,31.19089887329,55.865688809925615,0.3012475178972396,16.040023836106613,15.555938409122163,7.30602262683224,7.902323396130879,32.500936338234446,19.419765145626226,11.002208564663515,23.911954116536453,27.90438670159704
Acyl chain remodelling of PC,31.14917082053581,3.03704425767224,0.3012475178972396,22.904804522091514,46.029930883118695,19.193022047493084,1.8164639635515885,30.86529094199623,25.774115348135624,43.39994159589396,52.91286068905211,29.70006467509193
DDX58/IFIH1-mediated induction of interferon-alpha/beta,31.100440176948126,37.65984697674484,0.3012475178972396,19.038960266505608,36.96810293894679,35.04517339270042,20.17009142561404,35.55491259152794,19.51879850632313,34.31754809550152,34.27571542494446,32.32839681768505
Class C/3 (Metabotropic glutamate/pheromone receptors),31.086883473947495,40.22986005088989,0.3012475178972396,15.54440664303376,39.86038076547187,40.72088462979767,20.426137049378664,38.08793825601164,21.461828004518296,28.769440079959054,30.054886305406544,28.28866985348518
NR1H2 & NR1H3 regulate gene expression linked to lipogenesis,31.08035722353558,23.688253850167587,0.3012475178972396,20.51458237390167,40.6147719023152,37.86606736757221,19.252291868106386,35.02198984646844,18.49988503200568,33.04197876734714,40.162671454020895,25.703726848175474
Lysine catabolism,31.046729859051077,47.62129603690301,0.3012475178972396,22.411196967725743,45.006847297704795,38.82733269659607,18.667174979631625,42.821720413927615,24.210612065150357,26.494077867927004,40.93627525271767,31.9434649096247
Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC),31.046729859051077,56.563492381444355,0.3012475178972396,15.849293027589875,15.355796988102016,6.323858903183831,8.606115249107319,33.81955660996085,18.929487932744685,10.542712004498505,24.38238999791347,29.18588770627345
Regulation of Glucokinase by Glucokinase Regulatory Protein,31.046729859051077,56.563492381444355,0.3012475178972396,15.849293027589875,15.355796988102016,6.323858903183831,8.606115249107319,33.81955660996085,18.929487932744685,10.542712004498505,24.38238999791347,29.18588770627345
"SMAC, XIAP-regulated apoptotic response",31.019139638242233,23.244475401821056,0.3012475178972396,14.896013723784893,22.355510145342006,16.84204368612359,13.043103183978534,32.332743416834006,18.155719069158277,25.18326066676392,22.1310992725992,24.40793727051973
Complex I biogenesis,31.005598816235892,31.168305696913112,0.3012475178972396,19.449353290945883,31.62358671828182,22.15428643603692,5.657302712667353,24.17888676846916,21.005674476639726,22.969545957350274,28.918370733732992,24.806846991987538
Infection with Mycobacterium tuberculosis,30.97101108354045,40.0740159546628,0.3012475178972396,12.82756705511011,29.444814417609336,21.327999366058496,15.679335491920915,35.77804131941447,16.03666670114873,21.35694498160754,28.61893408374076,23.573751555212848
Signaling by ERBB2,30.950467108036918,5.747948265810603,0.3012475178972396,22.465620920192105,30.49765140076268,11.195004135807686,0.5350049155814122,25.897375127289276,23.18805276477747,42.70149719973974,48.70573628019054,30.130764682286348
Transcriptional activation of mitochondrial biogenesis,30.880876257841564,44.21729562330388,0.3012475178972396,18.60922280958414,29.15189214879474,19.66293359081007,10.46043978045533,28.58106342589885,19.564943757958954,16.541044414768788,28.67278125307615,23.475553085589926
RNA Polymerase III Chain Elongation,30.874369020459373,55.46566666698444,0.3012475178972396,15.917997242077462,15.209343224756248,8.190452736117269,7.274657217019862,34.72200998159259,23.489764557528776,20.213514157228996,27.816800772130733,42.08375516606048
Phase 0 - rapid depolarisation,30.846855998422985,55.88508713213399,0.3012475178972396,10.694104780166672,17.037581491271098,6.559575934352614,15.46098527140868,47.4931346642919,14.054670752916323,13.130533836143341,18.307547726854345,34.58329330047057
NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake ,30.798366218986285,26.28647005807967,0.3012475178972396,20.506754033928537,40.536742311800914,38.24203467646821,20.356661691543405,35.63119467900417,18.365116974504218,32.675689740635974,39.55057889490966,26.044328849211308
G2 Phase,30.7499153807942,58.009180247647656,0.3012475178972396,15.240899236292078,6.323924668391272,3.458493276844443,14.070950095472822,41.660887828287855,16.12560218062899,15.662745693552397,14.749336387769311,31.75338652669877
NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis,30.666594230380927,25.187028283927994,0.3012475178972396,20.4820961863636,40.458764049221934,37.93435031758726,19.98067018953192,35.22234855116399,18.312433037370525,32.44530965706036,39.29190351935622,25.687031839765282
The proton buffering model,30.640655408568733,28.283553489837846,0.3012475178972396,22.939811085309202,48.43696783786378,40.143808616068995,23.321654418881966,47.51479735356002,17.958933182381212,36.41435285502373,45.99263149923297,34.10959735375162
FGFRL1 modulation of FGFR1 signaling,30.640655408568733,41.96461343938613,0.3012475178972396,18.53730020367353,19.748118859283533,19.146419469514154,16.256752887828736,28.0054032897251,22.819060385854304,25.85163182275676,23.317433264419137,34.63283930403341
Mitochondrial Uncoupling Proteins,30.640655408568733,28.283553489837846,0.3012475178972396,22.939811085309202,48.43696783786378,40.143808616068995,23.321654418881966,47.51479735356002,17.958933182381212,36.41435285502373,45.99263149923297,34.10959735375162
The fatty acid cycling model,30.640655408568733,28.283553489837846,0.3012475178972396,22.939811085309202,48.43696783786378,40.143808616068995,23.321654418881966,47.51479735356002,17.958933182381212,36.41435285502373,45.99263149923297,34.10959735375162
Misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling,30.627195918939265,35.982207750533924,0.3012475178972396,12.057696225218844,30.781601606740793,25.356045497293646,25.285487175082007,44.49460430526858,23.00318053409562,32.39537682619817,30.38897741002797,32.77302547265402
N-glycan trimming in the ER and Calnexin/Calreticulin cycle,30.5928225693151,27.95076673857585,0.3012475178972396,18.23377896394316,33.63156362131546,25.916292730084127,7.633944637834101,18.9920541553138,18.996747077645512,32.40046806398644,36.14840723527698,25.99571993785401
BDNF activates NTRK2 (TRKB) signaling,30.55895927089823,34.816134666255,0.3012475178972396,23.96952759596281,35.85257433680757,17.369828603473717,19.809783415269447,47.742101196370726,10.69820200517824,26.09703392741427,41.018362856425796,29.339728470856283
G alpha (s) signalling events,30.55895927089823,38.36707951826613,0.3012475178972396,19.347621790547777,40.90541492709971,36.63103005219069,18.794072045334158,37.46049450400737,24.47014854996595,32.591408983589,39.705068479838076,27.27557262456863
"Transport of bile salts and organic acids, metal ions and amine compounds",30.510700372820196,10.916962012519479,0.3012475178972396,24.82838589732992,53.508260839435884,30.37251656376633,2.82700372222254,30.5527870215157,28.169254626190597,46.5501845333296,59.460780337835246,24.16693422472346
Lactose synthesis,30.455525181916038,35.19688266247394,0.3012475178972396,15.392475279091187,22.36808704151873,15.11902782100937,12.921610266576135,29.30646063427488,23.623434443034515,28.711765477969827,28.20723235857102,23.987267876289536
Manipulation of host energy metabolism,30.32401749241639,56.75943721631387,0.3012475178972396,16.651051689120273,19.386542934467656,25.16380116523642,26.462876021786833,48.34876389164861,15.911536996103855,18.435115032697336,17.528939610979105,33.49037155664166
PI5P Regulates TP53 Acetylation,30.11668277481866,16.765463273543283,0.3012475178972396,14.436343799985742,22.818450411399976,12.942059239249655,6.593456735874669,37.52477522428326,22.069905980555998,27.03119391001414,35.56801561073296,25.966132726358364
mRNA Editing,30.096915230777036,50.26463327254668,0.3012475178972396,18.136768054469712,35.15204478397252,33.7563696278256,24.2730989902315,34.08218811576796,17.627466902178853,24.035919211619948,36.00367584493114,31.43110493989357
SHC1 events in ERBB2 signaling,30.096915230777036,0.32416492297913707,0.3012475178972396,20.48933914155546,32.71231359825089,14.666253368665902,2.7558668640266184,25.145933772623696,20.82729344949393,39.3836027516237,47.01287337882035,31.511923718280052
Regulation of gap junction activity,30.042124260484744,35.477927774038314,0.3012475178972396,16.343616502456186,19.61434635332499,26.538262612889802,15.60198521559643,26.098627941837464,16.564676762536237,26.615613733846992,21.79209772450058,32.09854284807518
Rev-mediated nuclear export of HIV RNA,30.02189453095958,55.74577032997995,0.3012475178972396,15.665824783821419,11.797728118138322,5.736336620334719,7.559454133921272,32.75975969499217,18.439389976185716,9.469007988531152,18.906630791041525,27.376168469551327
Synaptic adhesion-like molecules,30.00857355180473,5.456566280809302,0.3012475178972396,24.612209379499923,41.04154360617473,35.370466304247266,9.041460968699369,36.531646683083494,23.531205397917933,42.466477907599305,50.43766763491767,28.358818578887586
SUMO is proteolytically processed,29.94007441474079,45.110147780315316,0.3012475178972396,14.806433092756327,21.622238167575812,11.553661346706967,5.217255631527805,26.938016089022042,20.203172186677673,21.079002913318927,25.243571488274494,26.85712627010772
Sodium-coupled phosphate cotransporters,29.892317933540845,6.355185512032536,0.3012475178972396,23.314454570261034,31.82759655441848,25.326953603777106,11.596576196590213,29.08879850333858,25.453110934600005,36.6768527574185,26.04994377105607,32.75268839836461
Cytosolic iron-sulfur cluster assembly,29.87902596360504,30.980623237766906,0.3012475178972396,22.067886502940933,41.437215527751825,26.70694277951976,15.74089285744093,31.958749554544738,21.57312760438321,47.91424758901207,55.78845058959479,36.651818139582886
Stimulation of the cell death response by PAK-2p34,29.82443810810114,32.76853592851385,0.3012475178972396,17.312243839268074,23.839395740275204,16.73683557618393,21.197929229121797,35.54354880875213,13.80344181546016,19.72125122253628,23.921701978834975,22.583773033815515
SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes ,29.79788694811208,22.28435740714624,0.3012475178972396,13.62995837064285,21.402596931863666,17.477919893922156,13.640515145352063,30.45523015472457,17.344651150008602,24.818019490313244,19.31707683205093,22.092296319963765
SMAC (DIABLO) binds to IAPs ,29.79788694811208,22.28435740714624,0.3012475178972396,13.62995837064285,21.402596931863666,17.477919893922156,13.640515145352063,30.45523015472457,17.344651150008602,24.818019490313244,19.31707683205093,22.092296319963765
Synthesis of Dolichyl-phosphate,29.791491645065292,6.763197942081031,0.3012475178972396,15.65104782706415,32.559602738974924,21.807002025724902,9.60827483605331,38.22549749193818,17.818316279733093,30.26689583743674,40.80101788939341,25.255640864018073
Antigen processing: Ubiquitination & Proteasome degradation,29.78509661430411,43.139029716593726,0.3012475178972396,15.36192959130951,30.026545157292105,25.842750732939876,13.646203779381558,29.004813255977215,16.925621964311976,12.259759764407905,17.149557363925393,21.08490826210771
Activation of PUMA and translocation to mitochondria,29.77870185700881,55.651733905026795,0.3012475178972396,15.979388310292137,31.56470433560664,17.52195955324165,14.117229263604626,29.5249518490318,17.409384781176982,18.68071777703192,40.957307506078756,25.04717584892025
Scavenging by Class B Receptors,29.724207524641873,28.059674343564893,0.3012475178972396,18.161608332806008,35.641589404637976,28.07741822190524,17.82269893344369,37.431129743899945,23.638397152760287,36.133966946370634,46.75154576173174,32.186576050022005
Calnexin/calreticulin cycle,29.63594272807659,25.80643951403479,0.3012475178972396,17.851770124454784,31.666532367496984,24.158839989239823,6.937657758694713,17.196804525267503,17.944351741648,32.30129113780824,35.80883233587485,24.09291853805381
Vitamin B1 (thiamin) metabolism,29.63594272807659,30.87609220126338,0.3012475178972396,17.177150654530937,31.70550645841029,18.07691354893943,8.621012724016612,26.68543221028689,25.01547325152327,35.04547481576405,46.32733464489725,33.909689598715985
Purine catabolism,29.608995309263154,57.88942606420297,0.3012475178972396,7.521554608506731,8.6857512957451,10.926652467856563,24.16065068865221,47.291322136594786,19.70279380010252,6.128027687379018,6.279156907083439,29.901225916834015
Acyl chain remodeling of DAG and TAG,29.602618864000252,37.865953406045946,0.3012475178972396,16.801598175167534,33.09950838053056,26.59389279495753,18.832647956100647,27.59530280312461,21.589125342349995,32.26787716603023,40.141823013426745,30.31585518019166
Integrin signaling,29.55513758237518,18.28421003781681,0.3012475178972396,17.2802448907544,27.079469877846115,9.84829373574532,1.3052426823227137,21.981062087246688,26.94925507809385,34.41971836289894,47.55353073437338,30.934875129880922
Establishment of Sister Chromatid Cohesion,29.52822727644011,41.0616661642164,0.3012475178972396,13.400340544142443,29.81148052299476,37.35324740174744,24.95084709447006,40.80043271202716,21.11630855919474,30.380482831889275,33.760695794965166,34.44264871068859
GRB7 events in ERBB2 signaling,29.50817173311525,9.251704946947465,0.3012475178972396,23.220665315764567,37.598643777794244,20.878310524817156,9.329600841587185,44.36730444321554,18.97401550335067,37.94965756379555,46.230996274724106,30.83769673551405
Activation of BH3-only proteins,29.488122921822903,55.50730660672635,0.3012475178972396,16.959155564633253,27.04672671423485,15.218434698247888,11.09663761643407,36.12004799088198,23.7487804424857,15.503757437498352,27.319132371754414,28.669475742910475
MAPK1 (ERK2) activation,29.481758368557124,31.791178157634587,0.3012475178972396,17.256964156808134,30.48637846497726,20.58274307147608,12.685381906192804,35.38408312608857,20.444145070673517,29.22532179093771,37.651401497351436,32.118678176337525
Nuclear import of Rev protein,29.407046777447352,55.437067708766186,0.3012475178972396,15.429118871168598,14.345071796918367,6.375768764849642,7.135659321945844,30.650502587929996,18.800797389227327,10.502193227023964,21.63675580657328,27.40111761511582
Antagonism of Activin by Follistatin,29.284699084886718,45.38632898255858,0.3012475178972396,18.90327148402162,8.037214648327335,13.743386976868443,10.788299929078818,15.321232698618749,16.782432774107026,13.00742833672284,13.775586000337759,29.660837838472954
"Incretin synthesis, secretion, and inactivation",29.237479330976495,30.26875440578133,0.3012475178972396,20.548256914198657,35.12365387067956,32.68337740137929,14.162594446497797,24.004445687815412,21.36568463574555,21.44580113998333,28.455269626980368,25.486382996861273
Interactions of Rev with host cellular proteins,29.224333182814014,55.48322222680585,0.3012475178972396,15.157510490319412,11.932018024945375,5.41428501605739,6.650975364850167,31.029089089195807,18.282549771721484,9.31022736293898,18.49781761526494,26.6536275185978
Regulation of gene expression by Hypoxia-inducible Factor,29.17716317282371,52.574908303440594,0.3012475178972396,7.255185975942304,19.392383574027328,18.18438765638575,19.52193788264968,41.19172474940077,20.521126125860768,13.663033737665183,14.585823762089582,27.080809494139594
Tie2 Signaling,29.082468283054506,14.994323320477415,0.3012475178972396,20.84141071094511,36.11143973253346,24.113511571171365,10.488919129919745,32.23185171127764,22.557170198801526,39.511916887424235,45.04252947295719,30.512894209480095
"Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)",29.063038955543895,29.549354345704945,0.3012475178972396,20.385001671801632,34.667600232748185,32.2536739030917,14.156322073091355,23.495796811767285,21.045919138617084,21.419882796639207,27.679348727950153,25.221257039915965
Activated NTRK3 signals through PI3K,29.063038955543895,42.40900535110824,0.3012475178972396,20.015242901666017,26.531164199924213,16.621698435139393,21.251503302775536,48.13671918444964,10.42524352969366,24.15554816106717,29.377371302643787,33.798716534323994
C-type lectin receptors (CLRs),29.056720540304056,50.78313883001113,0.3012475178972396,12.57331777233165,29.607801733628552,31.52385299707532,19.9733753561378,32.18853215161544,15.074616982437998,12.151574353616237,12.374697590540451,19.087644682880924
Glutathione synthesis and recycling,29.023256923331,38.92334064554399,0.3012475178972396,17.901546144177356,36.588085008188045,22.51429137741237,12.660291201901229,48.235868619723654,21.686825115995934,34.94701196447577,44.249283846672725,35.910924801790145
Post-translational protein modification,28.99659408170451,41.887288861692234,0.3012475178972396,17.669553133208304,31.537781295074623,25.94685840527949,13.44030122954492,27.631429840102605,19.320084224339247,14.680113601746703,23.08334767821733,21.88930010935181
ER Quality Control Compartment (ERQC),28.956388608367433,24.52429774582045,0.3012475178972396,17.45022393968059,30.67237747278987,22.969934622342027,6.166375924778953,16.10808690333288,17.43810168216063,31.35383145287431,35.07554178348453,23.34164563492926
Fructose biosynthesis,28.92975698913838,6.505045209946727,0.3012475178972396,21.816668365559597,35.08206999454762,11.34793729407856,0.45002972526362006,29.109813809241214,25.230407712152388,40.05971142033393,50.03347493542827,34.31531271825723
Sensing of DNA Double Strand Breaks,28.903137758946038,27.28634245460962,0.3012475178972396,16.047501387913712,35.22574257104967,21.576817555850912,10.690022447245267,27.312350319270454,20.00983228372331,36.37287100862725,37.52592379748517,33.729148879953655
Signaling by ERBB2 KD Mutants,28.862998465171277,4.25160716251862,0.3012475178972396,19.256429766159357,32.04184427603637,13.583478056932256,4.463070606278734,24.40998268316095,20.295709383212387,37.29886931921021,42.85368853788727,27.81653593401491
Mitochondrial biogenesis,28.79585178466809,40.71845764522306,0.3012475178972396,16.009692062286295,24.83771325850279,16.11873617992756,7.762930874353149,25.354562185993537,18.90768826996141,15.02611511338935,23.112421897159876,22.979102860475738
MET activates PI3K/AKT signaling,28.78280540460936,7.311676949963561,0.3012475178972396,17.3602985114203,19.057199686457384,18.857934350902262,7.6011779905021415,16.93955629347962,17.958933182381212,30.586802806623083,30.09238326191808,30.631838031775615
NOSIP mediated eNOS trafficking,28.77651628854559,14.425962134107841,0.3012475178972396,22.704674803585686,30.719092627679657,20.599399173289786,4.566192283755728,16.22949680362358,20.575534834871295,30.020135058292233,31.58495977802568,20.32063801463663
Arachidonic acid metabolism,28.756720812838598,7.311676949963561,0.3012475178972396,14.238853044516906,20.989590545628012,1.9819379337475387,1.158576286412326,15.29142165900025,21.341552996792757,29.891423558997904,49.80288852605809,26.918686191795096
NrCAM interactions,28.750433921354222,26.445035981638362,0.3012475178972396,12.240261951831107,27.910621304291286,19.476140291817938,7.975371683269531,34.93509053886309,20.638577090139986,17.982585463315772,25.24666346344833,24.520533318130187
Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA,28.656453535476807,8.003438731493446,0.3012475178972396,20.926159664731625,43.374930246238826,26.710364332953475,1.1258438415482888,28.214898903908992,24.38452001757826,38.12195396695185,48.05823705789087,21.29401692883216
Pregnenolone biosynthesis,28.623225650936657,12.602156231261747,0.3012475178972396,19.55081480932816,25.74305944503118,6.306126019947734,2.3175152201775036,38.87107063788437,23.41270417733069,37.65966137558654,45.112320803802014,32.07152218652087
"WNT5A-dependent internalization of FZD2, FZD5 and ROR2",28.56982390066828,30.46877991163843,0.3012475178972396,22.92150325146849,43.807242448408665,40.90131012688785,22.6149617823557,38.14774576216524,27.853722616016086,41.98920369772315,48.93074046851579,35.13233209089215
Hormone ligand-binding receptors,28.516473228556904,19.21397659014827,0.3012475178972396,18.039034985501733,35.704188570557264,35.949372046292154,17.38415022460348,27.009406524922387,26.10085449626503,34.709956534943785,33.64904484727005,29.849589916054555
TGFBR1 LBD Mutants in Cancer,28.49004836221994,27.277682644994794,0.3012475178972396,18.16907795510507,27.32449883315951,8.267611336470807,3.739196579085709,28.70256955160494,19.419765145626226,33.9035129146194,48.57609936705405,33.18862117720613
Pink/Parkin Mediated Mitophagy,28.470353369375484,48.67953440614463,0.3012475178972396,16.500755841096026,25.806927921586066,12.777585221294972,4.530443625107055,28.77631565847056,18.679778304314638,15.411077190096488,28.084232672310144,33.6073235135848
Intrinsic Pathway for Apoptosis,28.41038688991871,55.95454720593779,0.3012475178972396,16.312548718089438,28.76285276120721,22.146322629459124,17.369707935547208,37.64419759403262,21.81744263049205,11.021343085718586,21.97668707668324,26.154089424664473
Phospholipase C-mediated cascade; FGFR4,28.364354334127597,31.011104276754768,0.3012475178972396,19.189428470105774,31.143162990429403,33.85750524481247,18.06703287599345,34.454893989443526,23.698486303130682,28.334638387511404,34.79615387054094,26.757513845313913
NEP/NS2 Interacts with the Cellular Export Machinery,28.364354334127597,55.23430332707745,0.3012475178972396,14.370623660441181,10.297878065258928,3.7157797751220567,5.6694690133035905,29.685973475377168,16.739803710360164,8.078585662848296,18.5972848837715,25.691870018826663
Diseases of metabolism,28.324599239642485,2.038209602248168,0.3012475178972396,21.09256096386635,42.41762497011786,17.786681389370507,3.165842039674244,30.63443427660105,23.388593086707864,44.23640456173846,56.05446870911682,32.051401220276084
Netrin mediated repulsion signals,28.244715284839494,32.215147597705204,0.3012475178972396,23.691609207495183,52.13679745813021,46.37450798981456,24.224919680874272,42.3058190804623,25.749056400036505,44.80405850123734,55.04823961042893,35.63922319143392
NTRK2 activates RAC1,28.198360996992307,38.83749817420862,0.3012475178972396,22.243288147620174,33.773337037964865,21.47642723214639,24.248025990257137,47.38636515402026,15.532248602564508,20.470064722338094,31.428818182400963,29.378250644048094
Respiratory electron transport,28.178768947617545,26.03301193839319,0.3012475178972396,15.643661717408543,25.910092516167833,15.955642268781979,4.083229622941745,18.73749469059063,16.938944780191086,18.589453704154263,22.755846600333705,20.482800633992568
Ceramide signalling,28.159183665638142,22.203582489081793,0.3012475178972396,20.624094554746065,37.39120880816923,18.85501218524088,7.643369771304707,34.19615280433189,20.67846022021929,35.15526303821016,46.90000024796153,29.423388281750203
G beta:gamma signalling through PI3Kgamma,28.13960515203588,27.51236992478989,0.3012475178972396,18.82726038533856,12.439737958091769,7.0470227493311715,5.641000307226635,28.513318913484326,25.808249535983304,27.326087255823765,34.25186249113433,32.671961054722
Transcriptional Regulation by VENTX,28.086667627131675,39.933927591854925,0.3012475178972396,19.83848771849597,26.73053121003804,14.763439971587212,9.5755756612324,35.73139877102737,16.40875925462204,30.0518233785895,46.65081696360583,34.90606394389083
Signaling by MST1,28.053778901117518,18.309657341043597,0.3012475178972396,20.049686052234964,34.48690394211843,16.48268458676691,6.397135290957331,37.07114023329994,19.73385269952876,37.51649733340541,48.84499008397138,24.59774861432135
Acyl chain remodelling of PE,28.000924209276743,4.3086722042826,0.3012475178972396,23.19264837654052,44.6622691799119,21.885383039716068,1.2438280804791022,28.418716351664088,23.14690273454832,44.85565637712897,50.692571226816625,26.399689341773172
Pyrimidine catabolism,27.888265235012213,12.764969742876115,0.3012475178972396,18.7594897857953,29.93179024728568,10.707894634396444,0.8815923230466216,17.091693942303685,24.091045004723412,39.54058363993312,51.87024072013299,29.517397770766625
Regulation of RUNX1 Expression and Activity,27.875428378642287,5.5242399643554005,0.3012475178972396,22.651568577256032,43.57524692551788,20.136360262875566,0.4996320619713205,16.096564694581843,23.58998308975687,38.91772545349407,54.097761385462064,17.259591333143582
Long-term potentiation,27.74313731720932,29.03112972615543,0.3012475178972396,14.31997128456539,36.39014718840653,18.61292671280012,6.846850651470945,36.9195745181809,17.229828092297943,16.67956015600282,31.028118371971654,24.32463168909741
Suppression of apoptosis,27.736962994336874,35.008588836068235,0.3012475178972396,9.208562685465404,22.12049751942603,17.51266806058028,15.031049959772123,31.386349910584038,13.251388369861525,17.05867005325607,23.598487557499382,18.24673232493926
Ephrin signaling,27.65793375667456,2.193660743781849,0.3012475178972396,24.38200280846498,30.336121289872427,7.491807115031462,1.0032067316023257,11.180889255661388,13.89409996075063,40.760040826263,45.90849633589083,23.296096978292137
SLC transporter disorders,27.645151392916414,58.05866263626104,0.3012475178972396,11.3785155132167,6.049442849039657,7.81864122875614,14.936053941838416,36.16148196952826,15.615484473882928,3.2121112500681024,7.52434235042384,24.69917267809338
Formation of editosomes by ADAR proteins,27.633276558929136,45.88681241189783,0.3012475178972396,18.062837579939387,34.07185887302211,19.879435186525253,17.77254758149022,30.276562018192276,15.75302447843823,21.222623955894335,47.60141553303336,27.426078262989375
C6 deamination of adenosine,27.633276558929136,45.88681241189783,0.3012475178972396,18.062837579939387,34.07185887302211,19.879435186525253,17.77254758149022,30.276562018192276,15.75302447843823,21.222623955894335,47.60141553303336,27.426078262989375
mRNA Editing: A to I Conversion,27.633276558929136,45.88681241189783,0.3012475178972396,18.062837579939387,34.07185887302211,19.879435186525253,17.77254758149022,30.276562018192276,15.75302447843823,21.222623955894335,47.60141553303336,27.426078262989375
Hypusine synthesis from eIF5A-lysine,27.627113095436982,29.642926904256957,0.3012475178972396,17.417624206564394,16.773001975299863,17.91489732511384,11.395381056561193,23.533474985952427,25.52174459700976,31.11933547158818,34.93595848172945,32.820690826480366
Signal transduction by L1,27.58789034124183,44.614133147641475,0.3012475178972396,22.340951283853908,31.32475254385168,32.76674890573989,19.182257103452518,29.42953623704204,21.06937021896022,30.142049056818145,30.93062320097824,32.8142835277019
Synthesis of PC,27.44311799184863,4.766785567092949,0.3012475178972396,23.591767950694067,53.044284788523115,31.134021280521484,3.1683158613674505,27.91691861814586,26.35490897074515,44.47434023616325,58.906816682828214,22.962103379391802
Activation of AKT2,27.41061739898084,24.83043019345283,0.3012475178972396,19.45757718619429,28.112527615368712,16.891184165053573,11.35523900394359,37.22468945096618,22.87694681169827,37.29886931921021,48.0854504872012,35.30332352355593
Transport of fatty acids,27.312335429327273,48.136759337668614,0.3012475178972396,17.256964156808134,21.654314458067915,20.471197488520765,15.173855544123981,27.698526648290976,21.493225826482647,16.198683989427984,24.152629171786383,23.934738994487365
Amino acids regulate mTORC1,27.30620910255205,0.9982364807143281,0.3012475178972396,23.674801881838267,36.55542474366597,27.600157071846315,3.1034790699553767,11.39533673563955,21.85847613322576,43.979490495703054,45.405347703151726,25.226914816603564
FBXW7 Mutants and NOTCH1 in Cancer,27.280811763154357,3.1005924890365852,0.3012475178972396,21.83392018566022,43.023231638981294,28.199610187360538,1.1152268937118133,18.70005477316591,24.776024451385467,39.85526782917731,46.063679764140964,23.590982133057317
Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling,27.280811763154357,3.1005924890365852,0.3012475178972396,21.83392018566022,43.023231638981294,28.199610187360538,1.1152268937118133,18.70005477316591,24.776024451385467,39.85526782917731,46.063679764140964,23.590982133057317
Metabolism of steroids,27.275135569263973,9.561396580462434,0.3012475178972396,21.83392018566022,39.30040850576062,15.785404589438253,4.54121058999845,36.33347001598543,23.154902145016745,42.324371983722706,54.70231017861685,32.84048086353122
MAPK targets/ Nuclear events mediated by MAP kinases,27.275135569263973,23.087459554980686,0.3012475178972396,16.266003619591388,17.815710701250815,9.172245439604445,6.371160027975452,17.593344417874423,18.192181978949268,28.701613424805316,27.37572840583464,30.143602311601388
Lysosome Vesicle Biogenesis,27.196785674560083,22.831052645715502,0.3012475178972396,19.280996034699236,28.744294270203653,15.339321595598296,11.442062705681641,30.623876567794603,18.17038675532422,34.1973845389758,44.58876903696485,34.7314043979835
FMO oxidises nucleophiles,27.125103628837667,19.946080807580312,0.3012475178972396,17.34427278878114,29.966270058997925,8.171854011002258,1.1370007059219287,19.068913006628268,20.873478216892742,34.84740307231961,46.96199448591182,29.442181172602513
Cristae formation,27.086247941819288,33.20100865622193,0.3012475178972396,13.774158663447883,19.80973118220915,11.774128782492626,4.808885973303119,20.919628150010357,17.243692740660013,13.204304745059225,18.208891168017402,20.456617803420087
Entry of Influenza Virion into Host Cell via Endocytosis,27.034336303178875,26.982934162500353,0.3012475178972396,4.112689335687568,11.063454689654096,9.758806795548205,4.970757576565174,21.08936211466564,7.9766158127291975,3.403985703953054,3.458240117175663,9.365789264671955
Regulation of PAK-2p34 activity by PS-GAP/RHG10,26.949810844107986,22.107779366901163,0.3012475178972396,22.03257929423433,35.209422050861406,18.40696849465433,1.1105296943977752,11.414829101863148,23.280770797639764,35.06191263272552,43.26284900340515,21.427330988769693
RHO GTPases regulate CFTR trafficking,26.93066630717586,18.820427142567276,0.3012475178972396,20.640960389704865,31.80406274219857,27.976754254533077,10.881562349011862,26.902357217486493,20.24917548752353,29.24094966064048,38.97073455037464,27.859977727979956
Synthesis of diphthamide-EEF2,26.86586534248849,39.69629271732362,0.3012475178972396,11.229111510695141,21.380120767251466,24.363625841516367,14.326352039736573,28.311003651609386,19.810451822410126,18.246243679339695,19.843477382821813,26.306726855589645
Reactions specific to the complex N-glycan synthesis pathway,26.85978908385842,3.5479744529040502,0.3012475178972396,19.2323950781015,48.04696471801849,37.7107869324036,11.459803472607597,10.554433309484791,14.85129843113386,33.60820928910518,40.78386629169378,16.296450457811414
"Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.",26.814614350337205,25.80643951403479,0.3012475178972396,14.384768102316434,23.94231022224298,14.7685960212969,4.096589469704098,17.642339974294288,16.049230008142267,16.537384571355876,19.9803997957265,19.066935387806147
Regulation of PTEN gene transcription,26.78900750573772,36.78449377425747,0.3012475178972396,18.625833213662744,32.74785946021377,30.177662573303202,14.56806494586557,28.55493104188412,18.78586978441168,21.441613768776037,28.593876069146447,21.112280336877905
RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known,26.769921110827777,46.28267200936327,0.3012475178972396,18.586565563045543,26.81634966910029,30.10689223293269,19.651498787496408,31.28141148947749,20.040194100291085,24.159988459828693,23.608168739647834,31.52450774987577
TFAP2 (AP-2) family regulates transcription of cell cycle factors,26.69881928123931,26.466539084491057,0.3012475178972396,18.046967721654756,49.080646605764386,19.272340308754767,7.816188708431287,45.76110525332044,19.99489436081353,33.51360146240277,56.75278536508787,25.97805385797432
Release of apoptotic factors from the mitochondria,26.679765813531727,21.14676034257828,0.3012475178972396,10.337417100362034,12.55670291430935,8.70404855387612,9.098482298969824,24.502787266146935,16.662339374263436,19.746480529729126,14.868693296762435,21.39415633412964
SUMOylation of DNA damage response and repair proteins,26.654224823330864,55.65615484604875,0.3012475178972396,15.278615498345816,1.750599111700305,1.3015558450167326,3.5564022211704462,20.310553351694892,17.50343431302805,3.861232271535859,8.952558602383741,23.475553085589926
Activation of RAC1 downstream of NMDARs,26.62220597609796,35.40167235907134,0.3012475178972396,8.569438979224655,17.237775247320474,15.861379184469254,5.01617673229789,18.405866855146137,6.371671615653766,20.777892521797217,32.86059679420753,22.31102018230576
Activation of PPARGC1A (PGC-1alpha) by phosphorylation,26.570752842685973,0.7075563986836186,0.3012475178972396,15.621087719318998,35.96055475894729,18.20333448142477,1.3405684484987404,12.825248801068993,15.421885415090014,28.408351123334903,38.03871240864083,17.514684989789558
FGFR4 ligand binding and activation,26.512874202430744,28.31423555357782,0.3012475178972396,18.209871610756892,28.726200529904393,31.963865449406757,16.526316262594634,31.479830157870786,22.341201464042413,26.101171013112456,33.061494327325505,24.74695088506366
rRNA processing in the mitochondrion,26.493888568413738,28.720512131362888,0.3012475178972396,11.943941380063398,17.79824413930139,8.332946234782572,5.202264881208719,18.711815182644667,17.818316279733093,26.889026209436498,38.85660227923314,26.690323431442028
Rap1 signalling,26.365012825315283,28.724756613174286,0.3012475178972396,17.49113569393616,32.27245172840354,23.666935326085397,6.789404202537989,19.85921647027284,22.97813190949256,20.9712151507593,26.095363137252598,19.30897450327751
Ca2+ activated K+ channels,26.346081871921555,3.3344225459214227,0.3012475178972396,20.04135426685894,25.249884923782563,13.301199705793158,2.794124422990416,13.84053486819258,18.089140209624347,27.58127248928582,33.7249560245308,22.487724517953904
Metabolic disorders of biological oxidation enzymes,26.275560716006026,3.2644952969205066,0.3012475178972396,20.15262148266752,44.4531750051122,19.365464266746198,3.6195533021589648,32.30491256441897,20.763961235651838,41.01484924832157,53.76578049608712,26.733317406969913
Electric Transmission Across Gap Junctions,26.263544229171757,34.994075375101566,0.3012475178972396,15.719740578733177,22.755133813080977,24.685759469873798,12.369302431534313,26.548334529598865,18.037299963271604,21.428653844012562,28.091154067121725,22.29467488700374
Transmission across Electrical Synapses ,26.263544229171757,34.994075375101566,0.3012475178972396,15.719740578733177,22.755133813080977,24.685759469873798,12.369302431534313,26.548334529598865,18.037299963271604,21.428653844012562,28.091154067121725,22.29467488700374
SUMOylation of DNA methylation proteins,26.21244834059569,37.033394826020654,0.3012475178972396,17.579991808242152,25.547094913488195,28.542783300380446,15.521030346907795,27.559621839432264,16.840042943165123,24.52161341655068,31.020849267463905,25.72173561706975
Synthesis of glycosylphosphatidylinositol (GPI),26.174268981172354,19.93102239058,0.3012475178972396,15.324106683881979,33.63873765179567,17.78384414008828,5.849762396918367,19.89338657170896,18.141057369156133,19.422784233379417,36.31329883417515,21.470956500222332
Inhibition of nitric oxide production,26.136118173506045,38.99246366140561,0.3012475178972396,16.880512767254352,29.437581474625663,15.71347697287761,11.61927221795792,31.80790026029328,17.49644926691665,27.68437948074462,33.60982064959907,33.373030752682645
HDL clearance,26.11084524324288,12.175364737015181,0.3012475178972396,16.825025007204403,34.23536070023958,33.73451436945768,12.746638276621432,34.41495989306211,20.19614517407103,29.63273580085753,33.12078254541816,21.82224183865814
Toxicity of botulinum toxin type D (BoNT/D),26.098865376836223,38.773931297102344,0.3012475178972396,10.487136283736936,21.887157440407357,17.851584053069146,13.87332008853983,40.63861150190059,16.564676762536237,19.41917347733975,19.780614207507828,29.308295976055007
Toxicity of botulinum toxin type F (BoNT/F),26.098865376836223,38.773931297102344,0.3012475178972396,10.487136283736936,21.887157440407357,17.851584053069146,13.87332008853983,40.63861150190059,16.564676762536237,19.41917347733975,19.780614207507828,29.308295976055007
Amine ligand-binding receptors,26.09287599962522,34.3240065867909,0.3012475178972396,18.250217658367877,21.939287161257177,24.185078903749524,13.847993366847389,27.18396376203805,22.283991780497793,26.32784566631065,29.600524145928194,28.39621958982227
Chylomicron clearance,26.06120444885369,32.381239852408974,0.3012475178972396,19.14702865837732,37.31905549885202,38.09298716168336,25.69108928891934,33.03252436499558,18.015167875880305,33.61916729472529,35.12382655871749,31.411184212017332
Organelle biogenesis and maintenance,26.010311220806617,44.331491078052046,0.3012475178972396,15.67321562929842,20.7818112092781,19.335684207600963,11.749616747006554,25.853145631679908,17.236759812629394,8.154631161439644,14.549955095957873,19.780546747162916
Acyl chain remodelling of PS,25.978691145679317,0.4758701398348233,0.3012475178972396,20.607830403956005,41.860248838560054,17.382305526465444,0.972556384266962,27.37904929039475,23.772453557136117,41.54568368541795,49.54422806617136,23.742090261149208
TP53 Regulates Transcription of Death Receptors and Ligands,25.94068664079167,0.7106541823127123,0.3012475178972396,21.685408426267607,29.86820575895432,15.17789688381559,1.9209924133188097,17.785935176120102,20.920211039694127,42.09347682732626,46.17179793441177,27.194149589398926
Adrenaline signalling through Alpha-2 adrenergic receptor,25.90271069329082,45.17582931364125,0.3012475178972396,15.29363170330869,18.678991441910892,21.648040748473,14.956421754955764,34.24812169035172,16.558691464081523,18.551870194822072,26.5336362579157,26.142128447693846
RUNX2 regulates bone development,25.80086291921516,0.3842289068567718,0.3012475178972396,17.957390217220492,15.084409136884192,7.080858203395235,1.0365052199945204,18.25159463270983,16.846892375276518,30.494285652539382,38.87768512802334,27.828878094717872
Glycogen storage diseases,25.782139566292553,13.450425910635031,0.3012475178972396,16.025073401527756,24.04545301491481,21.11892187917648,15.810862306801576,26.48227173367062,17.74534169058632,33.38270993206882,36.30545513334591,32.74628639842316
Apoptotic execution phase,25.73152718888056,1.6591200251388927,0.3012475178972396,19.29790460967834,31.97504620691268,14.803011360375907,4.234446724705813,24.400578669958428,15.95345422898066,35.425504157962536,44.74524938058496,25.55245216636698
CLEC7A (Dectin-1) induces NFAT activation,25.70008168164818,53.984519475485556,0.3012475178972396,5.922039036503937,13.570306370819786,9.772785708346836,24.31623056362538,40.812452018054486,15.746407270816073,16.08304654533339,23.499282724428447,23.858188352105895
PTK6 Down-Regulation,25.6495521870996,1.889878029524577,0.3012475178972396,22.297540241768175,23.249168763899526,14.307933731909,4.307329151682972,30.351896536783336,19.903499420657273,38.2397233833253,39.85165864741982,27.549665741240066
Formation of the HIV-1 Early Elongation Complex,25.61858709587526,51.92964555730691,0.3012475178972396,15.104606717892251,14.745786354161456,9.642292942130132,12.155373225231267,33.61999930126858,17.20128686212939,26.363091127740688,29.82663036236041,34.82291672419607
Formation of the Early Elongation Complex,25.61858709587526,51.92964555730691,0.3012475178972396,15.104606717892251,14.745786354161456,9.642292942130132,12.155373225231267,33.61999930126858,17.20128686212939,26.363091127740688,29.82663036236041,34.82291672419607
Neurophilin interactions with VEGF and VEGFR,25.587212352521107,14.384618387840076,0.3012475178972396,16.801598175167534,20.84184629186338,10.29031438101716,2.9676637036188023,20.539693931609552,17.337697759112906,28.922952017580457,33.32602209947298,28.19234690730243
Vitamins,25.517744132727678,5.819567975643596,0.3012475178972396,15.474841645267043,26.395261218852426,15.22105320708136,5.7967527919696815,22.56549099290753,15.63603634751783,27.326087255823765,39.36913653193965,22.198472100237616
Phospholipase C-mediated cascade; FGFR3,25.499126076284018,28.581666748344762,0.3012475178972396,16.786291874622215,25.945303363571043,28.08504234957418,14.12299793617738,27.844306601920625,22.192766696875328,25.085477227099666,28.856456201376627,26.251654084075557
Vitamins B6 activation to pyridoxal phosphate,25.49363318246799,35.09471501653998,0.3012475178972396,14.731453113182406,19.87826250644602,10.802568499489453,8.439198832203594,19.257787482830683,17.907284934039627,30.521258291526443,33.14423502229109,24.253825020558768
Molybdenum cofactor biosynthesis,25.49363318246799,49.27048323170642,0.3012475178972396,10.73148207185305,34.60173747582001,27.12481483341259,22.077535871037302,36.68472510836941,11.380577035546427,14.63218228522114,27.385781102511473,20.6950700105464
RHO GTPases activate IQGAPs,25.487713429691286,45.041839857485925,0.3012475178972396,16.273090834850997,15.702026085645496,19.29571262178607,14.202248153011512,34.409614791785884,18.096243065406345,14.047495551603589,15.161272814372367,24.945018676575156
RUNX3 regulates YAP1-mediated transcription,25.481794063749174,7.780400958665681,0.3012475178972396,14.488015815778223,7.317868416375986,6.253655912200339,0.4412076325878588,6.397780724887778,17.27268508623542,23.812959601542495,26.917556817708103,20.224268481944417
Organic cation/anion/zwitterion transport,25.38080346506414,2.735231105915098,0.3012475178972396,23.020241045206934,40.59734453839531,18.63922735874844,3.5564022211704462,13.5315556882485,22.028670021590756,42.34916489052813,52.3110406548241,19.90311761283862
Sterols are 12-hydroxylated by CYP8B1,25.27369975724937,18.594844339683824,0.3012475178972396,12.34707000467229,18.402490096897022,9.864738277480013,5.491341057484975,17.253750652216524,15.995032347642496,22.811155218714074,29.684998681241158,20.181597796417726
Lipid particle organization,25.25517296476713,26.03704837038561,0.3012475178972396,16.266003619591388,27.415438461500237,26.643751354610586,17.941824779028575,26.705544987706027,16.868270488976425,32.46744889420279,31.619079077523306,25.226914816603564
Diseases associated with glycosylation precursor biosynthesis,25.211405225791914,12.225153598763045,0.3012475178972396,21.650986891113305,52.315410304180475,28.43101687227963,2.4756695999082883,28.66573279724161,25.765761916912833,44.44679585470593,58.89479758367584,22.00789231953113
BBSome-mediated cargo-targeting to cilium,25.19921007625808,56.87620685844716,0.3012475178972396,10.368179386531944,9.28986964103498,9.08084596640673,20.538866053735582,41.93321630151591,18.008080954536183,1.8946438612982162,9.535993229466134,34.17769844674122
Signaling by VEGF,25.155492225256147,4.977317972509753,0.3012475178972396,16.959155564633253,23.29993741929257,5.808739115217896,1.3509178699601003,23.243383380125813,20.00983228372331,35.82655330319266,44.58876903696485,28.00663038730704
Toll Like Receptor TLR1:TLR2 Cascade,25.049724044289043,0.421613715563553,0.3012475178972396,18.586565563045543,30.609997171619913,9.185769414110718,0.33532620406408137,16.668905523600493,21.596862293830515,36.32358654932788,48.26990889812891,24.21888211403127
GRB2:SOS provides linkage to MAPK signaling for Integrins ,25.049724044289043,30.980623237766906,0.3012475178972396,16.485589361564433,19.583870549966615,18.950472875491077,16.026099929969586,38.787178098864565,19.172691426490506,20.71104004195262,26.713333560527996,30.163118498752397
Toll Like Receptor 2 (TLR2) Cascade,25.049724044289043,0.421613715563553,0.3012475178972396,18.586565563045543,30.613434675568993,9.185769414110718,0.33532620406408137,16.668905523600493,21.596862293830515,36.32358654932788,48.26990889812891,24.21888211403127
Norepinephrine Neurotransmitter Release Cycle,25.018708933883655,52.0475344880324,0.3012475178972396,8.45792590147067,34.11589704480405,19.223139808729066,27.003516524008475,46.69458598841615,8.196254943069045,16.161122620455913,19.668762508364086,26.221034084928192
Listeria monocytogenes entry into host cells,24.81215113367843,25.20365626322726,0.3012475178972396,18.545341494300434,33.1920440074463,26.362108959376883,8.796193684954499,24.288813126096915,18.641932209131486,18.98110680502324,28.969602723931487,19.198145105810642
Keratan sulfate degradation,24.78796396086032,36.87328836259748,0.3012475178972396,11.403528313362921,4.031747558568314,2.4157334281353977,3.215844336745026,20.037357078756475,13.127210195737497,16.810591831539455,20.117810689525683,27.46284979786253
SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion,24.78796396086032,11.646959219228691,0.3012475178972396,15.051799229079494,20.097135577745156,6.728778028548327,1.1901620020535024,20.513172495302605,21.211881618966125,24.43094047285186,29.507821936378516,26.88812412640758
Synthesis of PIPs in the nucleus,24.675913814310768,15.432549421803673,0.3012475178972396,10.15108215673972,17.932972132003552,8.924481662256115,5.804243810040245,36.37778638222906,17.811267192383216,21.105118220871887,30.114722466785793,21.244231673082666
Vitamin C (ascorbate) metabolism,24.620196234595447,0.734786762098133,0.3012475178972396,24.290279495606214,46.2102512872413,24.499922984924037,0.33712321559975683,29.11473658149823,20.311232473386283,42.94267179410448,54.73628985768233,25.522686158896654
MECP2 regulates neuronal receptors and channels,24.608149517820365,6.761286035409416,0.3012475178972396,17.49113569393616,29.49827657490668,21.002327608855065,0.35153742824282885,4.135206707272365,19.972495714023143,38.99535322408681,41.44168173574063,20.848501348741056
Signaling by EGFR in Cancer,24.5774172975007,3.0190532793145337,0.3012475178972396,16.62058402962794,24.46854430928774,10.981019338122179,2.4183882951987377,20.588672058556025,18.966740007337428,31.951596279613746,35.873217257920714,24.09291853805381
MyD88:MAL(TIRAP) cascade initiated on plasma membrane,24.547122988161306,0.6096479817281539,0.3012475178972396,18.226299961855805,29.883245764132155,8.721690692177662,0.3790355417232494,16.300318312596424,21.085181520844973,35.837822501574706,47.62774974639328,23.324914970484606
Toll Like Receptor TLR6:TLR2 Cascade,24.547122988161306,0.6096479817281539,0.3012475178972396,18.226299961855805,29.883245764132155,8.721690692177662,0.3790355417232494,16.300318312596424,21.085181520844973,35.837822501574706,47.62774974639328,23.324914970484606
Asparagine N-linked glycosylation,24.491555502673805,22.62649275591943,0.3012475178972396,16.24253523995088,33.679447669915646,23.818083009088774,8.459458143546184,18.03020628702228,16.775596998578703,16.560396365305397,27.895804049007452,16.009521433722206
mitochondrial fatty acid beta-oxidation of saturated fatty acids,24.39880896206192,23.78900739485555,0.3012475178972396,13.9171762135172,18.736522421477947,20.915898947605378,12.702749158185147,32.22101957340735,20.388936310455886,21.521452349135632,26.297912936372736,22.5554312048326
WNT mediated activation of DVL,24.31243631982571,42.76327497151081,0.3012475178972396,19.66905934869547,27.353264926767523,29.433570306202682,17.13192712517537,24.727593331407203,19.103763425686605,24.61245126088688,24.587879813317453,29.478294022212378
PKA-mediated phosphorylation of key metabolic factors,24.25095688605482,42.53508182954123,0.3012475178972396,17.515046137361942,36.069850365168236,31.33848238832435,18.344685696254096,33.95679714551562,20.795365890758745,21.1744390180937,34.42810012624345,22.801616841014855
Receptor Mediated Mitophagy,24.226637199721413,42.930371827400435,0.3012475178972396,19.831290569650363,28.2881627500177,29.81827780337565,17.41996307920244,25.2501373910779,19.11881946671357,25.217713620875827,25.689183777171422,29.718937273263276
Glycogen storage disease type IV (GBE1),24.208509533734528,25.54473593927872,0.3012475178972396,16.406736176408515,27.67693291012324,24.786443240789385,14.633788061635244,26.224766527325666,18.90768826996141,31.212250619289986,33.62541345566776,28.5118774055252
Constitutive Signaling by NOTCH1 PEST Domain Mutants,24.154995623935278,31.003532163777923,0.3012475178972396,15.008797807643637,30.63602742730117,22.146322629459124,11.01119597788644,28.38909836101788,14.513103763157558,16.344012031268655,22.51560097920032,18.854874619069648
Signaling by NOTCH1 in Cancer,24.154995623935278,31.003532163777923,0.3012475178972396,15.008797807643637,30.63602742730117,22.146322629459124,11.01119597788644,28.38909836101788,14.513103763157558,16.344012031268655,22.51560097920032,18.854874619069648
Signaling by NOTCH1 PEST Domain Mutants in Cancer,24.154995623935278,31.003532163777923,0.3012475178972396,15.008797807643637,30.63602742730117,22.146322629459124,11.01119597788644,28.38909836101788,14.513103763157558,16.344012031268655,22.51560097920032,18.854874619069648
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants,24.154995623935278,31.003532163777923,0.3012475178972396,15.008797807643637,30.63602742730117,22.146322629459124,11.01119597788644,28.38909836101788,14.513103763157558,16.344012031268655,22.51560097920032,18.854874619069648
Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer,24.154995623935278,31.003532163777923,0.3012475178972396,15.008797807643637,30.63602742730117,22.146322629459124,11.01119597788644,28.38909836101788,14.513103763157558,16.344012031268655,22.51560097920032,18.854874619069648
The citric acid (TCA) cycle and respiratory electron transport,24.013649711827625,27.579812671863806,0.3012475178972396,13.109343638537279,20.168055933646322,12.044146493613406,3.752191746470322,16.127519923485096,14.791321578435676,13.434437798847433,17.61734950685561,16.68772163192602
MET interacts with TNS proteins,23.98330181749442,3.253044718074348,0.3012475178972396,15.636277187980685,16.316191887607054,12.552266836404833,1.9479196381680886,10.839418650463717,15.29850666419421,25.786914841127878,32.81390453542065,25.23214185386677
Defective B3GAT3 causes JDSSDHD,23.971415714216946,31.063460008214186,0.3012475178972396,12.31446676230988,4.727637474530429,3.150185481714983,1.8392930673512344,13.246088776586305,7.822461940006002,16.66380937832785,17.87592605061335,20.947169545757934
OAS antiviral response,23.959532437871346,30.937990187261175,0.3012475178972396,14.56194224557815,19.206423450056306,19.04324448663678,10.526624925556158,22.067469525644885,10.264131881827963,22.588961556776585,18.588736275576338,20.19207150245137
HIV Transcription Elongation,23.91202761633775,50.787303649978725,0.3012475178972396,13.365897445486784,10.844989279796726,6.584090934138638,10.365731187277254,31.14979591509014,15.272064115195407,22.658459537280258,26.811771475010833,33.14300179112522
Formation of HIV-1 elongation complex containing HIV-1 Tat,23.91202761633775,50.787303649978725,0.3012475178972396,13.365897445486784,10.844989279796726,6.584090934138638,10.365731187277254,31.14979591509014,15.272064115195407,22.658459537280258,26.811771475010833,33.14300179112522
Tat-mediated elongation of the HIV-1 transcript,23.91202761633775,50.787303649978725,0.3012475178972396,13.365897445486784,10.844989279796726,6.584090934138638,10.365731187277254,31.14979591509014,15.272064115195407,22.658459537280258,26.811771475010833,33.14300179112522
Formation of HIV elongation complex in the absence of HIV Tat,23.91202761633775,50.6677480389038,0.3012475178972396,13.428395385535461,10.850953540226717,6.584090934138638,10.493505697636056,31.050808487328617,15.027078059713995,22.602686831650626,26.575929579460468,33.18218618314579
Toxicity of botulinum toxin type G (BoNT/G),23.77754126950843,29.675182346702535,0.3012475178972396,4.348901028312302,6.351214538383733,7.027285213712071,7.93648509552543,29.509634589855555,8.250109654961223,7.288416083972487,3.701488394732213,20.815793473969794
Viral RNP Complexes in the Host Cell Nucleus,23.76879457292171,8.986730221707802,0.3012475178972396,12.422385096229275,16.161515864894866,8.095322957720294,0.8639390057247062,14.776942852022838,14.197397018077883,25.63444111703432,21.82963122683576,18.531596117994
phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex,23.713100229287097,40.59606720088905,0.3012475178972396,10.927665819300389,11.517712105786044,8.066543825485207,13.964804750404843,35.45372970079911,13.972264883452782,21.16767831364024,24.893909719865498,29.468067751795033
T41 mutants of beta-catenin aren't phosphorylated,23.713100229287097,40.59606720088905,0.3012475178972396,10.927665819300389,11.517712105786044,8.066543825485207,13.964804750404843,35.45372970079911,13.972264883452782,21.16767831364024,24.893909719865498,29.468067751795033
S33 mutants of beta-catenin aren't phosphorylated,23.713100229287097,40.59606720088905,0.3012475178972396,10.927665819300389,11.517712105786044,8.066543825485207,13.964804750404843,35.45372970079911,13.972264883452782,21.16767831364024,24.893909719865498,29.468067751795033
S45 mutants of beta-catenin aren't phosphorylated,23.713100229287097,40.59606720088905,0.3012475178972396,10.927665819300389,11.517712105786044,8.066543825485207,13.964804750404843,35.45372970079911,13.972264883452782,21.16767831364024,24.893909719865498,29.468067751795033
S37 mutants of beta-catenin aren't phosphorylated,23.713100229287097,40.59606720088905,0.3012475178972396,10.927665819300389,11.517712105786044,8.066543825485207,13.964804750404843,35.45372970079911,13.972264883452782,21.16767831364024,24.893909719865498,29.468067751795033
Misspliced GSK3beta mutants stabilize beta-catenin,23.713100229287097,40.59606720088905,0.3012475178972396,10.927665819300389,11.517712105786044,8.066543825485207,13.964804750404843,35.45372970079911,13.972264883452782,21.16767831364024,24.893909719865498,29.468067751795033
Conjugation of salicylate with glycine,23.707393881963394,28.9241559344378,0.3012475178972396,14.858790987276205,29.97744694891804,27.39885546601533,15.185763506980354,26.31004915015183,14.818090117424441,26.017259859138996,35.777663892209304,25.124380897726475
Nucleotide Excision Repair,23.665028308688978,21.37293741978751,0.3012475178972396,14.620168702519763,20.45873036094591,19.236283866437905,6.054995783679224,16.62134068436368,17.409384781176982,12.161499861610867,13.264599851928327,14.478770945381948
"Synthesis, secretion, and deacylation of Ghrelin",23.604399710476702,28.037515030777136,0.3012475178972396,16.406736176408515,18.318715920417034,24.401507000718208,10.510457634593813,16.97913316935465,14.346799592746184,10.038278411593998,10.51560884827357,16.057332981398343
Cytochrome P450 - arranged by substrate type,23.562129117577953,0.3256836292814956,0.3012475178972396,20.56450768287639,46.41848206528327,17.61797085495618,1.3853606233622067,23.826596454805316,20.77156125185369,42.39876298705005,55.27822881271975,23.00771812480092
Cellular responses to stress,23.544256879190215,35.70339463636462,0.3012475178972396,14.370623660441181,23.53142327347837,18.94754392991699,7.843793755061233,16.990981758202,14.144696425035574,11.527521349522177,14.795662037278948,16.899149079558512
Stimuli-sensing channels,23.538571158911385,11.756023854397304,0.3012475178972396,21.64370403711752,40.226575824741815,15.681030878515443,0.3119923539868332,18.607284389125567,24.61402321322563,44.42306097035062,54.06127342926405,24.213340857044777
Signaling by ERBB2 in Cancer,23.46594642968708,0.992845079466321,0.3012475178972396,15.05904051049339,24.81033062409997,10.059035672869213,2.874143438588557,17.658573631012672,16.266259127726034,32.67057860364602,37.14763637618997,22.69276033665551
RUNX3 regulates BCL2L11 (BIM) transcription,23.4481116738821,47.48300471997498,0.3012475178972396,11.580098871713744,34.14443116464737,26.75347437678314,19.82925092961246,27.302386370361184,20.055619523373267,14.642801764647366,31.962791548818416,18.905074547411253
CHL1 interactions,23.430283781967038,13.792573727267193,0.3012475178972396,15.886913430015895,22.153348515823676,14.0279980933428,3.831543080531241,14.371017854631006,14.229496907919343,30.69493036508454,35.584053464413905,26.00146263761108
TNFR2 non-canonical NF-kB pathway,23.297206936673927,49.152238436520705,0.3012475178972396,11.891959487702891,30.3938306176659,35.2016914299595,21.689192741969798,31.7634651515083,10.760266704508698,19.31984647193419,13.030205119155555,23.035544478646724
Metabolism of proteins,23.11018483825662,33.666040874090335,0.3012475178972396,14.583712618073108,23.541312943071734,20.25347471413855,9.949348243314219,18.43941522251716,16.00877191131115,9.737620640747597,15.161272814372367,14.804091778483132
Glycosphingolipid metabolism,23.09249096560344,21.9352633565073,0.3012475178972396,20.675912507995935,52.13679745813021,27.51199404169815,1.2638540692300193,22.52824017018414,23.405246533278387,42.768021670693955,59.04525916543437,18.477415692613487
Sialic acid metabolism,23.056721507095606,14.901793336863717,0.3012475178972396,21.199210965048863,51.39692214870221,23.547598718152457,0.7773884549125901,24.610136788750513,23.95167049769161,42.57359913208698,58.60752606910725,18.983472740598877
Ion influx/efflux at host-pathogen interface,23.014959583668315,42.43568205007273,0.3012475178972396,14.040798338487603,31.375450123406313,29.281164491150236,19.12174584181295,37.40729368559167,17.293925750088608,30.342596517783356,33.583128032336376,32.72595686343421
Cellular responses to external stimuli,22.98526834249525,35.564636131285845,0.3012475178972396,14.253329787084926,22.9724556961902,18.911353950159985,7.825384987390695,16.60995966159903,13.939729729868716,11.108125505668495,13.977893838462327,16.368333974483658
"Unblocking of NMDA receptors, glutamate binding and activation",22.97403946370344,34.816134666255,0.3012475178972396,8.26449674399322,30.27407613925349,13.962500409842088,9.50600580296254,41.40634260479074,10.868649931142361,9.374699155107791,23.392916472104716,23.15689390216082
IRF3 mediated activation of type 1 IFN,22.97403946370344,8.691458202030605,0.3012475178972396,11.501974887170583,13.562897015039374,8.066543825485207,6.170413816827386,7.8379163303756885,10.508471734703573,16.052487398034085,15.929478257953551,13.990432509352502
Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters,22.93836466888555,6.247631120089832,0.3012475178972396,14.33409074454125,27.215660508094395,6.999884973425824,1.7387804693776538,26.759964052375874,22.664446473184533,31.058765599419786,51.07365855610583,28.940882772097346
RNA Polymerase I Transcription Termination,22.902718460136803,33.85062406132536,0.3012475178972396,12.745116346597355,19.43860981585331,14.058612017176296,6.606355787947525,10.747374006771897,13.989808596074422,17.314890446899323,17.42645826988343,18.86350369469455
The retinoid cycle in cones (daylight vision),22.819122265797535,13.959451267581452,0.3012475178972396,12.442399385564233,33.63515083949317,24.733869248347006,5.717967132093528,20.95057600323078,14.340500043283626,25.27216459797138,37.23964853282459,14.221355691645758
Transport of Mature mRNA derived from an Intron-Containing Transcript,22.789561516493237,34.47139340992927,0.3012475178972396,8.182883491626557,5.07761550520947,7.430392677113745,7.582046231608287,16.75147787925246,14.138442896983568,4.551448744191684,7.9846116428444285,13.745844434621793
Voltage gated Potassium channels,22.783971186973012,7.080869727314329,0.3012475178972396,17.201306805716495,41.038522768369674,26.032468904338653,5.7967527919696815,31.215105211560424,12.654916429336959,27.45229222805837,37.260291853057964,19.844284235298332
Iron uptake and transport,22.748847594428085,8.196748571596412,0.3012475178972396,22.80464416328124,29.800332131862447,24.801395876568776,0.4353818054517282,2.900619497601486,20.24166447717206,40.487589537740234,34.994976382760875,19.31920940187506
Glycogen metabolism,22.748847594428085,8.65687234245508,0.3012475178972396,12.745116346597355,18.07563565031688,10.237458775280153,7.820786172149888,18.36423631302287,14.022034483532359,31.239539301175625,32.34518865030864,24.184383929199065
FGFR3c ligand binding and activation,22.696213753205008,25.22425989291274,0.3012475178972396,15.802999533830786,23.560693491300174,26.38892992427779,12.493056927985378,24.240747960849585,20.851130696403516,22.39478498304649,27.25217217252525,23.78258865763699
betaKlotho-mediated ligand binding,22.696213753205008,26.339013798462318,0.3012475178972396,12.579906794174633,22.848453149899587,20.095081801597335,20.683835001651065,41.5915318745095,17.723818069734968,22.34485101503137,25.09592663729811,22.03587722374637
Processing of Capped Intron-Containing Pre-mRNA,22.696213753205008,32.95426273657369,0.3012475178972396,12.253633579486815,16.243169380015342,15.324610172683972,8.208965135711173,16.95544871298375,15.656602285763247,8.503310640471899,12.998864682503013,12.580057633417173
Signaling by activated point mutants of FGFR3,22.69063410057759,25.21197206235983,0.3012475178972396,15.788158252201182,23.56372163135478,26.381520628810758,12.493056927985378,24.23625951929715,20.851130696403516,22.39478498304649,27.26220430270663,23.799484313001123
FGFR3 mutant receptor activation,22.685054889321762,25.215942448466425,0.3012475178972396,15.772893477360372,23.55080035281979,26.38892992427779,12.493056927985378,24.226889509607823,20.851130696403516,22.390504328402915,27.248958389555167,23.793989353903516
FGFR3 ligand binding and activation,22.655583345659714,25.19534167023146,0.3012475178972396,15.749795775843575,23.544340680547062,26.350702642147024,12.480830567600822,24.207761241624695,20.851130696403516,22.381533844946798,27.228118236860023,23.759383614324857
Downregulation of ERBB2:ERBB3 signaling,22.650008236052898,0.7406180800022348,0.3012475178972396,17.104325523178712,13.899167203018592,5.446827110441064,0.629507345193391,14.356763891316838,10.609805559872738,22.46397620109769,22.398527231549608,14.190038523929685
Defective ABCA1 causes Tangier disease,22.52519487812834,23.2816389982786,0.3012475178972396,15.818279016342347,28.68485519270177,17.693873329840745,4.505571659174163,18.979854204442873,19.088713341666,34.23699899788365,40.111611628192016,21.233864518122243
Conjugation of carboxylic acids,22.424885251827234,26.952217810106696,0.3012475178972396,14.084729757475818,29.099679387458796,25.88970671009613,15.831827955808748,25.354562185993537,14.087346688487779,25.159253118908843,34.54513275952616,24.109092494087076
Amino Acid conjugation,22.424885251827234,26.952217810106696,0.3012475178972396,14.084729757475818,29.099679387458796,25.88970671009613,15.831827955808748,25.354562185993537,14.087346688487779,25.159253118908843,34.54513275952616,24.109092494087076
Negative regulation of TCF-dependent signaling by DVL-interacting proteins,22.330339267126547,3.2984920569429153,0.3012475178972396,14.224383918155059,26.55950116603491,26.335299812772625,7.682171368782137,29.01508436471751,18.922220230294464,24.09835096415542,19.27551987486889,19.743353061303463
RUNX1 regulates transcription of genes involved in interleukin signaling,22.2596631708972,35.35088088997554,0.3012475178972396,16.032547840351004,25.338484146962244,22.96299933519461,12.23321109654946,32.48438285076601,20.52868473136646,31.282441026248144,33.92306677357954,34.3094257627409
Enzymatic degradation of Dopamine by monoamine oxidase,22.1713819523849,35.05913016555667,0.3012475178972396,14.993926656638301,27.25176912062935,12.520712260873434,10.765657972166455,34.93509053886309,16.558691464081523,17.12693054083187,32.4541573329026,26.399689341773172
Displacement of DNA glycosylase by APEX1,22.154062195930756,26.067223767644666,0.3012475178972396,12.669175141843033,24.197525395577816,22.71182158622283,6.941966455559946,20.029237074957464,14.314562551719824,16.91887169461977,24.78542959672083,18.54413358609106
Signaling by Overexpressed Wild-Type EGFR in Cancer,21.884150185770153,5.095018976132122,0.3012475178972396,16.070383608522857,46.760300500321286,19.467251601715763,0.309625373483978,10.286841125876085,16.564676762536237,39.038212447082934,55.8974410049054,20.261548404248142
Inhibition of Signaling by Overexpressed EGFR,21.884150185770153,5.095018976132122,0.3012475178972396,16.070383608522857,46.760300500321286,19.467251601715763,0.309625373483978,10.286841125876085,16.564676762536237,39.038212447082934,55.8974410049054,20.261548404248142
Vesicle-mediated transport,21.84935965854486,16.24946803394142,0.3012475178972396,13.767243800961348,13.974336021225067,6.359267245544617,4.808885973303119,21.479467028351454,16.544707766963487,28.4184523018916,33.5319074213208,28.523901989296633
Signaling by PDGF,21.814597718987425,29.091506704980404,0.3012475178972396,12.607044717618297,2.790801743004607,1.2188272681162602,0.7330980592395376,13.872467036463972,7.885025365603113,16.137713389308242,18.732645726411377,23.981750544090758
PLC-gamma1 signalling,21.797423318339753,18.097941799836565,0.3012475178972396,12.213541611214394,18.854195894778414,10.476170353982985,7.394869259525906,26.74024453913144,13.359061133977553,19.22511716862372,17.953945240230084,16.171472406486426
TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain,21.733467302782167,23.571655102227243,0.3012475178972396,8.009337695479116,12.310460130500047,5.887676333480017,8.75484916123197,18.60337486295801,12.348170372878592,14.436226769690528,20.75857786224285,24.09291853805381
RORA activates gene expression,21.66960820709402,19.293052561810594,0.3012475178972396,10.102018565364006,15.219955037078146,11.984040641726533,5.147721311967713,35.31501960152405,17.52481847660718,18.828641421731927,21.02361339571649,27.581068751230813
SUMO is conjugated to E1 (UBA2:SAE1),21.62333262984737,32.35696530971017,0.3012475178972396,6.4424443548265495,13.379255835572266,6.869085561221474,3.0003311305570564,17.43786741263434,12.74746326497855,11.252643222885895,12.209869740395023,12.413489614852454
Transport of Mature Transcript to Cytoplasm,21.58875704008176,33.58082648134995,0.3012475178972396,9.214143015812597,6.357839793837846,8.629839984889664,7.829985153728805,15.781879116999827,13.790725659055727,4.912179332051986,8.71130116292844,12.115540810842447
Recycling of bile acids and salts,21.58332221893056,38.612493188015854,0.3012475178972396,16.05498049488871,16.00195545908308,15.13324818332836,8.822178143404528,16.276803523891257,13.270249365515335,17.675596654915548,22.047360945069958,22.1195469673128
Gastrin-CREB signalling pathway via PKC and MAPK,21.467383747608494,3.893089539208305,0.3012475178972396,17.24920691504014,25.955700325713707,7.780844121816884,0.41587542430625646,15.58317246475467,18.72489162183456,37.75925019508527,43.30334945566675,24.12015406551672
Detoxification of Reactive Oxygen Species,21.4619651075267,46.34894766289672,0.3012475178972396,12.253633579486815,31.466522489817375,32.47188075838363,20.388587049457897,34.47194355816107,11.91847879228809,13.339129164413979,11.77043506583652,15.899383300628894
Synthesis of wybutosine at G37 of tRNA(Phe),21.375331031647836,0.6511503751667944,0.3012475178972396,14.363553876795407,22.728564068530524,7.704370006513764,1.3000537003243495,4.406164284608462,17.286982787769933,16.994262720352094,24.5718885697886,10.397057014250453
Cohesin Loading onto Chromatin,21.26575007659201,29.75475982050135,0.3012475178972396,7.53123291034705,28.08471114587527,35.65015857423843,23.565315422030373,34.576346174823385,15.870466709153911,25.33121729250652,26.99601923714596,24.069558387237983
TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain,21.248801264227783,21.198044682459763,0.3012475178972396,14.657078871050727,15.303927679314105,10.280846213611444,5.523189927731839,14.058897029395338,16.19585126505904,15.662745693552397,24.97284137289454,23.284818055944196
rRNA modification in the nucleus and cytosol,21.03021207177361,33.12139834598196,0.3012475178972396,11.798876466869917,8.206644821301138,5.399491834307502,7.902323396130879,29.82660829424014,12.415813897719334,11.587033350142008,17.49771634970254,22.108565896857097
Uptake and function of anthrax toxins,21.00761694528978,25.831696854074405,0.3012475178972396,14.31997128456539,25.71115563471192,11.8405386894904,4.9175573924866,15.30648468959792,10.896860574025778,30.72144467270372,39.70125903942274,23.52715399784192
mRNA Splicing,20.962077330814395,26.791703910843403,0.3012475178972396,11.658501505792064,20.727527679445654,16.708802320372392,7.190951304236032,15.847101195019977,14.784920465960617,9.032522701920067,14.139766039028661,10.118388515582817
HIV Infection,20.933786060815844,29.858145813626383,0.3012475178972396,11.501974887170583,14.169779988424557,17.69104329883734,8.520030435605763,13.843871391137847,14.513103763157558,6.518632171088841,6.2710797788195025,9.369125784021207
Organic cation transport,20.842537477165163,13.338623030985016,0.3012475178972396,22.101786779480303,37.2203020383835,12.889937556646215,0.5500498290461502,7.202986592896869,19.99489436081353,40.57161665308883,50.95530511720386,14.128179865766262
RUNX3 regulates NOTCH signaling,20.7572025744878,4.189921024229362,0.3012475178972396,13.888194877591598,29.98473855009969,22.869842478497677,5.908231586140484,20.9064252172091,20.513568576706653,26.09289530953482,28.499109126862333,20.5860529752113
P2Y receptors,20.723350619749432,19.537881200096255,0.3012475178972396,8.630546638834925,8.665960221217922,0.9704567987954693,0.941725037522921,19.767168164235628,16.160706875798304,17.107236578489083,28.64729391257271,25.687031839765282
Golgi Associated Vesicle Biogenesis,20.70092700041037,25.923053994277556,0.3012475178972396,14.429257539343634,25.437533497517933,18.805033907140466,12.143319664675213,25.887678316444966,14.925801491767295,36.367552661953106,40.32007098394916,30.36170570924456
Activation of BMF and translocation to mitochondria,20.678515895238505,5.504970148893686,0.3012475178972396,2.7227663141371616,0.3655732322689274,1.9316677000875866,4.231185886855109,7.035040705198829,2.228295115678346,0.3345108945945677,0.43484106141277956,2.2088322652560923
WNT ligand biogenesis and trafficking,20.616661732999727,6.834818428118168,0.3012475178972396,15.014375410418452,15.890107812686212,7.627685017573758,0.32978201672236224,3.1607640272120867,20.49041512931213,31.380617556221694,40.32390328895965,25.26739421686371
Regulation of cytoskeletal remodeling and cell spreading by IPP complex components,20.616661732999727,4.9029154998479045,0.3012475178972396,11.671534207256174,24.48913930023868,10.65776577159502,1.4027569014522465,12.944193787975848,16.932076841951204,15.015013227870913,32.62168551200742,13.614491112086618
G-protein beta:gamma signalling,20.599983629453963,17.06017735948498,0.3012475178972396,15.459734030642535,8.292774657363262,3.1187367387188907,2.206604157196387,20.289007792324508,21.422219058300332,20.73769039018322,30.675994025881216,26.196640151341725
The NLRP1 inflammasome,20.583312417575232,2.038209602248168,0.3012475178972396,16.959155564633253,25.93130149044932,13.076462690119932,0.5295258996119031,12.30802157872417,20.117380319894,37.79451619296232,37.72273906773927,24.161398083559035
Transferrin endocytosis and recycling,20.572329895342094,1.0383489931957752,0.3012475178972396,21.764935715450914,23.685452092917348,23.02430443228842,3.791611743646365,6.69808762446515,16.09802671068721,37.384361481862165,29.644838767337436,20.020677066213477
SLC-mediated transmembrane transport,20.51593122063369,36.294505221210954,0.3012475178972396,20.74408200836573,48.127526875451025,13.320473573446044,3.881849644685741,8.570145292032933,21.88183348313697,43.11810834993468,57.23981392955622,14.163605710244324
Negative regulators of DDX58/IFIH1 signaling,20.50496730495984,40.15965662187958,0.3012475178972396,10.656090219587814,9.75788090999086,13.735201420093357,11.02101740946101,15.386420472928005,5.072871406657991,15.124748706764816,8.791074913262173,18.420806206983553
Mitochondrial calcium ion transport,20.49967761862187,32.94018354327454,0.3012475178972396,9.920704584013988,21.13176625651792,8.98633575497649,6.668476739407345,33.089314998624,12.92765477315143,13.638620550027836,19.12710694719672,17.04618573051949
Class I MHC mediated antigen processing & presentation,20.495151658565188,50.17118363639525,0.3012475178972396,7.055969585967276,16.556297694703225,25.83657054802016,20.192895905972133,27.912093224637452,6.8317010017607,5.942471400985984,1.8853091731650737,14.81299352353328
Toll Like Receptor 7/8 (TLR7/8) Cascade,20.495151658565188,0.4873230668152574,0.3012475178972396,14.613442373938788,24.847881766996633,6.1960976522509075,0.3832576656614264,13.013556959387039,18.5142562132847,32.15135371286624,41.87496323291749,20.461318694245932
MyD88 dependent cascade initiated on endosome,20.495151658565188,0.4873230668152574,0.3012475178972396,14.613442373938788,24.847881766996633,6.1960976522509075,0.3832576656614264,13.016782514394263,18.5142562132847,32.15135371286624,41.87884718099909,20.456617803420087
Glycerophospholipid catabolism,20.4898622364825,20.24135557446008,0.3012475178972396,14.896013723784893,41.067409919868986,29.03656356288734,10.421270986986787,22.23919511312783,19.641211454781175,25.35076400640761,39.385998945361926,18.647784169821726
FGFR1c ligand binding and activation,20.439244239052744,22.823154842414024,0.3012475178972396,11.475752047578844,18.285935483387483,20.731545942333824,11.697015515915936,22.955532784382676,17.517829434264637,17.99442735276401,22.99151732859702,19.40380641910286
"Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)",20.36607466430571,18.403236764724433,0.3012475178972396,15.02160749809081,19.96603768330684,23.17168667999407,9.372364712180554,11.782433879110021,14.261633874489144,11.678861005314767,12.393550873228747,14.221355691645758
Glycine degradation,20.309970228855825,32.85181335791595,0.3012475178972396,6.758561980706029,13.881224141720317,9.049391932503736,6.510251049501052,21.026529064942252,13.158017175491194,7.744821563625593,11.487943908245505,9.793401840735795
Regulation of TP53 Activity through Methylation,20.270858628644103,36.17455776884197,0.3012475178972396,14.979063103842273,22.50789784261433,12.316133171621539,9.234697112002419,30.531245933079614,11.135972585376226,23.341979611447265,40.49813696042469,29.07683618919298
Synthesis of PA,20.220521280517097,34.81146125626723,0.3012475178972396,15.339146053315734,15.182327592226331,11.815216596920262,11.283873924061051,29.062871197347963,23.405246533278387,27.97381841528565,33.278530274881255,30.785261641537204
UNC93B1 deficiency - HSE,20.2096388455977,31.260037454084856,0.3012475178972396,11.073507164640057,5.700765846198141,14.228357576132836,23.00771255055541,31.997691699169025,13.076631378272966,13.72082419108453,7.008084754935883,25.874837993262346
TP53 Regulates Transcription of DNA Repair Genes,20.125658321375358,48.571540865495656,0.3012475178972396,11.34656298248451,2.1465647941113937,0.7996981148323079,4.5804176299738355,24.541687244662675,13.270249365515335,12.677256628899887,12.317643311746291,28.301118898586243
NFG and proNGF binds to p75NTR,20.103571496086786,17.69480034210179,0.3012475178972396,15.971925667382516,30.127281632053414,25.83318965080446,12.696808646115478,24.3715861759514,12.958572949988932,20.091824718485572,27.647450731766057,15.018993447861385
VLDLR internalisation and degradation,20.075886090639216,20.871584491000092,0.3012475178972396,18.586565563045543,21.14073422809571,23.331338772444234,12.374721400081791,20.829951622143927,20.91258683904801,28.875301456771634,30.426256457615846,26.751689571613028
Glycogen synthesis,20.025800123532438,3.7278630277502676,0.3012475178972396,11.073507164640057,18.129196657549613,12.769709393867785,7.061519142550892,17.08388268286984,14.346799592746184,27.942751954946,29.311634459796043,23.60192625771622
"Metabolism of ingested SeMet, Sec, MeSec into H2Se",19.9366248656524,32.73914370176087,0.3012475178972396,14.865985442618165,7.411408945577925,3.1688231326926934,5.132238262275916,19.210478373021516,15.360326019115723,24.97841051728673,25.78329221672129,24.98698196881762
EPHB-mediated forward signaling,19.914645963554577,38.0946074512997,0.3012475178972396,7.38324365674072,24.04545301491481,20.49179260936013,17.858933695895427,29.509634589855555,10.82861739770571,7.994153180996247,8.966406549855785,13.084430659673394
Formation of ATP by chemiosmotic coupling,19.892679584990947,21.947045681654256,0.3012475178972396,9.639202865475438,13.746217076744289,8.955380119508408,3.0171551878026226,11.953008075867228,11.912767352865249,7.789469082327612,8.327082727430486,12.140197524496958
Loss of Function of SMAD4 in Cancer,19.888224318004813,23.876935089343466,0.3012475178972396,8.658489532505623,29.665279913043012,25.197842097226875,19.781428530982065,41.96874146525872,16.03666670114873,22.951796894667613,31.058079230382372,25.07101734257314
SMAD4 MH2 Domain Mutants in Cancer,19.888224318004813,23.876935089343466,0.3012475178972396,8.658489532505623,29.665279913043012,25.197842097226875,19.781428530982065,41.96874146525872,16.03666670114873,22.951796894667613,31.058079230382372,25.07101734257314
SMAD2/3 MH2 Domain Mutants in Cancer,19.888224318004813,23.876935089343466,0.3012475178972396,8.658489532505623,29.665279913043012,25.197842097226875,19.781428530982065,41.96874146525872,16.03666670114873,22.951796894667613,31.058079230382372,25.07101734257314
Endogenous sterols,19.88301685225799,1.1193801428205454,0.3012475178972396,19.499251445808103,45.57591336585086,16.378242569953052,1.0897916830237797,23.243383380125813,18.17038675532422,39.04266693933854,52.36862396062613,20.979984021303615
O-linked glycosylation of mucins,19.877809865243048,5.324757229053797,0.3012475178972396,12.266636016618328,25.52247039799838,11.820138145330928,2.8796072222538047,22.34169951234022,11.941337720719389,32.714427754083985,44.12191464773493,25.88056838739732
Synthesis of UDP-N-acetyl-glucosamine,19.80011844783145,12.873920712146601,0.3012475178972396,9.092001299155562,18.874893153591554,0.47704008772491857,0.9957544299628855,16.018984098026245,10.519485077853556,8.575795510056947,26.224417244557166,9.81140755160593
Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE),19.761518884055494,9.944849750760476,0.3012475178972396,15.795578107357802,19.68273798139574,6.782474112382188,1.8267501242699473,14.64189988366079,13.771845966098487,31.277427283918954,44.69220091132283,22.266520858399304
Regulated proteolysis of p75NTR,19.728518049691072,7.673511852959323,0.3012475178972396,16.493171832643416,39.92061448076996,15.63866732034373,2.1060915691879027,23.43376140599837,15.905280791373457,28.592294021473833,54.82103756860128,25.249981055166938
Inositol phosphate metabolism,19.645580781497827,14.160225345960137,0.3012475178972396,13.294825870459553,15.030300993566655,0.8773604482898355,6.567375343808941,6.87652011377082,20.062623852534344,27.24961651474211,38.250814037396744,16.180798326718765
The NLRP3 inflammasome,19.59051396611043,5.783697939820651,0.3012475178972396,7.895399807034325,3.2709169291850038,0.5889866480459165,2.5809462654704096,14.571198052996902,20.234154545768376,12.576928540221308,20.89907435476103,24.103562229471123
Phase 1 - inactivation of fast Na+ channels,19.574643715310764,10.465464509863155,0.3012475178972396,7.121320004073191,17.02922246604665,3.880296340830145,6.532040468072193,24.15003001820532,6.341869978890626,20.022077876404136,23.93482241493499,23.018927483139333
Synthesis of very long-chain fatty acyl-CoAs,19.574643715310764,8.560973937457923,0.3012475178972396,17.201306805716495,25.806927921586066,14.407824214566679,0.31318216618399464,7.24646525562091,22.720473424886965,35.58137200819085,46.34000758771889,19.43534597593357
BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members,19.569479125941097,4.789501062452562,0.3012475178972396,11.918307294765823,36.575762382942486,16.553687559439947,3.3568073900404305,3.4789890530431036,17.978885911940644,36.3062251710852,38.63363723792362,7.343779751064642
NCAM signaling for neurite out-growth,19.52005263726336,12.683273632436064,0.3012475178972396,12.689793087739607,5.086255909031761,0.9797541529255348,0.6837051689187257,9.395704108156043,8.113508513015434,19.143229752416552,21.88037547257191,21.23904789434158
Creatine metabolism,19.509367058292117,27.9240702984846,0.3012475178972396,8.248397448117167,9.233508296358828,7.6504068816356,6.182852950336944,34.13307654040646,21.995817367162662,16.390116913914518,11.830523283687329,27.238012435377527
Metal ion SLC transporters,19.410736522104543,28.041707248901652,0.3012475178972396,9.114848941521624,20.097135577745156,14.840823645560436,16.320579774545532,30.092071186662906,13.220105515795849,20.248351730082025,23.631244729034172,22.533249326323336
PTK6 Regulates Cell Cycle,19.410736522104543,53.589646704947164,0.3012475178972396,1.6677938151382714,0.6502273354186712,2.3730605613173967,14.57442694603315,27.503117538304444,3.836117421633794,1.3841751284233517,1.4344541076249167,12.905110005888153
Retrograde transport at the Trans-Golgi-Network,19.361518336816864,2.6979351893852463,0.3012475178972396,15.23361241070097,21.631702470284864,11.22030173507949,1.6029629066128521,17.19305561296302,20.975131923793715,35.40239774514452,38.165580769001615,24.61535650172982
Activation of NOXA and translocation to mitochondria,19.339870276848835,45.49987891979294,0.3012475178972396,10.944947178218424,21.606209064945844,11.235356032292321,7.892727887348789,13.513835076126762,11.847268971647036,14.479749325257572,31.661004149994223,16.601455753815046
Deadenylation of mRNA,19.32923610648835,21.380569386727007,0.3012475178972396,6.461109598416409,10.960083656722144,4.9588297355657485,7.762930874353149,16.60995966159903,10.98104969527732,13.151543307524308,19.007890145574247,21.772996225257135
Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization,19.269138459373277,7.397247268990553,0.3012475178972396,3.856270060452218,5.7616846007942275,2.977432715271946,0.3832576656614264,13.381405152709014,10.381108565647102,0.370880266699018,0.580099068827282,7.492314754136872
Protein methylation,19.25303389010422,28.21102630068316,0.3012475178972396,13.846162327483457,26.51700120496119,20.30191078443963,7.25597357021593,16.915564014674764,15.815004268514729,13.631695642224752,21.13307096967404,16.349219343741144
Abasic sugar-phosphate removal via the single-nucleotide replacement pathway,19.11639818638505,19.348856730652326,0.3012475178972396,16.83268549009296,35.85994683495747,19.16632091460351,1.3975715567641243,18.741415325902427,12.704632262679658,21.499282782397508,35.82492360145479,19.60985127572947
Adenosine P1 receptors,19.100360427218906,17.505145737880856,0.3012475178972396,14.851598141710008,19.862916744773173,15.041940696550867,7.390408501601708,17.699020277639004,13.214070975872861,15.28419625500242,20.886845656599192,11.139907513213654
Carboxyterminal post-translational modifications of tubulin,19.07886462701477,57.47252573060157,0.3012475178972396,8.259236089519371,2.9529586565781214,12.009907587430309,20.2963118983126,39.13210207372203,11.93025319785107,0.48313496732334527,1.9592680390293857,16.658940662489023
Zinc transporters,19.030084692136935,24.074507477872242,0.3012475178972396,9.290557102134896,20.325278668815187,14.517648242038845,14.922657765327475,28.781210331057803,13.164038540916248,20.17464494261545,24.129291337100934,21.683594332240105
Interleukin-15 signaling,19.008630011093,2.679813365849072,0.3012475178972396,14.709161056416823,28.324986107735114,8.332946234782572,0.5975302027083317,21.04885107145021,22.811117959575753,32.69220471711737,48.6045036394102,22.801616841014855
FCERI mediated NF-kB activation,18.998091276330953,39.42896296264542,0.3012475178972396,6.195995405541556,21.867723097269295,26.873331283904623,16.172427424555078,25.478438091670277,8.181961275379066,4.997762851758307,1.3166979886704975,10.616949295263499
Anchoring fibril formation,18.8895692067426,9.759786201582212,0.3012475178972396,10.989637471596124,3.408334197355668,2.827578779209296,0.5728807288215364,7.1777048451173755,7.7218905530117325,14.036780998496273,10.603078767563195,19.78554091517311
Synthesis of dolichyl-phosphate-glucose,18.884500420929683,2.5416416945252105,0.3012475178972396,2.2205853212320137,16.494476802360218,10.802568499489453,4.430832033642951,2.1597658791872028,3.9073823560035432,9.507648975369426,11.967925452755857,2.835677223698362
Glycogen storage disease type 0 (liver GYS2),18.85226791188186,23.93503462612251,0.3012475178972396,15.59030677620042,24.928267178408017,24.60626001709957,12.883848884256942,21.134463429861437,14.684118339715319,22.12214924306625,27.25538584735608,21.844451919088964
EGFR Transactivation by Gastrin,18.847204124776624,0.7007331270197953,0.3012475178972396,15.925447200045076,21.454127471088302,8.23334098783991,1.0436830002287505,14.63470076639057,16.7048664624599,30.30473418581865,35.80103963704737,20.67896688820013
"Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3",18.79331025976276,13.880819957135815,0.3012475178972396,16.32807883895618,36.20383352231122,16.87571663194938,2.7805798267778523,15.082612697582869,17.194361977050516,39.73470902123263,49.50214846269191,23.44663934828807
CD28 dependent PI3K/Akt signaling,18.76115869500153,2.8936916771056262,0.3012475178972396,13.643716064688988,25.085056961158973,6.838074506551253,1.3437717450716886,23.030792220454632,19.473164159016452,35.379298381123505,45.50418942506364,23.02433138125894
mRNA Splicing - Major Pathway,18.750691639591345,24.235315735679347,0.3012475178972396,10.393034489479202,18.66108906548894,14.826363525460048,6.405699340388382,13.69710260198077,13.164038540916248,7.352800772381825,11.712832828852992,7.540215015555325
RNF mutants show enhanced WNT signaling and proliferation,18.74564186896416,10.65249579663429,0.3012475178972396,8.128716637327948,20.479939846547605,20.050373791140984,11.501394662236166,16.85515704863719,11.397642791137285,12.50975146893746,17.310986803918833,15.460469328091545
Downstream TCR signaling,18.729766237702886,36.87328836259748,0.3012475178972396,12.772055937509887,33.91289023208198,34.734086543209486,23.109021780169176,26.75524042405853,10.325177409314438,14.594934591827085,10.886245329757847,16.726729409788316
Phospholipase C-mediated cascade; FGFR2,18.428296447662667,20.180003209843036,0.3012475178972396,11.3785155132167,18.597602761425435,20.912830014271226,11.073656186433888,20.63733886928543,16.925621964311976,16.84259783799537,22.172854753208348,17.958020787333183
Deadenylation-dependent mRNA decay,18.358952123257165,30.947230387619154,0.3012475178972396,4.837041044156693,9.093562275747882,4.9851303947663,7.68638001122264,21.686072276782166,12.073073077517332,16.429691595268025,21.30591634889248,24.443442869703667
"SUMO is transferred from E1 to E2 (UBE2I, UBC9)",18.353959711858426,27.716138395621346,0.3012475178972396,4.857429521356303,10.187560010469882,4.795540282125154,1.9169477149951788,11.424430938374154,10.681702378657759,8.291993202742473,8.689724540790841,8.778639806581728
Response to metal ions,18.332905220629243,0.4417777022485364,0.3012475178972396,6.0052526954067265,29.890048668331133,2.863876710253815,4.671523414597484,16.704458741476707,8.044755172234245,23.049584373798485,48.57609936705405,20.036134253017078
Signalling to ERKs,18.26374774925782,31.87851233679323,0.3012475178972396,9.502058778313968,19.83373451538234,17.962778373830595,9.388333556106975,21.958232355731404,10.027721357266588,4.2768720794861315,12.277399069001435,8.226431177403267
"Activation, myristolyation of BID and translocation to mitochondria",18.22139623997938,36.486282275257565,0.3012475178972396,12.179996837697677,31.592142279974908,29.919290562703225,23.54199283557263,35.94910635701033,9.115366105693516,11.143346801454785,16.47743698229634,11.289531296928743
TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation,18.200421075755507,32.03879972346539,0.3012475178972396,11.613130998530304,17.85364427724735,9.584151886853046,4.9782113453351595,23.167765964437525,14.112696643658106,21.20556175022414,25.93462756403987,17.978095126710596
NOTCH3 Intracellular Domain Regulates Transcription,18.17945844608608,18.952849349472977,0.3012475178972396,11.015269407778584,14.617827663893653,15.710815536506741,13.665649414013915,16.0459178012825,12.90940781442614,14.436226769690528,10.92625589508252,18.018641380651133
Zinc influx into cells by the SLC39 gene family,18.11060225281399,23.323008135425727,0.3012475178972396,8.930604104828257,19.200976228221364,13.661887739617354,14.248250041703713,27.636230155122202,12.90940781442614,19.74246313351403,23.588808264202196,21.783891478201248
Processing of SMDT1,18.036572888753053,29.324669271330468,0.3012475178972396,8.177972357484483,19.860147419402786,8.402322990285835,7.554939794387333,33.951483237608656,10.436210396227324,12.434287638684255,17.36454864245648,14.087965350241529
Resistance of ERBB2 KD mutants to neratinib,18.008343109382174,12.58425383601723,0.3012475178972396,7.456440332641316,11.534788004478878,3.344533254558174,2.63578184083714,18.732476449716515,6.314468503864523,15.414603965457879,17.786830311562714,14.770541324820543
Drug-mediated inhibition of ERBB2 signaling,18.008343109382174,12.58425383601723,0.3012475178972396,7.456440332641316,11.534788004478878,3.344533254558174,2.63578184083714,18.732476449716515,6.314468503864523,15.414603965457879,17.786830311562714,14.770541324820543
Resistance of ERBB2 KD mutants to sapitinib,18.008343109382174,12.58425383601723,0.3012475178972396,7.456440332641316,11.534788004478878,3.344533254558174,2.63578184083714,18.732476449716515,6.314468503864523,15.414603965457879,17.786830311562714,14.770541324820543
Resistance of ERBB2 KD mutants to osimertinib,18.008343109382174,12.58425383601723,0.3012475178972396,7.456440332641316,11.534788004478878,3.344533254558174,2.63578184083714,18.732476449716515,6.314468503864523,15.414603965457879,17.786830311562714,14.770541324820543
Resistance of ERBB2 KD mutants to lapatinib,18.008343109382174,12.58425383601723,0.3012475178972396,7.456440332641316,11.534788004478878,3.344533254558174,2.63578184083714,18.732476449716515,6.314468503864523,15.414603965457879,17.786830311562714,14.770541324820543
Resistance of ERBB2 KD mutants to tesevatinib,18.008343109382174,12.58425383601723,0.3012475178972396,7.456440332641316,11.534788004478878,3.344533254558174,2.63578184083714,18.732476449716515,6.314468503864523,15.414603965457879,17.786830311562714,14.770541324820543
Drug resistance in ERBB2 KD mutants,18.008343109382174,12.58425383601723,0.3012475178972396,7.456440332641316,11.534788004478878,3.344533254558174,2.63578184083714,18.732476449716515,6.314468503864523,15.414603965457879,17.786830311562714,14.770541324820543
Resistance of ERBB2 KD mutants to AEE788,18.008343109382174,12.58425383601723,0.3012475178972396,7.456440332641316,11.534788004478878,3.344533254558174,2.63578184083714,18.732476449716515,6.314468503864523,15.414603965457879,17.786830311562714,14.770541324820543
Resistance of ERBB2 KD mutants to trastuzumab,18.008343109382174,12.58425383601723,0.3012475178972396,7.456440332641316,11.534788004478878,3.344533254558174,2.63578184083714,18.732476449716515,6.314468503864523,15.414603965457879,17.786830311562714,14.770541324820543
Resistance of ERBB2 KD mutants to afatinib,18.008343109382174,12.58425383601723,0.3012475178972396,7.456440332641316,11.534788004478878,3.344533254558174,2.63578184083714,18.732476449716515,6.314468503864523,15.414603965457879,17.786830311562714,14.770541324820543
tRNA modification in the nucleus and cytosol,17.97159883033405,51.3972560895051,0.3012475178972396,3.441930737797447,5.24059508960797,7.134649674825727,14.75493687520508,27.383827837315703,11.41506445002485,10.383976409658176,15.730006870775123,29.410698655118324
Downregulation of TGF-beta receptor signaling,17.961363655180012,48.048304863404574,0.3012475178972396,6.659556045896539,13.542608068023625,3.1452791383741423,5.459593534001122,25.072552211000826,8.909717148748218,1.7490845750567487,11.303816009672461,10.751396588293064
Frs2-mediated activation,17.956426213635456,4.946481212245672,0.3012475178972396,10.065824502029736,23.106598283405344,9.674169947896292,0.8918526101135841,13.207493794015383,15.190172907609002,12.222396535124057,23.505603332755445,8.869551064685837
Downregulation of SMAD2/3:SMAD4 transcriptional activity,17.808832359356593,41.59224566984677,0.3012475178972396,12.334401862869923,33.40839120499746,19.41575418982721,9.244758786866464,27.554827423282283,14.65823908224612,12.28688520600149,26.64636737279322,17.03660080347216
Insulin receptor recycling,17.772300280517072,1.9902367753257708,0.3012475178972396,20.71873545525511,19.565522971911115,20.167230531513894,2.6629561457590625,4.03899148212209,13.486943548255447,35.10265691069004,25.12973802397314,17.384205208109922
Defective NEU1 causes sialidosis,17.725285754508683,22.107779366901163,0.3012475178972396,19.79757125090357,51.37840007575132,24.50654598339503,0.8300004122432368,20.376366092805842,22.23415944435075,40.62161939880838,57.42234903312371,15.037277650624421
Heme degradation,17.6101184792572,12.517980440065063,0.3012475178972396,13.997335185817168,17.751475487809696,17.61797085495618,12.221558023034214,22.997898789078484,12.532659263616047,26.51919562108842,26.154555955151245,17.584986159151697
Inhibition of TSC complex formation by PKB,17.579035940068636,32.121989474725154,0.3012475178972396,14.79166667862669,13.018428374950025,16.140044668101442,7.753426657196796,16.967288820826493,16.091336249185765,21.44580113998333,19.873750943628306,23.99278556144518
Macroautophagy,17.568919023803534,25.80242069575729,0.3012475178972396,14.620168702519763,19.547184256344647,17.917744189130328,6.32379455201289,8.302634866643539,15.265553773301642,11.034007603016118,13.858922382024817,14.150398958696252
mRNA Editing: C to U Conversion,17.528125269950763,36.98720338306298,0.3012475178972396,6.9462865194923085,16.710412879297188,26.475868897584682,20.891711097526482,19.732748019502896,8.28414458356068,11.662777862305388,4.992504121812825,18.328499585871825
TCR signaling,17.528125269950763,37.41752942787059,0.3012475178972396,11.32052798021732,31.041197247169265,33.15038421695844,23.094312954267423,25.9521623018395,8.699586480985769,12.87916689540388,7.571681653712213,15.297242564029752
Formation of the Editosome,17.528125269950763,36.98720338306298,0.3012475178972396,6.9462865194923085,16.710412879297188,26.475868897584682,20.891711097526482,19.732748019502896,8.28414458356068,11.662777862305388,4.992504121812825,18.328499585871825
FGFR3b ligand binding and activation,17.51279578365422,15.547080959829428,0.3012475178972396,11.131544732210163,13.989722321868689,12.204309820076988,5.163229912368502,12.281181983493271,14.255729341476044,18.75264796623351,15.759541297984041,20.020677066213477
Activated point mutants of FGFR2,17.50792410258041,18.89082968471949,0.3012475178972396,10.957551969759287,17.760019647103196,20.329413481711104,10.521234552502433,18.741415325902427,16.209679373229726,16.063986394754313,21.732509806380715,16.94336855691651
"Sodium-coupled sulphate, di- and tri-carboxylate transporters",17.39349554757099,11.978160572428905,0.3012475178972396,8.844193531115927,31.728495418841202,14.310468832236188,6.717553450547854,15.94487448125121,14.314562551719824,20.07041890896172,25.567343277353444,12.64740103233321
Peptide hormone metabolism,17.383434336678658,29.93363775809128,0.3012475178972396,9.64458202857099,10.884765700129336,4.9878965773989385,8.213330850881695,22.387781651657942,12.710543807269943,21.13202953939567,30.70238501466495,24.443442869703667
Gene expression (Transcription),17.347359115781046,27.014058252241004,0.3012475178972396,9.6156612230272,11.252102646013508,14.381897099700273,8.85275280955393,13.003263749021091,11.989565442931085,5.245254196988936,5.96200394292834,7.434655762365362
Generic Transcription Pathway,17.259405312546534,28.283553489837846,0.3012475178972396,9.080588966019473,12.315043813845529,14.885021237919556,9.067086976300523,14.183377682539046,11.444017489862565,5.041926272437202,6.087944821221207,7.337680362433924
Metabolism of steroid hormones,17.22864676512746,0.6514894885727056,0.3012475178972396,17.604437531898167,40.239424865150674,13.888554991505671,0.32978201672236224,20.376366092805842,18.94402677754181,39.139161381472185,51.88609491714185,20.925436229958503
Pentose phosphate pathway disease,17.22381745613822,48.41307462987408,0.3012475178972396,9.603901891988457,6.449461297626323,8.668502439631855,15.913567276110191,22.350682712983826,10.969782231343611,7.07374733066956,4.897770027140953,17.77607559312243
YAP1- and WWTR1 (TAZ)-stimulated gene expression,17.182738962320787,2.3614157206765687,0.3012475178972396,7.321524763654775,0.7417743474196404,2.8923329850727786,0.36949573249284107,2.769417549632763,9.084154669572504,10.900051514846947,6.925974126856295,11.625764400588258
Estrogen biosynthesis,17.146881205314916,0.5481005925473036,0.3012475178972396,17.661704008605277,14.522489795934565,11.771847958510316,1.547159349141423,1.3620541526222512,19.756585669881332,27.61736257895947,30.193189130129255,15.442607570111855
Signaling by activated point mutants of FGFR1,17.126559549106258,17.554916795698166,0.3012475178972396,10.580274695610804,15.572216214822168,18.457979178622644,9.004469462583302,18.640673295278116,16.69804640134918,14.886717306579898,20.102742321715105,15.623210581884438
Signal amplification,17.091114753896832,25.82327654266007,0.3012475178972396,12.490208450760626,9.06880632253728,4.870520235521306,5.479692120798944,20.336570413000327,18.365116974504218,17.874626165619098,24.240037020729268,23.486471127284258
Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK),17.091114753896832,45.49467922551574,0.3012475178972396,7.2502880224281325,17.42050874366242,18.442221896460428,18.622356385833914,44.00694115877367,15.02062329741384,2.9412249878287593,7.7727866930550045,16.673327937946976
Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function,16.968177416548848,51.98168605692261,0.3012475178972396,11.652540441905881,23.594225497721208,17.876895920394304,7.975371683269531,17.78975263579807,15.101651735443896,16.966522796337554,21.59267573914716,19.514872548536687
Diseases of Programmed Cell Death,16.968177416548848,51.98168605692261,0.3012475178972396,11.652540441905881,23.594225497721208,17.876895920394304,7.975371683269531,17.78975263579807,15.101651735443896,16.966522796337554,21.59267573914716,19.514872548536687
Hydroxycarboxylic acid-binding receptors,16.881229353740245,0.5697085965896928,0.3012475178972396,13.802621983245151,27.241109724343897,23.32810480466655,3.6838959213304787,4.934301192159014,14.20328974508368,25.669187718564444,24.91197096667015,14.030168392135447
TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway,16.805094244725638,42.21454786419546,0.3012475178972396,7.526234562032715,19.602226990075106,27.823401487310278,19.81627672651296,28.062860110169684,4.576482668205927,11.705301057743076,2.7151758770018035,20.13859513285099
Methylation,16.805094244725638,18.70881651850484,0.3012475178972396,9.656367768187787,19.20369986507038,21.189364108831047,11.655054678514084,13.628522145945585,9.870555763711886,10.88746918532169,10.413222017059825,13.798571325071253
Cytochrome c-mediated apoptotic response,16.77987236992288,2.8112043916067364,0.3012475178972396,5.996139098039413,8.30442521281387,6.982214572849429,5.7967527919696815,13.22500136051684,10.913199999255268,18.53521939250697,10.590133235382378,9.712372550565386
Organic anion transport,16.713828839446442,23.356058200525975,0.3012475178972396,12.785729256082252,21.548709492796526,16.916196028568475,11.107315092755682,18.16805653821573,12.575536886935192,22.48706425320458,26.382146836439826,21.728271528699487
Metallothioneins bind metals,16.70907680251661,0.3823150252765755,0.3012475178972396,4.9651854055819955,28.93766089940106,1.9480947195450147,3.722917479590249,15.2302823392426,6.787551345550989,21.13202953939567,48.281729071353695,18.22650253043554
CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde,16.68902779031828,37.881528439716426,0.3012475178972396,1.8456401431563607,3.5472421177764697,1.3995054463125876,8.18902836707204,19.085815936420232,2.0332416058976297,0.3841739032330789,2.435006444840535,5.787851314314748
Alanine metabolism,16.63843720560539,0.37942368312685604,0.3012475178972396,14.033814325264167,27.258729769261873,19.428054703494187,10.455066205429723,15.002868430237603,9.575094150836675,18.622813275262164,19.260783454707592,5.074393604973001
Synthesis of 15-eicosatetraenoic acid derivatives,16.55237258513319,4.089833433213391,0.3012475178972396,10.517782130744745,19.821916961779856,15.249595954108978,8.353653942552207,17.099506939189645,10.82319191717242,20.000710178481658,25.301388372468697,12.500855996344786
Neurofascin interactions,16.54764507313861,14.387555500325467,0.3012475178972396,10.035542152804805,6.288668220205946,3.363289439297134,0.732060114128581,5.885496856026316,7.788860934020993,14.115562309320287,14.356562589578704,10.43810615049461
Conjugation of benzoate with glycine,16.527697526410645,17.173698051373606,0.3012475178972396,13.031499086725292,29.55517725802551,22.87304848851084,15.46098527140868,28.718113537415984,13.49304375676056,24.60304643615395,30.437272278531637,21.79439758368891
Antimicrobial peptides,16.45205078124155,5.645637907659782,0.3012475178972396,14.54770722099739,30.649281174542654,10.235349188381083,3.5590682121100503,0.31106238243999285,20.935462504414808,34.99295093895196,34.9046613659668,13.361545871210513
Synthesis of PE,16.36648910931247,1.9122167242822845,0.3012475178972396,7.521554608506731,0.6055771569758728,0.9479644866404632,0.5208459679847431,15.150773096815714,14.651867965244001,14.303444267248276,7.249341067427308,16.166985753234012
DSCAM interactions,16.336570785166042,20.064278926668862,0.3012475178972396,13.608553040372641,27.858653123376776,16.79256423700906,8.3189010401583,17.449882980962414,11.124620960919692,16.164739427381402,24.946025392672773,12.475815241766817
TRAF3 deficiency - HSE,16.24126696980142,32.49284659116585,0.3012475178972396,9.466688872330565,11.457209421558703,10.395006571555657,19.475411535904897,20.13819643484161,9.924198515137451,13.595806798526974,24.23361466446237,16.057332981398343
Late endosomal microautophagy,16.231562028766017,3.760287208096993,0.3012475178972396,8.804374310480105,11.210382536280045,3.009058860881182,2.6629561457590625,14.312464552879177,11.579837880940522,22.85296605695556,25.335715895466382,28.811774601103828
TRKA activation by NGF,16.20211886284268,12.89202504299844,0.3012475178972396,11.527863208207126,20.07854113014511,12.547184673453218,5.5304750205299325,20.645957006275417,14.571350328527265,16.78669614264827,21.42533721502616,14.528713258872909
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,16.20211886284268,48.536677860905485,0.3012475178972396,11.144262986888345,22.358456580072506,14.797465177136372,12.209909761930222,23.110943010279087,11.847268971647036,6.144368853619157,14.177667423281068,16.48014797296758
Olfactory Signaling Pathway,16.12224359377289,19.199550354452832,0.3012475178972396,10.787143103991166,24.353993592012532,21.856819080699836,11.184483099957705,21.188349553905855,13.868218475911092,16.660135435969156,20.426488740708916,11.980243595773471
Activation of Ca-permeable Kainate Receptor,16.097907535801127,4.37132086979149,0.3012475178972396,9.401801429274975,18.223471820716355,16.873367722277006,2.959733427484609,11.23228690735789,13.07099025062488,16.179553742881456,22.873879361420997,12.79945291187933
Ionotropic activity of kainate receptors,16.097907535801127,4.37132086979149,0.3012475178972396,9.401801429274975,18.223471820716355,16.873367722277006,2.959733427484609,11.23228690735789,13.07099025062488,16.179553742881456,22.873879361420997,12.79945291187933
CaMK IV-mediated phosphorylation of CREB,16.0932496162142,44.84952866223289,0.3012475178972396,3.545867198650391,7.963338310554127,3.2175482893832825,11.754897376557071,23.519439455347523,1.6196053864060251,1.0996537501905659,5.829224702195917,8.630742306499636
Signaling by BRAF and RAF fusions,16.013655242445164,49.925320339044504,0.3012475178972396,8.133932062760826,17.692577557125684,15.55570106490423,14.903878515247134,29.231577803405514,9.448543152201525,2.879293848558449,8.775377612838408,13.492602161599294
Diseases of Base Excision Repair,15.994047029480836,30.075397086520265,0.3012475178972396,8.83294903898111,12.698819795448472,18.931129812543382,7.121872316539501,17.662376655037985,13.829259962756256,9.098596762019513,5.641721872879177,17.715520869711835
JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1,15.989405111826187,52.87991986621225,0.3012475178972396,2.9905452447971204,2.365608858146447,10.81446464873609,15.644202237944459,28.528810790179882,3.979916004639732,2.9288274062043027,0.46960836407711326,26.88812412640758
Activation of caspases through apoptosome-mediated cleavage,15.84549815235897,32.03431453494569,0.3012475178972396,2.014553590832626,6.268648889664633,7.749783606597644,20.962335753844997,36.33894201127559,7.885025365603113,1.7995440153337385,2.19909878487072,17.120132004573478
Fc epsilon receptor (FCERI) signaling,15.835918364164238,41.52649073569369,0.3012475178972396,4.348901028312302,15.771323991110696,24.030078862792404,17.181235755796877,25.097000541285972,6.043816820451602,2.172421779840364,0.4886121127566146,9.04514716726336
Metabolism,15.831301261341647,1.0333360694173863,0.3012475178972396,14.569062187053142,18.91055605084466,6.886600480899787,2.9819978893526757,17.959738705632027,16.1189060450077,29.929023940854734,36.87125836567401,22.533249326323336
ABO blood group biosynthesis,15.782082948334084,8.890423824031252,0.3012475178972396,15.263606880813025,20.689748221386346,11.370832282251722,1.623017819133607,12.97210093074947,18.5438943094752,21.303639857016478,24.82282971815677,12.896835815011453
RUNX2 regulates chondrocyte maturation,15.688479665124905,7.921263831110093,0.3012475178972396,6.886880700867201,0.5340987689750277,0.6547509602794845,0.43381973660287576,6.735177486408769,7.133938281512551,8.966128994517305,8.323747035209387,15.050912688525495
Defects in vitamin and cofactor metabolism,15.678950048808927,12.716467707375724,0.3012475178972396,12.024751050218438,20.230717873995978,6.972845796455853,1.2557037775764173,22.80974324135088,14.664611465440236,31.2072405375881,39.80460275533899,26.436205622447577
Thromboxane signalling through TP receptor,15.654625794315999,30.99911696951998,0.3012475178972396,12.353595636960645,5.140139486422377,3.8028774185718643,6.453074733021605,18.21401239254861,18.679778304314638,14.981065367115631,18.037963794673065,24.31907859254536
Resolution of AP sites via the single-nucleotide replacement pathway,15.645106849649906,13.915624397994941,0.3012475178972396,16.888185812781884,31.549246605695203,12.803977061543877,0.9330984088573997,12.043870466714889,19.83322804545529,29.44975572914104,50.34934274778904,25.98379520536156
PTK6 Regulates Proteins Involved in RNA Processing,15.620810084412508,3.5161052778057833,0.3012475178972396,10.561893971106588,12.980930596842729,4.716124022591758,1.9568591720223982,25.63738791675818,8.869137492978847,28.00490238938777,32.625182069318214,22.390694834756022
5-Phosphoribose 1-diphosphate biosynthesis,15.586691245285081,39.149260170488496,0.3012475178972396,6.91608813243481,25.55741017220995,13.583478056932256,14.027694002515203,19.46398332850082,7.626495596068634,10.81183534129546,26.762529384760256,12.563734861387749
Signaling by WNT in cancer,15.5722758063035,30.117827198182617,0.3012475178972396,5.9039586579865935,2.5010748860477094,1.4514681795839746,6.699655152673193,24.756803272229625,8.250109654961223,11.775050816960796,13.129103621768605,19.929684245662884
ER-Phagosome pathway,15.533300779898411,43.20717861220549,0.3012475178972396,5.523832293587543,12.571244246347897,23.491553245795348,17.77821167752773,18.351895362624298,4.3440000801063725,5.55581122065435,1.037173496423292,11.139907513213654
Choline catabolism,15.504188129067138,16.157072884322154,0.3012475178972396,15.172464779643875,26.492332603061016,15.912893453749493,4.879706202644661,10.772672637689379,12.311514539000491,27.26990000654096,43.08605646745211,20.548082117488054
Carnitine synthesis,15.465302247732312,8.494616852918464,0.3012475178972396,6.975939409452333,14.004788872134478,20.668946043483864,15.473532575259613,19.86325866625909,14.093216715128529,15.677654172723726,4.458925558278527,12.446902068722622
FGFR2c ligand binding and activation,15.436256320810116,16.411032910652075,0.3012475178972396,10.256197108164633,14.761280472387698,18.423146928935207,8.539307644156258,16.590224394446583,14.818090117424441,13.18681201452071,19.533949115650923,14.347656967151586
Toxicity of botulinum toxin type C (BoNT/C),15.4317013880421,10.005669288393452,0.3012475178972396,2.218125113703212,4.691764721070185,9.954738947240815,9.95458363457819,26.830697172589673,12.89748789475785,7.850495986351895,8.327082727430486,9.57311828664813
Formation of RNA Pol II elongation complex ,15.388362528736936,45.15437987483161,0.3012475178972396,8.221495346182534,5.102826983716844,2.8967444066888204,7.475354493713827,23.725852835879,8.930200296298823,15.128239573882933,17.387076765214662,27.499643900514293
RNA Polymerase II Transcription Elongation,15.388362528736936,45.15437987483161,0.3012475178972396,8.221495346182534,5.102826983716844,2.8967444066888204,7.475354493713827,23.725852835879,8.930200296298823,15.128239573882933,17.387076765214662,27.499643900514293
Antigen processing-Cross presentation,15.359392400047959,43.21745718586034,0.3012475178972396,5.475910503085314,11.621523581809871,22.938474103245387,17.713540036373626,18.552657564286335,4.186534852884065,4.714874179947278,0.6880150467159729,10.574609440878971
Tandem pore domain potassium channels,15.345087459198052,21.64311179105865,0.3012475178972396,6.461109598416409,11.651827112054246,7.822570086300335,6.327888935744823,15.176930358317803,9.458948281790455,5.584826648976263,6.404150690081033,15.19974103805424
Signaling by NTRK1 (TRKA),15.29666534033121,7.192531703045267,0.3012475178972396,11.831864876701609,14.085844002053616,8.660186347568574,5.991766938361322,12.898719494144395,13.544460556420706,26.848270251474343,23.09622775082794,21.549068736161722
ADP signalling through P2Y purinoceptor 1,15.272653353535539,24.72349425077657,0.3012475178972396,10.065824502029736,3.1815097498431304,2.181754597890285,4.6643288971592725,14.556520542508855,15.905280791373457,11.246396973973102,13.705726159089389,20.015651663880025
VEGFR2 mediated cell proliferation,15.238934583940813,1.7752079397423115,0.3012475178972396,10.706202129546005,14.607439839005073,2.598504500846665,1.0060587057596806,15.154278853487343,13.201644022310694,30.7164693317178,34.4041938025451,20.251056268540903
Signaling by the B Cell Receptor (BCR),15.229549094193423,44.17733059509994,0.3012475178972396,5.079396505515055,16.578839389120557,25.31576426248056,19.774143192701498,25.632766348505296,5.711975242325924,3.1714337829658397,0.4694656224112536,9.254736188054524
mRNA decay by 5' to 3' exoribonuclease,15.215307680254812,54.06022248337911,0.3012475178972396,9.932668903848883,15.854417568569497,12.600577920722314,13.762136067059524,33.44262560822707,17.804219292946513,19.43984352428936,16.734641564914376,26.1660529442772
Transcriptional Regulation by E2F6,15.114130823008962,24.43942391814522,0.3012475178972396,10.776063931750528,11.750791616397422,17.16904080678244,9.193014534801568,13.027081263378694,9.75057057585959,11.194962106903176,9.509179849307392,9.20487154655757
trans-Golgi Network Vesicle Budding,15.114130823008962,22.38535996425774,0.3012475178972396,9.872580162657714,16.150548283164714,9.563240751202061,8.988851152910193,19.945610811043615,9.188204088011947,27.513885683123995,30.79357648641858,23.648600090028822
RUNX1 regulates transcription of genes involved in BCR signaling,15.032275157558395,32.55141787945975,0.3012475178972396,9.860654406462569,11.534788004478878,19.74322742697877,19.12893776655937,31.512884304351925,13.007835597865833,16.735626564330303,11.208791259929534,32.16641961566835
GRB2 events in ERBB2 signaling,15.00365781183105,0.6824680078218873,0.3012475178972396,12.179996837697677,17.290031982744136,6.3115014040989665,1.5276798836866345,12.51777004977249,13.365130298107246,25.559931868597054,28.929110635033656,15.446985826281145
SLIT2:ROBO1 increases RHOA activity,14.975069017444897,12.35354874582387,0.3012475178972396,10.70015260611781,7.519379629361436,2.0028644275657737,0.8973569585765386,10.470580540260347,9.875718645093999,10.709717830467428,20.056902333229612,11.31297261644493
Signaling by Retinoic Acid,14.960953299998353,6.114730017298726,0.3012475178972396,8.275346751536615,18.769719876157353,6.107223184088816,2.6440423584237815,21.265501326182708,15.683784184623729,23.030961965907004,31.83123635837233,21.427330988769693
CD28 dependent Vav1 pathway,14.956473409162331,25.280052400217983,0.3012475178972396,7.679913055645394,7.0467179446641115,17.13103172800234,17.662231018568335,18.022171978709455,4.089047204761983,3.4071725714272274,1.5102017305445539,9.126173287706944
RHO GTPases Activate WASPs and WAVEs,14.95199405925299,41.98552274588272,0.3012475178972396,6.562242086020818,22.107600046730905,19.713617501736397,19.03759219525517,25.528156017942976,8.418160518292414,3.11305175446612,5.591984554856418,9.82570561709272
Inflammasomes,14.947850225216573,0.5911617082901462,0.3012475178972396,6.28490289422032,3.2843165289095944,0.8083610451157555,3.9487240388219074,8.104484071922025,16.598248024905697,13.431164068022438,21.85498509126182,18.282436489840453
"Transport of vitamins, nucleosides, and related molecules",14.947850225216573,6.7356885077036575,0.3012475178972396,8.112760624514662,9.508584775188812,10.684235267989044,5.714097937979127,15.762665316261783,9.20902665646454,2.4143397984818473,2.116269071148372,7.268528646356083
HHAT G278V abrogates palmitoylation of Hh-Np,14.943371700180652,1.2995975321679873,0.3012475178972396,15.719740578733177,39.34308565072423,12.713562575444522,0.6334297051950106,10.30500678564722,11.550359710445873,24.08417158638142,53.10485130517174,11.428419973596686
TGF-beta receptor signaling activates SMADs,14.833222476965204,0.5218082228940415,0.3012475178972396,9.788918608834905,11.698867953661688,11.500058578485355,6.597646479480972,16.704458741476707,9.611959886378578,24.734429524204884,20.624060901718025,21.145228323268057
Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA,14.82396940712635,20.465698687293752,0.3012475178972396,10.505447818241668,11.506194645390353,14.03050686611727,10.643770969034643,14.728179897175599,16.577048075279396,14.339641846785318,14.705705204493965,12.659846906734687
Sodium/Proton exchangers,14.776415006878747,4.120403986782833,0.3012475178972396,9.987122077331657,24.530768327704447,7.9708050719135635,3.3568073900404305,25.857788178484807,12.85403596308554,26.363091127740688,36.05726761461026,19.551468161635626
Beta oxidation of palmitoyl-CoA to myristoyl-CoA,14.762397794365059,5.580828329646938,0.3012475178972396,5.21215544325812,3.376557296986792,1.909019749957794,2.9052188182114165,5.8602732449786625,10.486132999588008,2.559173608806162,3.973891417826693,7.181079174674916
Defective AMN causes hereditary megaloblastic anemia 1,14.743941069926757,14.010382976401424,0.3012475178972396,11.554148762601606,16.534117367649284,18.600440771631625,5.264810891247173,19.44290929421623,10.902305717045628,16.763520918298862,20.629966078867096,17.89750642870224
Defective CUBN causes hereditary megaloblastic anemia 1,14.743941069926757,14.010382976401424,0.3012475178972396,11.554148762601606,16.534117367649284,18.600440771631625,5.264810891247173,19.44290929421623,10.902305717045628,16.763520918298862,20.629966078867096,17.89750642870224
GP1b-IX-V activation signalling,14.677443144084844,15.106198331886064,0.3012475178972396,13.860429003839151,42.64598194579438,30.09902279395868,13.945140231793035,30.189936526165145,17.459865194949966,23.455880395166464,32.39987687574173,16.253118594179757
Signaling by FGFR3 point mutants in cancer,14.649182023248681,0.3159866453436321,0.3012475178972396,11.931120994074263,13.682050297223203,5.245766908698483,2.2882270292400784,9.526075696760367,12.996227453187966,25.786914841127878,21.538719087520754,17.02240677301866
Signaling by FGFR3 in disease,14.639989572314395,0.314844704893404,0.3012475178972396,11.918307294765823,13.669757837649962,5.237501910586916,2.280939193665565,9.520366248378942,12.996227453187966,25.782334094053557,21.526297629273852,17.027018565258594
Adherens junctions interactions,14.559489609472017,41.52142431100937,0.3012475178972396,7.07075923088204,3.896888253243134,0.9418139033777072,5.012583914648926,27.282045100079557,7.755337141239887,10.297119949446977,16.394830945473156,23.736601222967558
Sulfide oxidation to sulfate,14.531347728353895,1.3126899319846612,0.3012475178972396,9.33715126795983,19.212236184065596,6.737664102474262,0.8389172589052916,26.59358236624427,9.27101315227564,24.856717540684954,36.7749881786866,18.787578224518665
Interferon Signaling,14.432247916972582,38.27598036577543,0.3012475178972396,8.06339623468918,19.836503149218583,27.455395056329472,20.17009142561404,21.704141492006627,6.259253884511471,7.511553912653529,1.9640300270019913,12.322248986327532
MyD88 deficiency (TLR5),14.328791361935613,18.67935877788019,0.3012475178972396,7.101010256718163,6.6949587438655245,19.086778596693364,15.057946468537573,17.864042576888977,4.956485668701978,8.45620561013248,0.3888875542030998,4.963150912739323
Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6,14.29750230129735,56.727542944299216,0.3012475178972396,4.280880541869427,11.986900977392965,21.690930917999363,20.263878165730283,28.246157040835026,9.724949962687624,5.460250426088888,2.6422991362165673,15.511461279982106
Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects,14.29750230129735,56.727542944299216,0.3012475178972396,4.280880541869427,11.986900977392965,21.690930917999363,20.263878165730283,28.246157040835026,9.724949962687624,5.460250426088888,2.6422991362165673,15.511461279982106
Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6,14.29750230129735,56.727542944299216,0.3012475178972396,4.280880541869427,11.986900977392965,21.690930917999363,20.263878165730283,28.246157040835026,9.724949962687624,5.460250426088888,2.6422991362165673,15.511461279982106
Evasion of Oncogene Induced Senescence Due to p16INK4A Defects,14.29750230129735,56.727542944299216,0.3012475178972396,4.280880541869427,11.986900977392965,21.690930917999363,20.263878165730283,28.246157040835026,9.724949962687624,5.460250426088888,2.6422991362165673,15.511461279982106
Diseases of Cellular Senescence,14.29750230129735,56.727542944299216,0.3012475178972396,4.280880541869427,11.986900977392965,21.690930917999363,20.263878165730283,28.246157040835026,9.724949962687624,5.460250426088888,2.6422991362165673,15.511461279982106
Signalling to STAT3,14.288427311132697,5.842672266287403,0.3012475178972396,7.055969585967276,8.920438081572177,7.22803787000671,3.4024654572217443,15.101387366323074,10.929888723294944,8.195283723395287,5.404156409732747,8.440034040481772
Uptake and actions of bacterial toxins,14.171795290980077,7.074437202304344,0.3012475178972396,8.53028784792952,17.51095485972415,7.660578058299795,3.4493124496381546,9.573562115491814,9.389991737984314,21.374462817939044,30.94557924076215,15.278793229773575
p75NTR negatively regulates cell cycle via SC1,14.171795290980077,40.22486232200092,0.3012475178972396,16.62058402962794,37.15324960479306,32.26178068332966,18.922077568681082,34.310805244037724,11.703456994240913,15.918944582399286,27.856088940715722,12.583978614723996
MTF1 activates gene expression,14.167443180963645,5.728517626911192,0.3012475178972396,10.023858247055774,12.50077780525416,8.95342459142059,4.1581678232818735,7.401345091791869,7.645342943922827,11.301548948905308,10.071687834271726,12.384973104293032
SHC1 events in EGFR signaling,14.106988640573169,2.807412078553432,0.3012475178972396,12.070962301530582,20.715057936028973,7.1825799538686095,0.8119127360271308,10.92542727152652,14.255729341476044,27.350121815914633,32.519870006205906,14.638051109142598
Formation of apoptosome,14.074972102292941,0.5710252578637828,0.3012475178972396,5.515707853916249,5.954326630974076,4.783633596166093,2.9819978893526757,8.012826629760372,9.596380524812286,18.451357207633865,9.1826605327249,7.3658539578821065
Regulation of the apoptosome activity,14.074972102292941,0.5710252578637828,0.3012475178972396,5.515707853916249,5.954326630974076,4.783633596166093,2.9819978893526757,8.012826629760372,9.596380524812286,18.451357207633865,9.1826605327249,7.3658539578821065
Proline catabolism,14.056647225423951,32.719701824380664,0.3012475178972396,10.053775126743218,12.242263086191121,16.535238260037932,8.41418034383239,0.6915575276497365,8.624046548873151,11.653071660738926,12.879166715964416,18.688739442663056
Apoptotic cleavage of cellular proteins,14.010398542581209,10.20461364742422,0.3012475178972396,12.051252965717648,19.80068704445985,6.971154466454802,0.9667547352913739,9.697022209458481,8.418160518292414,24.885986498262774,33.151745135648774,14.90025944884085
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription,13.973522492991995,48.86364186194964,0.3012475178972396,8.685491942977611,13.391408111624022,10.698904140010136,9.932880525484459,15.824258006937947,10.076596658359716,4.378130854688669,8.579753414729865,14.424695775477954
Synthesis of PS,13.945980698722758,27.865346725016057,0.3012475178972396,8.641652287916209,1.2578331036241668,14.7685960212969,10.526624925556158,10.492373791172945,17.52481847660718,18.438994019966806,3.154619503274379,38.610512173569276
Nucleotide-like (purinergic) receptors,13.923105508535988,12.789105071420874,0.3012475178972396,4.68079139704762,4.163888622726682,0.3900057125332973,0.34212823542717613,12.572640379587737,11.380577035546427,10.909417366620865,19.632897912397148,18.80812972985111
Phase 3 - rapid repolarisation,13.909520602348309,7.680238659373323,0.3012475178972396,14.202495338227713,26.980864052088556,22.01954868873344,10.43239758331572,16.007495138933702,13.989808596074422,23.693338526717934,33.8398176618462,16.62527725330839
Energy dependent regulation of mTOR by LKB1-AMPK,13.86815499474464,8.873051731680214,0.3012475178972396,14.5548239233305,26.769974688523657,16.801244022328834,1.5960142216130606,5.789016725965509,15.849754981009053,15.154365018345894,26.846364348579733,11.416632534991354
"Defective ABCC9 causes dilated cardiomyopathy 10, familial atrial fibrillation 12 and hypertrichotic osteochondrodysplasia",13.799138185471145,4.570349816013524,0.3012475178972396,13.88164594810799,20.12764363097177,11.068968227149073,2.211280985598949,11.238231294916464,15.663199729628472,27.72053823532376,31.37541739495845,15.82788750097952
Transcription of the HIV genome,13.776715838647023,43.91908296200171,0.3012475178972396,7.275107336170913,4.638051779554392,2.8682616454062173,8.479743323796358,23.90777102095893,8.614455139592607,13.268214550098621,15.373640148041616,26.659442143873182
GRB2 events in EGFR signaling,13.776715838647023,3.3218470589578666,0.3012475178972396,11.937530351496562,20.67446190405796,7.340520295546018,0.7736877555925067,10.498392879127929,14.197397018077883,27.244914183692966,32.570757432805664,14.18133609714839
ATP sensitive Potassium channels,13.707938090793292,2.5228679551609106,0.3012475178972396,18.08665331433318,28.5349312511881,11.889681834192087,1.14440493119509,11.520095733100172,12.043288710889675,31.768749876823936,39.79203105053338,14.456282672055107
Negative regulation of TCF-dependent signaling by WNT ligand antagonists,13.680672509034213,3.435245752361877,0.3012475178972396,6.44703271774086,25.005246302729898,19.766889906716496,9.564943031077327,15.612958496572164,10.016985899736426,10.81183534129546,15.439781461080822,11.182807110312279
RNA Polymerase II Transcription,13.658027165209624,21.00480851035999,0.3012475178972396,7.096170421218301,7.803182798471193,11.694452132949136,7.172717821786922,10.176149271290083,9.473447095569327,3.0541586354161865,3.266248359253302,4.545963470990352
Pentose phosphate pathway,13.653760404698623,53.65081072824456,0.3012475178972396,10.029699346356258,10.002726148563628,9.834257335661999,16.4210989812514,25.932343646987146,9.043463677369543,2.9552388474191997,4.103783719926691,10.486951481608594
NOD1/2 Signaling Pathway,13.521273164993667,53.39636702112677,0.3012475178972396,3.758497573915928,11.14143968005576,19.4697567992482,20.99270549697213,26.44181733927648,2.736961870703433,2.6993258693816258,2.2217319483779905,12.73168428782995
Nuclear Events (kinase and transcription factor activation),13.512462956518387,3.713944553661447,0.3012475178972396,10.393034489479202,9.487505443237744,2.092970686814953,1.1370007059219287,5.415521438052844,11.02685814800776,20.31481133304469,18.3542039166632,18.07936820897832
RUNX1 regulates transcription of genes involved in differentiation of keratinocytes,13.499091162771967,7.1343399070089415,0.3012475178972396,13.010591645664281,25.022531082244534,9.37651223820677,0.6334297051950106,9.434176154250702,11.061111207814523,28.602427994177766,41.47685629207741,18.018641380651133
Plasmalogen biosynthesis,13.46748574035717,41.53717205025423,0.3012475178972396,12.233766886532567,27.48006715395637,9.067404854230777,2.1499209588806365,14.844359852049266,8.452875732933212,5.500264113125251,38.534001924857584,11.85334025227416
Toxicity of botulinum toxin type B (BoNT/B),13.422263963673307,23.368231313810984,0.3012475178972396,7.290458141009706,6.981499256307753,9.959225197522002,13.736913697342949,23.229437634269132,5.5648579350628005,10.980160807799901,3.909691945767771,15.511461279982106
Scavenging by Class A Receptors,13.381664810271515,18.000530136960247,0.3012475178972396,12.717438948914245,35.89346717975234,26.636310351864807,17.181235755796877,32.52885266841241,12.593886211430995,17.123204305908136,19.570050920220872,16.09969195999692
EGFR interacts with phospholipase C-gamma,13.354742252074672,10.000585122926354,0.3012475178972396,11.911902953927424,43.97709926042388,16.458413092623903,0.8562348923307156,4.480021953603858,12.121579883556143,35.57677208431799,53.991890666574875,15.17199236292421
Mucopolysaccharidoses,13.327848214425986,49.280994365866896,0.3012475178972396,14.702006222988402,15.829602177405416,10.933901698297875,5.307972408474015,29.488472487389814,11.626603003681739,8.138343956649452,11.483631284484119,13.640378373128067
Reversal of alkylation damage by DNA dioxygenases,13.251212185607326,34.658669210776594,0.3012475178972396,6.882121437570684,4.095066082392648,0.8908357020638273,5.677175010046148,24.624504937931476,12.939945910365516,6.349845194442177,16.543552538184336,24.201839964960485
Non-integrin membrane-ECM interactions,13.19283964131268,6.538989673767417,0.3012475178972396,5.397651441551116,0.39494053953231506,0.5246720347214037,1.903583579151511,1.7589675173094523,4.258146554550641,8.899996204198107,9.311477740246014,12.388861818917482
"BMAL1:CLOCK,NPAS2 activates circadian gene expression",13.148103733955388,35.33583539019172,0.3012475178972396,4.294901906103892,4.625235814426014,9.667710668602888,12.758998074251405,18.607284389125567,6.024153802227763,3.9048254816378383,2.920551066055372,9.34067965050078
Glutathione conjugation,13.121429207733845,45.2780907308797,0.3012475178972396,3.3265981604361285,9.721352931478727,5.6516746078043605,11.102181455671813,27.574850576091418,8.633953510789818,2.0224885905456236,7.454432060513665,7.663452593786204
Glucocorticoid biosynthesis,13.063357065308388,0.9908846086867356,0.3012475178972396,15.559557391421235,41.0255890067039,15.204173501634623,0.8985653450236822,19.689222805162903,12.643122234958193,34.76815244577035,47.56711361081123,14.973162917306045
Elevation of cytosolic Ca2+ levels,13.041255368889072,45.1212050255032,0.3012475178972396,2.810878987226778,2.522574790502482,8.34767005773363,24.65681538507334,30.91461347174364,5.27837968090431,6.163112504020497,3.5779718772425366,13.35749508611176
Beta oxidation of butanoyl-CoA to acetyl-CoA,12.93868678078057,27.107149545050074,0.3012475178972396,9.81268533127487,15.406406927944014,19.239233520511945,15.837318201492053,19.2791158360942,16.7185102449945,15.790233172504387,16.518821274153165,11.984062643332557
Oncogenic MAPK signaling,12.889948981867851,44.73792879830025,0.3012475178972396,7.255185975942304,13.669757837649962,12.827278456181029,12.58651846807562,22.894237535338284,9.27101315227564,1.7831061232428356,6.120282187525502,10.325478496600372
CTLA4 inhibitory signaling,12.87245420217407,50.21790543343942,0.3012475178972396,6.475203289443293,11.70571281011249,22.94861635259519,22.74738782028954,22.84249749720849,5.851037724600082,4.7558397356392135,0.5108394195988375,13.162195348951624
RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs),12.81940453948803,41.13372759163503,0.3012475178972396,4.098204894232212,7.197556176831627,15.083453473701644,19.809783415269447,18.791692315526213,5.243954803755056,4.466190446250673,0.7720321853784635,13.688457281044972
Toll Like Receptor 9 (TLR9) Cascade,12.801960384581585,1.8607208390784777,0.3012475178972396,9.4903739391424,17.36804697828996,3.163899840111809,1.0574794527488498,6.9138637550784345,12.649018677818997,24.39748335079397,32.97839724031154,13.781094434414216
Interferon alpha/beta signaling,12.731350081084727,30.857218945222236,0.3012475178972396,5.298288498651262,10.481046706878587,19.845337984802956,15.589951496964103,13.847208185207503,3.590421612681446,5.353791527034111,0.5856410507445385,10.69708033532267
Transfer of LPS from LBP carrier to CD14,12.68302385823602,2.027268825841649,0.3012475178972396,6.901476009509479,12.486279609793154,0.31203023987518813,8.857670373417905,1.3441342066508692,12.520573407855817,12.506601861963622,27.895804049007452,6.735776839011884
Chaperone Mediated Autophagy,12.65684999463524,4.64191927683194,0.3012475178972396,8.798930363745264,9.333700588302257,1.2376248302809143,0.4274039328557554,8.338372811281094,11.293748875474993,17.98641247046153,24.867134105542426,17.309309372124517
Plasma lipoprotein clearance,12.626296622693427,35.36075856145064,0.3012475178972396,4.484985258465532,17.46423129239771,15.550009042840982,16.684062966840305,22.706520952909045,3.7974854944068652,2.69655472673508,3.4616062403861263,6.0907410751183395
Metabolism of porphyrins,12.5561962478927,26.18116002318389,0.3012475178972396,5.445194004999888,8.78127828206744,14.233791424088666,12.629301235442865,19.1891895102536,6.642111084849945,10.533516234134579,5.708855727428158,10.883118724118098
HS-GAG degradation,12.46439957632403,52.86848919135556,0.3012475178972396,7.771197282686839,0.7167749296627556,5.113270211842579,13.18242268199638,30.211355100491744,6.0770818168775165,0.9357973866365559,1.1692214186074723,7.918044416235183
Regulation of gene expression in beta cells,12.403503402257876,1.3200201002334757,0.3012475178972396,9.31962179913972,4.3977834019819015,1.0487563426287758,1.2671718236539617,8.42695848196153,2.4745378730631677,7.071463407955339,8.325414847509897,4.103947597099715
Serotonin Neurotransmitter Release Cycle,12.395089695136116,42.67443639602207,0.3012475178972396,3.262745908774776,21.60003266647897,11.190225162199248,21.251503302775536,32.43379612365542,3.0301411141587415,9.851581691493081,7.67055528989948,17.852009908753907
Wax and plasmalogen biosynthesis,12.369230461469257,46.67959211600232,0.3012475178972396,6.862490619949949,29.89344971115797,17.90550028223375,17.426874973388212,34.087510235178094,9.275687482266516,8.67743683774397,35.01908712111041,15.502687137929536
Protein localization,12.343399719055267,6.130998572342262,0.3012475178972396,6.484709034665273,8.660144959915863,4.396554666958822,0.5358132513276741,3.8072478212725525,9.348253089908393,3.4666109251498303,8.210777188693612,6.973150655528396
Proton/oligopeptide cotransporters,12.339362195118175,29.596121659517255,0.3012475178972396,8.49155848403867,17.229364104055943,25.16380116523642,26.755238188244885,34.01439242399848,5.627987079543036,6.452883935422326,2.5470720324205613,14.537528173066518
Transcriptional regulation of pluripotent stem cells,12.32661854762427,18.908880832462224,0.3012475178972396,8.058205518128586,11.095603077204377,5.74804591715164,4.753160395989633,16.707817121351557,6.306112717419624,8.553390984942538,13.185628376294758,17.695599908232253
Fertilization,12.266395551320377,27.10302977227939,0.3012475178972396,6.635609846735057,10.87359043182099,19.365464266746198,0.690301264862849,5.994278441182981,13.352993262286958,14.962371201828661,10.169844636261573,7.208925351173977
Synthesis of IP3 and IP4 in the cytosol,12.266395551320377,10.87288744169964,0.3012475178972396,7.9767410518161235,4.418476626283532,1.4603386433346466,8.72372626977712,1.893935579844294,14.75140734688464,14.591510799515115,24.594350417438527,8.87278771169394
LDL remodeling,12.21467335109655,12.816324135410529,0.3012475178972396,9.092001299155562,18.80905823013575,10.515130091067958,4.624131116854901,15.712245400594192,9.04838805451058,19.789698316591902,25.260152307984228,13.531588555770274
Nef mediated downregulation of MHC class I complex cell surface expression,12.042355965825998,0.6045356246278305,0.3012475178972396,8.585873227189271,17.83318614209673,3.048011619266392,0.9529222321770892,16.641095192047352,13.220105515795849,23.318445590263565,41.65864658398591,18.998875393364163
Paradoxical activation of RAF signaling by kinase inactive BRAF,12.00924661499455,0.40398249501979,0.3012475178972396,9.046731096431127,7.313703735420986,2.2213451032309033,0.9098790834620915,1.820876248950245,9.463993384805045,21.813791293254553,20.66642866579476,10.167333171666282
Signaling by RAS mutants,12.00924661499455,0.40398249501979,0.3012475178972396,9.046731096431127,7.313703735420986,2.2213451032309033,0.9098790834620915,1.820876248950245,9.463993384805045,21.813791293254553,20.66642866579476,10.167333171666282
Signaling by moderate kinase activity BRAF mutants,12.00924661499455,0.40398249501979,0.3012475178972396,9.046731096431127,7.313703735420986,2.2213451032309033,0.9098790834620915,1.820876248950245,9.463993384805045,21.813791293254553,20.66642866579476,10.167333171666282
Signaling downstream of RAS mutants,12.00924661499455,0.40398249501979,0.3012475178972396,9.046731096431127,7.313703735420986,2.221655758250409,0.9098790834620915,1.820876248950245,9.463993384805045,21.813791293254553,20.66642866579476,10.167333171666282
Interleukin-17 signaling,11.970952746289738,3.29457027979066,0.3012475178972396,9.824580181187685,17.347880944989207,6.316879290495468,1.9298594674028768,8.77195772077751,9.25043153234616,24.497478843458655,26.74863389709906,16.49445453115925
Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE,11.915928007791663,10.74873051934906,0.3012475178972396,9.890655256400484,8.253906931310897,16.787052121941443,7.33907280637423,16.347069485456096,11.93025319785107,21.20556175022414,4.857553894460163,18.089257458784697
Defective MTR causes methylmalonic aciduria and homocystinuria type cblG,11.915928007791663,10.74873051934906,0.3012475178972396,9.890655256400484,8.253906931310897,16.787052121941443,7.33907280637423,16.347069485456096,11.93025319785107,21.20556175022414,4.857553894460163,18.089257458784697
mitochondrial fatty acid beta-oxidation of unsaturated fatty acids,11.882060537709863,4.714106219207707,0.3012475178972396,6.980734048350252,6.307004217987221,6.967469748003782,3.954991199210434,11.629203323545756,10.726511139225536,7.595605777465406,11.10091440887347,8.572306478495676
SHC-mediated cascade:FGFR4,11.831197373566745,1.7894677588579138,0.3012475178972396,9.836482689938201,12.62485219791726,6.638203720827919,5.0197709492619405,14.065943664996523,11.615332765950837,21.303639857016478,18.738258916271736,14.766264726917962
Beta-catenin phosphorylation cascade,11.623727326811304,37.14803463213007,0.3012475178972396,3.0405876108708854,2.5964898692418377,2.2152376239989913,10.010111010231304,27.045138088282,7.320967778611139,6.424204132225962,8.222066525123713,18.16001705183254
Retinoid cycle disease events,11.607163963232082,18.327415961733283,0.3012475178972396,10.156962409617169,21.31199313316152,12.72142040755851,6.567375343808941,9.003922427662406,13.13286391157049,14.083023092946487,25.07940092591417,9.968848762328598
Diseases associated with visual transduction,11.603260490583505,18.316693010199923,0.3012475178972396,10.145203607955423,21.289566281840763,12.72928068130687,6.571231365893373,9.012373457040281,13.127210195737497,14.079664680530719,25.07940092591417,9.965395209304436
ROS and RNS production in phagocytes,11.464847626029787,8.412209217410958,0.3012475178972396,17.973222477685606,14.700380200703199,8.494780788224118,2.1499209588806365,0.8255546039933548,10.62657858283636,32.55215481003766,24.969766602198845,12.551339009725432
Transport and synthesis of PAPS,11.435845799987383,44.66011882197617,0.3012475178972396,12.04481137494531,22.22578818070889,22.672114517448666,26.000960807409708,19.430198356488418,6.730124657813667,13.349558509700607,18.203685260874817,11.666199057904175
Toll Like Receptor 5 (TLR5) Cascade,11.424233074535898,0.8189768082665705,0.3012475178972396,10.776063931750528,19.338014758106006,6.695405621318417,0.5197034662442563,7.3657711498795395,10.098468581456858,23.826626838937326,29.11611585438017,14.946314329728207
MyD88 cascade initiated on plasma membrane,11.424233074535898,0.8189768082665705,0.3012475178972396,10.776063931750528,19.338014758106006,6.695405621318417,0.5197034662442563,7.367554540151506,10.098468581456858,23.826626838937326,29.11611585438017,14.946314329728207
Toll Like Receptor 10 (TLR10) Cascade,11.424233074535898,0.8189768082665705,0.3012475178972396,10.776063931750528,19.338014758106006,6.695405621318417,0.5197034662442563,7.3657711498795395,10.098468581456858,23.826626838937326,29.11611585438017,14.946314329728207
Rhesus glycoproteins mediate ammonium transport.,11.399463659627829,16.54895184362131,0.3012475178972396,10.244026967282679,34.24729701043896,27.372166232805434,11.372909309304648,22.017842895179314,11.538785563276235,21.51725866993223,19.792167439402274,12.951809448651142
Signaling by Ligand-Responsive EGFR Variants in Cancer,11.35386687203405,0.40058388295230773,0.3012475178972396,8.70745583481523,9.401014339366816,3.552704584555895,0.6079878859228184,8.399434813434363,10.62657858283636,18.610390917875982,18.203685260874817,11.380995416284872
SUMOylation of intracellular receptors,11.34167503930483,3.941178699328913,0.3012475178972396,10.787143103991166,19.8448086613762,11.842825744012817,6.0842679515797125,20.437816566395348,11.304851351173,22.33120498734986,35.07193005898759,23.116542415042694
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants,11.33782053442942,0.4007732189924891,0.3012475178972396,8.712868649999544,9.406798630578761,3.555200716650722,0.6079878859228184,8.399434813434363,10.64270110921544,18.622813275262164,18.234912539203172,11.39276330129668
Opsins,11.333966602389735,15.046878770718065,0.3012475178972396,8.391198311732861,26.445810936996843,15.719198650240342,15.322248264425046,17.01096420158857,9.177959619278448,11.851753385031017,21.74178511859115,9.236995069709323
Negative feedback regulation of MAPK pathway,11.32594924740147,13.487802477556171,0.3012475178972396,6.266222064203982,8.465345888258938,3.5014385774758967,2.136143133630934,5.597720146432415,8.020471169238357,24.44478005118024,19.876478594188598,16.3447065400718
DNA Damage Reversal,11.309612439932424,34.121523199571286,0.3012475178972396,5.354187699845414,2.766877905087168,0.5863259487364846,5.9416944580158875,23.859704723745814,11.375005222302791,4.44278476647776,14.179934235107662,21.789144333655805
Metabolism of ingested H2SeO4 and H2SeO3 into H2Se,11.29328815535479,26.449103972505288,0.3012475178972396,7.5628497272573965,6.42797983542085,8.84636370281114,14.57442694603315,31.534774387063543,5.9703378318270905,4.9895371687734285,5.823074856762301,10.464439195837254
Synthesis of PIPs at the early endosome membrane,11.285286063991592,8.132467472966015,0.3012475178972396,2.1977475435757183,8.43378031748576,20.016125725772042,15.46098527140868,17.601277855370842,6.708356506503341,10.056502444312025,7.977564034501183,11.293227698899548
NTRK3 as a dependence receptor,11.256837021809588,13.874749952110868,0.3012475178972396,2.4660369766313286,3.4051591188586054,1.9517835268793267,5.595761009749994,12.469632905686545,5.9329268027882645,9.232104647258724,8.591040284598966,14.821897978740965
Regulation of IFNG signaling,11.256837021809588,9.356547341897034,0.3012475178972396,11.97751527717963,2.158603043118632,0.37407156528252705,5.515295054028292,2.4557446655899136,12.606009238855798,17.708449214751763,23.244684069148036,12.409596920196787
Prevention of phagosomal-lysosomal fusion,11.158085049357886,17.993889677148598,0.3012475178972396,5.237771270583752,9.09535561105613,8.964172626997332,4.77528854486021,11.838946249845973,6.031727549130099,10.859414429943666,10.027223114606088,10.471838920628977
Defective CD320 causes methylmalonic aciduria,11.158085049357886,0.8093284719297141,0.3012475178972396,9.261205113160377,29.536360385563217,2.5272906250127765,1.5960142216130606,18.03824232438385,7.583803848627096,19.332511995476185,35.86177275344482,3.4359721389629816
Type II Na+/Pi cotransporters,11.154264164410066,1.7425686534417537,0.3012475178972396,8.407447294451215,18.833148755519172,11.999628146403934,4.671523414597484,12.982381126381807,9.348253089908393,12.54378916265951,11.43366080147689,9.013966999171178
Activation of Na-permeable kainate receptors,11.117434557341433,9.09122943745824,0.3012475178972396,6.0698526341296,8.099084926733664,4.424298376810996,7.347961949187938,13.055082764544263,7.836712863558065,6.954458364070959,14.027734023664697,6.790460422884005
Interleukin-38 signaling,11.068325387871061,9.1702806381751,0.3012475178972396,5.59914244243585,8.576617957675811,6.529335917834804,4.494851941926188,10.001923218678707,7.21146053489439,10.303076035694131,9.679632574184321,10.921858975733345
Activation of the TFAP2 (AP-2) family of transcription factors,10.974236306011546,11.629803383520255,0.3012475178972396,5.195021683193638,4.69296569972311,14.93524611808752,12.215733290488002,18.70362403015718,5.469778586165596,1.4855270214267633,0.7093532164902558,7.02206915865988
LGI-ADAM interactions,10.96226334128429,11.646959219228691,0.3012475178972396,2.968376321647114,13.906673560376303,6.503306722895692,1.662831879651435,8.894767701710835,1.9605308870802445,9.26077047916282,11.253974680147802,9.583847165179426
Oligomerization of connexins into connexons,10.868958251343088,16.462318149734223,0.3012475178972396,8.685491942977611,24.57945033242517,12.77996861983137,4.269451664834523,8.923438770939203,9.902852565488647,20.1136225209135,25.873691814916018,6.63041789516385
Transport of connexins along the secretory pathway,10.868958251343088,16.462318149734223,0.3012475178972396,8.685491942977611,24.57945033242517,12.77996861983137,4.269451664834523,8.923438770939203,9.902852565488647,20.1136225209135,25.873691814916018,6.63041789516385
Signaling by GPCR,10.832936818652435,2.7288542528879627,0.3012475178972396,8.508238363623803,15.545204762987394,1.1126743430485178,2.8409489609976917,4.2692207390649575,15.44230379955038,25.405362255329255,40.996722276083695,13.640378373128067
Acetylcholine Neurotransmitter Release Cycle,10.832936818652435,44.12765100509353,0.3012475178972396,1.3778226511650722,18.131839157127153,10.476170353982985,21.540613708063887,32.62404995896606,2.8592638159891033,6.709721428802328,3.812394828138145,18.673467706235712
Vitamin B5 (pantothenate) metabolism,10.812918219342523,2.63363841181616,0.3012475178972396,7.835882426416658,2.8255119881271,5.580979233016933,2.9621039377529423,8.025673137086969,8.472791568365507,14.06893739293742,9.591832886409971,13.583882400708822
alpha-linolenic acid (ALA) metabolism,10.80947006341497,49.58638219711869,0.3012475178972396,2.4521645460267427,8.95119166226652,0.8459872729452209,15.589951496964103,30.043875058807956,2.2096662260512714,1.360675438823386,2.751113342874263,11.23441505195335
alpha-linolenic (omega3) and linoleic (omega6) acid metabolism,10.80947006341497,49.58638219711869,0.3012475178972396,2.4521645460267427,8.95119166226652,0.8456193764495022,15.589951496964103,30.043875058807956,2.2096662260512714,1.360675438823386,2.7519319552506825,11.242101533521245
Blood group systems biosynthesis,10.797593263254692,2.9862790182893546,0.3012475178972396,13.48576980909934,15.265855252978717,15.773937377408728,9.19803288955414,18.43941522251716,11.345803549056471,15.91535710738571,19.666049277384236,7.9810063090378085
The phototransduction cascade,10.761391562824864,13.128267753249432,0.3012475178972396,11.87879704909745,25.236076785119224,10.851564395154341,0.8005208460388307,5.685090070172282,10.918649137670139,33.04197876734714,42.77376431459562,12.09091056988726
Free fatty acid receptors,10.757645637466458,11.646959219228691,0.3012475178972396,5.498032889865408,13.999875302349361,10.669916495242086,5.701879189756157,9.181042028609962,5.752738649523594,12.573770573276276,15.869795124667945,12.239408335249768
Highly sodium permeable acetylcholine nicotinic receptors,10.729606645420791,12.219484073313692,0.3012475178972396,7.38324365674072,20.521097578434997,17.023230413811934,9.224267117022977,10.874482181920056,8.87919525967099,18.89227535477697,19.15380349915033,11.869164325640327
Lewis blood group biosynthesis,10.713732961880986,3.0396115586566803,0.3012475178972396,13.379124899097189,15.233309197215444,15.773937377408728,9.409773691024212,18.43941522251716,11.10159687150862,15.708515787814914,19.698897299858334,7.789906975019683
Loss of phosphorylation of MECP2 at T308,10.682023144757933,33.756414455323444,0.3012475178972396,5.380472771189839,21.13176625651792,12.14110916175919,11.749616747006554,16.32351945346528,3.0811154104236853,14.093755874686027,28.856456201376627,12.930601029999048
Activation of NMDA receptors and postsynaptic events,10.682023144757933,56.99249552681582,0.3012475178972396,1.315421655381102,0.5993137478812484,6.584090934138638,20.509503462892894,37.5015029806306,3.0301411141587415,5.425730090258594,5.701194088524655,7.106178255493617
Activation of BIM and translocation to mitochondria ,10.646027849010341,30.221444981676,0.3012475178972396,10.915078826168699,17.307236477849525,12.611126618250346,5.375556511649471,15.459486028961424,10.403328138033975,12.990392497061977,16.72095646677924,16.601455753815046
eNOS activation,10.529802255553117,13.776989942532698,0.3012475178972396,5.5816115869049785,13.631286681531341,16.988575516961,12.227383958683928,10.21317213931506,4.764940765166489,7.807794258242108,5.7429951593244155,11.026947033461152
Toll Like Receptor 4 (TLR4) Cascade,10.466100824445729,5.667156616345228,0.3012475178972396,8.535641644914591,11.284231805773672,1.3226436405545028,1.872274949861151,4.390839877588067,10.291826272865507,18.46760618687606,26.498482131536868,11.038208615799123
Signaling by Erythropoietin,10.45841920216207,7.59140856858106,0.3012475178972396,10.096155328185585,13.38405128609612,1.0049360031807422,4.116962972434552,8.06625916856975,17.730849978239437,22.34912781097982,42.80430489617789,10.797717298610003
VxPx cargo-targeting to cilium,10.438771539195056,3.8186273642676563,0.3012475178972396,5.881254652999067,5.205708742615905,2.0768587373513063,0.36654985657957906,4.3496562132869,10.64270110921544,26.09703392741427,24.89513758954297,10.999868405516132
Transport of inorganic cations/anions and amino acids/oligopeptides,10.43110062468195,18.62051575925288,0.3012475178972396,11.365656245454025,22.8886214729945,3.3207814512029983,6.431751061359538,2.0606670970224332,15.974236258752047,30.40740466874729,39.812795753406014,9.800542518312138
Receptor-type tyrosine-protein phosphatases,10.419447780911367,7.655134090613158,0.3012475178972396,4.484985258465532,4.329389716575642,1.0465007103578035,0.6871087399202623,11.879048466958753,0.3557735238687358,7.111946330795649,7.751431900998785,8.698700165631537
Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells,10.391879789512252,3.676806296309417,0.3012475178972396,7.490347602821218,19.310859455672425,16.944409174542166,6.297981914119785,12.672607773626478,12.71645665923601,13.65279960614597,11.631920462608154,10.624406709169978
Metabolism of nitric oxide: eNOS activation and regulation,10.352434035677879,13.584790453829305,0.3012475178972396,5.31560798658793,12.940974130945154,16.59417354030665,11.714536113725048,9.907019807042658,4.64127611641805,7.352800772381825,5.326291863054186,10.654570618581728
Localization of the PINCH-ILK-PARVIN complex to focal adhesions,10.336860073518784,5.422192651574348,0.3012475178972396,6.266222064203982,4.996006794945369,6.999884973425824,2.764001044140745,5.626314711284209,6.501596716038289,12.10076356907422,17.614791917206027,15.269744891456508
Vasopressin-like receptors,10.309408345269164,22.6063046517272,0.3012475178972396,8.569438979224655,15.54000917718944,16.479954180672124,12.82134483710304,18.255465431440594,9.638706973000739,8.165404272058925,9.285002781437791,10.910352614963069
RA biosynthesis pathway,10.301788642033971,4.327217627500146,0.3012475178972396,4.446580178574576,12.537541076616519,2.830971081146054,1.3371300472811563,15.310009734485037,11.615332765950837,16.997974107484474,24.09581661203985,16.54301474817374
RUNX2 regulates osteoblast differentiation,10.298131357852066,18.901727007569463,0.3012475178972396,11.307703288203356,5.5979644751249085,1.6574957692936052,3.236971875988327,2.259889727738564,9.115366105693516,21.024879128730657,27.178095264476568,14.00804867239495
Interleukin-36 pathway,10.278644808898536,5.850472782921518,0.3012475178972396,6.056251982112325,18.178770301006427,14.353455399809084,8.500054373997761,9.012373457040281,6.024153802227763,10.132974274179045,14.892098204810283,5.839978429806328
AKT-mediated inactivation of FOXO1A,10.259177926618904,1.736677148448224,0.3012475178972396,8.335969672503268,3.392190162743467,1.0144421035162292,0.6364398874803944,6.185901032798938,1.9167407954224311,5.69379161267286,7.4054043774858815,3.5581694308764726
Defects in cobalamin (B12) metabolism,10.223945385823754,5.017016454510791,0.3012475178972396,3.1505714680285424,8.681967353256235,2.2919274291763685,4.310623587758514,9.762312527591696,4.849901222139632,14.815380735569557,16.183136129538166,10.945200026178238
Phosphorylation of CD3 and TCR zeta chains,10.220303160114945,26.251727057809404,0.3012475178972396,9.944640881365565,29.588968475730603,30.335931109778773,22.27374352781074,20.668068784737795,4.938367989159694,12.0571714450905,6.18245029739657,13.614491112086618
Methionine salvage pathway,10.212718765781396,3.1512351939452,0.3012475178972396,5.698445888019377,4.400348445835939,2.276262995702158,0.42499054933480673,1.762269735961766,5.822309790029575,4.095008833297488,4.07284442372603,5.671905578241521
ARL13B-mediated ciliary trafficking of INPP5E,10.197257399394791,18.385105696553534,0.3012475178972396,6.432972648468259,19.782234301400845,17.12184839033037,9.436704791672557,19.64574740412412,10.169480562627696,11.524511254877032,21.15169838386524,10.344305307262571
Defective MMADHC causes methylmalonic aciduria and homocystinuria type cblD,10.154276044471755,35.79085013892549,0.3012475178972396,7.021011287345114,25.088184083162833,11.52051290801777,4.9934386245174,10.323485646227978,4.879108673413853,12.795207205647904,19.18653193878412,10.809160126293271
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation,10.068300177197019,4.4518320373099876,0.3012475178972396,8.042005127266073,14.559582101737272,1.854142020865213,2.2228697514445908,4.345979707059167,11.41506445002485,22.011229598835087,32.114686781914166,11.245789495875279
Loss of Function of TGFBR1 in Cancer,10.056865987441345,0.6210424332868731,0.3012475178972396,7.933282687294049,2.5914756931153624,0.4123983261262967,1.7795346850399723,2.746995187316958,5.699975703931992,14.303444267248276,17.014325439345235,13.527509783536624
Intestinal infectious diseases,9.998597833684983,8.043501560097663,0.3012475178972396,7.036070188185985,12.615241940259569,13.387565072219516,6.833697230213949,9.354343812316197,8.343633785018966,12.935193450961131,15.970139273875382,12.293205259529847
Degradation of the extracellular matrix,9.956061511051956,12.641313187433505,0.3012475178972396,5.711887897924193,0.9259126193240392,1.6744706249853176,2.9819978893526757,0.7846671480742486,2.8511337471859575,5.380010610118378,7.802207958409475,11.045823037560815
Erythropoietin activates Phospholipase C gamma (PLCG),9.936922387329306,21.907665548347893,0.3012475178972396,8.286204416386214,7.390078181161843,0.8049980495015491,4.505571659174163,7.035040705198829,15.394553082277428,18.622813275262164,38.885790060186345,7.987394069116986
Glycogen breakdown (glycogenolysis),9.925568418246984,0.7151682974797979,0.3012475178972396,4.576495854866498,3.576912980238365,0.3077557371622919,1.4324911317885023,3.9835496635837284,2.812949970476111,19.55697702045704,15.301686008416096,7.666433888229423
SHC-mediated cascade:FGFR3,9.875449511898031,1.3544999775036497,0.3012475178972396,9.639202865475438,9.527547692350671,2.9809308335549587,1.1227698633176864,6.069241358837032,10.593046607305492,21.557430354801205,17.19465291352204,12.960102215289018
PD-1 signaling,9.852524340383566,25.531989272728072,0.3012475178972396,9.783152731084403,29.55517725802551,30.51471561998727,21.940306682267614,20.389024689878926,4.8718661745314105,12.191928150020647,6.598551249706497,13.553309858046658
PLCG1 events in ERBB2 signaling,9.83349164040242,1.999951767838976,0.3012475178972396,3.118663169523501,5.344229948205165,0.8395440081145928,0.8823296681126721,10.890276724450208,2.0156081425407373,5.875564666293706,5.142437887874654,3.8218238464638237
Beta oxidation of myristoyl-CoA to lauroyl-CoA,9.768209713867057,3.267176931700402,0.3012475178972396,6.214561181834133,3.5035036306195724,3.311732750947281,2.2786862567883217,4.225573112190775,8.245428741386355,5.553830356463724,6.91569192597763,8.149512771890137
Diseases associated with surfactant metabolism,9.722354410148721,2.214264687212934,0.3012475178972396,8.374966134125385,10.516799985301141,1.7694559679422288,3.5681964410434364,1.093729808737392,16.896933593555506,23.210091500827676,34.11558069368881,10.40443138421479
ERBB2 Regulates Cell Motility,9.684278676948356,9.509310110576433,0.3012475178972396,9.425062029577678,32.367334405448325,16.44355625223956,0.7149838500716919,3.1255919636914276,11.299299450177262,22.505460967525966,31.137784274653136,6.0710993889980545
Retrograde neurotrophin signalling,9.67308053502181,10.6660912876297,0.3012475178972396,12.320984086387796,12.84338954620196,14.410368012582165,12.197828302637168,11.798915465857334,14.118944415380291,19.12198380259414,19.801001175672916,17.690891429903107
IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation,9.658060993316024,0.3405593992983908,0.3012475178972396,4.177256148121824,7.146849681907903,0.6179040534779435,4.830559186986461,4.016865424753929,11.003941312176808,14.446440522161451,28.411867824511056,10.836295992300597
Translocation of ZAP-70 to Immunological synapse,9.581959295319795,25.232578541818114,0.3012475178972396,9.698532575020444,29.242505649524627,30.13977425553595,21.602731483659912,20.04584450051043,4.590747262551366,11.711683248931498,6.087944821221207,13.231484980813757
Costimulation by the CD28 family,9.574932903311486,27.18802492843755,0.3012475178972396,8.98273016384455,26.748416926136734,29.256504333053734,21.961222372833866,19.47234391864398,4.289083080123156,10.013908013725782,4.2683773674434695,12.668039875487958
Acetylcholine regulates insulin secretion,9.574932903311486,9.93442978143064,0.3012475178972396,8.391198311732861,9.629423731680216,1.8812196397742325,11.219970730803727,5.60170205512211,5.8795567792782135,13.495001241353107,31.569850978044382,10.498217291049036
VEGFA-VEGFR2 Pathway,9.521961797499278,3.218585602853055,0.3012475178972396,6.802866945297885,7.391664792275807,0.3376802877643708,1.0588387329134918,7.062607223171317,9.665493528465737,20.858417605008626,26.783572327735794,11.428419973596686
Caspase activation via Death Receptors in the presence of ligand,9.4350839645469,0.8778389917637758,0.3012475178972396,6.886880700867201,8.75083705190666,0.7610508336583796,3.7165862438293122,5.374262324089099,13.001851784384261,18.93058295575599,29.050674014101727,12.820222981901514
Infectious disease,9.427820697594985,14.137981286002212,0.3012475178972396,5.802726519045744,10.699720098760409,8.662105484272791,2.256658655671691,4.507296603169697,5.580179404633384,3.6356852426185506,3.8550134774290035,4.646506335100872
HCN channels,9.413006123511366,4.474201039771806,0.3012475178972396,5.237771270583752,0.6518284584746494,1.6626249804054405,0.4585416787620063,3.536396825052576,4.153370887043848,4.265440404809003,20.644901265648706,8.52156836693523
Defective CYP21A2 causes Adrenal hyperplasia 3 (AH3),9.3379368626583,3.6969182639063374,0.3012475178972396,12.751374019722345,38.98359467969298,13.479503777335047,0.5068428317987986,15.628189131883476,8.619253511243603,29.49789178516027,43.54870901995894,10.234222189319127
Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS),9.334471549364174,0.6758076144793328,0.3012475178972396,7.326448922495267,19.136906597407435,4.327199432640229,0.5060725115747169,1.1529043830946557,4.119292808614985,8.874251949387848,15.58454230518459,3.0119834636271507
PI3K events in ERBB4 signaling,9.319735718655654,3.064485366682943,0.3012475178972396,8.221495346182534,27.94389577147444,16.18310892897871,6.7805643591883165,10.636356917827715,6.540908050219736,16.126186977524988,22.962167231851613,6.83588699882756
Vitamin D (calciferol) metabolism,9.316275953162501,4.23662464915376,0.3012475178972396,7.2702021827303875,24.004250373202552,8.966129188982002,3.4802750485546285,12.094539813817274,11.043977642618543,23.101574519875687,35.416223086633806,15.395759889437947
Mineralocorticoid biosynthesis,9.155809789017932,3.511778391044934,0.3012475178972396,12.613642691065042,38.80848363697557,13.40090170338822,0.5295258996119031,15.590616337046727,8.388553620511846,29.15157520613106,43.477976313213944,10.077117466261168
Synthesis of PIPs at the late endosome membrane,9.141225657534083,5.985633835151301,0.3012475178972396,0.549886098853999,1.1447270605531679,4.918009485870924,5.538381936543914,8.53359192216582,1.5847713964104335,2.1410731465986754,1.495472922855948,5.575080810742149
Acetylation,9.119225079783334,2.2707972127708946,0.3012475178972396,10.56790153293455,33.896869736324625,6.867409114901228,1.1573643816062875,4.467591466942151,5.213830747374232,23.794023497874456,39.02652258163913,5.837429002626818
Cytokine Signaling in Immune system,9.108383165669343,43.787484659989495,0.3012475178972396,3.632542797578374,11.187683553422737,20.99925367825722,20.426137049378664,20.968324433051773,2.421992633478952,2.4849533336376686,1.488285921343453,8.52156836693523
Other interleukin signaling,9.101257499949464,6.1674911328411195,0.3012475178972396,4.628621319000702,4.124752491323258,1.7249932163937436,8.349246561250682,1.8973928349813518,10.737645312131612,9.25219492424221,26.203601069096667,7.2181269366923715
"Inactivation, recovery and regulation of the phototransduction cascade",9.086720145594294,12.386283623705914,0.3012475178972396,10.580274695610804,20.67446190405796,9.189737110080419,0.8222806738183512,5.3527290323588375,9.32789753375984,30.025060262960316,38.617478259223276,11.136238207236767
Adaptive Immune System,9.0499893592353,39.40265358601587,0.3012475178972396,4.564599181476118,11.658657242825605,21.448626655947624,20.554442682521366,20.033296980347927,2.128991919420227,2.8346450747316703,1.3353580729799754,9.000030207802672
APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway,8.943357846008595,1.4639296726753297,0.3012475178972396,11.359410927529035,24.680479197456258,5.670705355168103,0.39163631674284083,3.9945524769489285,12.891529892769821,19.91712554141184,45.3472999165447,12.744173984466109
Regulation of TLR by endogenous ligand,8.921612946034838,6.309947484426393,0.3012475178972396,6.960950388973192,11.120831454342031,0.7226939769682151,10.398641076872984,4.123988268577961,10.94113441688181,18.585558809396563,27.852841949678602,6.357217765485461
InlA-mediated entry of Listeria monocytogenes into host cells,8.910898265248964,15.254713726117727,0.3012475178972396,4.524416476998213,7.577185477776856,5.411375328362817,1.2155512154695587,7.950845171746716,5.635835041076975,8.173418021677023,9.242706016251546,8.273390729901907
Inhibition of Host mRNA Processing and RNA Silencing,8.878208148412917,1.6404909877996707,0.3012475178972396,9.627428214256685,20.099545509372323,22.75156343023982,5.307972408474015,7.883414256990531,10.408640094188138,15.272994280460015,13.452361705846076,6.946359530249389
Potassium transport channels,8.84558202696523,9.581817663982063,0.3012475178972396,5.616995109979116,17.6810913443202,13.645198578502693,8.718848798619824,10.526244614251867,7.011342767590213,9.842715380854086,14.57570119075013,5.817970031120693
Regulation of KIT signaling,8.838568915172962,31.288744515607714,0.3012475178972396,11.82548514011237,11.187683553422737,0.5660446946053841,13.131714338536609,0.9140348033541434,14.677741825468539,21.56622806373618,40.37567135525013,5.995199073242568
Hydrolysis of LPE,8.791445180389493,18.443560701257283,0.3012475178972396,5.147564962898748,2.9097446397782143,0.3936967754997325,2.49652702895408,0.6587378433745031,4.927295462767856,3.943354025055159,1.2625961266759145,12.989638811514125
Phenylalanine metabolism,8.780815091908957,40.502840238417136,0.3012475178972396,0.33507963802988266,0.3224952643612159,4.172825468255172,12.721484427055458,19.619830862549186,2.829097501045715,0.33977885201388197,3.7494008629968127,2.89018833782706
TWIK related potassium channel (TREK),8.773829910880718,6.1674911328411195,0.3012475178972396,4.865259128437951,10.951171031781318,7.757914809942972,2.136143133630934,5.363489671797463,4.4673756745706505,7.232666847384608,11.62294825726214,10.181305238095993
Carnitine metabolism,8.697891761953976,45.38180963416849,0.3012475178972396,1.0682796934680812,6.188101517675954,10.703569291156613,12.02629840930936,7.41419216482369,7.097648716307768,0.9579796935126811,2.660553114850333,3.164556157375144
Regulation of signaling by NODAL,8.690942627688857,11.7993338192524,0.3012475178972396,6.162837225470585,7.316291259786104,5.796384601197036,1.7200116378871966,6.767374674450332,6.035659962769887,11.337402085046998,18.512246251402587,10.393522313493381
TRAF6-mediated induction of TAK1 complex within TLR4 complex,8.575795902438122,0.49104946404934013,0.3012475178972396,3.692546706460748,6.152715825303143,0.6089228422970053,4.808885973303119,3.329026268292119,10.681702378657759,13.656102572033992,26.382146836439826,9.892277469057895
Generation of second messenger molecules,8.561715367932589,26.146488475615634,0.3012475178972396,8.508238363623803,26.143257721046886,28.40385971002386,21.068154762491382,18.728554159304576,3.778383089096807,9.61803891463554,3.8417092604995684,12.08707293328397
Myogenesis,8.53688545417651,17.17693540150955,0.3012475178972396,6.144356373344275,5.7360765731869705,7.188354370220559,5.853682720872449,4.7669185207904325,3.8391494386926297,1.6529880115957885,0.7986815974157044,2.0303008353968868
NF-kB is activated and signals survival,8.490625067067494,17.882210287006455,0.3012475178972396,3.632542797578374,6.780531792082416,5.106807256338301,2.4233261999801714,8.714901494197443,4.860876786570707,7.95893251055977,9.256793387059767,9.041875382630833
Aflatoxin activation and detoxification,8.444498275501031,17.04630007858181,0.3012475178972396,6.743828574449406,18.53191420358941,7.495643783311652,3.3656328256286585,2.3480481087064824,12.007459122126395,31.59820383897604,31.421503345837674,11.03059693466895
Pyrimidine biosynthesis,8.426972175768734,14.192168130408016,0.3012475178972396,2.0168705612459124,2.477697206609607,1.5896387336072435,2.1518365008359335,8.017738401440871,8.776413011696055,0.8452915312619311,4.726059238343673,9.840313066487248
Interactions of Tat with host cellular proteins,8.402352055812646,31.84462967533129,0.3012475178972396,11.646212540641155,26.53803062578341,22.697517343285856,12.889833154663389,17.67447265830936,6.734306286500779,7.267888736816305,12.698098176977263,12.07908183783322
Defective ABCC6 causes pseudoxanthoma elasticum (PXE),8.338763177272702,16.56578839743048,0.3012475178972396,2.9905452447971204,7.562309605630799,12.700230608795838,7.483992637448088,3.1384690982364094,4.15972480465659,2.2937775734843306,2.0958571468048106,0.8722971213323483
Phosphate bond hydrolysis by NTPDase proteins,8.335512787636237,5.914933030396767,0.3012475178972396,8.12350294862056,29.137035845228798,6.822597519538487,3.031628360417277,17.388829244183167,5.328698284572825,17.606560520659812,43.61161706272245,11.865365580944987
Signaling by MET,8.29336880583408,1.6200924846835518,0.3012475178972396,4.280880541869427,0.9570951260248249,1.1923923995219328,2.460420725909329,0.6222360238049646,2.542166741649223,6.345558279523001,7.756498967590726,9.818555208951379
SHC1 events in ERBB4 signaling,8.283068510712583,1.5991045744031949,0.3012475178972396,8.374966134125385,9.935343014027314,2.658066103521729,0.9612053758220557,6.511295239295751,9.510745031095611,18.6259812398875,19.255087964108746,10.790194791151404
Transcriptional Regulation by MECP2,8.27630227393631,51.751089165342364,0.3012475178972396,10.776063931750528,25.08192969157164,7.62381064441794,11.501394662236166,6.443434980348767,12.544751219783958,31.846325613695335,42.01013084222808,4.21813616905898
TRAF6 mediated NF-kB activation,8.273355361690983,11.589727021120956,0.3012475178972396,5.410699422689224,12.542170466458314,12.731659502981062,7.287930054303828,12.818541805768795,5.240880536928092,10.862327734586447,9.808030550314033,8.34809172719633
TAK1 activates NFkB by phosphorylation and activation of IKKs complex,8.273355361690983,12.0986541035334,0.3012475178972396,5.410699422689224,12.19408007569575,12.656823353628814,7.154175675335786,12.752305508834432,5.30561386797677,10.477530972480576,9.277057644364863,8.582415595393908
Post NMDA receptor activation events,8.263068531800155,56.29264368267115,0.3012475178972396,0.45749640488145993,0.665134887006836,5.660294518754408,20.350191827207105,35.44831305636752,1.7485605027058402,8.297285042454389,10.658013438570004,5.092182818763981
TFAP2 (AP-2) family regulates transcription of other transcription factors,8.259834190475795,6.887014723203035,0.3012475178972396,1.7082225974836642,2.9753941138378277,1.629100431173485,0.8665172857418165,9.870590273319484,7.234101037161401,8.483830010470605,7.846453014533182,8.518403557240937
Downregulation of ERBB4 signaling,8.235478001708788,13.158966458819952,0.3012475178972396,3.622357881342313,5.963508200471255,4.477671182170004,1.1573643816062875,7.56595302710406,4.506341381060806,7.516564538441117,8.304629001472073,8.064059625365221
Metabolism of amine-derived hormones,8.197116721065065,16.047105923680903,0.3012475178972396,1.3227080645072389,6.221616598506374,4.99399361175188,12.79611419967675,42.7720517512396,9.001932912982227,0.7187724983811283,2.8237053089271797,6.949178898138748
"GABA synthesis, release, reuptake and degradation",8.137861390329492,41.974789110950354,0.3012475178972396,6.655188128343474,16.36129320773363,9.387860374252528,12.455951972087982,20.9770142189247,2.1085161249350004,4.181023058692297,1.9568898471582272,8.545187314959184
"Defective B4GALT7 causes EDS, progeroid type",8.103230903650696,13.236338031128053,0.3012475178972396,9.296164370688723,39.564608713392765,24.310964157061296,20.027737853226924,36.56563302288981,13.778015588411845,20.567921318580133,26.105558135359438,13.300964557055968
Hydrolysis of LPC,8.100031982237248,37.71714243196408,0.3012475178972396,2.2468085585674604,3.2730644111354574,6.730434919965356,7.376357950295814,6.864188270985429,4.982520589342568,1.2424265815657805,0.32610623521016857,8.484194334684805
PAOs oxidise polyamines to amines,8.020324217869208,17.622816046642836,0.3012475178972396,5.752610545320253,3.426259369903712,0.9612170217336197,4.41716089762113,2.401786406938695,1.1945059150763222,7.829129438222057,4.462830395667642,1.2951852023241563
Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA,7.9548440717101805,6.336488325191461,0.3012475178972396,3.622357881342313,3.4714482402312066,6.980522161841561,8.24347158803514,16.053476479692048,7.5317314746980815,4.981580800081641,6.86186971685948,7.878520554529064
Beta oxidation of octanoyl-CoA to hexanoyl-CoA,7.903411260440527,10.172359788132407,0.3012475178972396,3.7338373718764655,2.838283983956533,6.630735717449457,8.24820370128141,12.634597663409984,9.33258700550975,5.20471950938425,5.3024191715261155,8.775422468880553
PDE3B signalling,7.893664022806906,8.43862663500871,0.3012475178972396,6.404303507897452,15.436388182587727,12.96936208250115,7.8345866707382035,13.758270551702383,5.608252297345454,10.668859056913613,15.810539069833146,8.633930066793022
PKB-mediated events,7.893664022806906,8.43862663500871,0.3012475178972396,6.404303507897452,15.436388182587727,12.96936208250115,7.8345866707382035,13.758270551702383,5.608252297345454,10.668859056913613,15.810539069833146,8.633930066793022
Defective MMAA causes methylmalonic aciduria type cblA,7.8876480588820375,10.842623146176768,0.3012475178972396,3.7553941832649205,19.836503149218583,12.194299549977492,10.488919129919745,12.203353548246339,2.6942498343973607,8.675156082977256,11.926232780088192,9.976057701912975
Activation of BAD and translocation to mitochondria ,7.8876480588820375,45.85274449353536,0.3012475178972396,3.9188585914855403,1.6469574938649805,0.31824892922220616,2.403087439739996,23.84072698267834,11.662173594803546,0.3395802205168157,2.2875957768800474,12.875674935797008
Defective MUT causes methylmalonic aciduria mut type,7.8876480588820375,10.842623146176768,0.3012475178972396,3.7553941832649205,19.836503149218583,12.194299549977492,10.488919129919745,12.203353548246339,2.6942498343973607,8.675156082977256,11.926232780088192,9.976057701912975
Tachykinin receptors bind tachykinins,7.881060222035803,15.75636818620992,0.3012475178972396,6.719108983840809,6.216775117631677,2.866068677939828,2.785939286852093,6.666068749182464,3.212104143276226,6.919247084231849,12.398046396019142,6.0399920284693005
RNA Polymerase III Transcription Initiation From Type 1 Promoter,7.812772960550239,44.46076388303786,0.3012475178972396,1.4016259370107396,4.565515275315713,5.830157813863126,8.764992840836602,10.029063639564322,5.651549178951455,0.3076296163705426,1.0790083169840996,7.4156773012260775
Fatty acid metabolism,7.792548943948178,37.11140724149552,0.3012475178972396,10.896034294601666,20.00943742037204,0.9873718799455766,9.31911410949937,0.4686571891870936,7.174958222973754,31.04821340605506,40.62613937294353,8.086699255096448
NCAM1 interactions,7.786004781137248,8.18039581170878,0.3012475178972396,3.889352093570083,2.019039474267402,2.472205640649186,3.0520660642042454,0.5658681904682212,1.9910009720006818,3.642313453991864,3.763779223843865,8.143054456757529
Formyl peptide receptors bind formyl peptides and many other ligands,7.782876885602347,2.096140013933909,0.3012475178972396,6.028512223915738,8.43549702275964,1.3965085861733817,1.3405684484987404,1.5150251114541964,12.025366878135596,21.011650592079185,16.579135360809293,8.13659889444629
Phase 2 - plateau phase,7.74906546687508,31.02035271433137,0.3012475178972396,0.7674702558899933,3.4073597364615993,4.216617422080756,1.3525272122139713,19.871708139834684,2.4923650273232107,2.3936476545047083,6.624013595178782,12.455021715817209
Formation of TC-NER Pre-Incision Complex,7.739137455984102,0.7265858052164252,0.3012475178972396,7.368100704386905,6.955147128725222,8.757032350984673,1.2876769670991757,2.6888945712969665,6.787551345550989,3.554471053389922,3.5899971965609616,2.338863685540639
rRNA modification in the mitochondrion,7.722415835597327,5.00110768962531,0.3012475178972396,1.789356546278766,2.5220244563353247,0.5246720347214037,0.5295258996119031,2.217699051397015,5.422715111156487,10.983091717039828,16.592759242019365,11.714565592612228
Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD),7.695530744327553,3.1362082135276825,0.3012475178972396,5.44101983660485,9.399185662267653,2.7593089746137385,1.2776379009813015,8.817401552283847,6.8317010017607,11.9219610767771,14.11955373187082,6.08524310943484
Heparan sulfate/heparin (HS-GAG) metabolism,7.692423232505602,2.9927559392030814,0.3012475178972396,3.929785146785296,3.9978433188225173,0.40573932933061496,2.5543289763255954,0.3354006212580713,3.387001604187088,13.847746090396797,18.302003302091833,8.545187314959184
AKT phosphorylates targets in the cytosol,7.658824097126052,1.4489953514865384,0.3012475178972396,4.277241630052548,2.0793173132307645,0.8376308140997201,1.1542342687331621,6.9996151066873935,1.154826699628454,6.181614939498162,7.663395929180458,3.7974940011274967
Interleukin-20 family signaling,7.652341608746835,1.3672818790033945,0.3012475178972396,10.343355756157413,15.384713710596808,3.1048718534718964,2.590948178419505,5.134718288146444,12.452631963910399,19.066579380075527,43.980228860085404,8.099856140845878
RAF activation,7.632343151649026,1.2439721112374287,0.3012475178972396,4.845134267740402,6.614710414360887,1.9243409357424628,0.557361734237933,5.95972489324539,6.765387570558155,14.01503870439759,16.060157911401706,9.024353949936609
MHC class II antigen presentation,7.605627668538617,26.568747265379347,0.3012475178972396,8.625488618756027,25.144531335817277,27.51199404169815,22.73131206026834,19.00030837564209,3.898195887774867,8.994925998416852,3.7307996102300325,11.767451026642364
Ras activation upon Ca2+ influx through NMDA receptor,7.592430938005266,29.830117668339707,0.3012475178972396,1.6146313019116967,9.883777494474764,9.605087334254685,7.729172612050932,15.835677475106113,1.9254039672228334,0.8916956009470408,3.40865142675938,4.446629996128663
SHC-related events triggered by IGF1R,7.538917167747067,3.172554487931115,0.3012475178972396,6.877363922770607,6.783825645170158,1.850811815166074,0.37405454220456713,2.903515890289016,8.8892591444365,17.449925879192598,18.12510465629772,8.440034040481772
Downstream signaling of activated FGFR3,7.535845452867695,1.8783493192332634,0.3012475178972396,8.313868138514302,7.435221331145852,1.9309351752518495,0.6070908939338661,3.3457734927881027,8.674574144012194,19.59960496202818,14.338771550972021,11.597598601236509
SHC-mediated cascade:FGFR2,7.492577441260674,20.18740750911587,0.3012475178972396,2.3545584847241887,6.298691075645508,9.9947396590963,5.3516323567196595,7.180009457300171,3.983014164658546,1.4719284715408967,4.102709257400181,3.3315294544148597
Transport of nucleotide sugars,7.479487299742827,4.638874280293528,0.3012475178972396,6.911317948340695,14.458781618308736,1.9163086991322464,2.86037548606153,6.124913102205869,4.60868070643429,8.344484617825975,10.236285285276676,7.672682069435895
STAT6-mediated induction of chemokines,7.409765782561665,18.524682269991374,0.3012475178972396,5.72076154850805,6.960300689962289,2.7693459335500132,0.5200568954022776,14.96894272224817,4.153370887043848,2.990625654884281,10.084290249811577,8.229534219258593
TP53 Regulates Transcription of Cell Death Genes,7.396754162787348,41.89801377902558,0.3012475178972396,1.4196443494560131,8.066301651197044,11.081365334463527,16.513414178550505,18.988106005005697,4.223859204963541,0.42918634693544927,0.3797108281730917,1.2002770975322983
Branched-chain amino acid catabolism,7.3605414873749915,27.729039041666717,0.3012475178972396,4.454023726625293,0.39908070073114704,3.6854770160239747,9.674231467590033,18.962999905156423,3.5782513125320428,0.669889589161617,1.3975110809751121,9.701566536373972
Synthesis of PIPs at the Golgi membrane,7.357511264927338,20.625346484450496,0.3012475178972396,6.135127388272778,8.257297012552682,10.971217620821227,10.586810284126138,18.37235025931785,5.057797050865767,4.9082357079193555,19.53124527185611,14.71129285859625
Miscellaneous transport and binding events,7.354481647055177,50.609538384165475,0.3012475178972396,1.6146313019116967,1.5198743962908294,1.717007272070739,7.0524886418689166,9.819566307658864,4.022427268824593,2.5220267483926184,3.6242299915446474,4.51672013685809
Metal sequestration by antimicrobial proteins,7.28209369120209,22.163251918322814,0.3012475178972396,8.625488618756027,7.673648457106021,4.573139915711598,9.188369804349191,12.216419223685406,9.32789753375984,22.942714454395087,6.387564565301438,2.8636874201901863
NADE modulates death signalling,7.236329849575772,24.872823670357395,0.3012475178972396,12.586497472515536,8.383969852405556,4.252610917990734,1.9189693806085062,6.906551403020442,8.997334912379767,7.240166800255139,19.590988296695848,8.361476251043326
Cargo recognition for clathrin-mediated endocytosis,7.233328854011596,3.1352670533624702,0.3012475178972396,4.101754938255935,4.534380466662145,1.4985653334586437,1.5973195834310183,7.3657711498795395,4.5341079442431305,12.604421734629287,14.0056552202214,11.512688796903563
Membrane Trafficking,7.230328463594046,4.715643567714994,0.3012475178972396,3.726847158133199,2.4761321102330696,1.4908673838849102,2.1613147242573314,7.795257189228181,4.3440000801063725,11.815050339104545,10.012800566369048,13.470932134478296
Class I peroxisomal membrane protein import,7.188011918575539,3.0769658959578106,0.3012475178972396,9.555924486995938,13.23442568629564,1.0126747290234515,13.704583700932368,1.641882125256044,8.997334912379767,6.794395346332851,21.744645936025204,6.478668923869749
Interferon gamma signaling,7.178763384395022,31.09165339457555,0.3012475178972396,5.380472771189839,16.807224474679206,25.16045402880864,19.342634431894126,16.034418840900578,2.8758180875876747,4.0038533113884,0.3410910427067706,7.754011120961656
"Antigen Presentation: Folding, assembly and peptide loading of class I MHC",7.178763384395022,36.91412590789057,0.3012475178972396,1.881192128840794,3.6397268445175177,14.523138812591098,14.594030502675903,9.157807810649823,0.7970116073990179,0.62995132049342,3.8284318532119683,5.310540727947755
mRNA Capping,7.1561787565794805,39.3818149689261,0.3012475178972396,4.333671401567865,5.767961079195728,2.6860884090233577,6.798250300103854,16.802939963257977,5.023901165155415,8.231060609352062,11.444850519021886,17.090605057099296
RHO GTPases activate KTN1,7.136891224919974,11.314928949305642,0.3012475178972396,8.177972357484483,7.530429244170456,5.521306456281174,4.042441679454379,10.139785714915925,6.462412498550443,3.331571004483705,4.533030956677831,3.148704017189325
Constitutive Signaling by EGFRvIII,7.095151503884815,2.9507032985829196,0.3012475178972396,6.256893094101918,5.699408947354949,1.5008559891794635,0.3778494382575689,4.4937782047523305,7.3766590508780165,13.847746090396797,13.078225191332667,6.961019766269311
Signaling by EGFRvIII in Cancer,7.095151503884815,2.9495636177235878,0.3012475178972396,6.252380430781194,5.703750052881801,1.501461179532542,0.3778494382575689,4.501537511044647,7.38105947435161,13.847746090396797,13.078225191332667,6.9581978264012445
Glyoxylate metabolism and glycine degradation,7.033846644519812,12.454904189177222,0.3012475178972396,3.4147523598931113,5.208539949163281,1.2902024609802476,0.471934924823444,1.9080252222929739,3.973987913723956,3.3483159058977954,6.4475416891891975,2.2808336988611817
Signal regulatory protein family interactions,7.0050541759078415,1.5076515142196463,0.3012475178972396,5.621244574880131,10.125851577180569,0.34777674818786086,6.997442811067977,4.204809844404067,15.000497907535788,18.651205748850856,37.60564889743925,11.71079410279661
Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum),6.998882327737353,9.333513701689418,0.3012475178972396,1.629727194568302,6.536183518550076,3.7169255644591352,2.5095141453821186,0.4313142026468695,2.3675892496026276,0.8601325686296818,0.41498138384411587,3.974450713523382
Cytosolic sensors of pathogen-associated DNA ,6.986267801210595,25.741264084862127,0.3012475178972396,3.2726008373907898,1.4942753777543196,3.578494969497332,1.483290462126676,4.998324671178434,6.930148947069563,1.981508284173456,2.483207652463549,5.4473727204011935
Insertion of tail-anchored proteins into the endoplasmic reticulum membrane,6.960796446315026,11.015043057477085,0.3012475178972396,6.5477422645378445,5.536401596710151,3.9544434797957466,2.4680382840041983,11.769317987594674,5.655339512321564,12.990392497061977,16.795996442374395,9.712372550565386
PECAM1 interactions,6.9546461056180044,4.369854368993228,0.3012475178972396,3.966966484100862,3.330863257921853,3.418283786415816,9.188369804349191,0.6171194858480843,9.929376319075237,10.37799493151427,29.344493829412066,3.212383430509364
Myoclonic epilepsy of Lafora,6.871623357976083,12.069584800486544,0.3012475178972396,3.692546706460748,6.077492878510179,4.713174428786818,0.9890291419876863,6.097042338829061,4.573124121739482,7.419839088220139,7.751431900998785,7.1934168811090995
Transcription-Coupled Nucleotide Excision Repair (TC-NER),6.865516741879932,0.4308632300646962,0.3012475178972396,6.616365710945646,6.899962219623046,8.886511188973925,1.5865616061713348,2.7140697412508477,6.708356506503341,3.23160272021578,2.6652690487001722,2.0180428315566146
Signaling by plasma membrane FGFR1 fusions,6.8530335755499285,12.822140150634013,0.3012475178972396,1.3345214903702751,11.950996617727348,2.5551557591211966,7.522013982763992,19.580808543954557,31.352520596887423,5.454101530819723,8.435591063235249,3.3315294544148597
MECP2 regulates transcription of genes involved in GABA signaling,6.8310088897541394,18.84252035644042,0.3012475178972396,6.210065531594786,19.19825254002357,11.15507463917497,11.790467248592169,19.300456418772672,7.183925201952304,10.471520335920047,20.54711944919821,12.140197524496958
Astrocytic Glutamate-Glutamine Uptake And Metabolism,6.822019184705169,0.9847957161627252,0.3012475178972396,8.66322803930098,14.903762999828757,8.188910694038757,1.7696656806244746,2.0643080147019814,10.44153114790047,16.328773564722397,29.67830691428447,10.551996769838057
Neurotransmitter uptake and metabolism In glial cells,6.822019184705169,0.9847957161627252,0.3012475178972396,8.66322803930098,14.903762999828757,8.188910694038757,1.7696656806244746,2.0643080147019814,10.44153114790047,16.328773564722397,29.67830691428447,10.551996769838057
Defective LARGE causes MDDGA6 and MDDGB6,6.816214983684603,28.279342807774466,0.3012475178972396,2.2282300698857336,15.365787486258785,9.786775289445515,16.23550548476447,26.194676664973457,3.192016458082978,4.47991872911209,10.199794238741333,6.975975898955607
Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,6.816214983684603,29.17068300452121,0.3012475178972396,1.5378035419156877,0.759553205071728,0.7559524853676522,0.8005208460388307,1.215969387671907,2.104305837834915,0.5072078334760466,0.8836517501622464,2.681075909935216
RAB GEFs exchange GTP for GDP on RABs,6.794255505413893,1.004891510139409,0.3012475178972396,4.775318625178469,2.509078004695214,4.059715638292327,1.9988236340318113,3.9025377091030093,4.0518652291765385,9.430450509480025,9.350373207646708,11.171155220302357
Dopamine Neurotransmitter Release Cycle,6.775503309851747,40.70285998267479,0.3012475178972396,3.7165107909782797,19.99719328953644,8.030575103087205,18.892728081052933,26.259553418520085,0.9499486093917724,7.2476710024549265,6.151323605892007,11.089151532017453
Defective Mismatch Repair Associated With MLH1,6.772889411426172,1.6469379664086665,0.3012475178972396,6.083765831881639,8.59224362239221,6.6706647861370145,2.997942103529629,4.3136387053901615,7.307530447878209,9.15052529636982,12.249704128480545,4.396732181746483
Defective Mismatch Repair Associated With PMS2,6.772889411426172,1.6469379664086665,0.3012475178972396,6.083765831881639,8.59224362239221,6.6706647861370145,2.997942103529629,4.3136387053901615,7.307530447878209,9.15052529636982,12.249704128480545,4.396732181746483
Serotonin receptors,6.744681884370499,7.372378697349324,0.3012475178972396,6.4516228328771605,0.9650262882460146,3.660393850917218,2.1060915691879027,4.935883193867491,8.13299143671035,8.751001542264907,5.430077375895906,10.980415749895117
TICAM1 deficiency - HSE,6.729161608515123,13.301464337689836,0.3012475178972396,2.7017434218913223,2.0077033078083364,1.8042321515539805,9.559819405649506,10.001923218678707,5.576417492735178,3.3301225341797402,7.608082197838453,5.583069345193159
Alpha-oxidation of phytanate,6.610021245819844,21.907665548347893,0.3012475178972396,3.2065168438951877,6.098862115570853,9.914823640423569,18.22423147977401,24.953855739984913,4.00580175794824,3.179199524878092,2.7790459756085735,8.841637735599653
Alpha-protein kinase 1 signaling pathway,6.594669681168767,9.678643273371733,0.3012475178972396,2.8199316667826766,3.8657501044765348,2.9415427842274937,0.45437822287430085,5.222155484285926,4.166351419514403,5.264627157213108,5.511355966101221,6.185305237150368
Association of TriC/CCT with target proteins during biosynthesis,6.58245774434533,10.503717623265544,0.3012475178972396,9.710353450707709,6.023139969662893,7.24166401837356,5.268200956393486,7.497650644386831,3.9928468738234724,0.7872826802725204,0.7855610590776513,4.326331965488884
ChREBP activates metabolic gene expression,6.489471400330133,19.348856730652326,0.3012475178972396,6.366286241897742,3.818511132827937,2.7421155432263498,3.961548856154043,14.36761223247641,13.377637608451098,14.058214349856026,14.456981953463446,16.07109640262589
Trafficking of myristoylated proteins to the cilium,6.486651004230106,21.7308764240328,0.3012475178972396,0.3671790223921119,2.180419755608674,1.515974965791384,6.3152904925945705,20.45533848461673,1.792904033357287,0.312771419398865,2.958752295352064,4.32846791976856
Formation of Incision Complex in GG-NER,6.4714559091814206,4.1040195125302805,0.3012475178972396,4.105306735965439,4.94970790319562,6.433930649668682,0.45507962971512905,1.8664626506210218,5.240880536928092,3.4956767559391175,2.4077009479810156,1.5269329274960752
Death Receptor Signalling,6.45319234340915,3.040773928365279,0.3012475178972396,6.065415639815419,5.172228666379716,1.2290908712621664,1.2217897155839255,5.506077938175389,6.3589318547060625,4.224923097107531,7.943730707328456,4.074254573567513
Signaling by FGFR3 fusions in cancer,6.416474041158258,4.786140793727958,0.3012475178972396,7.131331182784055,7.088453141643348,1.692277848623037,0.3210403736812457,3.094786787146642,7.962228430837349,16.78300839597327,14.405431314988233,8.083626326729945
Dual incision in TC-NER,6.410594857729841,1.3679380980957256,0.3012475178972396,5.337085808955745,5.128374480078728,6.784138587204704,1.0365052199945204,1.5874360007621258,4.938367989159694,2.3842835754229124,1.8789697704879458,1.16934654357974
Metabolism of RNA,6.315874529343311,7.52742936507025,0.3012475178972396,5.462775968875692,7.224972174851219,7.235866295367917,1.8331410927493728,2.4724514676158558,5.046576640955702,2.221685139442413,2.2532244983039216,1.4691237570815538
Sema4D mediated inhibition of cell attachment and migration,6.310046818243029,2.42748384841288,0.3012475178972396,3.5320343357123907,5.949602762392003,2.787157028613226,0.6208380225980258,2.496680616123866,6.157279703412355,10.483543386850037,9.030294210579301,12.28095152139889
Regulation of PTEN mRNA translation,6.288986552907814,31.355496785209997,0.3012475178972396,1.440151778736823,0.3248162048587488,2.470458762844302,7.605706737980009,6.362521267136957,3.369097188280304,6.680426063335585,0.8051108427924986,22.176076799792764
The activation of arylsulfatases,6.283172622124253,12.955954467752203,0.3012475178972396,7.040887535695357,21.263895384577122,6.085837662644386,0.963977327578571,1.636462652309164,6.804956410436651,26.282903181899126,42.66781252506795,15.000720884940714
Thrombin signalling through proteinase activated receptors (PARs),6.216678557781733,12.113202664350965,0.3012475178972396,6.327794750102376,0.8201437663673834,0.5949116993255215,2.595825270850802,7.482085947991981,12.043288710889675,9.424774705540557,8.767947658618885,15.451364552692787
Caspase activation via extrinsic apoptotic signalling pathway,6.201831258398917,2.492852985844588,0.3012475178972396,5.908329198375509,9.597450687739032,0.5685781912635242,4.746193259143872,2.6531353062371035,9.301614342161606,18.879760535254082,30.57776270255825,8.6612004891345
Zinc efflux and compartmentalization by the SLC30 family,6.196062318414549,2.603111612267714,0.3012475178972396,5.345632953856849,13.61901812048118,2.966429482714129,2.0541656942856426,0.44426590538655314,6.584769010849247,8.089020486855631,19.204246654107177,5.633901502075884
Cell surface interactions at the vascular wall,6.19331598326053,1.9459709078405825,0.3012475178972396,6.11164445714235,5.996627544522589,2.870455612530489,7.777024675433613,0.7560712995346011,12.89748789475785,16.321156917826276,37.66790176382184,6.316484766916996
Neurotransmitter release cycle,6.187551404183468,49.18813571903863,0.3012475178972396,4.330006868114326,22.938982951078973,11.52276617399712,23.015081811073166,38.91337193938001,0.9363424127415801,4.571385978818347,3.626455369250742,11.00746890105391
Defective Mismatch Repair Associated With MSH3,6.139630135746641,26.146488475615634,0.3012475178972396,0.41156743217748976,1.6059603840398293,4.574449689525685,7.4419371525638365,6.221163087570823,2.0332416058976297,1.1460646914407466,0.43425369817693726,3.5028632505135526
Nef mediated downregulation of CD28 cell surface expression,6.112882243448314,16.417672421709074,0.3012475178972396,5.958879724983743,8.554647187659373,8.649319037752216,5.174802371914093,11.993312886323611,6.98451820497491,9.055299094042928,6.96268683863164,10.40443138421479
Pyruvate metabolism and Citric Acid (TCA) cycle,6.107159498607497,24.855936405465567,0.3012475178972396,2.6755525888927707,2.786664231609747,1.493150243400681,1.357846015995245,5.134718288146444,3.2532718711601842,0.4425474556428032,2.292842000549527,2.5831396681296956
Wax biosynthesis,6.09544984693298,32.958809076501176,0.3012475178972396,1.8524708797620923,15.357872848225133,12.811498759926137,20.15461756304696,33.191567040613606,5.206314883664087,5.41933757585813,18.838396270664703,9.943190085299165
Dual Incision in GG-NER,6.092729142721782,35.920101483074696,0.3012475178972396,4.2309750746585735,2.0939206225475524,0.569519170169003,2.55191358433927,12.60012303296366,3.510186023795282,4.864983499643844,8.583423501058528,14.052306447751002
Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET),5.997615622554595,27.036189444047405,0.3012475178972396,0.412296365244996,0.411556946616822,4.9851303947663,18.56838576112249,25.722491988306892,7.36286531419937,0.5386611083277937,16.809713737035125,10.419188364669791
RNA Polymerase II Pre-transcription Events,5.95936684163044,34.31936658222852,0.3012475178972396,2.3387698644319657,1.314088626487941,0.599701504406343,4.54121058999845,13.409804099914805,2.95940443254466,6.3147301776213975,7.506239141652384,16.634739848071877
Cytosolic sulfonation of small molecules,5.956681675605739,32.484248412871715,0.3012475178972396,2.6810718411487744,16.847254586114957,14.27374735852718,10.576001328100023,12.735131452186717,5.871523030279473,2.2111457957316913,1.2850645168177368,4.96546878639618
IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR),5.942449460402441,2.5707111510938403,0.3012475178972396,6.5434165135832405,20.471120150659004,19.527034428818602,6.250914079675081,9.295590732049005,5.469778586165596,16.926632071756874,21.327798532467614,9.940040495751209
IKBKB deficiency causes SCID,5.942449460402441,2.5707111510938403,0.3012475178972396,6.5434165135832405,20.471120150659004,19.527034428818602,6.250914079675081,9.295590732049005,5.469778586165596,16.926632071756874,21.327798532467614,9.940040495751209
Utilization of Ketone Bodies,5.9338648189598215,1.2949089559090436,0.3012475178972396,4.364160845547427,2.4761321102330696,0.479279549892749,1.119701461549629,2.3044136740800023,1.9039097950120254,7.345237122608706,13.07359701815169,1.3589096824105675
Caspase-mediated cleavage of cytoskeletal proteins,5.919391226577755,54.12623349653356,0.3012475178972396,0.4548809603840231,5.17659327028375,2.691744057135811,27.419682239590312,38.1428042009961,0.65054473241694,9.797855218149628,13.286640827050762,1.8886069467423054
RNA polymerase II transcribes snRNA genes,5.890773623998644,4.74747440489387,0.3012475178972396,2.657744051411663,0.4525566064861742,2.6353953304549185,1.8351061988975368,1.9033214969898764,4.464063498709391,0.4637539598480594,4.07284442372603,0.7832500139141988
Advanced glycosylation endproduct receptor signaling,5.890773623998644,8.402689828010578,0.3012475178972396,4.158240504727485,9.898765060115782,10.256692774007089,5.793164310928924,9.70884925443039,3.5073103048767837,7.797279549906363,7.228001556511961,6.020167423288413
Peptide hormone biosynthesis,5.890773623998644,6.867483173510128,0.3012475178972396,5.761518952889475,9.277493828532533,10.669916495242086,2.443400667031371,5.987520862952709,5.383245490642863,10.219395280341764,10.318170292869485,6.1309539118873655
Cilium Assembly,5.873423099060672,1.6494408926161181,0.3012475178972396,5.21622962197286,4.278003187702599,0.4100020966107136,0.5703178884863153,4.153599795133256,5.5726569605429,19.70406422648653,17.86755396765709,7.271421701359249
Coenzyme A biosynthesis,5.812240117084911,0.393254167288092,0.3012475178972396,4.981900760836681,0.36699636817005515,3.7802138844926865,1.4416018276267324,1.8235440492288342,4.569766956532863,9.232104647258724,2.307891249456796,5.924148251219342
Toxicity of botulinum toxin type E (BoNT/E),5.783368488061248,14.314769793221679,0.3012475178972396,5.5196243823874855,14.657731367793374,2.1466855776214215,3.0003311305570564,19.365271166428006,1.2193704468219153,11.468786713002197,15.275274663862625,9.283336985447159
Synthesis of Ketone Bodies,5.760381533708668,0.5310722454427965,0.3012475178972396,5.885615815944801,4.804287444094771,0.7371809214976468,0.720988828266769,2.4545581263420626,2.0627921989412803,11.376610937172904,16.868399604150902,2.469462875032727
MicroRNA (miRNA) biogenesis,5.757748355956492,11.732939958642028,0.3012475178972396,4.8038992576445345,9.0461696454911,4.949161822769786,0.5141314064665184,0.7358065898601204,5.446078408468241,5.465601524970485,7.932650269595408,0.5307470000909504
Immune System,5.7435120191639015,41.969701441018834,0.3012475178972396,2.064477535264971,5.375432677100876,15.70509496375636,20.509503462892894,18.779205409605286,0.6558386928286868,0.47907781962636875,5.81852925428714,6.014705046637098
MAP kinase activation,5.714827521779177,0.904679502200735,0.3012475178972396,4.944263782518003,10.238040860241897,3.4082685261379244,1.1370007059219287,4.579358639941929,5.175757017456766,16.06759205791025,16.551591599118805,10.449343962532467
Acyl chain remodeling of CL,5.706426377165585,19.671142445357603,0.3012475178972396,0.8420040555600429,7.364193180424681,2.0380266694660594,2.7254453623893093,10.712528188493424,2.0222400349331187,2.1984306340389104,5.002314216049217,3.347134424760653
Suppression of phagosomal maturation,5.703807392170675,14.128631557719405,0.3012475178972396,2.412900283607055,5.788724914867688,7.265800932633873,4.349579146321367,7.437570516770196,2.6302734538160264,5.628425335398243,5.6587946668800635,4.014971093801665
Interleukin-23 signaling,5.657962359284801,2.0619774197789127,0.3012475178972396,4.454023726625293,3.512971236722953,0.509786943690924,3.884951450984157,2.0010638969083456,9.04838805451058,9.644913020193606,29.07965867938689,5.765951868458861
"Activation, translocation and oligomerization of BAX",5.652481596413205,11.675187326180842,0.3012475178972396,1.1283708684968548,1.1763271733951215,1.2255852405249061,3.387021461736581,6.849351102073188,5.9742478685027764,3.077716843838931,4.0336758254912395,5.531419959325333
Neutrophil degranulation,5.64413140121911,37.496437797494806,0.3012475178972396,2.631286959188869,4.440644428209084,11.904850908895911,16.186369836730563,16.75147787925246,0.5969219792442905,0.32432998357033466,2.4979669048466997,3.515166771101433
Interleukin-1 processing,5.627182625737703,0.7096937999954743,0.3012475178972396,2.1403540413290583,0.6391357722298152,1.4409841122404559,1.0856329688620259,6.16950094318292,6.853686287035471,4.427133290523155,7.261694533611998,8.07048377173945
Glucuronidation,5.564559965482478,26.27797451767782,0.3012475178972396,4.469489382639014,3.005426003433379,6.399906696843484,1.7571719484699495,1.1213785758041015,8.147543806158104,3.5476873880129327,7.095797490517541,15.502687137929536
Class A/1 (Rhodopsin-like receptors),5.54774218002545,6.153241349091102,0.3012475178972396,4.787515689094433,6.822924773965374,1.118087870911542,6.457214938674408,0.7885519094002207,11.882845726596612,16.572082938000754,31.588402195199297,6.793243169725676
Mitochondrial Fatty Acid Beta-Oxidation,5.5056858724783595,4.664809491546041,0.3012475178972396,2.2156666106510894,3.0981453276709994,0.8379954008405275,0.31557446220018653,2.117975199707726,2.071841404686818,2.561857827263582,2.4689726630154762,2.719901562104459
Defective Mismatch Repair Associated With MSH2,5.5056858724783595,22.646690119152247,0.3012475178972396,0.39379168515184637,2.3509175965143125,4.446613875510298,9.701560066718491,8.575534745697155,2.1245126086288773,2.744525614747035,0.8069233391629619,7.390883755057167
Defective SLC3A1 causes cystinuria (CSNU),5.497724770551655,0.7572855555654737,0.3012475178972396,5.546060960744223,2.0599554146025727,0.3831253421806592,1.0588387329134918,4.467591466942151,1.7240882472652792,9.531356247178945,6.817250981737546,3.540361028018053
Defective SLC7A9 causes cystinuria (CSNU),5.497724770551655,0.7572855555654737,0.3012475178972396,5.546060960744223,2.0599554146025727,0.3831253421806592,1.0588387329134918,4.467591466942151,1.7240882472652792,9.531356247178945,6.817250981737546,3.540361028018053
Loss of MECP2 binding ability to the NCoR/SMRT complex,5.489502202228317,26.351965155368458,0.3012475178972396,1.4136223918351734,7.753476058634168,7.368941059044467,10.581405171173943,27.065388072474022,3.264794403893311,0.9822416424663639,3.8345533525579114,8.182708184671789
Calcitonin-like ligand receptors,5.44178959518219,41.57032191064305,0.3012475178972396,2.208301328285611,1.7791074843305494,1.8035351365014662,6.997442811067977,28.35246757444859,4.51327397328162,1.4050599521463754,4.956008910440033,10.38998814120167
Beta oxidation of hexanoyl-CoA to butanoyl-CoA,5.439241914785078,9.279792193091724,0.3012475178972396,4.0419055032700815,3.282164642650136,5.095296641934801,7.536213196418448,4.82635109097749,8.230782517980673,4.14529510152159,3.9365454439792504,4.333003216037775
Glycoprotein hormones,5.388966626103143,6.694955765268258,0.3012475178972396,5.1089634213974335,8.64822768378044,9.711518125067103,2.45098655957365,5.741637017041771,4.51327397328162,9.410152755686731,9.410053292227934,5.716169574666048
RNA Polymerase II Transcription Termination,5.36964674192787,2.7509094498198237,0.3012475178972396,2.2205853212320137,0.8345491998953309,3.387217891097193,2.80797668125223,2.8575382954518274,3.2036694352386803,0.34243526800000434,1.0594663086993612,0.9561944722045858
Regulated Necrosis,5.355946457911736,4.285317248604901,0.3012475178972396,4.669025785509436,0.6377750995948159,2.1163664548813887,0.9459423629343998,2.3699222849933457,10.060616998020887,1.7731386229404402,1.506925448453828,2.2060290993909164
RIPK1-mediated regulated necrosis,5.353422318874205,4.28846834893241,0.3012475178972396,4.669025785509436,0.6377750995948159,2.119213204511879,0.9459423629343998,2.371081351210684,10.060616998020887,1.7731386229404402,1.506925448453828,2.2074304043402155
Negative regulation of activity of TFAP2 (AP-2) family transcription factors,5.334172961518062,4.872335186882461,0.3012475178972396,1.934900045579744,14.277795116294781,5.365090943004315,2.129402555533724,19.89338657170896,9.296616113891364,12.98364507184092,18.694715110297118,9.311984805248501
Biosynthesis of DHA-derived SPMs,5.281659803185333,1.9236332784381236,0.3012475178972396,2.0796219141784293,1.2892528351153336,1.2593050431669905,3.264328254418901,1.4350563275842974,5.317149143022081,2.239900800379757,9.546144519654407,2.9912086276019587
Synthesis of PIPs at the ER membrane,5.240456928728695,4.134903587255941,0.3012475178972396,4.481247854241171,8.524629688931467,1.8486814292798461,0.34492211140437745,0.7143514714716499,3.711433029262752,6.247980942502223,8.762239745012426,2.599097419118961
Interleukin-2 signaling,5.19942933473328,30.933578358622928,0.3012475178972396,1.315421655381102,5.569814682373747,18.672240032397518,18.344685696254096,13.589031338113855,0.40206732291523795,1.0483820664599481,1.7849552311825092,8.179615061767707
Disinhibition of SNARE formation,5.128534795933489,0.8076255765795497,0.3012475178972396,2.357110851872084,2.703088260858952,1.2205948018357593,0.5431965903965179,10.807621843424782,3.881861142522806,21.703673116581996,28.32436127842922,12.968397707515908
DAP12 signaling,5.1181656415316015,3.8884993418102165,0.3012475178972396,4.911286048063167,8.576617957675811,0.5875446043973633,6.080262004027164,1.6937154881262884,10.676316489235466,19.55697702045704,39.21909288450734,6.012111479204251
RNA Polymerase III Transcription Initiation From Type 2 Promoter,5.1181656415316015,40.44848784349807,0.3012475178972396,0.6276845179050202,2.741014544112263,4.193449404845173,7.251558284722353,6.921180353798449,3.581161326322044,0.8849025871100675,0.36204692588163656,4.262919583732815
TRIF(TICAM1)-mediated TLR4 signaling ,5.11052927939838,0.717101899363024,0.3012475178972396,4.936361890454637,8.48488823369927,2.657403856177428,1.3853606233622067,4.172554253597293,3.3512471416799614,12.550098234477709,14.01045985314227,8.68531850998036
MyD88-independent TLR4 cascade ,5.11052927939838,0.717101899363024,0.3012475178972396,4.936361890454637,8.48488823369927,2.657403856177428,1.3853606233622067,4.172554253597293,3.3512471416799614,12.550098234477709,14.01045985314227,8.68531850998036
Enzymatic degradation of dopamine by COMT,5.094745690968464,14.336847198722555,0.3012475178972396,11.38440230509726,11.779193456455145,2.248326863488821,3.995000905955459,1.5834669168683566,4.025544659882701,17.62277070167461,24.574940596839955,10.631866867367464
Dopamine clearance from the synaptic cleft,5.094745690968464,14.336847198722555,0.3012475178972396,11.38440230509726,11.779193456455145,2.248326863488821,3.995000905955459,1.5834669168683566,4.025544659882701,17.62277070167461,24.574940596839955,10.631866867367464
Interleukin receptor SHC signaling,5.0922944422109175,7.836364648081144,0.3012475178972396,3.528780869370036,3.644309775712747,2.503635054274634,8.389201549464032,0.7997180666355365,10.637325596285054,9.81554870147764,31.175964362345358,2.985602754381421
"Defective AVP does not bind AVPR1A,B and causes neurohypophyseal diabetes insipidus (NDI)",5.062731384267916,11.62719148499569,0.3012475178972396,6.2430628032132525,8.11058770709891,8.631755588220068,6.293898177860267,10.611228495262724,5.9209610865840085,2.651805642585124,3.663365611549759,4.497369953395325
Biosynthesis of specialized proresolving mediators (SPMs),4.971396224038156,1.1026497668925426,0.3012475178972396,0.3802114368175506,4.888402695713081,8.78149433381726,7.325412288956936,0.5111881173498029,3.756340531555427,0.9876121971061026,3.2018452627042415,4.087924065228077
Dermatan sulfate biosynthesis,4.955589501464316,7.773626075781641,0.3012475178972396,0.7335411210724093,2.8092264370519553,3.970048248198263,0.7527938332225241,1.4955210693760148,0.3375222718847783,0.9287910926744789,0.7239857266750139,3.9134569460240884
Phenylalanine and tyrosine metabolism,4.950503038307698,46.101605459265045,0.3012475178972396,0.41302660869180097,0.4190807154205034,3.695091231874572,9.723375713977264,8.394106485123404,5.240880536928092,2.113682459490119,2.0060793860486976,2.636879099761859
ECM proteoglycans,4.937403717907441,8.56564165974809,0.3012475178972396,1.4976971052323285,9.6355855752411,5.201963184843544,3.603566232011574,1.9139741803592192,0.8655301052159872,0.633492140985269,0.455461977645623,4.843837452434227
Circadian Clock,4.913662386612921,15.221538248748727,0.3012475178972396,7.368100704386905,14.448453717146368,2.723280789796436,2.813097345362085,2.4407721102612405,5.148892077656666,18.82472167296848,27.16408947943778,7.296558126014887
Muscarinic acetylcholine receptors,4.887327510688183,9.068547212588435,0.3012475178972396,2.137949408316804,5.9587803675397515,5.426186735661779,6.672692630637563,7.0751317579876085,3.898195887774867,5.697811801025404,4.441196053719649,4.012929898079603
SOS-mediated signalling,4.876973530045772,2.646378424165853,0.3012475178972396,6.1535929857027085,6.967269150806228,2.1801545557792736,0.9554479842882522,5.207208412076142,7.243108187995654,14.58433306391335,14.162560820039888,7.12158466018946
Inositol transporters,4.805892660105716,10.306868031944376,0.3012475178972396,2.7316557967796875,6.024543271309929,4.746572777331047,7.177106713714207,13.786773147170589,2.5189199996100076,3.853038002005847,5.61839349989934,6.051218994594927
Pyruvate metabolism,4.7825005108875835,23.84350627838734,0.3012475178972396,2.210754717949753,0.7853544137032822,0.41620041195278834,0.8352492231393344,5.374262324089099,2.504323280864776,0.4874362233818452,1.1841590490751983,2.8430151430073027
Glycogen storage disease type XV (GYG1),4.764671635580895,16.300810409765322,0.3012475178972396,9.396497138837905,18.88677701241105,23.36838979538594,3.1061967727367237,5.16440587774545,7.29877937510778,5.595035993995145,5.788672792449396,4.439857941829503
Glycogen storage disease type 0 (muscle GYS1),4.764671635580895,16.300810409765322,0.3012475178972396,9.396497138837905,18.88677701241105,23.36838979538594,3.1061967727367237,5.16440587774545,7.29877937510778,5.595035993995145,5.788672792449396,4.439857941829503
p38MAPK events,4.741390867427269,16.43476178812661,0.3012475178972396,1.6808809553032547,7.420496792778623,9.940954050370275,5.128598218268227,8.208359686895284,1.0404210635235576,0.5643006159615592,1.3668094595402185,1.1133680654121834
Toxicity of botulinum toxin type A (BoNT/A),4.7207787187869785,12.084114815553063,0.3012475178972396,4.196319802652267,11.297972317373405,1.2781429246797462,2.354956544684559,15.658992459459549,0.5603738737975641,8.728353006884896,12.47931410782082,7.521091809460075
Biosynthesis of EPA-derived SPMs,4.697616438068584,1.3944252973373614,0.3012475178972396,0.6567640176757537,1.3896420325778216,4.174061322438586,5.673321314011593,0.7747972179746527,4.666381817886522,0.3848569824116412,4.598705187000712,3.270369536796103
N-glycan antennae elongation in the medial/trans-Golgi,4.640882666476724,41.6867257844578,0.3012475178972396,0.44156038945566317,11.499410670772656,5.507534459822713,8.138767662488526,27.332702845835634,3.21782022808452,1.930048861278244,2.981470223415949,12.206290816565321
Synthesis of Leukotrienes (LT) and Eoxins (EX),4.602499226243857,0.7921331557033443,0.3012475178972396,0.34119673173215886,3.940125170966512,8.922529655229724,7.278743856104507,0.5065373953445642,4.247951434190334,0.4485650903777101,5.8321719799601714,5.131031190458221
Sodium/Calcium exchangers,4.597883836425263,21.079685439274872,0.3012475178972396,1.8644681246785202,25.76060391032383,9.978180077618758,12.83971435518946,8.791788154002813,0.7012937151872495,12.546943563898212,24.87020479500604,2.9968207020493103
Binding and Uptake of Ligands by Scavenger Receptors,4.597883836425263,0.4118761315429869,0.3012475178972396,6.852686673972173,5.080406299079197,1.0487563426287758,3.0003311305570564,0.4718181923016547,10.164235507893904,13.39587509464782,31.951955068019938,4.800859437021858
Histidine catabolism,4.549474353098427,11.796701385099192,0.3012475178972396,6.655188128343474,1.4636588836390039,0.5194597687986466,2.441050069132899,3.9581131919242494,4.38591738010305,6.656158455801238,0.6704349295192863,7.845712132313615
Regulation of PTEN localization,4.470925629835718,7.616126396834577,0.3012475178972396,2.322280979101064,3.3560985271593373,2.230712532140823,0.3258538720961145,4.394538286153651,2.8182421500382304,5.238981630322629,5.7101834534472085,5.123408812798456
Trafficking and processing of endosomal TLR,4.43835920841142,18.94193705766247,0.3012475178972396,2.051990666237419,2.652673476735292,10.703569291156613,17.41368638044259,10.231267957904715,0.875897781993739,0.3409987848219074,5.233419608139391,2.469462875032727
NR1D1 (REV-ERBA) represses gene expression,4.403413750665232,3.1312214792612,0.3012475178972396,8.867037897415232,18.052054151636074,15.243963810955025,4.4029314333586935,4.468808236295845,4.29933337201034,14.83019114252098,20.31208278966064,5.583069345193159
"TICAM1,TRAF6-dependent induction of TAK1 complex",4.3986578174964945,9.018188282271813,0.3012475178972396,2.1230555431266462,3.6491509460172407,2.630977116574165,0.38184580897824194,4.037358339635304,2.892172765544207,5.0838974480174945,5.19170707855584,4.873956741226904
Defective SLC40A1 causes hemochromatosis 4 (HFE4) (macrophages),4.354425404362204,37.04879781184559,0.3012475178972396,0.7217612258813725,15.47434373748263,3.098988900479128,3.0658091763823085,6.364669047824525,2.5142155007631675,1.3177113717451967,4.605498327062162,3.5438868590961228
Defective CP causes aceruloplasminemia (ACERULOP),4.354425404362204,37.04879781184559,0.3012475178972396,0.7217612258813725,15.47434373748263,3.098988900479128,3.0658091763823085,6.364669047824525,2.5142155007631675,1.3177113717451967,4.605498327062162,3.5438868590961228
Regulation of TP53 Activity through Association with Co-factors,4.354425404362204,27.716138395621346,0.3012475178972396,3.4799658762606693,1.1145350275787966,0.48007651791765943,1.588351231211051,1.8055201275756878,0.4758109141160626,6.354407467853834,3.0680405287075825,1.291815822243325
Synthesis of pyrophosphates in the cytosol,4.349699798020917,14.393743870562515,0.3012475178972396,3.7234898418824742,0.5807873718134017,0.42319619867377095,4.41716089762113,0.40195893898727175,1.9340904587653742,6.849112848011781,4.10485827308369,3.875253935739135
Signaling by high-kinase activity BRAF mutants,4.312662302358372,2.4468516838978083,0.3012475178972396,5.328546264910748,2.3708761395803806,0.3150205438701655,2.229788897475201,0.6781709313559946,4.721058003480778,13.427890596806305,12.228589587062762,4.660947211153082
Nephrin family interactions,4.278268165720776,7.951865986939991,0.3012475178972396,0.7484902672448384,8.066301651197044,9.528224753531626,7.274657217019862,10.053449962247656,4.213710125580494,10.624602359233597,4.831725494299326,6.988121076659743
Loss of MECP2 binding ability to 5mC-DNA,4.2612579082828645,1.1333303178615022,0.3012475178972396,3.4317911469968982,2.6257968449597007,2.1751619561889735,1.9902793177939706,2.6461595517119467,5.084124177428059,10.204126550039597,3.8014661802724934,3.1784323150483162
The AIM2 inflammasome,4.205038922703525,15.135903989099488,0.3012475178972396,7.505942358351851,26.15007362975264,17.611899415699686,10.586810284126138,8.874813219467258,1.0968004181791646,9.800605227941741,25.397865459977144,3.448395216997091
Signaling by Interleukins,4.178431523826201,42.186803690993756,0.3012475178972396,0.8248137998072222,2.2268563345445784,10.896653096353365,17.41368638044259,13.912388573151697,0.40206732291523795,0.9387976629233695,7.725843695295941,2.7948970275483243
Biosynthesis of DPA-derived SPMs,4.159469593682764,1.060753469421097,0.3012475178972396,0.6702162765699491,2.0411488244026925,4.197719111842451,5.4357729381746855,0.34848361907692577,5.145575463083346,0.6285132884087041,3.7250189542131893,2.5322268362520233
Biosynthesis of DPAn-3 SPMs,4.159469593682764,1.060753469421097,0.3012475178972396,0.6702162765699491,2.0411488244026925,4.197719111842451,5.4357729381746855,0.34848361907692577,5.145575463083346,0.6285132884087041,3.7250189542131893,2.5322268362520233
Transcriptional activation of p53 responsive genes  ,4.145409746249815,8.745555797566064,0.3012475178972396,3.226315386272116,6.432912302268443,3.0969537286576783,0.746840217060642,3.021556039968522,0.4681717546052042,12.948981602234975,14.785768260856846,4.310353935776546
Transcriptional  activation of  cell cycle inhibitor p21 ,4.145409746249815,8.745555797566064,0.3012475178972396,3.226315386272116,6.432912302268443,3.0969537286576783,0.746840217060642,3.021556039968522,0.4681717546052042,12.948981602234975,14.785768260856846,4.310353935776546
GPCR ligand binding,4.124112176808777,8.735833814557319,0.3012475178972396,4.079390476229318,4.7545497919020425,1.4971188524343506,7.287930054303828,0.33802669815112674,10.885638794001617,14.717475113474329,27.604684844505723,5.776895853230331
Rab regulation of trafficking,4.124112176808777,2.987428013578239,0.3012475178972396,3.9817293553297906,3.049195622097393,2.3783193118476946,1.0693217737179745,2.401786406938695,2.372370115259703,13.095663859296986,11.328636447995596,9.08054546234365
Phase 4 - resting membrane potential,4.078521196892261,40.20329631236282,0.3012475178972396,7.615913350023025,4.129950652317449,0.463738738926836,14.708105602077813,9.561823870171715,4.503012493844699,20.143931221047534,15.148281323191283,1.9766668493848343
Calcineurin activates NFAT,4.045173951215924,0.4276912433948635,0.3012475178972396,5.104937120507207,3.0500999207652244,5.922026641265633,1.9676227774999062,5.441908582804409,3.09546114135962,3.138759003489791,0.3150880536045712,2.0544698924704323
Negative regulation of the PI3K/AKT network,4.031076145306412,29.273429518069385,0.3012475178972396,3.685601138647444,5.587232251498259,1.8318165565151037,17.10263316479364,0.7674109521911034,11.793318421054705,19.079158127761154,35.76572696490992,4.006292051030895
Erythropoietin activates RAS,3.9765592097906604,14.3394665052968,0.3012475178972396,5.931090657593121,6.071031183585251,0.33281605844413764,3.9421785543219325,2.8362595748049593,9.240465405057158,16.198683989427984,26.280604135098493,5.318316730946807
PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1,3.946037702889103,7.504631136402356,0.3012475178972396,1.5012918679244571,2.779493747798031,1.7394336478333015,0.4655232460136767,3.3676911866376664,2.58902432013086,3.5788995566886386,3.7615033685944916,4.565428673499759
Toll Like Receptor 3 (TLR3) Cascade,3.932133584669445,1.3258668099801532,0.3012475178972396,3.377646703824575,5.748872724070807,2.620732974320727,2.3526586897559474,3.8213827961519926,1.9147588377797902,9.363385775957605,8.540913267385259,7.678933002512878
TGFBR1 KD Mutants in Cancer,3.9232230728726702,18.14891698661775,0.3012475178972396,0.7945106987505498,18.158474830878173,7.190076027104024,11.744336078103878,22.035675151478497,4.337484164388285,4.093616375443834,14.18734014391187,5.601823868042512
SMAD2/3 Phosphorylation Motif Mutants in Cancer,3.9232230728726702,18.14891698661775,0.3012475178972396,0.7945106987505498,18.158474830878173,7.190076027104024,11.744336078103878,22.035675151478497,4.337484164388285,4.093616375443834,14.18734014391187,5.601823868042512
Ketone body metabolism,3.921126010984455,1.4255186179077963,0.3012475178972396,4.364160845547427,2.643585924840784,0.44220213081998194,1.9568591720223982,1.0163313781421364,1.278760525492299,8.47001172950725,12.155588367417153,1.0734794129373524
Serine biosynthesis,3.860434563702266,52.12603718254019,0.3012475178972396,5.5816115869049785,9.540101309238782,1.1936292864321352,18.38780959933681,15.781879116999827,8.41342752674631,23.3847121838649,26.611136494364587,0.4365743784257817
Relaxin receptors,3.851361191723336,6.130998572342262,0.3012475178972396,3.7837923964666094,9.691378504533098,7.741657007182334,7.619646214626533,5.7551138641922845,4.648324731297712,6.1747410115857875,8.988349133179488,4.922167829035783
Integrin cell surface interactions,3.846957571666419,4.7809744804085605,0.3012475178972396,1.124967738456853,8.114231340595488,6.0945255950318025,5.991766938361322,3.8829387940337496,0.4802379684846844,0.4425474556428032,0.35218141261345465,3.0370313683845933
CD209 (DC-SIGN) signaling,3.837902352570466,17.53002205117427,0.3012475178972396,4.98558731873425,2.8844869521644156,2.254238371385502,6.864960535570211,0.9752934608115079,9.245447789985784,12.69788069783532,22.582481173886126,4.678180153329861
SUMOylation of transcription factors,3.7664071866417306,20.45433875760677,0.3012475178972396,0.8995033433576234,2.785814388860396,0.7207678043881715,0.39785581594280006,0.3577172459255151,1.434086180096143,1.101207683827213,6.086563696336701,1.3795582580279435
Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives,3.7459708902179245,1.3944252973373614,0.3012475178972396,0.4810657167715628,2.5285459695140236,4.992609637802373,6.281018031022614,0.4209421820323787,4.717638564254144,0.8247460501192269,3.1266081756971413,2.2432493741953183
Estrogen-stimulated signaling through PRKCZ,3.6708854546928955,1.9618859355295142,0.3012475178972396,4.861343446617889,5.274586014288772,1.6702167581667084,0.8377686745837446,4.334701952294068,7.12039239222719,16.84259783799537,14.739153832809823,6.6246536557422155
Cysteine formation from homocysteine,3.653002899858039,36.75859454935825,0.3012475178972396,0.4463263059453818,0.8838228786555882,0.35468228151250936,7.682171368782137,11.219500885004566,3.43277961432232,0.5366234176155913,1.360713859797819,9.10527988767928
IRAK2 mediated activation of TAK1 complex,3.626142798866577,9.441737780268603,0.3012475178972396,1.6945193093721767,2.700104307850137,2.035247559120945,0.5517062052397402,3.682207233746388,2.343277930703032,4.04834164047236,3.86371865132675,4.478065730435782
Activation of the phototransduction cascade,3.6196369830720427,5.015420084474774,0.3012475178972396,6.38056567634701,11.31406555268619,6.4623090659576565,3.4053358844202357,0.973868073872463,3.348449689449902,13.83346050606825,21.820315935312152,6.173942377812518
G alpha (i) signalling events,3.5772282148685663,36.92950508186463,0.3012475178972396,1.2579825794559472,1.515487087391444,10.534300625636323,18.231281211112382,16.150921722471367,0.4394734221635353,1.6430140307578862,8.107927605630518,3.0616958811912247
AMPK inhibits chREBP transcriptional activation activity,3.566302351003021,19.995837179828445,0.3012475178972396,3.6391629259882556,14.960011564380991,11.830336124215227,17.275031888760388,20.289007792324508,3.6153565286509015,3.035043933642359,8.79479471282758,4.889055188690122
Signalling to ERK5,3.562090632686767,14.615083304137338,0.3012475178972396,1.5162209812863785,1.736033518341332,0.8717396208109319,4.657140591920401,10.139785714915925,0.8823921744874441,0.433391053188273,1.887632058684983,2.691609378986069
Regulation of necroptotic cell death,3.5489626234218083,3.8327651437997035,0.3012475178972396,3.128268742383115,1.1633958027819276,3.7265863053810087,1.9609569713627955,1.2472685194129849,4.775536014233933,1.0585589974417131,1.4592970913473977,1.2731764356691084
IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation,3.5447628580233905,10.234203302727794,0.3012475178972396,1.2506945900222068,1.325897381160874,1.3096222389083423,0.36461705140875755,2.202028946513444,2.6017638673651065,1.9595584359682419,0.7690167356258772,2.676064543010231
IRAK1 recruits IKK complex,3.542791595033897,10.239352251953958,0.3012475178972396,1.2489949108087108,1.3263790562414444,1.309079929829074,0.36461705140875755,2.202028946513444,2.6017638673651065,1.9605769337965429,0.7692910971767829,2.6776523024094048
TRIF-mediated programmed cell death,3.5319262460755283,0.7885940560847016,0.3012475178972396,1.9871945223465715,3.061141643791595,2.803563436257519,5.483471358956239,1.132199945323976,5.379559514648788,8.349794846069774,21.195652524313456,5.74103133434684
Interconversion of polyamines,3.529959277423003,30.387814756748107,0.3012475178972396,2.0819854280926053,0.7492742336974595,3.198481173568908,15.569698967414201,10.222217916144718,1.663221756059678,4.7949234205819895,6.718530352381157,0.3698732570902938
Endosomal Sorting Complex Required For Transport (ESCRT),3.512467384930054,0.4428591722742109,0.3012475178972396,9.132172360941777,13.21217714855699,9.21252342196244,1.6612349658822465,0.7700312484671548,8.679387294126023,9.182288899224929,10.021080936108907,1.3091820690041782
Budding and maturation of HIV virion,3.4884003639589265,0.396598267016936,0.3012475178972396,6.621022374018161,6.626779313257872,4.325935041405316,3.0977725459723766,0.863342321771473,6.131999215984133,6.41475113015858,6.0007414660169855,0.48584883291858766
IRAK4 deficiency (TLR5),3.455638177418111,10.881016593682682,0.3012475178972396,2.1278455197108173,5.4384032719118345,6.896207122174695,13.312200969464467,8.04183784578148,0.388855978363235,3.359991015449838,2.1928238007153524,1.5205474284950482
Activation of AMPA receptors,3.438353906942334,13.619203597877394,0.3012475178972396,0.35899598419706996,2.1778041846810665,1.1860233026083082,6.549695036641128,14.301638209768262,4.886357220589655,0.7515825446177115,0.6052255130150133,5.921577487226884
Fibronectin matrix formation,3.4189356550127044,2.04221860106692,0.3012475178972396,3.8015689326510325,1.5227268268611494,0.7740157060132759,4.849360791327332,3.6219644351788647,0.6967227967412015,4.120935595236854,7.299089117850655,2.338863685540639
NOTCH2 intracellular domain regulates transcription,3.406109075782046,2.254389335128623,0.3012475178972396,2.9622465920588374,5.5993060728512285,0.6026034534286827,4.304036119779795,2.220156787959927,1.7118109238103603,5.695801546764386,15.689666952824068,1.4727801657179773
DAP12 interactions,3.361051306021569,6.611204837557636,0.3012475178972396,3.3839897098603435,6.475301520762146,1.199286869564728,6.901257606459307,0.9559242810983889,8.181961275379066,16.548714012656795,35.92671068156081,4.346625424787533
Defective AVP does not bind AVPR2 and causes neurohypophyseal diabetes insipidus (NDI),3.361051306021569,12.18996217458255,0.3012475178972396,1.8080841152868001,1.5338591619129904,4.240686198472926,6.034089430865325,8.951871976288913,2.1700549525057604,0.6347214300972481,1.4361735015566715,2.153907910985549
Autophagy,3.359143392370844,10.597339308154387,0.3012475178972396,6.32325372850866,5.289930054744513,8.043168134155533,1.5276798836866345,0.7307378521036487,5.375874919102136,1.6220512464631918,1.9871819619486457,0.9993591080020873
CREB phosphorylation,3.3442884942611117,1.8764489793088104,0.3012475178972396,0.5627134894125099,0.8741266089139637,1.958434084869027,1.4490623977368864,1.8686676474101362,1.0570058164006473,1.093000883142742,2.660553114850333,1.2710307713097617
Activated NTRK2 signals through RAS,3.340231892477454,4.638874280293528,0.3012475178972396,4.763138829386046,3.859430457616148,0.8763709535374762,0.3972342793825911,2.5416486389517936,6.169796700209719,10.865241324474683,10.294550562778966,5.175594518849402
Constitutive Signaling by Aberrant PI3K in Cancer,3.338331168368921,42.43057421616164,0.3012475178972396,1.196444175489313,3.0826339421275937,15.558349858798083,24.95084709447006,22.017842895179314,0.8488892049715284,0.6916024946680577,6.4444194178896455,4.584939866612444
SUMOylation of transcription cofactors,3.336431060043633,5.918727458851444,0.3012475178972396,2.0746498827441884,0.7681850469938996,2.4417609579722166,1.438001783817008,4.472283605781483,1.8311504460840324,0.4538526473226573,0.40998851553426996,2.7544552596142116
Alternative complement activation,3.3151960147773725,0.662271507102261,0.3012475178972396,14.443431683091168,46.569779585616374,17.699958218703866,0.6325026672157157,8.002163252533116,4.176436267337281,34.623072919481466,54.689009220468826,9.448926280845134
CD28 co-stimulation,3.2641891174630144,7.801293540918169,0.3012475178972396,4.391354637579095,6.681328289597185,0.8689385447884785,4.463070606278734,2.3221358002429833,9.063483254357923,18.70598073620416,29.039911202786136,5.809796667751943
RIP-mediated NFkB activation via ZBP1,3.2305124583748244,17.233357337259875,0.3012475178972396,0.3229418407335616,2.8987796509562243,1.234103450200295,1.1769744709754795,1.6969409700934661,1.6254167483149258,1.9472701936680519,2.8482231598051806,1.146251276437815
Regulation of TP53 Activity through Acetylation,3.2286506426238795,1.727746695707924,0.3012475178972396,1.4438905606679522,2.347184593161126,4.201715994247431,0.9205952281683628,1.1229520748928918,1.9844304612430235,2.2734570271690626,0.6861580411012101,0.6992211345249589
Beta-oxidation of very long chain fatty acids,3.2225650648313846,27.56200360563412,0.3012475178972396,6.032934168526398,17.528273727566972,1.6434653919583335,4.77528854486021,1.3819284718608356,1.6956807947855022,21.804940905486646,30.763308594997923,3.010273349421286
Signaling by FGFR4 in disease,3.220706002566594,4.81979338768436,0.3012475178972396,3.8417676231618025,3.1469555518582863,0.8924537464315377,0.5703178884863153,4.338372975089395,4.897378752034508,9.70484194010533,7.771185230313193,4.216033063910806
Cargo concentration in the ER,3.189383507628497,0.5892870559206976,0.3012475178972396,2.3907002729524356,1.9806475253004867,1.38328836648823,1.0195397080960436,0.36541535910443373,1.5445208188362953,0.32908476554435784,0.4173882700603706,0.6678348950006414
TP53 Regulates Transcription of Caspase Activators and Caspases,3.1707727987509764,16.792982753983985,0.3012475178972396,2.0071153721338164,3.7721333111287874,10.611051021727498,11.102181455671813,5.586702653975018,0.9252831262557655,0.46558013040657037,1.1949036130015995,1.3318050165648183
Release of Hh-Np from the secreting cell,3.150389794766306,27.246402895017642,0.3012475178972396,6.38056567634701,17.640042608359504,6.494003369140536,3.671033274980746,2.967897677594524,4.320144218125514,19.72526676680372,17.084702454759146,3.200451530062037
Activation and oligomerization of BAK protein,3.150389794766306,11.552326376205986,0.3012475178972396,1.4420203475936455,0.5078429898881202,0.3769561677750195,2.3700820298607006,4.859224747088093,2.5066691475310376,1.5084077132490346,1.1803214036083431,3.5438868590961228
Interleukin-21 signaling,3.142307964483861,16.845540413593046,0.3012475178972396,0.39449190332303546,0.5552743751985598,5.837114696790882,11.41224794396224,7.290362972518409,1.0845624760839352,0.8440038689235282,13.745836985479652,3.540361028018053
Syndecan interactions,3.1409794884891533,6.658413431224255,0.3012475178972396,6.768292372377306,32.668661460905426,17.62037241018473,12.58651846807562,28.946374590810997,7.156744596024656,9.363385775957605,15.794539402031402,6.145173686009616
Ficolins bind to repetitive carbohydrate structures on the target cell surface,3.1409794884891533,4.698494274178134,0.3012475178972396,2.3466561026973034,2.473303227479564,5.474509317050671,4.423847578567527,5.761724381754734,1.458326463636192,1.2839165082507398,0.6496598166713152,0.9353515643165776
Innate Immune System,3.1409794884891533,35.832015713689266,0.3012475178972396,0.8235433398815328,1.6953692524730033,10.167687185221777,16.835761673885575,13.83354872697266,0.7501885729115992,1.8622933243254334,10.029082858652643,1.827126925285712
Mitochondrial iron-sulfur cluster biogenesis,3.130834715701363,3.744969940718069,0.3012475178972396,1.552703295767875,3.50698892690671,2.614001542706471,0.4353818054517282,0.5972566893821579,3.3841864402720847,1.8776971809020588,1.515728372870624,0.4265979652412558
TRP channels,3.129008437188696,0.40575632047677834,0.3012475178972396,4.592478248417629,3.6613978584502394,0.7849707694845611,3.1738200559698266,1.3968348433713085,11.205914336942682,5.213141278510931,8.756808591767165,2.348335808171457
N-glycan trimming and elongation in the cis-Golgi,3.102329468332375,1.5102370766731539,0.3012475178972396,4.060624016080661,6.442783436990824,8.259194768689445,3.470997790416108,1.439007447288995,1.877685082378206,4.627674568498121,2.7222934386196282,2.5523720295313557
Regulation of innate immune responses to cytosolic DNA,2.994118857843272,3.324309735043284,0.3012475178972396,3.699230606801359,3.3214333987279954,1.4041268450127624,2.6924486215749766,4.2616902878973,3.7688523990836678,3.901372278960801,7.027299137864501,3.85073559577701
TYSND1 cleaves peroxisomal proteins,2.990317816705338,32.484248412871715,0.3012475178972396,1.0950303000254884,4.605193697663259,0.36425784448272847,4.331874604867737,9.834524286681681,4.099026505795333,1.1768944521176832,2.7420783923355048,5.305449522109236
Signalling to RAS,2.9582677915007562,15.175347051140001,0.3012475178972396,0.805810162664483,3.2788130005746847,6.062065318803667,3.5652457836170672,5.374262324089099,0.515307483573914,0.7788619494814033,0.37211379100542286,0.5452278971295038
MAP3K8 (TPL2)-dependent MAPK1/3 activation,2.924411345666286,27.75146930645442,0.3012475178972396,6.788081165249576,5.902240650295034,0.41172043624238946,14.720889189240557,5.284901255793061,7.489323491961671,12.303737015011562,11.719517066719963,0.9410264407873843
Regulation of MECP2 expression and activity,2.851185697978728,37.55409724741956,0.3012475178972396,0.5874951228941296,2.5220244563353247,2.5473763469028365,10.515845455295779,23.092275677366942,0.4842666545801072,2.347003147530311,0.4027949429849831,1.0609189125911507
Defensins,2.843553940335948,2.759978333724112,0.3012475178972396,2.85631052299635,9.559097829930513,6.164627230299434,1.0561214620020971,6.221163087570823,6.064667775918633,4.531559730062355,6.896643999673372,3.598687873049395
The IPAF inflammasome,2.8398672130790463,22.712176866271644,0.3012475178972396,2.210754717949753,7.170196280502538,13.21475775456746,11.389761250104078,6.777108265490782,0.3372151242944347,0.9882202018633375,0.48372013398559216,2.4742327464791507
Interaction With Cumulus Cells And The Zona Pellucida,2.8224413611597643,1.3150542206741256,0.3012475178972396,2.6255717190624517,1.8592753390226402,0.4524994634839798,5.495124704143693,4.7343923776102335,2.318620319637855,4.143635153644256,4.137762178673214,0.8938992208891754
RNA Pol II CTD phosphorylation and interaction with CE,2.811438805395209,31.379384538006903,0.3012475178972396,1.6677938151382714,2.462546521399344,0.8892910099782777,4.207248920204058,9.759856350402535,2.28056281869707,3.9858428049261914,5.4684399544222435,9.90319689153379
RNA Pol II CTD phosphorylation and interaction with CE during HIV infection,2.811438805395209,31.379384538006903,0.3012475178972396,1.6677938151382714,2.462546521399344,0.8892910099782777,4.207248920204058,9.759856350402535,2.28056281869707,3.9858428049261914,5.4684399544222435,9.90319689153379
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,2.811438805395209,25.065927863180768,0.3012475178972396,0.8640514990113332,1.2475425735737729,11.054376983307861,15.146323100492054,8.183708337985085,1.0598944158251138,0.9496871439378286,12.529241284195686,2.7932656835135097
Defective B3GALT6 causes EDSP2 and SEMDJL1,2.7999652416389864,5.736233111273243,0.3012475178972396,4.3452291237677,31.100079520232477,17.665443403025243,16.90815842533134,28.315860996537953,7.938078187219759,11.204462532312254,15.386733214504337,5.623107658606392
Biosynthesis of E-series 18(S)-resolvins,2.769087302802381,2.613184452259554,0.3012475178972396,0.367834884370966,3.1895284778545823,6.561209676279054,7.559454133921272,0.44454606614726366,3.052792823365547,1.1531533266016292,2.47172098149423,1.617208635977726
HIV Life Cycle,2.7422584148377105,20.423483309020337,0.3012475178972396,0.6509752874098682,0.5711541487635795,0.3294652795039696,4.487811052120833,8.14556665565146,0.88495422388452,2.594918383067741,3.805025072295911,9.115723368265904
Biosynthesis of DPAn-3-derived protectins and resolvins,2.7367236046376187,1.9130612590922704,0.3012475178972396,0.3051660627462829,3.5494977718377183,5.990761444009763,6.833697230213949,0.8333148036560798,3.57534267499501,1.3409784062446524,2.1680536348075776,1.4230355202515375
Activation of AMPK downstream of NMDARs,2.6453646382135583,54.90898972043035,0.3012475178972396,0.5967304117531753,10.600124430169286,2.6938542178523477,26.749201742970143,35.45601051210758,0.970033644716356,14.44303568985565,22.211407455802558,1.4558446013811155
Biosynthesis of protectin and resolvin conjugates in tissue regeneration (PCTR and RCTR),2.632398055444535,0.4096267441305651,0.3012475178972396,3.147530646739859,6.22646014709109,3.464771001101598,0.8400670887644978,1.4509026709027883,2.4947039786228316,5.270916920524273,4.517926641620605,2.4122948744826354
Biosynthesis of D-series resolvins,2.600706713938507,2.8049661553120875,0.3012475178972396,0.4327847298492564,3.515213729005336,7.144443054836934,8.208965135711173,0.5591434170815417,2.892172765544207,1.2680482004601952,2.2135492767932257,1.4777424298242237
COPII-mediated vesicle transport,2.597211110391983,0.42369694583745066,0.3012475178972396,2.8227792095519453,5.931847448204355,4.5277753384076425,0.690301264862849,0.6487364552109035,1.6552835595717694,1.2785171443265908,3.1836802912291113,0.3497668618446694
Biosynthesis of E-series 18(R)-resolvins,2.580651060805311,3.2299669507474915,0.3012475178972396,0.45430158487232153,3.593064110500911,6.725763525472525,6.816290143832438,0.5489120234058222,3.2093766851965597,1.3100116790914897,2.1128631277568886,1.3648677046598154
Synthesis of Lipoxins (LX),2.55858290232438,1.0715007391403202,0.3012475178972396,0.7664909997606808,7.409820140741791,9.9947396590963,8.893974572263255,1.0209679127863283,2.5839890042201383,2.4593789502450076,1.1366902615564174,2.103169707365116
"POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation",2.5384691144815816,5.002701408734446,0.3012475178972396,2.840946003964682,3.1687898249852173,1.3605828580788855,1.32660889691302,3.2383098624269295,1.8625844723070735,1.5404409809149189,2.4404583960321466,4.648735096605675
"Defective CHST14 causes EDS, musculocontractural type",2.525806428844995,0.7748181004273113,0.3012475178972396,3.5632678307077432,34.03920562761515,23.06431981115478,13.544462758409926,15.590616337046727,6.29344580817068,9.136133279190823,12.127457541916234,2.703517799846977
Amino acid transport across the plasma membrane,2.5242121388375547,52.813802942083555,0.3012475178972396,0.8918388856865633,2.9139892899650346,2.561798472812773,19.996080405109446,16.799236670349483,0.5519697465154675,8.083802180661703,7.981087446074693,2.9014456750095885
Regulation of pyruvate dehydrogenase (PDH) complex,2.48779109365806,15.205123919019215,0.3012475178972396,0.3700228134729038,0.31768410736855385,1.1363200003080505,0.3557159790491058,2.432474077308709,1.7058108494890722,0.6351317544799105,0.9233677420778483,0.9184608821298902
Biosynthesis of DPAn-3-derived maresins,2.4661807916327523,2.2229574832857755,0.3012475178972396,0.40306702094000024,3.998925763151687,6.727420434905084,7.536213196418448,1.0818270690178837,3.324573980212389,1.590355008948439,1.842041196900484,1.2643789586308047
IRAK4 deficiency (TLR2/4),2.457352055562424,9.415991104836086,0.3012475178972396,0.8744366153371718,2.0696224645294534,2.7526298667593867,7.946109138750271,0.6720852039099402,6.4408284060408,5.183302602758964,16.213112360939085,3.4256814405055875
Biosynthesis of DPAn-3-derived 13-series resolvins,2.4557856505787012,2.2220184072251095,0.3012475178972396,0.4037822566188908,4.016533774675428,6.7369872454302175,7.563635928076387,1.0833619034863657,3.317230581305443,1.5912334361516867,1.8317935738854552,1.2587005546025032
TWIK-related alkaline pH activated K+ channel (TALK),2.4415563301277348,1.301086929328078,0.3012475178972396,1.9673905413922537,1.4601251045690429,0.5505933426488051,0.4126542106383931,0.3621924381716981,3.2590301649605213,2.3924804605788355,0.7347202527385814,2.70032380113675
Biosynthesis of aspirin-triggered D-series resolvins,2.4201787636235714,3.57975530759113,0.3012475178972396,0.5370555209024361,3.982289820804234,7.430392677113745,7.493317746873801,0.6878082565232784,2.987483781023722,1.4649755655432541,1.880437671290238,1.215005383057438
Linoleic acid (LA) metabolism,2.411446629967838,24.320192416618234,0.3012475178972396,0.4888909769801218,5.501770248144602,0.4008776831482095,8.529304609162425,14.459878451597696,0.7849278942711524,2.5348589372316077,3.85142731426596,3.419617259367189
RNA Polymerase I Transcription Initiation,2.397366312165123,23.54264292507374,0.3012475178972396,1.2244604652126176,3.0500999207652244,0.39384011031252697,2.3127055466924835,10.16091577325816,0.7107162581743494,3.3785266456979626,11.130022807869773,11.12859038378643
Mitochondrial transcription initiation,2.3815521842920404,20.754521405472627,0.3012475178972396,3.0251937684911168,7.740332209406445,0.7327352788043476,1.2809785846915676,4.994342156543002,1.1501320204232595,4.024050309754799,10.002947440740348,3.5686855901187573
FasL/ CD95L signaling,2.367818509277152,3.555396618420304,0.3012475178972396,6.837842404758023,1.2323241870287678,2.7571673415456024,8.827086813602204,0.3439401523698579,5.9209610865840085,6.209971649467406,8.771662244903892,2.6932028783507382
EPH-Ephrin signaling,2.367818509277152,16.393956395418744,0.3012475178972396,0.6638953016752591,2.0242665696579345,6.483084277748336,10.765657972166455,7.228594057829072,0.5230771823447798,1.0782173278673932,2.9889848214136405,0.8876822821009359
Acrosome Reaction and Sperm:Oocyte Membrane Binding,2.3556563586525097,3.147422458842039,0.3012475178972396,2.049648527223822,6.68991522873806,5.71868999883513,2.197010309979789,1.6461790193375472,3.22354225395173,4.9855580920752365,5.087723531732191,3.3372494531568773
Heme biosynthesis,2.343775612462299,15.168981473516968,0.3012475178972396,0.9602096980219182,0.36597655554335673,2.7929362344829047,5.109212622003939,3.7104804872091783,0.4741763473266136,0.32414460907490683,5.308254485174482,0.863381901085219
MyD88 deficiency (TLR2/4),2.343775612462299,9.701841234936957,0.3012475178972396,0.806833641905566,2.0276773581242757,2.959194200577082,7.950747282405843,0.6232569277139596,6.2423400275139285,5.130367643954523,16.331479934293966,3.373984253925335
"Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2",2.296645955431782,19.995837179828445,0.3012475178972396,1.0586792340020492,3.0255440107841864,8.859628346664852,4.089906452778408,0.49276489637911286,0.8538828722682756,3.49717023401388,0.5945461482538253,6.7330076393764315
Translation,2.2864367020030767,3.806112969596856,0.3012475178972396,1.7987058543663907,5.588572446573068,2.4375383455833273,0.7689217846282588,0.5716316477389709,0.9797232347065534,1.3262059553820755,1.5107205242990673,1.6672187119257582
Ribosomal scanning and start codon recognition,2.269317469181502,0.6349909779860585,0.3012475178972396,1.7733718686535493,0.4385703691621628,0.36425784448272847,1.6109178316821877,4.298238782527112,2.158858736772331,1.420129493650124,2.095185458845957,2.2562913570641596
Collagen biosynthesis and modifying enzymes,2.253998029227847,0.38405096668641986,0.3012475178972396,0.6109895454656693,8.852919855449347,6.525782595857296,7.325412288956936,6.409648714182206,0.48780989895823684,0.5240895916737278,0.6679505545311171,1.1594464392557426
Neurotoxicity of clostridium toxins,2.2404582874909713,16.29072821837095,0.3012475178972396,2.407467358511517,6.273512837483228,1.3255388112419833,1.5063740714689524,4.135206707272365,0.5205484625994711,2.6109226648004706,2.743951626500781,5.639167619163025
"Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S",2.2286803971454168,0.5973404799439845,0.3012475178972396,1.7824250063980618,0.44707850509029395,0.37325505950441623,1.5973195834310183,4.231128630365006,2.2497027737864106,1.4089609573439168,2.0787300678472618,2.168267227247159
CS/DS degradation,2.223783263650773,4.975729123906648,0.3012475178972396,1.3977208524109943,6.777238757317632,6.803503667323865,6.6377028785969445,1.3898815451203572,0.7163446244724757,1.8742625553431076,2.584215431304147,3.94274964249414
Biosynthesis of DHA-derived sulfido conjugates,2.2208472126692973,0.6654417794196142,0.3012475178972396,2.9251011092318757,6.72488217698627,3.416114423620495,0.7117092724087634,1.2069930200253498,2.2825298303236012,5.5933161781652085,4.686628969868418,2.0345208325250645
Biosynthesis of maresin conjugates in tissue regeneration (MCTR),2.2208472126692973,0.6654417794196142,0.3012475178972396,2.9251011092318757,6.72488217698627,3.416114423620495,0.7117092724087634,1.2069930200253498,2.2825298303236012,5.5933161781652085,4.686628969868418,2.0345208325250645
Defective ABCC8 can cause hypoglycemias and hyperglycemias,2.209131104748096,23.571655102227243,0.3012475178972396,12.918911136030667,16.454885815802022,5.078757110092137,4.57330185253177,0.64451442998406,9.348253089908393,21.548634278719092,25.92797974229273,5.6499785796452535
Translation initiation complex formation,2.2059642148188843,0.5609953006590368,0.3012475178972396,1.7733718686535493,0.4542749881553498,0.3651820449702941,1.5901422046693292,4.120423455458279,2.131111971380107,1.3929371440143483,2.059199739874225,2.1189349426136044
Agmatine biosynthesis,2.192595654433082,11.420633750767195,0.3012475178972396,0.4091741806257513,6.775732393753995,3.65083058220771,1.3052426823227137,1.4594603891252813,0.7946289054014868,9.29303119501009,2.7622869519370012,0.8143363043320032
MAP2K and MAPK activation,2.150607212710743,1.5598011510836842,0.3012475178972396,2.8049399510215958,0.38922526108992056,0.9241446405105668,1.7444826281237455,1.118011186285104,2.0222400349331187,6.9169926088253115,4.186846281785542,3.079284732452477
The role of Nef in HIV-1 replication and disease pathogenesis,2.1491706680132068,9.295002826012336,0.3012475178972396,3.022225614829716,2.2261316926398518,4.164043316863571,8.349246561250682,0.31779769960107607,7.2250999877586475,9.090102600758582,27.347226717865407,3.217980305026282
Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane,2.146056564356485,3.3344225459214227,0.3012475178972396,0.7374964804276698,3.3956098095765515,0.3686926523180957,1.137959337879462,0.8893519532310749,1.4091638840483527,11.220510552853389,9.990399676600779,3.325562092092321
Complement cascade,2.1412693405608745,5.330247816562216,0.3012475178972396,4.608491433061363,8.875297381280319,2.1801545557792736,9.082777423773752,1.2545092558192046,8.513007806665083,14.328810495348172,37.86187910346312,1.6660587852374358
Phase II - Conjugation of compounds,2.128131106760106,23.087459554980686,0.3012475178972396,0.6398959008922144,2.2057182290373714,3.141668412931952,4.248371842732112,5.48845491687699,1.4198444453632735,3.9287119788610982,2.256766815548114,0.5780251657019069
Nucleobase catabolism,2.0970259692512174,46.83635238441769,0.3012475178972396,0.8463383938835128,4.604007108554241,1.5136692640280571,15.031049959772123,16.727625106225332,0.34549880806741484,9.699076579418444,24.018807372014695,0.9427745066276301
Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells,2.0970259692512174,1.1032011255255183,0.3012475178972396,0.805810162664483,0.39831205096598404,0.9112148808610868,1.7183750866743912,0.5136896660610486,1.4233381835060694,0.4138767929763022,1.9655415680925454,0.8793847029960595
Glycogen storage disease type II (GAA),2.0774539623292925,11.020402538606817,0.3012475178972396,0.6787737346650299,1.8096035217612274,1.8586762125954464,0.931856407337496,0.40451185935996387,1.157887113104742,3.4854760004884473,1.2846119296520657,2.0303008353968868
Regulation by c-FLIP,2.071598854692792,0.7909003235318082,0.3012475178972396,2.195807816152191,4.740610064504719,0.49184860238649614,0.9949144318217797,2.1173803008046432,2.1745923702319967,7.752607624383842,7.479528016069572,6.49332168666376
CASP8 activity is inhibited,2.071598854692792,0.7909003235318082,0.3012475178972396,2.195807816152191,4.740610064504719,0.49184860238649614,0.9949144318217797,2.1173803008046432,2.1745923702319967,7.752607624383842,7.479528016069572,6.49332168666376
Dimerization of procaspase-8,2.071598854692792,0.7909003235318082,0.3012475178972396,2.195807816152191,4.740610064504719,0.49184860238649614,0.9949144318217797,2.1173803008046432,2.1745923702319967,7.752607624383842,7.479528016069572,6.49332168666376
Insulin processing,2.0652712504644137,0.393254167288092,0.3012475178972396,1.2940438626942317,2.2141096826629867,2.2803166471345255,2.19235156720702,0.9937004504749475,1.3571716265413922,6.319278442943651,5.77138556072145,3.7776988465896397
"Interleukin-3, Interleukin-5 and GM-CSF signaling",2.063872367098458,15.617598849615911,0.3012475178972396,2.5440175559099236,1.4914570525787283,5.158642643674753,11.02101740946101,0.7619697248198745,7.043105000662747,6.345558279523001,25.12665366858738,0.9898321387957967
GPVI-mediated activation cascade,2.0608350677077705,3.336890904385085,0.3012475178972396,2.059527313893798,4.568137584019237,3.5515921251344955,3.3747502331863855,1.8257166422537605,2.464490531742368,1.144467485111239,1.9633906169199988,1.8696302456307117
Activated NTRK3 signals through RAS,2.05943812768125,6.443814051175086,0.3012475178972396,3.6083577290540636,2.7309102318727128,0.5704618129784867,0.47142583056079596,1.458636413500591,4.5163363323889865,8.9257803291966,8.209122846956864,3.6179568643209805
Alpha-defensins,2.018961747480538,1.6422320621192006,0.3012475178972396,1.9101750491120557,5.501770248144602,1.6374843928511573,0.6443221592430316,2.872652002306586,2.1403373545289655,4.702804245384284,4.515388041288735,2.663492905251272
Erythropoietin activates Phosphoinositide-3-kinase (PI3K),2.0175836901633426,19.158375280810038,0.3012475178972396,1.466980200769366,0.7080550971262585,5.412830116488197,11.372909309304648,0.6434665422981266,4.989854709913643,2.1660077611638293,16.17244118050662,0.5463979640148438
Multifunctional anion exchangers,1.9872008975560307,8.91988534804841,0.3012475178972396,1.8955269323441397,1.3945318348489981,2.2711393256837873,6.354088676766376,3.7373188660708707,2.4596002433402253,1.8290681966426712,2.5569712114400693,1.6635052385169276
STING mediated induction of host immune responses,1.9826306387497081,12.958726448929717,0.3012475178972396,1.0217516063198946,2.7731815869429415,1.4289076084054575,0.5366227266805761,2.5545495274892014,2.3042429759179974,0.9496871439378286,1.458061353618672,3.3967578487065797
Recycling of eIF2:GDP,1.9764668443045608,0.804645092289487,0.3012475178972396,1.979816456930297,1.3330349042121208,3.0058037286067587,1.0897916830237797,2.980400987031618,0.7195607508356302,0.7327593780699254,0.5506998251865446,0.46859059653917917
Scavenging of heme from plasma,1.9751081036517286,1.5998448103444642,0.3012475178972396,4.116246566316456,2.0696224645294534,1.9886490906141343,3.9487240388219074,0.8961539262053343,6.432381103138471,8.539798460158028,24.07926908526702,2.1980695572487945
"Formation of the ternary complex, and subsequently, the 43S complex",1.9609880324409865,0.43447933437019864,0.3012475178972396,1.6385659075388856,0.5651360663825006,0.3146251381040235,1.4507487603399492,3.7746682600110075,1.964556405787376,1.2216860831337648,1.8057694896479222,1.9558756421700032
Disease,1.9598765088804924,9.873556306114061,0.3012475178972396,1.2655346308058002,1.5863674068396911,4.590066677572739,2.5933860295992797,1.0290274267992643,1.4182161084511893,0.7977243623756736,1.4312897249780852,0.3074967608899183
Activation of C3 and C5,1.9598765088804924,7.597823166886443,0.3012475178972396,9.944640881365565,40.31217777671839,12.062440163457959,1.3336973462022128,3.8555192413980754,4.5341079442431305,25.3216761285973,43.91177538145376,4.742951296690917
Regulation of TNFR1 signaling,1.9569348430113223,19.30785718045551,0.3012475178972396,0.8857830153953745,2.830788541165919,2.6052122810453193,4.151428346622864,1.3433593344305728,0.43793570107825064,2.493350713415223,0.9957926469554923,3.015655905458027
NOTCH1 Intracellular Domain Regulates Transcription,1.9460619736639788,23.15323815845658,0.3012475178972396,2.9306625346832798,1.2493685965625045,0.3287373131770217,7.098703988128743,3.839474982719594,3.1774202295749636,10.437146045687925,11.618608025291365,3.246286038078852
Beta defensins,1.935224912832413,2.070769139957548,0.3012475178972396,2.0421336731045177,7.652950688749002,6.492379028423976,1.460175462262012,4.934301192159014,4.7503794534226165,3.1728377444823357,5.105344521270767,2.686339564659711
Toll-like Receptor Cascades,1.9307283197401048,20.79315582838361,0.3012475178972396,2.287251057155986,3.451900576054711,1.6632802317587232,8.666880591482812,1.842389117175655,4.949179041405269,9.130554332583442,18.81192957498018,2.747251106173696
Degradation of GABA,1.8933155231626977,7.286964378823371,0.3012475178972396,0.3562271685112574,4.757235060433499,3.9918569786400715,7.568143714021482,11.329787275211045,0.7572946000841589,1.2673070506090218,1.228030867423831,0.9926613303514018
Endosomal/Vacuolar pathway,1.8919951759376346,22.11112854084192,0.3012475178972396,0.45191959572760865,0.7199483090559582,8.821805661349275,11.637156245743151,3.6186604089251824,0.7978719560245497,2.0864949154373496,12.118282486838753,0.9805905131353098
Pyrophosphate hydrolysis,1.882891589245324,2.4297209549146865,0.3012475178972396,1.3524792570453774,4.429552741560866,2.3155035548950793,2.9052188182114165,0.4568419033457191,3.30685978864931,7.579930597789434,4.814884311105319,1.6767703799711955
Chemokine receptors bind chemokines,1.881576098560815,20.773833982549885,0.3012475178972396,0.401426464133365,0.5558777825687578,6.641790640372153,11.614442114788261,4.988503670147506,1.628983020510118,2.9706367368406705,9.971453530659852,0.6121341505403485
Negative regulation of MET activity,1.8787080961231315,46.7952767541482,0.3012475178972396,4.981900760836681,10.843001271907852,0.7038520687389503,14.2535402794802,3.96320968374046,0.617455672423804,19.041064695158113,27.333177777343423,2.547265579995998
Intestinal saccharidase deficiencies,1.87119232468334,8.001328208061809,0.3012475178972396,1.3581000127162108,0.9382639359654456,0.3011764153086121,4.894767555092634,4.750640019081889,0.9322414046267854,0.6018615597734246,1.892515223955452,1.7668409924596193
Negative regulation of MAPK pathway,1.8590616673607405,12.58425383601723,0.3012475178972396,1.742154678196205,3.998925763151687,7.837108952803625,5.916431034845925,4.468808236295845,0.7970116073990179,0.3182766374360095,0.45428278190959515,0.718511221096784
RUNX3 Regulates Immune Response and Cell Migration,1.8469776236488773,31.063460008214186,0.3012475178972396,1.1783756242969505,0.3559860580578735,10.532156856346065,16.793122887206124,6.097042338829061,0.5879070785781927,0.7288455594231034,12.488633934465096,3.5028632505135526
Transport of organic anions,1.8441427006172957,2.5920164582604843,0.3012475178972396,0.69387885096218,1.7890330580047353,1.582907824749139,5.09772121727147,2.0033682229415914,2.2475093281727867,5.452141441558985,14.5086289287393,3.054538198038851
ER to Golgi Anterograde Transport,1.8428454164655448,0.6898905234342416,0.3012475178972396,0.6398959008922144,0.4385703691621628,0.8360849949021321,0.629507345193391,4.812303025644507,1.9778730448078068,3.7119945892026487,2.156306563734989,5.8425284144173775
phospho-PLA2 pathway,1.8140461502825873,1.9298993484642053,0.3012475178972396,0.7058063737239854,1.6914967887743109,0.6040770327609905,0.8815923230466216,0.3787183562859263,0.31692085820660215,0.5025621587664377,1.129383062532718,0.40159867663983057
TNFR1-induced proapoptotic signaling,1.8114808270248077,19.064533671090476,0.3012475178972396,1.1980955945631646,3.9914014998920795,3.301370671193848,4.6499584987257,1.503408115751461,0.8083342634835855,2.181515893947715,1.4106390413642984,2.7860028916048596
Classical Kir channels,1.8114808270248077,1.1473866274596647,0.3012475178972396,3.5632678307077432,0.7107203395341815,1.628455410622053,1.5607360715637892,3.6359559200612197,5.994966892241331,2.018893508802347,3.7567087278861178,3.448395216997091
Peroxisomal protein import,1.8089178970603055,9.030622969643707,0.3012475178972396,1.4707644302664922,5.3287995718433505,1.1363200003080505,1.7836423832880024,1.1616225724003408,0.746652852017266,3.6064667053365693,7.400203587674073,0.729302517189028
Late Phase of HIV Life Cycle,1.8089178970603055,17.032428650027708,0.3012475178972396,0.32431303269838296,0.42790596790276053,0.45267754624265805,3.4617345786302858,6.606943041230586,0.5917568859601161,1.9951920940060344,3.1600939265657217,7.403415984838768
Binding and entry of HIV virion,1.7955188965106652,13.637853503407062,0.3012475178972396,1.229969142975961,3.0928315669290694,9.001996851880058,11.524414951643141,2.78757943903901,0.5670015650111081,3.009581613225278,0.37250846595156606,1.9569313596410147
Constitutive Signaling by Overexpressed ERBB2,1.7791694986654658,6.90878170852992,0.3012475178972396,2.608212125717574,2.671636682331367,0.678899426971982,0.40605427988768567,1.1236266362740195,2.9705671427064706,8.717184553139791,7.830081152025895,3.454233716821696
TNFs bind their physiological receptors,1.765901210090959,19.697232266755954,0.3012475178972396,0.42265506052669344,2.241092066719334,12.539383585224932,15.713395818868216,7.910293545438423,1.5220708613167435,0.40263836467561076,10.48517026770253,2.656429787094116
Sperm Motility And Taxes,1.7571673469781393,11.028590677852204,0.3012475178972396,0.6531077675678498,1.5382800484952115,3.2725053633550365,0.5791407668132073,18.45533081624233,1.6415063452414695,0.5165893755565586,3.2928650003425872,0.7654151785559042
Reuptake of GABA,1.7499484960994687,7.593455602794757,0.3012475178972396,2.6810718411487744,3.0482914224832665,3.737683464615438,2.2228697514445908,1.4046106209011522,0.32990836154889125,0.48282603409107994,1.4446585247353707,0.48011344995832606
Small interfering RNA (siRNA) biogenesis,1.7472081071048116,10.91444177049455,0.3012475178972396,2.8318541993437867,12.674245629248032,0.735227548466464,2.588776450402454,0.7485491613451056,1.6254167483149258,0.9904970292547916,13.45016127625849,2.0027221399434185
Signaling by TGF-beta Receptor Complex,1.7429844061435054,32.42530397396595,0.3012475178972396,1.1445898283844893,2.241092066719334,1.4869094277007742,3.304191415552347,4.206484325981815,1.0391070194924217,2.6180835701001146,0.3123483236799608,1.1442508965527292
Synthesis of PI,1.7402510181353668,10.679696040552011,0.3012475178972396,0.7664909997606808,0.4441112509227339,3.9571041127403452,15.316272309732675,6.462667431141544,6.853686287035471,11.059665149344648,12.76793160232833,3.081019097076483
Regulation of actin dynamics for phagocytic cup formation,1.7036073111232333,19.671142445357603,0.3012475178972396,0.4091741806257513,3.7978882688988516,13.951369890498063,15.569698967414201,13.320812749352307,0.6473395585052177,1.6177935613338852,11.134261957367963,1.7849567585175623
Josephin domain DUBs,1.699448473909349,0.836987020178152,0.3012475178972396,2.187980056317115,5.938226456385042,2.536177964433466,2.9952812449334694,0.5192683930435649,2.008989362348308,3.842259742655001,8.126800821008588,4.335141013462581
GPCR downstream signalling,1.6969942846515482,16.552124053208637,0.3012475178972396,2.110358767027876,3.6713657023203172,2.1516390115389634,8.646357520072872,1.499577303174634,5.635835041076975,12.094267720847327,24.46986118047187,3.054538198038851
TWIK-releated acid-sensitive K+ channel (TASK),1.6969942846515482,1.2043107418752321,0.3012475178972396,0.6233323692619489,6.089015301809161,0.6431429484479797,1.8590920221875105,2.2226162427894005,0.4503249404124551,1.8506048664099979,2.20258891740694,1.4618284622563897
Termination of O-glycan biosynthesis,1.692845921220726,1.4613953827873118,0.3012475178972396,0.9133582160712799,6.397324078941076,1.1789457189558454,0.4274039328557554,6.381076866402746,0.49993746733707445,7.675370811342499,18.7854822523434,6.316484766916996
Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4),1.6657012331692138,1.8035620422589043,0.3012475178972396,0.8744366153371718,0.3819851280715032,1.694753421866031,5.523189927731839,0.784388459767141,3.0699727336637332,1.3723937585717627,6.205371897471222,1.4024507295372095
Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5),1.6657012331692138,1.8035620422589043,0.3012475178972396,0.8744366153371718,0.3819851280715032,1.694753421866031,5.523189927731839,0.784388459767141,3.0699727336637332,1.3723937585717627,6.205371897471222,1.4024507295372095
Regulation of signaling by CBL,1.664490557427094,28.247477866669218,0.3012475178972396,0.32078956048120666,1.2498264449984982,13.398455880819057,18.164491372264926,7.5238170324606415,1.167558742283978,0.6675070118431261,9.474091021901781,2.9165777498081185
Interleukin-35 Signalling,1.6560636368244952,21.998968863358503,0.3012475178972396,3.5662725781944418,1.2887825897160075,2.6096046915237086,7.610236843264313,0.9724442568490297,6.66405578501034,5.487117390467455,20.986824948511394,1.709869466074778
Defective CHST3 causes SEDCJD,1.6390521833158804,1.3051581990790244,0.3012475178972396,2.3008244066737156,30.52069242576365,19.110035354381235,11.910734850030014,13.751306223937412,3.756340531555427,5.456061944164453,7.557201315513221,1.3893272118265032
Global Genome Nucleotide Excision Repair (GG-NER),1.627847239656494,4.230115717421482,0.3012475178972396,1.8789743377047476,2.1992574841135712,3.1628683739241255,0.6097853860953847,0.3518174932550868,2.4367965180741358,0.8938184046732498,0.30745367919029315,0.38348919626631894
Digestion and absorption,1.6081730429290275,4.09953950359506,0.3012475178972396,1.5397540519820938,1.3435175751229675,1.4250533809052357,1.8103599921967606,1.4904026344580579,0.3338015474926859,1.7212698422154131,1.6269951863982386,1.007115086544783
Cargo trafficking to the periciliary membrane,1.6027455482778417,45.14332107587889,0.3012475178972396,0.4147059735661241,0.857869536616852,3.0706468249313406,9.177967384718043,11.047753853071312,0.9084049632324657,9.78597028950399,3.357101446660786,1.5721543055686222
Regulation of thyroid hormone activity,1.5987410925280645,0.5673752143244781,0.3012475178972396,2.3466561026973034,0.4339084865375067,0.4532502835581585,3.071206554018909,1.77503782228834,1.5865244079926901,4.395664820505113,3.4452655738636793,4.310353935776546
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells,1.5865313690437934,11.451745718036141,0.3012475178972396,0.7069399688669401,6.946375217656813,11.330224079546253,13.100130690671643,11.599530570555029,0.7443756682052496,0.3667360404875743,0.8002642068391036,0.4702519749317438
"Formation of the active cofactor, UDP-glucuronate",1.5865313690437934,4.028970357384477,0.3012475178972396,0.5608172953208168,2.36636627544932,0.4687526203611299,0.6880974174789,1.659579664753038,0.8591208184915858,0.7169500492689108,0.980305528981028,0.6767119966747702
Lysosomal oligosaccharide catabolism,1.5827867319472406,26.94361156113849,0.3012475178972396,0.34490458990955475,2.267297034230253,2.9036299521940547,2.687194261035099,1.2499234100186614,2.404705992249437,3.3187549502080143,2.224307030458724,2.556995271876867
Digestion,1.5827867319472406,3.507454635860876,0.3012475178972396,1.481217332483679,1.1451508201018126,1.147306726956536,1.547159349141423,1.3295770750343119,0.3424375539476348,1.6584410037999862,1.58946278155006,0.9777852669467498
TNFR1-mediated ceramide production,1.5788139991762207,17.903392412174835,0.3012475178972396,0.9744201199169046,3.8195618480931666,2.7611937890294085,4.099789801137264,1.0767835001634078,0.8692122163986093,1.490634567431209,1.5026813412455535,2.5457275732256517
HIV Transcription Initiation,1.5718220202803346,8.086071091376052,0.3012475178972396,1.742154678196205,1.0047113126065428,1.9189853659228866,1.1053810287652475,1.2440684542676264,1.628983020510118,0.31681127505768264,0.4668381058678431,1.1010025054947712
RNA Polymerase II Promoter Escape,1.5718220202803346,8.086071091376052,0.3012475178972396,1.742154678196205,1.0047113126065428,1.9189853659228866,1.1053810287652475,1.2440684542676264,1.628983020510118,0.31681127505768264,0.4668381058678431,1.1010025054947712
RNA Polymerase II HIV Promoter Escape,1.5718220202803346,8.086071091376052,0.3012475178972396,1.742154678196205,1.0047113126065428,1.9189853659228866,1.1053810287652475,1.2440684542676264,1.628983020510118,0.31681127505768264,0.4668381058678431,1.1010025054947712
RNA Polymerase II Transcription Initiation,1.5718220202803346,8.086071091376052,0.3012475178972396,1.742154678196205,1.0047113126065428,1.9189853659228866,1.1053810287652475,1.2440684542676264,1.628983020510118,0.31681127505768264,0.4668381058678431,1.1010025054947712
RNA Polymerase II Transcription Initiation And Promoter Clearance,1.5718220202803346,8.086071091376052,0.3012475178972396,1.742154678196205,1.0047113126065428,1.9189853659228866,1.1053810287652475,1.2440684542676264,1.628983020510118,0.31681127505768264,0.4668381058678431,1.1010025054947712
RNA Polymerase II Transcription Pre-Initiation And Promoter Opening,1.5718220202803346,8.086071091376052,0.3012475178972396,1.742154678196205,1.0047113126065428,1.9189853659228866,1.1053810287652475,1.2440684542676264,1.628983020510118,0.31681127505768264,0.4668381058678431,1.1010025054947712
Beta-oxidation of pristanoyl-CoA,1.5692629227013908,38.523089522241484,0.3012475178972396,3.1536140270881368,30.95865889950948,6.384979013940167,1.740679830817825,9.45778134739466,0.3749687645536237,18.317300006187484,35.31005204371415,2.2920819803716412
Competing endogenous RNAs (ceRNAs) regulate PTEN translation,1.5597453072391059,25.583752555709715,0.3012475178972396,0.36479471308536987,2.094613370728385,0.5365340187097434,4.210210876884197,2.5816909764834612,0.5295927555252811,2.3948151806038402,2.9794972195318508,12.563734861387749
GABA synthesis,1.5474932767393295,0.809748173799689,0.3012475178972396,1.4996143320959336,6.416110114574477,2.858012187364139,0.769999041094854,0.47211870498232444,0.5288122024519188,5.181401107039281,8.900475212153012,0.6656830139450899
Catecholamine biosynthesis,1.5215594175501748,8.187362352097725,0.3012475178972396,0.5370555209024361,1.7198848018684483,0.6909298539921329,5.793164310928924,35.25090969875484,5.179362987553712,0.6657789336294176,0.5246480382559598,5.48794497850941
Fcgamma receptor (FCGR) dependent phagocytosis,1.5122169618312042,25.84452008776346,0.3012475178972396,0.45372322874704535,3.0033879603816227,14.016840130400563,17.02981762003913,14.087726330348382,0.807240956439383,1.9792199490200817,13.09980516741598,1.8798525016896663
Intraflagellar transport,1.5097202883326992,45.43720710724095,0.3012475178972396,6.990637341422392,25.172519584981142,0.7749152642437315,13.492564305352905,2.804266688346826,9.260719283595078,33.160103081571215,50.114608783219836,3.676624669402434
Butyrophilin (BTN) family interactions,1.4949925051854553,9.929365252313168,0.3012475178972396,1.3958903758754362,4.456018809322159,3.5435708223207367,1.128923398294564,0.7880506071382388,3.402136381944604,4.179354411330687,4.824746265105165,4.150405543777926
RSK activation,1.4816996122977937,0.5508757954801244,0.3012475178972396,0.4241499231053976,0.34492455220596074,0.890449327596978,0.8775678318345342,0.9319139221270072,0.41476001908203597,0.5592939470438767,1.3778642926419729,0.4748481233343033
IKK complex recruitment mediated by RIP1,1.4738509719015587,10.051100457906808,0.3012475178972396,2.4326152323264107,4.704419690224378,0.9674471628351278,4.018539645849909,0.712541531911296,1.9625429791266018,8.550843697933132,16.88214788644814,2.962742645430948
Transcription from mitochondrial promoters,1.472738824434319,17.903392412174835,0.3012475178972396,2.3413116695280145,4.558571335845515,1.815041826919245,1.6310320492576054,3.8829387940337496,0.8015702700453958,5.113681536517098,7.053642665884797,2.5536679465899432
Na+/Cl- dependent neurotransmitter transporters,1.4542251054435364,18.62761342943711,0.3012475178972396,1.3858086011539335,4.94970790319562,2.7593089746137385,1.0693217737179745,1.4471614403091704,5.438378123633857,5.153558616950115,5.875277199277542,1.3976483305349772
RUNX3 regulates CDKN1A transcription,1.4491267393070473,39.31183567929379,0.3012475178972396,1.4256821374980995,9.939420789958406,1.7539449220349985,5.4035920765236645,1.143544566853833,4.0317835808725215,0.8843482977699019,7.6065005225344695,0.7938166095987702
TNFR1-induced NFkappaB signaling pathway,1.4469293543517523,18.05468769893776,0.3012475178972396,0.6787737346650299,2.5449148678537408,2.22989985062643,3.9918482686610948,1.164155653385188,0.3013651717804847,2.0569282883302207,0.8287464310646241,2.183833539496205
Biosynthesis of protectins,1.4469293543517523,3.436504078360177,0.3012475178972396,0.8165337150009415,0.5888283866650788,0.6755096305242398,0.35209014257922744,3.5940728645491475,1.8311504460840324,0.4944250364127547,2.892415795445584,2.70032380113675
Regulation of Complement cascade,1.4431749326148826,6.739772384194385,0.3012475178972396,3.790843121866766,6.906897423609707,2.9547251402762105,10.026259404977468,2.179502823387032,7.0565711291457776,12.516366313705827,35.277607849725946,1.0321163255363466
Melanin biosynthesis,1.4420791325289009,0.6369698306556758,0.3012475178972396,2.1230555431266462,1.414890299826668,2.958207391844759,3.6195533021589648,1.0997124773667333,1.0062340513722414,3.3269786407804336,1.741682956073474,1.6133335408147156
ALKBH3 mediated reversal of alkylation damage,1.4317181343141254,0.3176018595335896,0.3012475178972396,2.927750183745726,7.157598153163213,6.316879290495468,0.560315933640412,2.811735790605008,0.48282277705224996,4.372466617791476,1.4101487211251984,0.8912628646055588
Chondroitin sulfate biosynthesis,1.4266702259363588,2.0431037111224444,0.3012475178972396,2.7620158026255255,29.822630694593908,22.45952288449774,15.112871674953857,17.5151753571982,3.8232156662451584,6.574881001175045,8.291342123664498,1.3318050165648183
Mitochondrial ABC transporters,1.4229494279073573,0.5105392229326643,0.3012475178972396,1.7400428380582587,1.3557507675559726,11.800106893326834,9.761902779863552,6.190397308995779,1.5051334260599987,11.626694393731437,0.9890725827898372,5.0898299582471696
Intestinal absorption,1.4126732988490154,25.9058032963813,0.3012475178972396,0.4147059735661241,5.01393267054852,7.082564680479989,13.892449972880343,7.827379898997759,0.941678894369919,0.7332290295003787,0.6868568932347626,0.4830813429790308
Crosslinking of collagen fibrils,1.4050536154346263,1.3560320406131383,0.3012475178972396,0.4219096086329804,7.895637328067301,6.364667535595474,5.954191065063358,5.712183873312225,0.5587380554234609,0.949098835492482,0.8726138179121036,0.48691672177079814
Purine salvage,1.400064826330997,35.1097079027027,0.3012475178972396,0.8700085837585281,16.26548741633045,0.6423669116609417,9.266024494284645,10.268397387627642,2.404705992249437,7.152832182722529,13.316158286509177,6.266821712969907
Lipophagy,1.3976899123328823,24.52429774582045,0.3012475178972396,1.4852665092047808,0.34589226234436693,0.8405019402456871,6.229958854739951,8.156333166812935,1.3088305895122752,6.4507201113002,6.448972329443201,0.5629839349164625
Invadopodia formation,1.384935407784735,5.832864051381019,0.3012475178972396,0.6026077815262362,7.4970212597497605,12.827278456181029,15.521030346907795,9.840335456134767,1.8227432791986176,0.8577479371340805,0.678816287325807,0.37690248489995476
NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10,1.3774087446171148,3.130036608777437,0.3012475178972396,0.4327847298492564,0.8364628416144164,1.5649337106057002,0.41825015617069405,1.126103881050527,1.288810839985987,0.6486322342461397,0.51553983092451,2.168267227247159
Formation of annular gap junctions,1.3686213094387782,18.98253058466379,0.3012475178972396,4.2309750746585735,3.8657501044765348,6.809108385220564,15.804250652506813,10.404753416849863,2.1064103105593563,5.336439396970441,2.649386061485988,7.409545267555147
Glutamate Neurotransmitter Release Cycle,1.361149553921758,40.862031224027824,0.3012475178972396,1.466980200769366,3.7607160487604547,3.0793139199554274,20.2760222714843,30.44470326108222,1.1024964705508702,0.6799213731967091,5.2185737018871805,6.850972957149453
"Biosynthesis of A2E, implicated in retinal degradation",1.3511499468862689,0.5521590696373985,0.3012475178972396,0.4895203323304997,1.0162933685892244,0.7573897707884142,1.2438280804791022,3.7479325364114553,0.5661748776260738,0.6709735300158607,1.4542694238344123,1.6987934828036422
Diseases of Mismatch Repair (MMR),1.350104272804681,6.600707251228414,0.3012475178972396,4.446580178574576,3.831079486713202,1.6192190816620395,1.0693217737179745,0.5576321199460228,2.9568082654275907,4.999623815148575,8.760520831840331,0.6231865358564135
Physiological factors,1.3338164175871117,0.9994750395883801,0.3012475178972396,0.3125076248929247,2.7401743008366792,0.806853832974097,1.4011077932848475,1.1842862999586494,0.3424375539476348,0.36178028445293287,0.9721609981985152,0.4765271627282229
Regulation of IFNA signaling,1.3252012733245353,1.4910492992731654,0.3012475178972396,3.7025751801962024,3.685192498268384,0.621582910608637,4.137680637387845,0.7220634548857511,5.793658400988334,5.480952114778141,12.79927122533851,0.8678318653032746
RNA Polymerase III Transcription,1.3231393829251041,18.382083271498555,0.3012475178972396,0.8363995293104999,0.4630108088683143,2.352686929489975,4.602393495145316,1.4887292983829725,0.4427753059999315,3.8564661651587726,3.3793788706964842,0.5042247421398445
RNA Polymerase III Abortive And Retractive Initiation,1.3231393829251041,18.382083271498555,0.3012475178972396,0.8363995293104999,0.4630108088683143,2.352686929489975,4.602393495145316,1.4887292983829725,0.4427753059999315,3.8564661651587726,3.3793788706964842,0.5042247421398445
"POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation",1.3133138400528612,3.758953816034703,0.3012475178972396,2.1355464761656795,1.7466490762941242,0.8830061983718038,0.8439773884884012,1.241423067885164,1.3328639455171047,0.7276912086467785,1.2330875752461392,3.2906854007585595
Reduction of cytosolic Ca++ levels,1.2886028234382987,17.993889677148598,0.3012475178972396,0.6589115689364645,6.555190312607629,0.8846135105499094,1.0693217737179745,1.747442432186022,0.9458077590738756,4.0985609193893024,11.593741700587735,1.2205584291713216
Activated NTRK2 signals through FRS2 and FRS3,1.2789343863866434,14.627880806032847,0.3012475178972396,0.9349740050155915,0.675574542208413,1.992384470809508,2.3053720409365464,2.0079819918158446,1.3187995061083928,2.623772030350214,1.7561130005295333,0.5373929705061209
"PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases",1.2693106908634222,7.194514961051881,0.3012475178972396,2.2712275800483255,0.4526998295746673,1.4634214855889074,1.257235543925868,1.5014918799308483,3.778383089096807,5.584826648976263,6.034457145967394,3.054538198038851
Collagen degradation,1.2585088746822815,2.9194907272941837,0.3012475178972396,3.0251937684911168,24.45845579643507,16.109838291862737,12.623377240088201,21.15684464452961,3.9770834743590693,5.4829175509344905,7.281281787616784,2.9819521565366243
TBC/RABGAPs,1.2538532261931434,10.78444259650031,0.3012475178972396,1.8834116047998741,2.646531883496761,0.31754417861824313,1.233772901699133,1.1478749519782014,0.7326250170981068,15.07538983276257,12.833089607102881,4.614425011947428
RUNX2 regulates genes involved in cell migration,1.2382850526727953,14.725468267165864,0.3012475178972396,0.8491601527565791,11.642619025249537,11.719987746033263,10.119711009719873,9.72371671370374,3.7144066900793455,3.8225860941306626,4.218767595167209,2.1710389159427232
Nef and signal transduction,1.234884820192227,16.765463273543283,0.3012475178972396,0.38178290123646885,2.0165466779442,13.490430730107787,16.849986168367405,7.664241984229096,1.1356654974757936,0.763390873869528,7.709341906932671,2.134768764727602
Aryl hydrocarbon receptor signalling,1.2098884298615313,0.30968739065394485,0.3012475178972396,0.9820651437252199,1.5645645897939602,1.6251583235348421,2.2157050535844816,0.5462873397393975,1.9340904587653742,1.1374131107394387,0.4772738430002573,2.7215055639620687
Platelet Adhesion to exposed collagen,1.1982127768079787,1.4570249017386172,0.3012475178972396,1.1618618424216764,2.9317462448847698,1.5180440447009165,1.3631778354196984,0.9297335825893753,1.8562716445494205,0.7872826802725204,1.669800670922544,1.235438098466791
Tyrosine catabolism,1.1889678224166365,35.57972894562256,0.3012475178972396,0.6233323692619489,0.4196708805184354,2.0659009734916185,2.9896911736007374,0.6273836160533023,3.590421612681446,3.6407815658661,0.6652408334587445,0.9944758496258272
Biosynthesis of maresins,1.173896903866702,1.2972518021230934,0.3012475178972396,0.3566524278454312,1.9180760445652656,5.055538786954227,4.080036694240134,0.34620588225585885,2.2785967354937284,0.8549241385590463,1.5835385915756597,0.32286163346427754
Defective Mismatch Repair Associated With MSH6,1.165935410506734,2.320435527981958,0.3012475178972396,0.45430158487232153,0.9210205811007807,0.9262050739392621,2.211280985598949,2.2410872502921526,0.8118443649376598,1.3467770706846125,1.0956979922303134,2.560325249046102
"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",1.1559114269917932,35.7497086093217,0.3012475178972396,1.4871733014911057,2.314794309169905,3.8212955768683328,20.867739095003486,3.7603789781237666,8.250109654961223,13.952934858081916,27.989936918305595,1.2860594863970047
Regulation of TP53 Expression,1.1559114269917932,4.892186134933202,0.3012475178972396,1.1535565176004012,3.0143302559480265,1.8105734297637854,3.5470116188682925,0.7031084492116608,0.7371335119510435,1.8588762226549143,5.532883044974678,2.1950348363988947
Defective ABCG8 causes gallbladder disease 4 and sitosterolemia,1.1447883330119062,2.090927515076099,0.3012475178972396,0.5468776630948824,0.3136204100054477,1.8503447779948983,0.33374928936195986,0.5697265000933351,0.8039682112811436,0.6345298993148605,0.5438471075151201,0.7839071244804501
Defective ABCG5 causes sitosterolemia,1.1447883330119062,2.090927515076099,0.3012475178972396,0.5468776630948824,0.3136204100054477,1.8503447779948983,0.33374928936195986,0.5697265000933351,0.8039682112811436,0.6345298993148605,0.5438471075151201,0.7839071244804501
CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling,1.138101993586854,27.094399590234595,0.3012475178972396,1.0586792340020492,1.9806475253004867,4.443764150126849,6.054995783679224,6.09494819345044,0.8409915907791076,7.288416083972487,3.2409131745996986,0.525545610148448
Androgen biosynthesis,1.1371792358698745,35.02356362218278,0.3012475178972396,1.4034614623956436,1.5227268268611494,1.5020665120981491,8.418965388718593,16.209999540993604,2.2497027737864106,1.636462652309164,1.032646543855013,0.43993803938098675
Collagen formation,1.1328137421458804,2.965687603166356,0.3012475178972396,0.3087506665224417,10.44760542978856,8.625691171474665,9.856349786178226,11.041565999186455,0.8083342634835855,0.899869827680443,1.0310909456664907,0.3308833211104649
RAS signaling downstream of NF1 loss-of-function variants,1.1206949575867373,19.345407514143794,0.3012475178972396,0.5608172953208168,1.2624237258553377,3.40718561826444,3.165842039674244,1.2440684542676264,1.1868222690604289,2.307062553542606,2.47172098149423,0.3345965215042242
PPARA activates gene expression,1.1206949575867373,9.686277446638876,0.3012475178972396,2.00224858386025,3.1572741749075206,0.4244881744139253,1.9882104379378833,0.5908732218970341,2.497044284312503,8.062380616801512,9.186194444700847,2.410810050231098
Synthesis of 5-eicosatetraenoic acids,1.11205688783331,6.249455392209464,0.3012475178972396,1.8312865499861553,10.74042522379617,14.605102507806313,10.174551147279132,3.032326795149299,1.458326463636192,4.007359146158148,0.36077559742551824,0.6745392670734899
MET activates RAS signaling,1.11205688783331,2.004147902368242,0.3012475178972396,1.0217516063198946,0.8606864813012644,0.877741558745567,1.2187865995653486,0.6720852039099402,2.889612494331547,1.8016981529797418,7.056930277976281,0.9872321850249639
TNF signaling,1.108885428849026,18.35658359798569,0.3012475178972396,0.4268333997316359,1.640734867130822,1.6359495074273767,3.2069715320022376,0.7525224771828797,0.3129757250524832,1.5341415750078673,0.43971055539726317,2.2839405271907665
RHO GTPases Activate NADPH Oxidases,1.0980564128497474,29.347753725934382,0.3012475178972396,1.8126609558182103,1.0633712444969565,5.743231277663849,15.941235788490989,10.501254589489413,3.5411043022422715,11.127357558739147,18.70032249228631,0.5814132367985828
FRS-mediated FGFR3 signaling,1.0980564128497474,8.902763345402795,0.3012475178972396,3.7025751801962024,0.9994035093954547,0.793851476143954,1.430818936764493,0.5024523568675529,3.3273595270995635,9.301627149589761,5.0168178448818095,3.7358125201833348
Interleukin-2 family signaling,1.093789107770837,14.882252672657698,0.3012475178972396,1.7149767007710364,0.7723061916422933,5.923563880695851,11.495748048133047,1.8033631369185064,6.027796513164206,3.967371383785755,20.59319898771979,0.3885174771355525
"TICAM1, RIP1-mediated IKK complex recruitment",1.0897584530567885,11.451745718036141,0.3012475178972396,0.3522134924716575,0.8215062288671535,0.7749152642437315,0.8562348923307156,0.5743448104258709,2.7913351946417446,1.0393518534281283,1.6023551306461792,0.45318732997172073
Interleukin-33 signaling,1.0897584530567885,5.321185247360153,0.3012475178972396,0.4840165225264495,2.3708761395803806,0.5790668538282213,0.3632634017527755,2.274675047117115,0.7922513155170269,0.526091597852442,1.7058025401884558,0.5739350171398189
Suppression of autophagy,1.0855127584237902,0.8850689843872438,0.3012475178972396,4.648799433541562,13.06324281749909,1.1492289274048522,0.43314753035619735,2.0366710492228606,1.1899375517015849,7.44059729097305,21.450468103213403,1.8971482354557947
RNA Polymerase III Transcription Initiation,1.0448975530879097,6.566589791091792,0.3012475178972396,2.654998125015104,0.8111264062926488,0.6651883711355472,2.005310783718704,0.5207001598699632,2.382197424068147,6.665804618991323,5.9217862167178765,3.3390728071095097
"Cobalamin (Cbl, vitamin B12) transport and metabolism",1.0375015543388404,4.125149842586541,0.3012475178972396,0.5921004743973435,2.1308092292904126,0.7719947243765569,2.103947871613372,3.439361066747269,1.3328639455171047,1.7774078368160262,7.857467981595984,1.270073839601285
Defective HLCS causes multiple carboxylase deficiency,1.0344707650255731,0.6883735428922764,0.3012475178972396,1.6634456022815578,2.5906678063123656,0.41329236828072635,1.6492124872711074,4.824530400605693,1.2973781173222236,5.788888185182133,8.511708785025549,5.80162968638279
Propionyl-CoA catabolism,1.0217328185774752,4.443401601884138,0.3012475178972396,0.5552228569599497,1.1904496731817242,1.3878760396867469,3.928822362251875,0.52213518652365,0.7326250170981068,1.392141362132714,2.587041498483256,1.0925568623615913
Intestinal hexose absorption,1.0198068990469515,9.597291436803149,0.3012475178972396,2.619863829304145,4.3473555283372916,5.974526964282821,7.479502772637198,9.786351587299391,2.5967138223681223,0.955753983084992,0.7096035607793171,2.34177613918266
Diseases of Immune System,0.9999576841472394,14.686644112524135,0.3012475178972396,0.31384002580037695,0.6355225793573613,4.787957003035801,11.401002108193788,0.7544048813098287,5.476940216323811,2.234960584989544,10.357063656699006,1.6252117326834468
Diseases associated with the TLR signaling cascade,0.9999576841472394,14.686644112524135,0.3012475178972396,0.31384002580037695,0.6355225793573613,4.787957003035801,11.401002108193788,0.7544048813098287,5.476940216323811,2.234960584989544,10.357063656699006,1.6252117326834468
GTP hydrolysis and joining of the 60S ribosomal subunit,0.987488078078361,0.3285289677823041,0.3012475178972396,1.0632393424054338,1.0181823607166067,0.40698362075531336,1.8181657536994091,2.602094270400039,1.5310874631776121,0.7576918617563779,1.1929833291981145,1.114236028408231
Cap-dependent Translation Initiation,0.9607667210578421,0.3256836292814956,0.3012475178972396,1.0814842643708649,1.0461404212670677,0.41620041195278834,1.777858022507267,2.5792385901293238,1.5501652386488978,0.7631251606162578,1.1947035334898175,1.0910730064332979
Eukaryotic Translation Initiation,0.9607667210578421,0.3256836292814956,0.3012475178972396,1.0814842643708649,1.0461404212670677,0.41620041195278834,1.777858022507267,2.5792385901293238,1.5501652386488978,0.7631251606162578,1.1947035334898175,1.0910730064332979
L13a-mediated translational silencing of Ceruloplasmin expression,0.9393782736388775,0.30956361649862585,0.3012475178972396,1.0768695705565499,1.042070182787076,0.41629961325132986,1.7918754009959743,2.5174104279178393,1.4976686819993263,0.7448080659072946,1.173480444322254,1.0413121433971595
Events associated with phagocytolytic activity of PMN cells,0.9375596345686812,1.0694358620945759,0.3012475178972396,0.8320994442288664,1.2711725614404557,0.5702205704764364,0.4688274655367909,1.1545086970813523,1.2739842103151944,1.001158163718216,3.179329607321954,0.8143363043320032
FCERI mediated MAPK activation,0.9205273836931328,6.73378096513346,0.3012475178972396,3.0251937684911168,0.7933688954423049,5.2574635858894,6.749183155358345,2.700710392220995,4.772093958450605,6.82675000685646,22.327273505378237,1.0910730064332979
HuR (ELAVL1) binds and stabilizes mRNA,0.9147071336383816,7.575454415406558,0.3012475178972396,0.9602096980219182,0.5346817356794282,2.158685015835601,1.7200116378871966,0.7572572476237841,0.36297143130542403,3.4206858202500348,2.2875957768800474,4.344484345839098
Biotin transport and metabolism,0.9019176409451616,0.3979857496058167,0.3012475178972396,1.373959495303254,2.993362175013343,0.4615538745127347,2.1778957048263834,3.683749730952155,0.8812252209823055,5.813407378527629,9.216336148236246,4.869106792869352
rRNA processing,0.900149396022194,3.8976828830984878,0.3012475178972396,0.31139009791368893,2.5139968886349995,1.0727111617787337,1.0376135467022944,0.46895535589813575,0.324426619441595,0.4160230175026146,0.37594422811179573,0.728066199430397
Transport to the Golgi and subsequent modification,0.8865033753213318,0.40398249501979,0.3012475178972396,0.3314579582248474,1.025829713229817,2.0294494030194863,0.493035254632223,2.650392794666504,1.0954365518147913,2.012752588702222,1.431786231697763,4.060870262425666
Rhesus blood group biosynthesis,0.877879585179868,1.4764095379429836,0.3012475178972396,0.9775194001077314,0.31457652104306116,0.8505298247948816,0.8222806738183512,0.45304901593939834,1.0404210635235576,0.5102496917836401,0.5685040751424373,0.3433295604591306
Formation of a pool of free 40S subunits,0.873211096285631,0.357210795303307,0.3012475178972396,1.0402287354161601,1.1361119032591958,0.4515344131602317,1.7002355078640803,2.3315993532150787,1.4233381835060694,0.6927130096248086,1.0830542928663467,0.9805905131353098
Digestion of dietary carbohydrate,0.8695328288069791,2.2789080882589556,0.3012475178972396,0.9885348274983113,0.5208609296132111,0.5984927697290736,0.818438976895251,0.46602250945082224,0.6375730280707007,0.8760460720391666,0.7810131762788274,0.40730005038301825
Peroxisomal lipid metabolism,0.8668368135523017,42.75815513520967,0.3012475178972396,0.7496744886546542,5.772603208948113,0.8339517758227949,9.345530995483514,3.884278423247701,1.5516578371004022,5.811373063337345,10.859709939157463,1.8564683916303932
ZBP1(DAI) mediated induction of type I IFNs,0.8660881731240174,8.276425504192053,0.3012475178972396,1.1856294161010579,5.209822335713991,2.8319297781945796,0.5003939262962412,0.3518174932550868,0.8061488455497576,3.8757327637646757,4.620513500640351,0.42872937817042345
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC),0.8645925367190929,0.37676120228669024,0.3012475178972396,1.0768695705565499,0.9146722534638627,0.32853333109374255,1.9923495681338925,2.5106517389074487,1.527664202615756,0.7219645910878356,1.1807413032499166,1.107264569429104
Nonsense-Mediated Decay (NMD),0.8645925367190929,0.37676120228669024,0.3012475178972396,1.0768695705565499,0.9146722534638627,0.32853333109374255,1.9923495681338925,2.5106517389074487,1.527664202615756,0.7219645910878356,1.1807413032499166,1.107264569429104
Gap junction degradation,0.857075702620272,17.59787109700212,0.3012475178972396,2.5936250010560262,1.9444344407033767,5.744740146455068,16.54715998100881,8.454815860899963,1.2464984581131857,3.073095266114566,0.7999778738072854,5.601823868042512
RNA Polymerase III Transcription Initiation From Type 3 Promoter,0.8496010920345597,3.6258965433272135,0.3012475178972396,0.49358314919474194,0.645007948907248,2.462830520114967,2.598265902087998,0.585345900080577,0.6829125149760686,1.0150511331238474,1.794632226291928,0.9269923289925088
Digestion of dietary lipid,0.8469480629255359,5.192040723709173,0.3012475178972396,0.4275869922774675,0.37339437820794297,0.40698362075531336,4.9175573924866,9.195471204060095,0.6156846984487588,0.38126237603025137,0.6406423698988117,1.5987844617851288
CLEC7A/inflammasome pathway,0.8215573261999733,4.102609852940406,0.3012475178972396,1.7475198996615393,14.858103136974117,10.821673921172625,5.820489871034369,2.354780284869482,0.6384834081699158,5.143034009149336,13.01330178273365,0.7896221713497563
Initial triggering of complement,0.8208402181382736,6.4754554023645134,0.3012475178972396,2.874862268900971,5.129644738003272,3.5094058252656133,8.904203868755891,2.4462323812598097,5.2475875963742435,10.123972324339306,31.473609869311353,0.5957561229762535
Interleukin-18 signaling,0.8079793882821427,11.449156303212256,0.3012475178972396,0.45829847745021296,2.739334159040314,10.141242170190926,11.819935589883217,2.749797936309412,4.9600034020105035,0.7151310890888343,11.085389549426658,0.4503569618465327
rRNA processing in the nucleus and cytosol,0.7952468324926507,3.634964943823635,0.3012475178972396,0.32786912741704255,2.309128613944589,0.9767253966673255,1.0826336571769626,0.5442372582953646,0.36164984986302473,0.3801411141191364,0.33367791993988155,0.6559118373387621
MET activates STAT3,0.7762768088491588,0.31645413375550224,0.3012475178972396,1.829106210741921,2.2500545777571195,1.5165848224826879,0.33374928936195986,0.3390371473226121,1.5051334260599987,5.793218883363441,15.00534885571967,5.278965519611322
Synthesis of 12-eicosatetraenoic acid derivatives,0.7640852184386122,1.67781366125629,0.3012475178972396,0.9950314511814491,3.0928315669290694,1.8785759734008198,1.7082277604801201,2.4569315351151655,1.4019940848202168,1.244617433113535,1.4840750522959698,0.6034289847634202
RUNX3 regulates RUNX1-mediated transcription,0.7640852184386122,8.917639222031584,0.3012475178972396,0.5771676001693348,0.6407165019636456,1.4812845553335159,4.463070606278734,1.1849896538166729,1.127778272909583,2.44106949038048,5.272280963615113,1.0032321109161415
Eukaryotic Translation Elongation,0.763409209365248,0.3048028800745879,0.3012475178972396,1.0100371145239253,1.1305317208386876,0.40838342626679847,1.8145116968127564,2.1123707862109824,1.3877221732911384,0.5793481845090795,0.9649771046957257,0.7712573929260637
MET activates PTK2 signaling,0.761837388541825,0.3863646216169507,0.3012475178972396,2.233420170259836,23.10360087208569,12.348129742719888,8.827086813602204,15.590616337046727,2.497044284312503,4.102114780638367,7.736766111580692,1.2534965003545977
IRF3-mediated induction of type I IFN,0.7602680482203811,2.70032343411911,0.3012475178972396,1.088126910343204,0.32517049350525057,0.5151464256083688,2.2955285463858406,0.9864324530517781,0.48282277705224996,0.9774938571701234,0.8996678948370447,0.4030700361851271
Defective CHSY1 causes TPBS,0.7551326457578043,1.2369153558101675,0.3012475178972396,1.372149715708342,27.338880058810723,16.34780359038155,9.167571201143868,9.029288302226366,1.8436850310824688,4.47991872911209,5.269501082102181,0.37722773277256444
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),0.7473624650060289,0.3194358230818734,0.3012475178972396,0.9775194001077314,1.1365328291614485,0.396774460435672,1.7981909793489605,2.154696120364074,1.3696608319850645,0.6065128673697118,0.9443104385653764,0.8730147818250735
Eicosanoids,0.7466988391661227,13.95336314752075,0.3012475178972396,2.3114105039475037,6.255230595822586,0.5227131653412064,4.349579146321367,3.8465728040658997,3.015969106820238,10.065472067794605,15.410562231232042,1.2568004958390153
RUNX2 regulates genes involved in differentiation of myeloid cells,0.7451523415273406,0.8140313320591065,0.3012475178972396,0.7787484725210561,3.723492715867105,2.1396630316590635,3.6516457260121884,2.9913350027871264,0.6214472916061566,0.5809087485092304,0.6843053914617038,1.9558756421700032
Proton-coupled monocarboxylate transport,0.7409658443367624,2.598203561866793,0.3012475178972396,0.8750772898666077,1.0806061451173328,0.6009122579482042,0.8815923230466216,1.4527757663197496,0.7173421041105738,0.8595915986148667,1.037173496423292,0.6788899198001581
Creation of C4 and C2 activators,0.7350433849522291,4.803727921105749,0.3012475178972396,2.5179584502950187,0.9058854652095077,4.442478173624415,6.435883870350793,2.624074233272646,4.282346673824986,5.931084350711013,21.287218443580546,0.8226947600282508
Peptide chain elongation,0.7285023667170802,0.3226524024564696,0.3012475178972396,0.9379899973955889,1.200221827294743,0.437010300830064,1.8164639635515885,2.0893207867643224,1.3395822772925323,0.539008952446469,0.8693209271405089,0.8450718210086889
Collagen chain trimerization,0.7285023667170802,1.0320676252097192,0.3012475178972396,0.9489436187154476,19.821916961779856,11.871526841289377,8.641503679124172,11.216530904427609,1.3172502824639611,2.9831358478854457,4.624499269287418,0.4326388773908356
"Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways",0.7243798226968351,44.585642276286706,0.3012475178972396,0.4548809603840231,1.6361353384994037,7.841042793956908,18.12661319347878,14.434063471772486,2.6514187720147184,2.5704058783265937,6.028187368700434,1.3396759478818394
Viral mRNA Translation,0.7133835669879706,0.33294822201272145,0.3012475178972396,0.9475383177411689,1.1827127861743114,0.4246501599096085,1.808411954727527,2.0995203097601403,1.304210988609495,0.5493726984355811,0.8701664724873395,0.8279155051770056
PI Metabolism,0.7007960665668129,13.563026935754808,0.3012475178972396,0.3724355325423852,2.8646691069859056,13.18160080141752,15.906937394994195,7.958743826245431,0.3318502128275342,2.5375275198090566,0.4803081731368437,5.4069637125195475
mTORC1-mediated signalling,0.6833265996595093,3.29457027979066,0.3012475178972396,5.414572243260742,12.390828525242613,5.2574635858894,2.810536316586405,4.1500201764117195,1.0075185145496142,3.430528987118256,7.781873400150759,0.5307470000909504
CD22 mediated BCR regulation,0.677712379254144,4.765238119834941,0.3012475178972396,2.1403540413290583,0.45585464959213595,4.565482805050883,6.829425553284854,3.0546847577805667,3.904318820420243,4.836266773242632,18.43918924945674,0.5992155655333451
Biosynthesis of DPAn-6 SPMs,0.6773210343228666,2.7185251265822226,0.3012475178972396,0.45372322874704535,0.6762883387590164,0.5887360663579158,0.7574907532347026,0.329588289989083,0.5101086092316811,1.1036551644418218,0.3117568128348661,0.35057426893774396
Role of LAT2/NTAL/LAB on calcium mobilization,0.6773210343228666,5.3511020637095985,0.3012475178972396,2.0819854280926053,0.4221754204553927,5.180136525988247,6.527873628230021,2.922174254240397,3.5503054558428873,5.1155682715813375,19.022525345982885,0.7332783195324513
Synthesis of IPs in the nucleus,0.6750517145448999,14.320942027307169,0.3012475178972396,0.5632228011366358,0.3738070582241585,1.8018993863328396,6.405699340388382,7.752443778816274,0.6042917215753945,2.2559621237047955,1.324513879505457,0.7995819441073408
Classical antibody-mediated complement activation,0.6686619329317404,4.73513855038646,0.3012475178972396,2.306113813937525,0.6842741507168855,4.436505863112037,6.444476175470118,2.8666504784265587,3.820191021348619,5.390800961308421,19.716856587922678,0.6888966935063718
Selenocysteine synthesis,0.6672353366146048,0.3752644021058061,0.3012475178972396,0.9225165411002932,1.2323241870287678,0.4532502835581585,1.7571719484699495,2.0356255370290905,1.280278535025294,0.526091597852442,0.8636943198965324,0.7980261091487648
Signaling by SCF-KIT,0.6643893993014964,42.49133579554254,0.3012475178972396,1.7311245282931988,0.38019255326627066,6.556013409532975,15.017610665582946,4.992483591938839,2.2785967354937284,4.842263471612978,14.829524111725807,0.9277456519933871
Galactose catabolism,0.6643893993014964,9.976719240704496,0.3012475178972396,2.67831135300963,6.761732122865889,4.090752734156519,2.1315624541285345,7.8484604688942845,1.4902266744692871,0.859050927311054,4.342832716712541,1.9195582610473927
Defects in biotin (Btn) metabolism,0.6629700561841302,0.5949247663210545,0.3012475178972396,1.1073524669344952,2.451577323775021,0.6062560355659605,2.4282701236145443,3.1497301290739506,0.678422720127976,5.041926272437202,8.104372735751932,4.0721951996494985
Interleukin-10 signaling,0.6517908229105005,16.21517979753127,0.3012475178972396,0.4283419084723975,0.4772554850134118,3.4609496576940746,6.659722925450897,1.1346898631206968,1.7340808325033739,2.870166725965027,8.574112946418033,0.6559118373387621
RAS GTPase cycle mutants,0.6495832621860744,11.88415943847778,0.3012475178972396,0.9271181097492555,0.6518284584746494,2.0387885341590852,1.8001319216343235,0.9644592174111004,1.5810341050423904,2.5819101207641495,1.7968833570775653,0.6295771773741096
Regulation of expression of SLITs and ROBOs,0.6425567326741182,1.6875921183229472,0.3012475178972396,0.3186490280618018,2.432522870529124,1.1733492061659783,1.090946450912679,0.8327885340688319,0.5064518303416546,0.4947422917666223,0.3708137481702545,0.40433450783712965
Activation of Matrix Metalloproteinases,0.6411722052046969,0.8433428979320946,0.3012475178972396,0.6350371123919195,13.626443729802247,10.201488562661936,10.065413938033982,12.552125794937071,1.0019359431395745,1.2792632993827457,1.110291448185711,0.40581497325230875
Modulation by Mtb of host immune system,0.6405900840337925,5.182852998449271,0.3012475178972396,0.3100678293324652,0.3576759698587378,0.4105227047071176,1.582741659299455,0.3420962183179321,1.2739842103151944,1.0954358563139102,3.6705770477718365,1.007115086544783
Post-transcriptional silencing by small RNAs,0.6368147213184034,21.507805049231987,0.3012475178972396,1.301728401682164,9.404969605606283,1.0476280661063375,2.4580601046251114,0.3526537683860778,0.5178152712698643,0.33997771589896436,8.990093618823774,4.392158815293776
Selenoamino acid metabolism,0.6298836887368183,0.4351186335000003,0.3012475178972396,0.8995033433576234,1.2737146540326612,0.4689398679787067,1.740679830817825,2.0033682229415914,1.2162055524345572,0.5531681644852463,0.841510726330968,0.7535997263732009
Response of EIF2AK4 (GCN2) to amino acid deficiency,0.6185168591810968,0.39601259687703066,0.3012475178972396,0.8550512883315873,1.3523836673750562,0.5151464256083688,1.6793684689128676,1.9186940950072553,1.1822740197786337,0.4888047484498378,0.7638297228301417,0.7438164164394804
HS-GAG biosynthesis,0.6185168591810968,29.722051573885928,0.3012475178972396,0.37288765701337384,0.7484981921665756,3.2165052598528066,21.940306682267614,18.259336455157836,0.5511618055332433,1.929041417170655,5.717851869931602,2.3566114566003318
Signaling by ROBO receptors,0.6132747000741523,1.9599316154627955,0.3012475178972396,0.3328604580128355,2.3691195653015544,1.2188272681162602,1.013559872638009,0.8168836226037121,0.5160706742687516,0.42945588808734775,0.4347158729661018,0.3690275514485354
Regulation of lipid metabolism by PPARalpha,0.6119381173149261,10.961716590226494,0.3012475178972396,1.252395887532986,2.2186739139622444,0.39469696801325005,2.3401474486032603,0.3802748406549962,1.615816920656184,6.7025289206821395,6.988898964632617,1.503648157609148
FCERI mediated Ca+2 mobilization,0.6051916310349639,7.370366679106928,0.3012475178972396,2.1206631054599296,0.6303883481297914,6.085837662644386,8.393979011257274,3.5854761565526654,3.9770834743590693,5.682669097450757,21.779600852887146,0.6470130928385713
Eukaryotic Translation Termination,0.5969656101075482,0.4009627176624393,0.3012475178972396,0.8744366153371718,1.3060869299159212,0.479279549892749,1.7063513933549757,1.8782136414212849,1.1930582716412363,0.4855448241437932,0.7817900304664372,0.728066199430397
RUNX3 regulates p14-ARF,0.5966366641469967,3.8437258721023633,0.3012475178972396,0.4848574377669905,0.5380678817788304,0.6705920847210578,3.49275986553276,3.9597265611716925,1.3877221732911384,0.539008952446469,0.6406423698988117,0.7398019154493543
Antigen activates B Cell Receptor (BCR) leading to generation of second messengers,0.5966366641469967,11.161023226246876,0.3012475178972396,1.8148288314214078,0.4236665998969748,7.285896832184142,10.1912293460877,4.573547621295062,3.9928468738234724,5.06703328143936,21.50749976261347,0.3459264368645866
Inactivation of CDC42 and RAC1,0.5938045815681707,7.045702258598637,0.3012475178972396,0.8165337150009415,1.2904214326098498,1.373106385760121,2.2639008582648974,2.5186168883071822,0.9029714004853814,1.2501520462344728,0.8559805098243751,1.4667672341444495
Insulin effects increased synthesis of Xylulose-5-Phosphate,0.5909822687062168,14.735025167263574,0.3012475178972396,0.7254485432891482,9.323410170859088,2.8533775137450736,0.9205952281683628,4.254167400228373,0.5483135646539385,1.771006547897525,9.210470304009892,2.8002913239809035
Clathrin-mediated endocytosis,0.5889262024080523,8.029430423977319,0.3012475178972396,0.4290981489902395,0.766383010927454,2.006616240668512,1.220287501768987,0.7318932893798449,0.8488892049715284,2.347003147530311,1.435675849882115,1.1747676870375676
"Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1",0.584077586963492,5.821316370949019,0.3012475178972396,1.1570145019395748,4.8262898896969295,0.5875149169036649,3.0520660642042454,0.42788816534254276,1.1013552605883794,7.383657525373169,10.006944427890524,1.2492528221072152
"Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2",0.584077586963492,5.821316370949019,0.3012475178972396,1.1570145019395748,4.8262898896969295,0.5875149169036649,3.0520660642042454,0.42788816534254276,1.1013552605883794,7.383657525373169,10.006944427890524,1.2492528221072152
Orexin and neuropeptides FF and QRFP bind to their respective receptors,0.5835421773073232,0.8365542589160079,0.3012475178972396,0.6876321854044187,0.3686368496257745,0.3145325614871688,0.5415619236559719,0.5172930251838901,0.6156846984487588,0.3365248474423116,0.3411654855777851,0.4215679502726329
RAF-independent MAPK1/3 activation,0.5792586807527708,0.7513684964663468,0.3012475178972396,0.6187824140533735,1.7520410065691023,2.943770763919788,2.0032320106164616,0.9622276528148012,0.6148009143753308,0.5362772436557858,0.42876219260677245,0.9890394986875141
SDK interactions,0.5720240754251866,0.992845079466321,0.3012475178972396,0.34180874234106345,0.857869536616852,0.4105227047071176,0.6614587378944325,1.0997124773667333,0.3424375539476348,1.0425680094371108,1.6854669373165774,0.7504021445402054
COPI-independent Golgi-to-ER retrograde traffic,0.5692772120928996,3.2859964451800927,0.3012475178972396,1.1570145019395748,1.98738115917331,2.417706388511489,0.5720252922924823,2.23184046752688,0.6194490449821984,0.40613406702932325,0.38350553818995603,1.3082043291415932
Eicosanoid ligand-binding receptors,0.5665400284086125,0.32915535767720533,0.3012475178972396,0.39702841313865367,1.3304156581130024,0.44587535550980867,0.7538540082343078,1.1494743248923653,1.0690470921093,0.3577232224918094,0.9142149334059,0.4030700361851271
Activation of the AP-1 family of transcription factors,0.5557675465873029,4.698494274178134,0.3012475178972396,0.806833641905566,3.2224714789598394,2.837763012979101,1.5960142216130606,1.5234442030606492,0.42795453922212795,2.204901908359174,0.9829566769243857,1.3418974132500134
Major pathway of rRNA processing in the nucleolus and cytosol,0.5422611247782176,2.7810833081873434,0.3012475178972396,0.4348619655393351,1.98985123957892,0.8195211900668575,1.2352863985654166,0.7933967144020323,0.5108649488608429,0.32769685204312815,0.3933788472600071,0.415431111570793
MET promotes cell motility,0.5376925181441915,0.36899481664121875,0.3012475178972396,2.021758964955757,22.431241492389436,12.088751702640554,9.28694057638305,14.908480804791921,2.353034212493316,4.302000208070678,7.47613006768896,1.0452905572288134
FCGR activation,0.5376925181441915,9.788684105976133,0.3012475178972396,1.0521572722475427,0.8537566473812412,9.085112208124894,9.916427239357464,6.16025628280028,2.110623280946906,2.757997458746044,15.53092521894571,0.6678348950006414
Diseases associated with N-glycosylation of proteins,0.5251856125400106,9.19823572182616,0.3012475178972396,4.414936769194647,2.428712186766169,0.6028609288265032,2.3930048655410485,4.844860184006912,1.1853812103804384,0.6978300509106928,2.3124438319669056,2.2660414202205295
Xenobiotics,0.519113040242734,0.572127228955107,0.3012475178972396,0.46814025172833695,0.5801603405825427,0.39469696801325005,0.6614587378944325,0.6920023218078397,0.6062533332102505,0.6380640624110387,1.2467902137445923,0.8165947393552221
Histamine receptors,0.5172433331347976,0.32866728864340883,0.3012475178972396,0.530502181497274,1.871204305886502,1.1684951462275905,0.5567450356741086,0.40893586657265013,0.6957477753673402,1.5043370882594729,1.527508265430912,1.6067316863528072
SUMOylation of immune response proteins,0.5119243733058031,2.214264687212934,0.3012475178972396,0.3119482598058293,0.39126763491999533,0.35390393386563784,4.827042841490068,2.0102914347788854,1.8543299869564245,0.3192390698086411,1.6956163555821884,1.4194576506978331
mRNA 3'-end processing,0.5093868711520341,2.3122383167129446,0.3012475178972396,0.6266498026066749,1.9584683912275216,0.5707031787070682,0.5125729055656147,0.4973258496079806,0.4124510037092349,3.6034216092470084,1.7063754462722942,2.0874730155827437
Regulation of gene expression in early pancreatic precursor cells,0.504807577795854,1.2346446509766078,0.3012475178972396,1.0586792340020492,2.1600204454320218,0.9245447145271976,0.5622184303938431,1.7277895800964462,0.6526148581789587,1.2438868333859798,1.0066220062189226,1.3916019622731965
LDL clearance,0.4989011753999123,11.147094699515883,0.3012475178972396,1.3209433331282792,0.7993594693968358,0.7094611365097314,3.985262332459687,0.7042302769443711,3.5224830575971797,5.78685873652212,7.34048067792675,2.5654477482301874
Defective GCLC causes Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency (HAGGSD),0.4977624172469176,7.4910787756207995,0.3012475178972396,1.2692027826160917,3.9244421572531767,0.41492968342232106,0.5622184303938431,0.7042302769443711,2.1448369642880025,2.2073503901455807,4.435921467710492,0.6514519949425807
Peptide ligand-binding receptors,0.4946032240061449,21.74662837826228,0.3012475178972396,1.625439850995084,2.159311691695006,3.4410728790233707,10.332481871294071,3.1544204284934083,5.2475875963742435,9.716673946147141,20.749523233081824,1.0200846349820563
TLR3-mediated TICAM1-dependent programmed cell death,0.4921294209556798,4.624922648591643,0.3012475178972396,1.8478329562752982,8.599769441800603,2.346619444724051,0.32926477552659283,1.370952865534386,2.744902731489641,4.8710002585235745,12.74877915303706,0.801140098131066
Proton-coupled neutral amino acid transporters,0.4863293212053593,1.4639296726753297,0.3012475178972396,3.594388021981392,3.6420178979654603,1.4648458480103967,0.8585706080339958,0.3187559178285113,1.3121480562851653,6.288520048385996,8.872624647734238,1.8886069467423054
Dissolution of Fibrin Clot,0.48587858591360894,32.02982930403434,0.3012475178972396,0.4760315449125145,1.3028002056745935,6.0457261643806515,11.935038312039705,12.281181983493271,0.5424340294949572,1.5456639383160244,2.0830036792155457,0.5691530193695311
mTOR signalling,0.48410056313405125,0.717101899363024,0.3012475178972396,5.294178090307549,13.686903430262461,7.729320663335865,1.0856329688620259,1.9246633594073002,2.360305090417461,2.8947060299585177,6.8568849977148325,0.37604265514245705
CYP2E1 reactions,0.4744317557516325,0.660236906176817,0.3012475178972396,0.3833598089565042,0.35460408628082607,0.3844484479583766,0.5508774437070737,1.0537157930567078,0.6567698923709699,0.3754898803398825,0.5183650899888392,0.9719682677224324
Axon guidance,0.47203286109914755,6.191620910227522,0.3012475178972396,0.434312448526467,1.1175048282854638,1.8534309069082042,0.47142583056079596,0.585345900080577,0.6310454734273286,0.9861721393898498,2.2593670426974235,0.5341880046376615
TCF7L2 mutants don't bind CTBP,0.4709439787951702,0.3450284760107947,0.3012475178972396,0.3762000107219505,4.177350920717194,1.092582441304835,0.49228298757669575,1.4007192549898606,0.976980413830793,4.680504521228629,6.283901628139109,1.7810754234992265
Serotonin and melatonin biosynthesis,0.46920784065099685,4.904490019465197,0.3012475178972396,0.9663549052208716,1.1623106946471173,0.34854288749463763,1.0856329688620259,1.0209679127863283,0.41476001908203597,2.9860813484104938,2.3485465203536546,0.40992669741809856
Free fatty acids regulate insulin secretion,0.4642469360460095,23.43860727599136,0.3012475178972396,0.9211391420326649,0.6958615386425397,3.711799938020386,8.539307644156258,1.2062794968604307,0.6279075674283442,0.47907781962636875,0.7081681757026269,2.6530252104672334
Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion,0.4625298699024389,19.389901381404304,0.3012475178972396,0.33976514299164823,0.7710038656136616,8.077284421475703,13.595993537498167,0.46470993020796936,0.7859976163695529,1.2424265815657805,1.629108836958991,2.300240590616141
Fatty acyl-CoA biosynthesis,0.4621011658275993,6.324128839378073,0.3012475178972396,2.5584457406105057,1.1451508201018126,1.33472068909197,1.1801442074007853,2.2895163528985654,1.3395822772925323,1.13129146344545,1.7630091317004757,0.43993803938098675
Lectin pathway of complement activation,0.45274740763757854,1.8027529352286473,0.3012475178972396,0.5627134894125099,1.050612732031426,1.2108862530265958,2.236980746144866,0.7810168592215794,0.5595554089274386,1.7582580332623103,3.441908864869624,1.0826779610072905
Leukotriene receptors,0.44854087057515796,0.35372821660480747,0.3012475178972396,0.3762000107219505,1.1224025938674078,0.379510956620501,0.7954176264453616,1.0752553576809538,0.9727631907432991,0.3351106201406713,0.7742853187121539,0.5143696840247538
Citric acid cycle (TCA cycle),0.4462412934288289,3.0908943831602005,0.3012475178972396,0.8137865783881462,0.41920631083648774,0.7134980590044515,1.4928422339695704,2.08565277835543,0.7512223888348104,2.2962869575002465,0.6645608721525048,2.5523720295313557
Cation-coupled Chloride cotransporters,0.4458278380321884,0.7151682974797979,0.3012475178972396,0.6750329126514701,3.6514454455733723,0.6449198798490259,0.5567450356741086,2.0690097556585734,0.36815929970750677,1.4649755655432541,2.3323801166429132,3.5170493119646866
Fatty acids,0.4454148554909984,7.5387064453455235,0.3012475178972396,0.6887437968938371,1.8779408779981484,0.8900630873606517,1.3940410493516495,5.267670351323039,0.39512010055586927,2.1946487112986532,3.824860160625938,0.6231865358564135
Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT),0.44126049811898266,1.8104009964249714,0.3012475178972396,0.6567640176757537,0.8111264062926488,0.3614500688919499,0.5287258569548244,1.000779084985518,0.5223048303633738,0.5812846487611202,0.7508808556628165,0.38763435331791685
Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS),0.4279305403645061,0.48707806926264935,0.3012475178972396,0.6187824140533735,2.6820967955653296,0.4105227047071176,0.518916439296697,2.496680616123866,2.313904332373775,2.914885545473333,11.076646032786616,2.38178454745077
Synthesis of PIPs at the plasma membrane,0.4244980484778477,9.576852614037174,0.3012475178972396,0.5829143171875476,3.4191333254996468,17.175032382007686,17.947496940985847,3.8198045770237683,1.590270071306154,3.607989753396224,1.3386028556266187,1.7837412160210213
Interleukin-37 signaling,0.4228958736649534,50.44113114626299,0.3012475178972396,1.7379326728188094,1.3129049029846085,8.229299520230324,16.299874156358502,8.333065840451109,3.1274623604111054,7.2629706376384116,13.068969606310242,0.34412323304616993
Activation of RAS in B cells,0.4147062820351728,15.093181912220189,0.3012475178972396,1.1125254458334402,0.3563777694833033,2.3228621546048247,3.171067260484791,0.7143514714716499,2.2050848881790728,3.42905354401808,3.845290136133168,1.0281706266823254
Cross-presentation of particulate exogenous antigens (phagosomes),0.4143230045916465,13.801804826936527,0.3012475178972396,0.3562271685112574,0.4800112070243831,6.520307094689295,9.484828721399708,3.059291854730856,2.158858736772331,3.8596432367192888,10.828747905439435,0.472545743839261
"TET1,2,3 and TDG demethylate DNA",0.41275121092135253,5.45294388034689,0.3012475178972396,3.1345939160593197,13.055982944668342,10.800394795781763,2.14532238506916,0.6218343229020977,2.2236904509062563,13.448504358385643,12.261020256764239,1.427892737712835
Metabolism of amino acids and derivatives,0.40411837535005257,1.2518945139167448,0.3012475178972396,0.5151294631327836,1.7198848018684483,0.905838948106704,1.6452990264778649,2.050580929219524,0.7710326903813819,0.5888165252096945,0.9721609981985152,0.718511221096784
LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production,0.40082810982360406,2.1957602198262007,0.3012475178972396,3.377646703824575,3.8360621592846473,2.9306167326045798,0.8892226000930573,0.46682829789479663,2.8048963756231724,4.182692036223214,7.833567898697097,1.6835456981585422
Miscellaneous substrates,0.39640167452207414,0.9189848506259901,0.3012475178972396,0.42265506052669344,0.6762883387590164,0.7840621016032391,0.5440156383785979,1.2581399155354414,0.3043121671636527,0.9059477690494437,1.0780130295588568,1.3125804921283284
SRP-dependent cotranslational protein targeting to membrane,0.39315833556823915,0.5946166798716802,0.3012475178972396,0.5627134894125099,1.7520410065691023,0.6326604145853745,1.5259352859334967,1.4300696396443269,0.9541014535371136,0.3678237251615484,0.5028058195100866,0.5330388682237623
Defective GALNT12 causes colorectal cancer 1 (CRCS1),0.389935018155248,0.6868591728449522,0.3012475178972396,0.3724355325423852,3.9465197775263134,0.38986473113955217,0.5133515919503165,3.2268698972621763,1.643300645761719,4.45647275812264,13.909438803896364,3.214164303800715
Interleukin-27 signaling,0.38900627736856974,20.993292978931713,0.3012475178972396,2.2712275800483255,0.3558956935108349,2.8923329850727786,7.404134295122366,1.0186477953522795,2.712715694319991,1.5850404922648103,11.609641207137761,0.5413003637977509
IkBA variant leads to EDA-ID,0.37793397867997575,1.517531034628735,0.3012475178972396,2.4438118364666335,12.208397566596126,12.813884593740351,6.483703895594208,2.849998917019405,0.7254598113412226,9.040987755791075,13.042201403652365,1.4184214258224812
Signaling by NTRK3 (TRKC),0.3764721834130468,10.831708444401219,0.3012475178972396,0.44911648368230955,0.34132517212480934,3.008061130564675,2.1757065778859355,0.3805061822464913,1.6752911041254324,3.0823425462429968,2.435006444840535,1.4581895728577963
Defective DHDDS causes retinitis pigmentosa 59,0.3744601877816628,8.721121815459394,0.3012475178972396,0.3684920142024474,0.3589783865733596,0.41172043624238946,1.1933544627703996,1.013174037805819,0.7107162581743494,1.2974160123649927,0.3956910012249235,1.2577501004538572
Influenza Viral RNA Transcription and Replication,0.3713528379971271,1.1996244517735586,0.3012475178972396,0.6509752874098682,1.3777138134832,0.48191581850984055,1.655217077455487,1.4751133890017505,0.9404553872564004,0.4358878434591578,0.6489933145041257,0.4854226540954295
MET activates RAP1 and RAC1,0.36553110332883015,0.7796009194512028,0.3012475178972396,1.0521572722475427,3.255603818172,0.7396840480527584,1.2861200329195697,0.448287158515092,1.0075185145496142,0.3886921363900323,1.2850645168177368,1.5895039009081318
Dopamine receptors,0.36356497701005497,11.130334092478398,0.3012475178972396,1.6126201973269638,11.2611455477458,8.924481662256115,10.087657770956852,15.689178542024319,4.203574789199086,3.1357240958128436,3.3043382479147994,4.7205568866071275
Regulation of cortical dendrite branching,0.36323317385744336,17.730355598727687,0.3012475178972396,0.47207421101687974,0.46177426065073246,0.5688185955353305,4.28672430825942,4.892485246550321,0.5622305828978936,1.0102001681781303,0.5461721882368644,1.1893030709404515
Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC),0.3618185789062477,0.5822187475908143,0.3012475178972396,0.5508185942205932,3.0712983419598285,0.3298813485486197,0.4886376859937861,2.7229149394649683,2.1631375644305124,3.223514296681629,11.816798647755219,2.535293078638392
Biosynthesis of maresin-like SPMs,0.3571820015384006,0.32999469240493845,0.3012475178972396,0.3264849136440577,0.41010040102319806,0.8104493909243404,0.8014057886157933,0.8082714789659124,0.3810730560175199,0.36978455537898547,0.31947410354980266,1.1924971704124478
Conjugation of phenylacetate with glutamine,0.3568569819155606,0.3513691548250211,0.3012475178972396,0.6167382511030048,1.8013114250715316,1.060575807889143,2.455963839480036,0.9752934608115079,0.3024990127970974,1.067922833819162,0.7893445506904554,0.950459959732139
Formation of Senescence-Associated Heterochromatin Foci (SAHF),0.3501505557936265,3.9686086579417963,0.3012475178972396,0.3180782864047837,1.7981411382031327,0.5737168970198223,0.4764391685887391,0.9968175192805977,0.6611637224966176,4.0022282878104205,2.089089178075347,0.9119094316232821
Dectin-2 family,0.3466744833438081,15.547080959829428,0.3012475178972396,0.38584221549955144,1.3735866772512455,5.175324273024372,8.024388587345985,0.7397342404129993,0.3372151242944347,4.895893551555934,22.227276723406575,0.6858909229903261
Loss of function of MECP2 in Rett syndrome,0.3423942489099727,14.82339595382407,0.3012475178972396,1.2863872608803626,1.0045583915899186,0.8049980495015491,7.200077428950689,15.66645486635791,1.3075203854227653,3.6219479638702357,0.6843053914617038,1.143365449575229
COPI-mediated anterograde transport,0.3423942489099727,3.1352670533624702,0.3012475178972396,0.4591018983200868,0.9984334093775634,1.914607050728524,0.6569640333924477,1.457812758978161,0.5898295706445534,3.6049439905686036,1.1528854214233397,2.358074486260931
Pervasive developmental disorders,0.34208493913503407,14.820410161339927,0.3012475178972396,1.2846551109009168,1.0045583915899186,0.8040714838969044,7.200077428950689,15.66645486635791,1.3075203854227653,3.6219479638702357,0.6836088957297403,1.1424805258678603
CREB1 phosphorylation through the activation of Adenylate Cyclase,0.34022187875064286,11.360535907720834,0.3012475178972396,0.32786912741704255,0.5847981727554661,0.5530780884949325,6.379705082362883,3.3811223461252666,0.5568907752637388,0.4720378306860794,0.6349707080745367,3.2644655628763855
Assembly of collagen fibrils and other multimeric structures,0.33273338358797877,1.0036480285873037,0.3012475178972396,1.1872706738961671,18.32740124134134,12.627138789392308,10.548600358878264,14.54559698865047,1.6100269162950176,2.9677004159001004,3.8345533525579114,1.1216927892210953
Influenza Life Cycle,0.3293918124823239,1.2391889272350454,0.3012475178972396,0.6144784529571934,1.3468703614900406,0.4707459976641158,1.7122326614493064,1.4490312289514957,0.8602659043592535,0.43415069304301435,0.6663701560991804,0.4621849536433809
Gap-filling DNA repair synthesis and ligation in TC-NER,0.32158137860527347,12.671407427976641,0.3012475178972396,0.4888909769801218,0.8405206673649799,2.3485568062224624,0.46202287220590993,1.7198728721864631,0.43640247420453826,1.0156729383973866,1.7575160723005436,2.832136669997383
mRNA decay by 3' to 5' exoribonuclease,0.3114692544536893,0.784403429320107,0.3012475178972396,4.508565119849125,2.2415813945744536,2.471332133023081,1.260541976592129,0.5515460607471713,0.39981215198884773,1.705262256251242,1.9887052157645038,1.3325642897104046
Role of phospholipids in phagocytosis,0.31043295462449255,8.416831927815638,0.3012475178972396,1.4996143320959336,0.3818798917943665,6.727420434905084,8.524486275218454,5.038501427108886,2.60922421137833,4.160384892010698,17.34488864729991,0.3067793197821917
Influenza Infection,0.31043295462449255,1.245417495713697,0.3012475178972396,0.6177596105596853,1.383305565720488,0.4821103980322095,1.7183750866743912,1.407476146060162,0.8666815860587724,0.4311776017767747,0.6364950911779358,0.46320917857945204
Diseases of carbohydrate metabolism,0.30582403718200907,36.45523819824176,0.3012475178972396,1.3563040954365149,0.359070587151966,2.2421744597714075,1.6612349658822465,5.59971093940411,1.121538862526243,4.581242983465888,3.144586572276484,0.7170725474663662
Breakdown of the nuclear lamina,0.30316735457196187,10.2662726023844,0.3012475178972396,0.434312448526467,1.7524127199786104,0.7970573504316578,0.9529222321770892,0.3562343243272749,0.5145453828662911,3.071719727209723,1.3192248242672007,1.0818287909693787
